id	sid	tid	token	lemma	pos
dti-1311	1	1	untitled	untitled	ADJ
dti-1311	1	2	drug	drug	NOUN
dti-1311	1	3	target	target	NOUN
dti-1311	1	4	insights	insight	NOUN
dti-1311	1	5	2007	2007	NUM
dti-1311	1	6	:	:	PUNCT
dti-1311	1	7	2	2	NUM
dti-1311	1	8	29–38	29–38	NUM
dti-1311	1	9	29	29	NUM
dti-1311	1	10	review	review	NOUN
dti-1311	1	11	correspondence	correspondence	NOUN
dti-1311	1	12	:	:	PUNCT
dti-1311	1	13	omar	omar	PROPN
dti-1311	1	14	m.e	m.e	PROPN
dti-1311	1	15	.	.	PROPN
dti-1311	1	16	abdel	abdel	PROPN
dti-1311	1	17	-	-	PUNCT
dti-1311	1	18	salam	salam	PROPN
dti-1311	1	19	,	,	PUNCT
dti-1311	1	20	email	email	NOUN
dti-1311	1	21	:	:	PUNCT
dti-1311	1	22	omasalam@hotmail.com	omasalam@hotmail.com	X
dti-1311	1	23	please	please	INTJ
dti-1311	1	24	note	note	VERB
dti-1311	1	25	that	that	SCONJ
dti-1311	1	26	this	this	DET
dti-1311	1	27	article	article	NOUN
dti-1311	1	28	may	may	AUX
dti-1311	1	29	not	not	PART
dti-1311	1	30	be	be	AUX
dti-1311	1	31	used	use	VERB
dti-1311	1	32	for	for	ADP
dti-1311	1	33	commercial	commercial	ADJ
dti-1311	1	34	purposes	purpose	NOUN
dti-1311	1	35	.	.	PUNCT
dti-1311	2	1	for	for	ADP
dti-1311	2	2	further	further	ADJ
dti-1311	2	3	information	information	NOUN
dti-1311	2	4	please	please	INTJ
dti-1311	2	5	refer	refer	VERB
dti-1311	2	6	to	to	ADP
dti-1311	2	7	the	the	DET
dti-1311	2	8	copyright	copyright	NOUN
dti-1311	2	9	statement	statement	NOUN
dti-1311	2	10	at	at	ADP
dti-1311	2	11	http://www.la-press.com/copyright.htm	http://www.la-press.com/copyright.htm	PROPN
dti-1311	2	12	modulation	modulation	NOUN
dti-1311	2	13	of	of	ADP
dti-1311	2	14	visceral	visceral	ADJ
dti-1311	2	15	nociception	nociception	NOUN
dti-1311	2	16	,	,	PUNCT
dti-1311	2	17	infl	infl	PROPN
dti-1311	2	18	ammation	ammation	NOUN
dti-1311	2	19	and	and	CCONJ
dti-1311	2	20	gastric	gastric	ADJ
dti-1311	2	21	mucosal	mucosal	NOUN
dti-1311	2	22	injury	injury	NOUN
dti-1311	2	23	by	by	ADP
dti-1311	2	24	cinnarizine	cinnarizine	PROPN
dti-1311	2	25	omar	omar	PROPN
dti-1311	2	26	m.e	m.e	PROPN
dti-1311	2	27	.	.	PROPN
dti-1311	2	28	abdel	abdel	PROPN
dti-1311	2	29	-	-	PUNCT
dti-1311	2	30	salam	salam	PROPN
dti-1311	2	31	department	department	PROPN
dti-1311	2	32	of	of	ADP
dti-1311	2	33	pharmacology	pharmacology	PROPN
dti-1311	2	34	,	,	PUNCT
dti-1311	2	35	national	national	ADJ
dti-1311	2	36	research	research	NOUN
dti-1311	2	37	centre	centre	PROPN
dti-1311	2	38	,	,	PUNCT
dti-1311	2	39	tahrir	tahrir	PROPN
dti-1311	2	40	st	st	AUX
dti-1311	2	41	.	.	PROPN
dti-1311	2	42	,	,	PUNCT
dti-1311	2	43	dokki	dokki	PROPN
dti-1311	2	44	,	,	PUNCT
dti-1311	2	45	cairo	cairo	PROPN
dti-1311	2	46	,	,	PUNCT
dti-1311	2	47	egypt	egypt	PROPN
dti-1311	2	48	.	.	PUNCT
dti-1311	3	1	abstract	abstract	PROPN
dti-1311	3	2	:	:	PUNCT
dti-1311	3	3	the	the	DET
dti-1311	3	4	effect	effect	NOUN
dti-1311	3	5	of	of	ADP
dti-1311	3	6	cinnarizine	cinnarizine	NOUN
dti-1311	3	7	,	,	PUNCT
dti-1311	3	8	a	a	DET
dti-1311	3	9	drug	drug	NOUN
dti-1311	3	10	used	use	VERB
dti-1311	3	11	for	for	ADP
dti-1311	3	12	the	the	DET
dti-1311	3	13	treatment	treatment	NOUN
dti-1311	3	14	of	of	ADP
dti-1311	3	15	vertigo	vertigo	NOUN
dti-1311	3	16	was	be	AUX
dti-1311	3	17	assessed	assess	VERB
dti-1311	3	18	in	in	ADP
dti-1311	3	19	animal	animal	NOUN
dti-1311	3	20	models	model	NOUN
dti-1311	3	21	of	of	ADP
dti-1311	3	22	visceral	visceral	ADJ
dti-1311	3	23	nociception	nociception	NOUN
dti-1311	3	24	,	,	PUNCT
dti-1311	3	25	infl	infl	PROPN
dti-1311	3	26	ammation	ammation	NOUN
dti-1311	3	27	and	and	CCONJ
dti-1311	3	28	gastric	gastric	ADJ
dti-1311	3	29	mucosal	mucosal	NOUN
dti-1311	3	30	injury	injury	NOUN
dti-1311	3	31	.	.	PUNCT
dti-1311	4	1	cinnarizine	cinnarizine	PROPN
dti-1311	4	2	(	(	PUNCT
dti-1311	4	3	1.25–20	1.25–20	NUM
dti-1311	4	4	mg	mg	NUM
dti-1311	4	5	/	/	SYM
dti-1311	4	6	kg	kg	PROPN
dti-1311	4	7	,	,	PUNCT
dti-1311	4	8	s.c	s.c	PROPN
dti-1311	4	9	.	.	PROPN
dti-1311	4	10	)	)	PUNCT
dti-1311	4	11	caused	cause	VERB
dti-1311	4	12	dose	dose	NOUN
dti-1311	4	13	-	-	PUNCT
dti-1311	4	14	dependent	dependent	ADJ
dti-1311	4	15	inhibition	inhibition	NOUN
dti-1311	4	16	of	of	ADP
dti-1311	4	17	the	the	DET
dti-1311	4	18	abdominal	abdominal	ADJ
dti-1311	4	19	constrictions	constriction	NOUN
dti-1311	4	20	evoked	evoke	VERB
dti-1311	4	21	by	by	ADP
dti-1311	4	22	i.p	i.p	PROPN
dti-1311	4	23	.	.	PROPN
dti-1311	4	24	injection	injection	NOUN
dti-1311	4	25	of	of	ADP
dti-1311	4	26	acetic	acetic	ADJ
dti-1311	4	27	acid	acid	NOUN
dti-1311	4	28	by	by	ADP
dti-1311	4	29	38.7–99.4	38.7–99.4	NUM
dti-1311	4	30	%	%	NOUN
dti-1311	4	31	.	.	PUNCT
dti-1311	5	1	this	this	DET
dti-1311	5	2	effect	effect	NOUN
dti-1311	5	3	of	of	ADP
dti-1311	5	4	cinnarizine	cinnarizine	NOUN
dti-1311	5	5	(	(	PUNCT
dti-1311	5	6	2.5	2.5	NUM
dti-1311	5	7	mg	mg	PROPN
dti-1311	5	8	/	/	SYM
dti-1311	5	9	kg	kg	PROPN
dti-1311	5	10	)	)	PUNCT
dti-1311	5	11	was	be	AUX
dti-1311	5	12	unaffected	unaffected	ADJ
dti-1311	5	13	by	by	ADP
dti-1311	5	14	co	co	NOUN
dti-1311	5	15	-	-	NOUN
dti-1311	5	16	administration	administration	NOUN
dti-1311	5	17	of	of	ADP
dti-1311	5	18	the	the	DET
dti-1311	5	19	centrally	centrally	ADV
dti-1311	5	20	acting	act	VERB
dti-1311	5	21	dopamine	dopamine	NOUN
dti-1311	5	22	d2	d2	NOUN
dti-1311	5	23	receptor	receptor	NOUN
dti-1311	5	24	antagonists	antagonist	NOUN
dti-1311	5	25	,	,	PUNCT
dti-1311	5	26	sulpiride	sulpiride	ADV
dti-1311	5	27	,	,	PUNCT
dti-1311	5	28	haloperidol	haloperidol	NOUN
dti-1311	5	29	or	or	CCONJ
dti-1311	5	30	metoclopramide	metoclopramide	NOUN
dti-1311	5	31	,	,	PUNCT
dti-1311	5	32	the	the	DET
dti-1311	5	33	peripherally	peripherally	ADV
dti-1311	5	34	acting	act	VERB
dti-1311	5	35	d2	d2	NOUN
dti-1311	5	36	receptor	receptor	NOUN
dti-1311	5	37	antagonist	antagonist	NOUN
dti-1311	5	38	domperidone	domperidone	NOUN
dti-1311	5	39	,	,	PUNCT
dti-1311	5	40	but	but	CCONJ
dti-1311	5	41	increased	increase	VERB
dti-1311	5	42	by	by	ADP
dti-1311	5	43	the	the	DET
dti-1311	5	44	d2	d2	PROPN
dti-1311	5	45	receptor	receptor	NOUN
dti-1311	5	46	agonist	agonist	NOUN
dti-1311	5	47	bromocryptine	bromocryptine	NOUN
dti-1311	5	48	and	and	CCONJ
dti-1311	5	49	by	by	ADP
dti-1311	5	50	the	the	DET
dti-1311	5	51	non	non	ADJ
dti-1311	5	52	-	-	ADJ
dti-1311	5	53	selective	selective	ADJ
dti-1311	5	54	dopamine	dopamine	NOUN
dti-1311	5	55	receptor	receptor	NOUN
dti-1311	5	56	antagonist	antagonist	NOUN
dti-1311	5	57	chlorpromazine	chlorpromazine	NOUN
dti-1311	5	58	.	.	PUNCT
dti-1311	6	1	the	the	DET
dti-1311	6	2	antinociception	antinociception	NOUN
dti-1311	6	3	caused	cause	VERB
dti-1311	6	4	by	by	ADP
dti-1311	6	5	cinnarizine	cinnarizine	NOUN
dti-1311	6	6	was	be	AUX
dti-1311	6	7	naloxone	naloxone	ADJ
dti-1311	6	8	insenstive	insenstive	ADJ
dti-1311	6	9	,	,	PUNCT
dti-1311	6	10	but	but	CCONJ
dti-1311	6	11	enhanced	enhance	VERB
dti-1311	6	12	by	by	ADP
dti-1311	6	13	propranolol	propranolol	NOUN
dti-1311	6	14	,	,	PUNCT
dti-1311	6	15	atropine	atropine	NOUN
dti-1311	6	16	and	and	CCONJ
dti-1311	6	17	by	by	ADP
dti-1311	6	18	yohimbine	yohimbine	NOUN
dti-1311	6	19	.	.	PUNCT
dti-1311	7	1	the	the	DET
dti-1311	7	2	antinociceptive	antinociceptive	ADJ
dti-1311	7	3	effect	effect	NOUN
dti-1311	7	4	of	of	ADP
dti-1311	7	5	cinnarizine	cinnarizine	NOUN
dti-1311	7	6	was	be	AUX
dti-1311	7	7	prevented	prevent	VERB
dti-1311	7	8	by	by	ADP
dti-1311	7	9	co	co	NOUN
dti-1311	7	10	-	-	NOUN
dti-1311	7	11	treatment	treatment	NOUN
dti-1311	7	12	with	with	ADP
dti-1311	7	13	the	the	DET
dti-1311	7	14	adenosine	adenosine	ADJ
dti-1311	7	15	receptor	receptor	NOUN
dti-1311	7	16	blocker	blocker	NOUN
dti-1311	7	17	theophylline	theophylline	NOUN
dti-1311	7	18	or	or	CCONJ
dti-1311	7	19	by	by	ADP
dti-1311	7	20	the	the	DET
dti-1311	7	21	atp	atp	PROPN
dti-1311	7	22	-	-	PUNCT
dti-1311	7	23	sensitive	sensitive	ADJ
dti-1311	7	24	potassium	potassium	NOUN
dti-1311	7	25	channel	channel	NOUN
dti-1311	7	26	(	(	PUNCT
dti-1311	7	27	katp	katp	X
dti-1311	7	28	)	)	PUNCT
dti-1311	7	29	blocker	blocker	NOUN
dti-1311	7	30	glibenclamide	glibenclamide	NOUN
dti-1311	7	31	.	.	PUNCT
dti-1311	8	1	cinnarizine	cinnarizine	PROPN
dti-1311	8	2	at	at	ADP
dti-1311	8	3	2.5	2.5	NUM
dti-1311	8	4	mg	mg	NOUN
dti-1311	8	5	/	/	SYM
dti-1311	8	6	kg	kg	PROPN
dti-1311	8	7	reversed	reverse	VERB
dti-1311	8	8	the	the	DET
dti-1311	8	9	baclofen	baclofen	NOUN
dti-1311	8	10	-	-	PUNCT
dti-1311	8	11	induced	induce	VERB
dti-1311	8	12	antinociception	antinociception	NOUN
dti-1311	8	13	.	.	PUNCT
dti-1311	9	1	cinnarizine	cinnarizine	PROPN
dti-1311	9	2	at	at	ADP
dti-1311	9	3	2.5	2.5	NUM
dti-1311	9	4	mg	mg	NOUN
dti-1311	9	5	/	/	SYM
dti-1311	9	6	kg	kg	PROPN
dti-1311	9	7	reduced	reduce	VERB
dti-1311	9	8	immobility	immobility	NOUN
dti-1311	9	9	time	time	NOUN
dti-1311	9	10	in	in	ADP
dti-1311	9	11	the	the	DET
dti-1311	9	12	porsolt	porsolt	NOUN
dti-1311	9	13	’s	’s	PART
dti-1311	9	14	forced	force	VERB
dti-1311	9	15	-	-	PUNCT
dti-1311	9	16	swimming	swimming	NOUN
dti-1311	9	17	test	test	NOUN
dti-1311	9	18	by	by	ADP
dti-1311	9	19	24	24	NUM
dti-1311	9	20	%	%	NOUN
dti-1311	9	21	.	.	PUNCT
dti-1311	10	1	cinnarizine	cinnarizine	PROPN
dti-1311	10	2	inhibited	inhibit	VERB
dti-1311	10	3	the	the	DET
dti-1311	10	4	paw	paw	NOUN
dti-1311	10	5	oedema	oedema	NOUN
dti-1311	10	6	response	response	NOUN
dti-1311	10	7	to	to	ADP
dti-1311	10	8	carrageenan	carrageenan	NOUN
dti-1311	10	9	and	and	CCONJ
dti-1311	10	10	reduced	reduce	VERB
dti-1311	10	11	gastric	gastric	ADJ
dti-1311	10	12	mucosal	mucosal	NOUN
dti-1311	10	13	lesions	lesion	NOUN
dti-1311	10	14	caused	cause	VERB
dti-1311	10	15	by	by	ADP
dti-1311	10	16	indomethacin	indomethacin	NOUN
dti-1311	10	17	in	in	ADP
dti-1311	10	18	rats	rat	NOUN
dti-1311	10	19	.	.	PUNCT
dti-1311	11	1	it	it	PRON
dti-1311	11	2	is	be	AUX
dti-1311	11	3	suggested	suggest	VERB
dti-1311	11	4	that	that	SCONJ
dti-1311	11	5	cinnarizine	cinnarizine	PROPN
dti-1311	11	6	exerts	exert	VERB
dti-1311	11	7	anti	anti	ADJ
dti-1311	11	8	-	-	ADJ
dti-1311	11	9	infl	infl	ADJ
dti-1311	11	10	ammatory	ammatory	NOUN
dti-1311	11	11	,	,	PUNCT
dti-1311	11	12	antinociceptive	antinociceptive	ADJ
dti-1311	11	13	and	and	CCONJ
dti-1311	11	14	gastric	gastric	ADJ
dti-1311	11	15	protective	protective	ADJ
dti-1311	11	16	properties	property	NOUN
dti-1311	11	17	.	.	PUNCT
dti-1311	12	1	the	the	DET
dti-1311	12	2	mechanism	mechanism	NOUN
dti-1311	12	3	by	by	ADP
dti-1311	12	4	which	which	PRON
dti-1311	12	5	cinnarizine	cinnarizine	VERB
dti-1311	12	6	modulates	modulate	NOUN
dti-1311	12	7	pain	pain	NOUN
dti-1311	12	8	transmission	transmission	NOUN
dti-1311	12	9	is	be	AUX
dti-1311	12	10	likely	likely	ADJ
dti-1311	12	11	to	to	PART
dti-1311	12	12	involve	involve	VERB
dti-1311	12	13	adenosine	adenosine	NOUN
dti-1311	12	14	receptors	receptor	NOUN
dti-1311	12	15	and	and	CCONJ
dti-1311	12	16	katp	katp	NOUN
dti-1311	12	17	channels	channel	NOUN
dti-1311	12	18	.	.	PUNCT
dti-1311	13	1	keywords	keyword	NOUN
dti-1311	13	2	:	:	PUNCT
dti-1311	13	3	cinnarizine	cinnarizine	NOUN
dti-1311	13	4	,	,	PUNCT
dti-1311	13	5	visceral	visceral	ADJ
dti-1311	13	6	pain	pain	NOUN
dti-1311	13	7	,	,	PUNCT
dti-1311	13	8	infl	infl	PROPN
dti-1311	13	9	ammation	ammation	PROPN
dti-1311	13	10	,	,	PUNCT
dti-1311	13	11	gastric	gastric	ADJ
dti-1311	13	12	mucosa	mucosa	NOUN
dti-1311	13	13	,	,	PUNCT
dti-1311	13	14	rat	rat	NOUN
dti-1311	13	15	,	,	PUNCT
dti-1311	13	16	mice	mouse	NOUN
dti-1311	13	17	.	.	PUNCT
dti-1311	14	1	introduction	introduction	NOUN
dti-1311	14	2	cinnarizine	cinnarizine	NOUN
dti-1311	14	3	(	(	PUNCT
dti-1311	14	4	stugeron	stugeron	NOUN
dti-1311	14	5	r	r	NOUN
dti-1311	14	6	)	)	PUNCT
dti-1311	14	7	is	be	AUX
dti-1311	14	8	a	a	DET
dti-1311	14	9	calcium	calcium	NOUN
dti-1311	14	10	-	-	PUNCT
dti-1311	14	11	channel	channel	NOUN
dti-1311	14	12	blocker	blocker	NOUN
dti-1311	14	13	used	use	VERB
dti-1311	14	14	in	in	ADP
dti-1311	14	15	treatment	treatment	NOUN
dti-1311	14	16	of	of	ADP
dti-1311	14	17	vertiginous	vertiginous	ADJ
dti-1311	14	18	disorders	disorder	NOUN
dti-1311	14	19	(	(	PUNCT
dti-1311	14	20	pianese	pianese	PROPN
dti-1311	14	21	et	et	PROPN
dti-1311	14	22	al	al	PROPN
dti-1311	14	23	.	.	PROPN
dti-1311	14	24	2002	2002	NUM
dti-1311	14	25	)	)	PUNCT
dti-1311	14	26	and	and	CCONJ
dti-1311	14	27	migraine	migraine	NOUN
dti-1311	14	28	(	(	PUNCT
dti-1311	14	29	mansooreh	mansooreh	NOUN
dti-1311	14	30	et	et	PROPN
dti-1311	14	31	al	al	PROPN
dti-1311	14	32	.	.	PROPN
dti-1311	14	33	2006	2006	NUM
dti-1311	14	34	)	)	PUNCT
dti-1311	14	35	.	.	PUNCT
dti-1311	15	1	among	among	ADP
dti-1311	15	2	its	its	PRON
dti-1311	15	3	most	most	ADV
dti-1311	15	4	rare	rare	ADJ
dti-1311	15	5	adverse	adverse	ADJ
dti-1311	15	6	effects	effect	NOUN
dti-1311	15	7	are	be	AUX
dti-1311	15	8	extrapyramidal	extrapyramidal	ADJ
dti-1311	15	9	symptoms	symptom	NOUN
dti-1311	15	10	and	and	CCONJ
dti-1311	15	11	depression	depression	NOUN
dti-1311	15	12	;	;	PUNCT
dti-1311	15	13	these	these	DET
dti-1311	15	14	effects	effect	NOUN
dti-1311	15	15	can	can	AUX
dti-1311	15	16	persist	persist	VERB
dti-1311	15	17	during	during	ADP
dti-1311	15	18	weeks	week	NOUN
dti-1311	15	19	,	,	PUNCT
dti-1311	15	20	months	month	NOUN
dti-1311	15	21	or	or	CCONJ
dti-1311	15	22	years	year	NOUN
dti-1311	15	23	after	after	ADP
dti-1311	15	24	the	the	DET
dti-1311	15	25	withdrawal	withdrawal	NOUN
dti-1311	15	26	of	of	ADP
dti-1311	15	27	the	the	DET
dti-1311	15	28	drug	drug	NOUN
dti-1311	15	29	(	(	PUNCT
dti-1311	15	30	negrotti	negrotti	PROPN
dti-1311	15	31	and	and	CCONJ
dti-1311	15	32	calzetti	calzetti	ADJ
dti-1311	15	33	,	,	PUNCT
dti-1311	15	34	1997	1997	NUM
dti-1311	15	35	;	;	PUNCT
dti-1311	15	36	fabiani	fabiani	PROPN
dti-1311	15	37	et	et	PROPN
dti-1311	15	38	al	al	PROPN
dti-1311	15	39	.	.	PROPN
dti-1311	15	40	2004	2004	NUM
dti-1311	15	41	;	;	PUNCT
dti-1311	15	42	teive	teive	VERB
dti-1311	15	43	et	et	PROPN
dti-1311	15	44	al	al	PROPN
dti-1311	15	45	.	.	PROPN
dti-1311	15	46	2004	2004	NUM
dti-1311	15	47	;	;	PUNCT
dti-1311	15	48	hirose	hirose	NOUN
dti-1311	15	49	,	,	PUNCT
dti-1311	15	50	2006	2006	NUM
dti-1311	15	51	)	)	PUNCT
dti-1311	15	52	and	and	CCONJ
dti-1311	15	53	can	can	AUX
dti-1311	15	54	be	be	AUX
dti-1311	15	55	explained	explain	VERB
dti-1311	15	56	by	by	ADP
dti-1311	15	57	the	the	DET
dti-1311	15	58	inhibition	inhibition	NOUN
dti-1311	15	59	of	of	ADP
dti-1311	15	60	the	the	DET
dti-1311	15	61	passage	passage	NOUN
dti-1311	15	62	of	of	ADP
dti-1311	15	63	calcium	calcium	NOUN
dti-1311	15	64	in	in	ADP
dti-1311	15	65	striatal	striatal	ADJ
dti-1311	15	66	neurons	neuron	NOUN
dti-1311	15	67	and	and	CCONJ
dti-1311	15	68	a	a	DET
dti-1311	15	69	direct	direct	ADJ
dti-1311	15	70	anti	anti	ADJ
dti-1311	15	71	-	-	ADJ
dti-1311	15	72	dopaminergic	dopaminergic	ADJ
dti-1311	15	73	features	feature	NOUN
dti-1311	15	74	(	(	PUNCT
dti-1311	15	75	dopamine	dopamine	NOUN
dti-1311	15	76	d1	d1	NOUN
dti-1311	15	77	and	and	CCONJ
dti-1311	15	78	d2	d2	PROPN
dti-1311	15	79	receptor	receptor	NOUN
dti-1311	15	80	blockade	blockade	NOUN
dti-1311	15	81	)	)	PUNCT
dti-1311	15	82	because	because	SCONJ
dti-1311	15	83	of	of	ADP
dti-1311	15	84	the	the	DET
dti-1311	15	85	similar	similar	ADJ
dti-1311	15	86	chemical	chemical	NOUN
dti-1311	15	87	structure	structure	NOUN
dti-1311	15	88	with	with	ADP
dti-1311	15	89	neuroleptic	neuroleptic	ADJ
dti-1311	15	90	drugs	drug	NOUN
dti-1311	15	91	(	(	PUNCT
dti-1311	15	92	reiriz	reiriz	NOUN
dti-1311	15	93	et	et	PROPN
dti-1311	15	94	al	al	PROPN
dti-1311	15	95	.	.	PROPN
dti-1311	15	96	1994	1994	NUM
dti-1311	15	97	;	;	PUNCT
dti-1311	15	98	brucke	brucke	NOUN
dti-1311	15	99	et	et	PROPN
dti-1311	15	100	al	al	PROPN
dti-1311	15	101	.	.	PROPN
dti-1311	15	102	1995	1995	NUM
dti-1311	15	103	)	)	PUNCT
dti-1311	15	104	with	with	ADP
dti-1311	15	105	more	more	ADJ
dti-1311	15	106	than	than	ADP
dti-1311	15	107	80	80	NUM
dti-1311	15	108	%	%	NOUN
dti-1311	15	109	d2	d2	NOUN
dti-1311	15	110	-	-	PUNCT
dti-1311	15	111	receptor	receptor	NOUN
dti-1311	15	112	occupancy	occupancy	NOUN
dti-1311	15	113	being	be	AUX
dti-1311	15	114	required	require	VERB
dti-1311	15	115	for	for	ADP
dti-1311	15	116	drug	drug	NOUN
dti-1311	15	117	-	-	PUNCT
dti-1311	15	118	induced	induce	VERB
dti-1311	15	119	parkinsonism	parkinsonism	NOUN
dti-1311	15	120	to	to	PART
dti-1311	15	121	appear	appear	VERB
dti-1311	15	122	(	(	PUNCT
dti-1311	15	123	hirose	hirose	NOUN
dti-1311	15	124	,	,	PUNCT
dti-1311	15	125	2006	2006	NUM
dti-1311	15	126	)	)	PUNCT
dti-1311	15	127	.	.	PUNCT
dti-1311	16	1	cinnarizine	cinnarizine	PROPN
dti-1311	16	2	has	have	AUX
dti-1311	16	3	been	be	AUX
dti-1311	16	4	reported	report	VERB
dti-1311	16	5	to	to	PART
dti-1311	16	6	possess	possess	VERB
dti-1311	16	7	anti	anti	ADJ
dti-1311	16	8	-	-	ADJ
dti-1311	16	9	infl	infl	ADJ
dti-1311	16	10	ammatory	ammatory	NOUN
dti-1311	16	11	and	and	CCONJ
dti-1311	16	12	pain	pain	NOUN
dti-1311	16	13	alleviating	alleviate	VERB
dti-1311	16	14	properties	property	NOUN
dti-1311	16	15	.	.	PUNCT
dti-1311	17	1	cinnarizine	cinnarizine	PROPN
dti-1311	17	2	inhibited	inhibit	VERB
dti-1311	17	3	the	the	DET
dti-1311	17	4	ear	ear	NOUN
dti-1311	17	5	oedema	oedema	NOUN
dti-1311	17	6	induced	induce	VERB
dti-1311	17	7	by	by	ADP
dti-1311	17	8	croton	croton	PROPN
dti-1311	17	9	oil	oil	NOUN
dti-1311	17	10	or	or	CCONJ
dti-1311	17	11	capsaicin	capsaicin	NOUN
dti-1311	17	12	in	in	ADP
dti-1311	17	13	mice	mouse	NOUN
dti-1311	17	14	and	and	CCONJ
dti-1311	17	15	reduced	reduced	ADJ
dti-1311	17	16	oedema	oedema	NOUN
dti-1311	17	17	induced	induce	VERB
dti-1311	17	18	in	in	ADP
dti-1311	17	19	the	the	DET
dti-1311	17	20	rat	rat	NOUN
dti-1311	17	21	hind	hind	NOUN
dti-1311	17	22	paw	paw	NOUN
dti-1311	17	23	by	by	ADP
dti-1311	17	24	subplantar	subplantar	ADJ
dti-1311	17	25	injection	injection	NOUN
dti-1311	17	26	of	of	ADP
dti-1311	17	27	carrageenan	carrageenan	NOUN
dti-1311	17	28	(	(	PUNCT
dti-1311	17	29	blazso	blazso	PROPN
dti-1311	17	30	et	et	PROPN
dti-1311	17	31	al	al	PROPN
dti-1311	17	32	.	.	PROPN
dti-1311	17	33	1999	1999	NUM
dti-1311	17	34	)	)	PUNCT
dti-1311	17	35	.	.	PUNCT
dti-1311	18	1	intraperitoneal	intraperitoneal	ADJ
dti-1311	18	2	or	or	CCONJ
dti-1311	18	3	intrathecal	intrathecal	ADJ
dti-1311	18	4	cinnarizine	cinnarizine	NOUN
dti-1311	18	5	caused	cause	VERB
dti-1311	18	6	a	a	DET
dti-1311	18	7	dose	dose	NOUN
dti-1311	18	8	-	-	PUNCT
dti-1311	18	9	dependent	dependent	ADJ
dti-1311	18	10	antinociception	antinociception	NOUN
dti-1311	18	11	in	in	ADP
dti-1311	18	12	the	the	DET
dti-1311	18	13	rat	rat	NOUN
dti-1311	18	14	tail	tail	NOUN
dti-1311	18	15	-	-	PUNCT
dti-1311	18	16	fl	fl	NOUN
dti-1311	18	17	ick	ick	NOUN
dti-1311	18	18	test	test	NOUN
dti-1311	18	19	(	(	PUNCT
dti-1311	18	20	rego	rego	PROPN
dti-1311	18	21	et	et	PROPN
dti-1311	18	22	al	al	PROPN
dti-1311	18	23	.	.	PROPN
dti-1311	18	24	1990	1990	NUM
dti-1311	18	25	)	)	PUNCT
dti-1311	18	26	.	.	PUNCT
dti-1311	19	1	cinnarizine	cinnarizine	PROPN
dti-1311	19	2	administered	administer	VERB
dti-1311	19	3	via	via	ADP
dti-1311	19	4	subcutaneous	subcutaneous	ADJ
dti-1311	19	5	(	(	PUNCT
dti-1311	19	6	del	del	PROPN
dti-1311	19	7	pozo	pozo	PROPN
dti-1311	19	8	et	et	PROPN
dti-1311	19	9	al	al	PROPN
dti-1311	19	10	.	.	PROPN
dti-1311	19	11	1987	1987	NUM
dti-1311	19	12	)	)	PUNCT
dti-1311	19	13	or	or	CCONJ
dti-1311	19	14	intracerebroventricular	intracerebroventricular	ADJ
dti-1311	19	15	route	route	NOUN
dti-1311	19	16	(	(	PUNCT
dti-1311	19	17	miranda	miranda	PROPN
dti-1311	19	18	et	et	PROPN
dti-1311	19	19	al	al	PROPN
dti-1311	19	20	.	.	PROPN
dti-1311	19	21	1993	1993	NUM
dti-1311	19	22	)	)	PUNCT
dti-1311	19	23	produced	produce	VERB
dti-1311	19	24	a	a	DET
dti-1311	19	25	dose	dose	NOUN
dti-1311	19	26	-	-	PUNCT
dti-1311	19	27	dependent	dependent	ADJ
dti-1311	19	28	antinociception	antinociception	NOUN
dti-1311	19	29	in	in	ADP
dti-1311	19	30	acetic	acetic	ADJ
dti-1311	19	31	acid	acid	NOUN
dti-1311	19	32	writhing	writhe	VERB
dti-1311	19	33	test	test	NOUN
dti-1311	19	34	in	in	ADP
dti-1311	19	35	mice	mouse	NOUN
dti-1311	19	36	.	.	PUNCT
dti-1311	20	1	this	this	DET
dti-1311	20	2	effect	effect	NOUN
dti-1311	20	3	is	be	AUX
dti-1311	20	4	naloxone	naloxone	ADJ
dti-1311	20	5	insensitive	insensitive	ADJ
dti-1311	20	6	(	(	PUNCT
dti-1311	20	7	miranda	miranda	PROPN
dti-1311	20	8	et	et	PROPN
dti-1311	20	9	al	al	PROPN
dti-1311	20	10	.	.	PROPN
dti-1311	20	11	1993	1993	NUM
dti-1311	20	12	)	)	PUNCT
dti-1311	20	13	.	.	PUNCT
dti-1311	21	1	cinnarizine	cinnarizine	NOUN
dti-1311	21	2	(	(	PUNCT
dti-1311	21	3	20	20	NUM
dti-1311	21	4	mg	mg	NUM
dti-1311	21	5	/	/	SYM
dti-1311	21	6	kg	kg	PROPN
dti-1311	21	7	)	)	PUNCT
dti-1311	21	8	,	,	PUNCT
dti-1311	21	9	inhibited	inhibit	VERB
dti-1311	21	10	100	100	NUM
dti-1311	21	11	%	%	NOUN
dti-1311	21	12	ethanol	ethanol	NOUN
dti-1311	21	13	-	-	PUNCT
dti-1311	21	14	induced	induce	VERB
dti-1311	21	15	lesion	lesion	NOUN
dti-1311	21	16	formation	formation	NOUN
dti-1311	21	17	by	by	ADP
dti-1311	21	18	71	71	NUM
dti-1311	21	19	%	%	NOUN
dti-1311	21	20	(	(	PUNCT
dti-1311	21	21	lozeva	lozeva	PROPN
dti-1311	21	22	et	et	PROPN
dti-1311	21	23	al	al	PROPN
dti-1311	21	24	.	.	PROPN
dti-1311	21	25	1994	1994	NUM
dti-1311	21	26	)	)	PUNCT
dti-1311	21	27	.	.	PUNCT
dti-1311	22	1	the	the	DET
dti-1311	22	2	present	present	ADJ
dti-1311	22	3	study	study	NOUN
dti-1311	22	4	aimed	aim	VERB
dti-1311	22	5	to	to	PART
dti-1311	22	6	investigate	investigate	VERB
dti-1311	22	7	the	the	DET
dti-1311	22	8	effects	effect	NOUN
dti-1311	22	9	of	of	ADP
dti-1311	22	10	cinnarizine	cinnarizine	NOUN
dti-1311	22	11	on	on	ADP
dti-1311	22	12	visceral	visceral	ADJ
dti-1311	22	13	pain	pain	NOUN
dti-1311	22	14	caused	cause	VERB
dti-1311	22	15	by	by	ADP
dti-1311	22	16	intraperitoneal	intraperitoneal	ADJ
dti-1311	22	17	injection	injection	NOUN
dti-1311	22	18	of	of	ADP
dti-1311	22	19	acetic	acetic	ADJ
dti-1311	22	20	acid	acid	NOUN
dti-1311	22	21	in	in	ADP
dti-1311	22	22	mice	mouse	NOUN
dti-1311	22	23	,	,	PUNCT
dti-1311	22	24	a	a	DET
dti-1311	22	25	model	model	NOUN
dti-1311	22	26	of	of	ADP
dti-1311	22	27	visceral	visceral	PROPN
dti-1311	22	28	infl	infl	PROPN
dti-1311	22	29	ammatory	ammatory	NOUN
dti-1311	22	30	pain	pain	NOUN
dti-1311	22	31	(	(	PUNCT
dti-1311	22	32	chemonociception	chemonociception	NOUN
dti-1311	22	33	)	)	PUNCT
dti-1311	22	34	and	and	CCONJ
dti-1311	22	35	to	to	PART
dti-1311	22	36	pharmacologically	pharmacologically	ADV
dti-1311	22	37	characterize	characterize	VERB
dti-1311	22	38	and	and	CCONJ
dti-1311	22	39	investigate	investigate	VERB
dti-1311	22	40	the	the	DET
dti-1311	22	41	possible	possible	ADJ
dti-1311	22	42	neural	neural	ADJ
dti-1311	22	43	pathways	pathway	NOUN
dti-1311	22	44	involved	involve	VERB
dti-1311	22	45	in	in	ADP
dti-1311	22	46	its	its	PRON
dti-1311	22	47	analgesic	analgesic	ADJ
dti-1311	22	48	effect	effect	NOUN
dti-1311	22	49	.	.	PUNCT
dti-1311	23	1	in	in	ADP
dti-1311	23	2	addition	addition	NOUN
dti-1311	23	3	,	,	PUNCT
dti-1311	23	4	the	the	DET
dti-1311	23	5	behavioral	behavioral	ADJ
dti-1311	23	6	effect	effect	NOUN
dti-1311	23	7	of	of	ADP
dti-1311	23	8	cinnarizine	cinnarizine	NOUN
dti-1311	23	9	on	on	ADP
dti-1311	23	10	locomotor	locomotor	NOUN
dti-1311	23	11	activity	activity	NOUN
dti-1311	23	12	and	and	CCONJ
dti-1311	23	13	on	on	ADP
dti-1311	23	14	immobility	immobility	NOUN
dti-1311	23	15	time	time	NOUN
dti-1311	23	16	in	in	ADP
dti-1311	23	17	porsolt	porsolt	NOUN
dti-1311	23	18	’s	’s	PART
dti-1311	23	19	forced	force	VERB
dti-1311	23	20	-	-	PUNCT
dti-1311	23	21	swimming	swimming	NOUN
dti-1311	23	22	test	test	NOUN
dti-1311	23	23	,	,	PUNCT
dti-1311	23	24	its	its	PRON
dti-1311	23	25	effect	effect	NOUN
dti-1311	23	26	on	on	ADP
dti-1311	23	27	acute	acute	PROPN
dti-1311	23	28	infl	infl	PROPN
dti-1311	23	29	ammation	ammation	NOUN
dti-1311	23	30	caused	cause	VERB
dti-1311	23	31	by	by	ADP
dti-1311	23	32	subplantar	subplantar	NOUN
dti-1311	23	33	carrageenan	carrageenan	NOUN
dti-1311	23	34	and	and	CCONJ
dti-1311	23	35	the	the	DET
dti-1311	23	36	effects	effect	NOUN
dti-1311	23	37	of	of	ADP
dti-1311	23	38	the	the	DET
dti-1311	23	39	drug	drug	NOUN
dti-1311	23	40	on	on	ADP
dti-1311	23	41	gastric	gastric	ADJ
dti-1311	23	42	mucosal	mucosal	NOUN
dti-1311	23	43	damage	damage	NOUN
dti-1311	23	44	caused	cause	VERB
dti-1311	23	45	by	by	ADP
dti-1311	23	46	indomethacin	indomethacin	NOUN
dti-1311	23	47	was	be	AUX
dti-1311	23	48	studied	study	VERB
dti-1311	23	49	.	.	PUNCT
dti-1311	24	1	drug	drug	NOUN
dti-1311	24	2	target	target	NOUN
dti-1311	24	3	insights	insight	NOUN
dti-1311	24	4	2007	2007	NUM
dti-1311	24	5	:	:	PUNCT
dti-1311	24	6	230	230	NUM
dti-1311	24	7	omar	omar	PROPN
dti-1311	24	8	m.e	m.e	PROPN
dti-1311	24	9	.	.	PROPN
dti-1311	24	10	abdel	abdel	PROPN
dti-1311	24	11	-	-	PUNCT
dti-1311	24	12	salam	salam	PROPN
dti-1311	24	13	materials	material	NOUN
dti-1311	24	14	and	and	CCONJ
dti-1311	24	15	methods	method	NOUN
dti-1311	24	16	animals	animal	NOUN
dti-1311	24	17	sprague	sprague	NOUN
dti-1311	24	18	-	-	PUNCT
dti-1311	24	19	dawley	dawley	NOUN
dti-1311	24	20	strain	strain	NOUN
dti-1311	24	21	rats	rat	NOUN
dti-1311	24	22	weighing	weigh	VERB
dti-1311	24	23	120–130	120–130	NUM
dti-1311	24	24	g	g	NOUN
dti-1311	24	25	of	of	ADP
dti-1311	24	26	body	body	NOUN
dti-1311	24	27	weight	weight	NOUN
dti-1311	24	28	or	or	CCONJ
dti-1311	24	29	swiss	swiss	ADJ
dti-1311	24	30	male	male	NOUN
dti-1311	24	31	albino	albino	NOUN
dti-1311	24	32	mice	mouse	NOUN
dti-1311	24	33	20–22	20–22	NUM
dti-1311	24	34	g	g	NOUN
dti-1311	24	35	of	of	ADP
dti-1311	24	36	body	body	NOUN
dti-1311	24	37	weight	weight	NOUN
dti-1311	24	38	were	be	AUX
dti-1311	24	39	used	use	VERB
dti-1311	24	40	(	(	PUNCT
dti-1311	24	41	national	national	ADJ
dti-1311	24	42	research	research	NOUN
dti-1311	24	43	centre	centre	NOUN
dti-1311	24	44	,	,	PUNCT
dti-1311	24	45	cairo	cairo	PROPN
dti-1311	24	46	)	)	PUNCT
dti-1311	24	47	.	.	PUNCT
dti-1311	25	1	standard	standard	ADJ
dti-1311	25	2	laboratory	laboratory	NOUN
dti-1311	25	3	food	food	NOUN
dti-1311	25	4	and	and	CCONJ
dti-1311	25	5	water	water	NOUN
dti-1311	25	6	were	be	AUX
dti-1311	25	7	provided	provide	VERB
dti-1311	25	8	ad	ad	NOUN
dti-1311	25	9	libitum	libitum	X
dti-1311	25	10	.	.	PUNCT
dti-1311	26	1	animal	animal	NOUN
dti-1311	26	2	procedures	procedure	NOUN
dti-1311	26	3	were	be	AUX
dti-1311	26	4	performed	perform	VERB
dti-1311	26	5	in	in	ADP
dti-1311	26	6	accordance	accordance	NOUN
dti-1311	26	7	with	with	ADP
dti-1311	26	8	the	the	DET
dti-1311	26	9	ethics	ethic	NOUN
dti-1311	26	10	committee	committee	PROPN
dti-1311	26	11	of	of	ADP
dti-1311	26	12	the	the	DET
dti-1311	26	13	national	national	PROPN
dti-1311	26	14	research	research	PROPN
dti-1311	26	15	centre	centre	NOUN
dti-1311	26	16	and	and	CCONJ
dti-1311	26	17	followed	follow	VERB
dti-1311	26	18	the	the	DET
dti-1311	26	19	recommendations	recommendation	NOUN
dti-1311	26	20	of	of	ADP
dti-1311	26	21	the	the	DET
dti-1311	26	22	national	national	PROPN
dti-1311	26	23	institutes	institutes	PROPN
dti-1311	26	24	of	of	ADP
dti-1311	26	25	health	health	NOUN
dti-1311	26	26	guide	guide	NOUN
dti-1311	26	27	for	for	ADP
dti-1311	26	28	care	care	NOUN
dti-1311	26	29	and	and	CCONJ
dti-1311	26	30	use	use	NOUN
dti-1311	26	31	of	of	ADP
dti-1311	26	32	laboratory	laboratory	NOUN
dti-1311	26	33	animals	animal	NOUN
dti-1311	26	34	(	(	PUNCT
dti-1311	26	35	publication	publication	NOUN
dti-1311	26	36	no	no	INTJ
dti-1311	26	37	.	.	PUNCT
dti-1311	27	1	85–23	85–23	NUM
dti-1311	27	2	,	,	PUNCT
dti-1311	27	3	revised	revise	VERB
dti-1311	27	4	1985	1985	NUM
dti-1311	27	5	)	)	PUNCT
dti-1311	27	6	.	.	PUNCT
dti-1311	28	1	equal	equal	ADJ
dti-1311	28	2	groups	group	NOUN
dti-1311	28	3	of	of	ADP
dti-1311	28	4	6	6	NUM
dti-1311	28	5	mice	mouse	NOUN
dti-1311	28	6	each	each	PRON
dti-1311	28	7	were	be	AUX
dti-1311	28	8	used	use	VERB
dti-1311	28	9	in	in	ADP
dti-1311	28	10	all	all	DET
dti-1311	28	11	experiments	experiment	NOUN
dti-1311	28	12	.	.	PUNCT
dti-1311	29	1	the	the	DET
dti-1311	29	2	doses	dose	NOUN
dti-1311	29	3	of	of	ADP
dti-1311	29	4	cinnarizine	cinnarizine	NOUN
dti-1311	29	5	used	use	VERB
dti-1311	29	6	in	in	ADP
dti-1311	29	7	the	the	DET
dti-1311	29	8	study	study	NOUN
dti-1311	29	9	were	be	AUX
dti-1311	29	10	based	base	VERB
dti-1311	29	11	upon	upon	SCONJ
dti-1311	29	12	the	the	DET
dti-1311	29	13	human	human	NOUN
dti-1311	29	14	dose	dose	NOUN
dti-1311	29	15	after	after	ADP
dti-1311	29	16	conversion	conversion	NOUN
dti-1311	29	17	to	to	ADP
dti-1311	29	18	that	that	PRON
dti-1311	29	19	of	of	ADP
dti-1311	29	20	rat	rat	NOUN
dti-1311	29	21	according	accord	VERB
dti-1311	29	22	to	to	ADP
dti-1311	29	23	paget	paget	PROPN
dti-1311	29	24	and	and	CCONJ
dti-1311	29	25	barnes	barnes	PROPN
dti-1311	29	26	(	(	PUNCT
dti-1311	29	27	1964	1964	NUM
dti-1311	29	28	)	)	PUNCT
dti-1311	29	29	.	.	PUNCT
dti-1311	30	1	drugs	drug	NOUN
dti-1311	30	2	cinnarizine	cinnarizine	PROPN
dti-1311	30	3	(	(	PUNCT
dti-1311	30	4	arab	arab	PROPN
dti-1311	30	5	drug	drug	PROPN
dti-1311	30	6	co.	co.	PROPN
dti-1311	30	7	,	,	PUNCT
dti-1311	30	8	cairo	cairo	PROPN
dti-1311	30	9	)	)	PUNCT
dti-1311	30	10	,	,	PUNCT
dti-1311	30	11	guanethidine	guanethidine	NOUN
dti-1311	30	12	,	,	PUNCT
dti-1311	30	13	propranolol	propranolol	NOUN
dti-1311	30	14	hydrochloride	hydrochloride	NOUN
dti-1311	30	15	,	,	PUNCT
dti-1311	30	16	yohimbine	yohimbine	NOUN
dti-1311	30	17	hydrochloride	hydrochloride	NOUN
dti-1311	30	18	,	,	PUNCT
dti-1311	30	19	naloxone	naloxone	ADJ
dti-1311	30	20	hydrochloride	hydrochloride	NOUN
dti-1311	30	21	(	(	PUNCT
dti-1311	30	22	sigma	sigma	PROPN
dti-1311	30	23	,	,	PUNCT
dti-1311	30	24	st	st	PROPN
dti-1311	30	25	.	.	PROPN
dti-1311	30	26	louis	louis	PROPN
dti-1311	30	27	,	,	PUNCT
dti-1311	30	28	u.s.a	u.s.a	NOUN
dti-1311	30	29	.	.	PUNCT
dti-1311	30	30	)	)	PUNCT
dti-1311	30	31	,	,	PUNCT
dti-1311	30	32	bromocryptine	bromocryptine	NOUN
dti-1311	30	33	(	(	PUNCT
dti-1311	30	34	novartis	novartis	NOUN
dti-1311	30	35	pharma	pharma	PROPN
dti-1311	30	36	,	,	PUNCT
dti-1311	30	37	cairo	cairo	PROPN
dti-1311	30	38	)	)	PUNCT
dti-1311	30	39	,	,	PUNCT
dti-1311	30	40	haloperidol	haloperidol	NOUN
dti-1311	30	41	,	,	PUNCT
dti-1311	30	42	indomethacin	indomethacin	PROPN
dti-1311	30	43	(	(	PUNCT
dti-1311	30	44	kahira	kahira	PROPN
dti-1311	30	45	pharm	pharm	PROPN
dti-1311	30	46	&	&	CCONJ
dti-1311	30	47	chem	chem	PROPN
dti-1311	30	48	.	.	PUNCT
dti-1311	31	1	ind	ind	PROPN
dti-1311	31	2	co.	co.	PROPN
dti-1311	31	3	,	,	PUNCT
dti-1311	31	4	cairo	cairo	PROPN
dti-1311	31	5	)	)	PUNCT
dti-1311	31	6	,	,	PUNCT
dti-1311	31	7	glibenclamide	glibenclamide	NOUN
dti-1311	31	8	(	(	PUNCT
dti-1311	31	9	hoechst	hoechst	PROPN
dti-1311	31	10	orient	orient	PROPN
dti-1311	31	11	,	,	PUNCT
dti-1311	31	12	cairo	cairo	PROPN
dti-1311	31	13	)	)	PUNCT
dti-1311	31	14	,	,	PUNCT
dti-1311	31	15	atropine	atropine	NOUN
dti-1311	31	16	sulphate	sulphate	NOUN
dti-1311	31	17	,	,	PUNCT
dti-1311	31	18	baclofen	baclofen	PROPN
dti-1311	31	19	(	(	PUNCT
dti-1311	31	20	misr	misr	PROPN
dti-1311	31	21	pharm	pharm	PROPN
dti-1311	31	22	co.	co.	PROPN
dti-1311	31	23	,	,	PUNCT
dti-1311	31	24	cairo	cairo	PROPN
dti-1311	31	25	)	)	PUNCT
dti-1311	31	26	,	,	PUNCT
dti-1311	31	27	domperidone	domperidone	NOUN
dti-1311	31	28	(	(	PUNCT
dti-1311	31	29	janssen	janssen	NOUN
dti-1311	31	30	-	-	PUNCT
dti-1311	31	31	cilag	cilag	PROPN
dti-1311	31	32	,	,	PUNCT
dti-1311	31	33	switz	switz	PROPN
dti-1311	31	34	)	)	PUNCT
dti-1311	31	35	were	be	AUX
dti-1311	31	36	used	use	VERB
dti-1311	31	37	.	.	PUNCT
dti-1311	32	1	analytical	analytical	ADJ
dti-1311	32	2	-	-	PUNCT
dti-1311	32	3	grade	grade	NOUN
dti-1311	32	4	glacial	glacial	ADJ
dti-1311	32	5	acetic	acetic	ADJ
dti-1311	32	6	acid	acid	NOUN
dti-1311	32	7	(	(	PUNCT
dti-1311	32	8	sigma	sigma	PROPN
dti-1311	32	9	,	,	PUNCT
dti-1311	32	10	st	st	PROPN
dti-1311	32	11	.	.	PROPN
dti-1311	32	12	louis	louis	PROPN
dti-1311	32	13	,	,	PUNCT
dti-1311	32	14	u.s.a	u.s.a	PROPN
dti-1311	32	15	.	.	PUNCT
dti-1311	32	16	)	)	PUNCT
dti-1311	32	17	was	be	AUX
dti-1311	32	18	diluted	dilute	VERB
dti-1311	32	19	with	with	ADP
dti-1311	32	20	pyrogen	pyrogen	ADV
dti-1311	32	21	-	-	PUNCT
dti-1311	32	22	free	free	ADJ
dti-1311	32	23	saline	saline	NOUN
dti-1311	32	24	to	to	PART
dti-1311	32	25	provide	provide	VERB
dti-1311	32	26	a	a	DET
dti-1311	32	27	0.6	0.6	NUM
dti-1311	32	28	%	%	NOUN
dti-1311	32	29	solution	solution	NOUN
dti-1311	32	30	for	for	ADP
dti-1311	32	31	i.p	i.p	PROPN
dti-1311	32	32	.	.	PROPN
dti-1311	32	33	injection	injection	NOUN
dti-1311	32	34	.	.	PUNCT
dti-1311	33	1	all	all	DET
dti-1311	33	2	drugs	drug	NOUN
dti-1311	33	3	were	be	AUX
dti-1311	33	4	dissolved	dissolve	VERB
dti-1311	33	5	in	in	ADP
dti-1311	33	6	isotonic	isotonic	ADJ
dti-1311	33	7	(	(	PUNCT
dti-1311	33	8	0.9	0.9	NUM
dti-1311	33	9	%	%	NOUN
dti-1311	33	10	nacl	nacl	NOUN
dti-1311	33	11	)	)	PUNCT
dti-1311	33	12	saline	saline	NOUN
dti-1311	33	13	solution	solution	NOUN
dti-1311	33	14	immediately	immediately	ADV
dti-1311	33	15	before	before	ADP
dti-1311	33	16	use	use	NOUN
dti-1311	33	17	.	.	PUNCT
dti-1311	34	1	indomethacin	indomethacin	PROPN
dti-1311	34	2	was	be	AUX
dti-1311	34	3	dissolved	dissolve	VERB
dti-1311	34	4	in	in	ADP
dti-1311	34	5	a	a	DET
dti-1311	34	6	5	5	NUM
dti-1311	34	7	%	%	NOUN
dti-1311	34	8	solution	solution	NOUN
dti-1311	34	9	of	of	ADP
dti-1311	34	10	sodium	sodium	NOUN
dti-1311	34	11	bicarbonate	bicarbonate	NOUN
dti-1311	34	12	.	.	PUNCT
dti-1311	35	1	acetic	acetic	ADJ
dti-1311	35	2	acid	acid	NOUN
dti-1311	35	3	-	-	PUNCT
dti-1311	35	4	induced	induce	VERB
dti-1311	35	5	writhing	writhe	VERB
dti-1311	35	6	separate	separate	ADJ
dti-1311	35	7	groups	group	NOUN
dti-1311	35	8	of	of	ADP
dti-1311	35	9	6	6	NUM
dti-1311	35	10	mice	mouse	NOUN
dti-1311	35	11	each	each	PRON
dti-1311	35	12	were	be	AUX
dti-1311	35	13	administered	administer	VERB
dti-1311	35	14	vehicle	vehicle	NOUN
dti-1311	35	15	or	or	CCONJ
dti-1311	35	16	drug	drug	NOUN
dti-1311	35	17	(	(	PUNCT
dti-1311	35	18	1.5	1.5	NUM
dti-1311	35	19	,	,	PUNCT
dti-1311	35	20	2.5	2.5	NUM
dti-1311	35	21	,	,	PUNCT
dti-1311	35	22	5	5	NUM
dti-1311	35	23	,	,	PUNCT
dti-1311	35	24	10	10	NUM
dti-1311	35	25	or	or	CCONJ
dti-1311	35	26	20	20	NUM
dti-1311	35	27	mg	mg	NUM
dti-1311	35	28	/	/	SYM
dti-1311	35	29	kg	kg	PROPN
dti-1311	35	30	,	,	PUNCT
dti-1311	35	31	s.c	s.c	PROPN
dti-1311	35	32	.	.	PROPN
dti-1311	35	33	)	)	PUNCT
dti-1311	35	34	.	.	PUNCT
dti-1311	36	1	after	after	ADP
dti-1311	36	2	30	30	NUM
dti-1311	36	3	-	-	PUNCT
dti-1311	36	4	min	min	NOUN
dti-1311	36	5	pretreatment	pretreatment	NOUN
dti-1311	36	6	interval	interval	NOUN
dti-1311	36	7	,	,	PUNCT
dti-1311	36	8	0.6	0.6	NUM
dti-1311	36	9	%	%	NOUN
dti-1311	36	10	acetic	acetic	ADJ
dti-1311	36	11	acid	acid	NOUN
dti-1311	36	12	(	(	PUNCT
dti-1311	36	13	0.2	0.2	NUM
dti-1311	36	14	ml	ml	NOUN
dti-1311	36	15	/	/	SYM
dti-1311	36	16	mice	mouse	NOUN
dti-1311	36	17	)	)	PUNCT
dti-1311	36	18	was	be	AUX
dti-1311	36	19	intraperitoneally	intraperitoneally	ADV
dti-1311	36	20	(	(	PUNCT
dti-1311	36	21	i.p	i.p	PROPN
dti-1311	36	22	.	.	PUNCT
dti-1311	36	23	)	)	PUNCT
dti-1311	37	1	administered	administer	VERB
dti-1311	37	2	(	(	PUNCT
dti-1311	37	3	koster	koster	PROPN
dti-1311	37	4	et	et	PROPN
dti-1311	37	5	al	al	PROPN
dti-1311	37	6	.	.	PROPN
dti-1311	37	7	1959	1959	NUM
dti-1311	37	8	)	)	PUNCT
dti-1311	37	9	.	.	PUNCT
dti-1311	38	1	each	each	DET
dti-1311	38	2	mouse	mouse	NOUN
dti-1311	38	3	was	be	AUX
dti-1311	38	4	then	then	ADV
dti-1311	38	5	placed	place	VERB
dti-1311	38	6	in	in	ADP
dti-1311	38	7	an	an	DET
dti-1311	38	8	individual	individual	ADJ
dti-1311	38	9	clear	clear	ADJ
dti-1311	38	10	plastic	plastic	ADJ
dti-1311	38	11	observational	observational	ADJ
dti-1311	38	12	chamber	chamber	NOUN
dti-1311	38	13	,	,	PUNCT
dti-1311	38	14	and	and	CCONJ
dti-1311	38	15	the	the	DET
dti-1311	38	16	total	total	ADJ
dti-1311	38	17	number	number	NOUN
dti-1311	38	18	of	of	ADP
dti-1311	38	19	writhes	writhe	NOUN
dti-1311	38	20	made	make	VERB
dti-1311	38	21	by	by	ADP
dti-1311	38	22	each	each	DET
dti-1311	38	23	mouse	mouse	NOUN
dti-1311	38	24	was	be	AUX
dti-1311	38	25	counted	count	VERB
dti-1311	38	26	for	for	ADP
dti-1311	38	27	30	30	NUM
dti-1311	38	28	min	min	NOUN
dti-1311	38	29	after	after	ADP
dti-1311	38	30	acetic	acetic	ADJ
dti-1311	38	31	acid	acid	NOUN
dti-1311	38	32	administration	administration	NOUN
dti-1311	38	33	.	.	PUNCT
dti-1311	39	1	further	further	ADJ
dti-1311	39	2	experiments	experiment	NOUN
dti-1311	39	3	were	be	AUX
dti-1311	39	4	designed	design	VERB
dti-1311	39	5	in	in	ADP
dti-1311	39	6	an	an	DET
dti-1311	39	7	attempt	attempt	NOUN
dti-1311	39	8	to	to	PART
dti-1311	39	9	elucidate	elucidate	VERB
dti-1311	39	10	the	the	DET
dti-1311	39	11	mechanisms	mechanism	NOUN
dti-1311	39	12	by	by	ADP
dti-1311	39	13	which	which	PRON
dti-1311	39	14	cinnarizine	cinnarizine	NOUN
dti-1311	39	15	exerts	exert	VERB
dti-1311	39	16	its	its	PRON
dti-1311	39	17	anti	anti	ADJ
dti-1311	39	18	-	-	ADJ
dti-1311	39	19	nociceptive	nociceptive	ADJ
dti-1311	39	20	effect	effect	NOUN
dti-1311	39	21	.	.	PUNCT
dti-1311	40	1	the	the	DET
dti-1311	40	2	dose	dose	NOUN
dti-1311	40	3	of	of	ADP
dti-1311	40	4	2.5	2.5	NUM
dti-1311	40	5	mg	mg	NOUN
dti-1311	40	6	/	/	SYM
dti-1311	40	7	kg	kg	PROPN
dti-1311	40	8	of	of	ADP
dti-1311	40	9	cinnarizine	cinnarizine	NOUN
dti-1311	40	10	was	be	AUX
dti-1311	40	11	selected	select	VERB
dti-1311	40	12	to	to	PART
dti-1311	40	13	be	be	AUX
dti-1311	40	14	used	use	VERB
dti-1311	40	15	in	in	ADP
dti-1311	40	16	the	the	DET
dti-1311	40	17	subsequent	subsequent	ADJ
dti-1311	40	18	experiments	experiment	NOUN
dti-1311	40	19	.	.	PUNCT
dti-1311	41	1	thus	thus	ADV
dti-1311	41	2	,	,	PUNCT
dti-1311	41	3	the	the	DET
dti-1311	41	4	effect	effect	NOUN
dti-1311	41	5	of	of	ADP
dti-1311	41	6	co	co	NOUN
dti-1311	41	7	-	-	NOUN
dti-1311	41	8	administration	administration	NOUN
dti-1311	41	9	of	of	ADP
dti-1311	41	10	the	the	DET
dti-1311	41	11	alpha-2	alpha-2	PROPN
dti-1311	41	12	adrenoreceptor	adrenoreceptor	NOUN
dti-1311	41	13	antagonist	antagonist	NOUN
dti-1311	41	14	yohimbine	yohimbine	NOUN
dti-1311	41	15	(	(	PUNCT
dti-1311	41	16	5	5	NUM
dti-1311	41	17	mg	mg	PROPN
dti-1311	41	18	/	/	SYM
dti-1311	41	19	kg	kg	PROPN
dti-1311	41	20	,	,	PUNCT
dti-1311	41	21	i.p	i.p	PROPN
dti-1311	41	22	.	.	PROPN
dti-1311	41	23	)	)	PUNCT
dti-1311	41	24	,	,	PUNCT
dti-1311	41	25	the	the	DET
dti-1311	41	26	beta	beta	ADJ
dti-1311	41	27	adrenoreceptor	adrenoreceptor	NOUN
dti-1311	41	28	antagonist	antagonist	NOUN
dti-1311	41	29	,	,	PUNCT
dti-1311	41	30	propranolol	propranolol	PROPN
dti-1311	41	31	(	(	PUNCT
dti-1311	41	32	2	2	NUM
dti-1311	41	33	mg	mg	PROPN
dti-1311	41	34	/	/	SYM
dti-1311	41	35	kg	kg	PROPN
dti-1311	41	36	,	,	PUNCT
dti-1311	41	37	i.p	i.p	PROPN
dti-1311	41	38	.	.	PROPN
dti-1311	41	39	)	)	PUNCT
dti-1311	41	40	,	,	PUNCT
dti-1311	41	41	the	the	DET
dti-1311	41	42	muscarinic	muscarinic	ADJ
dti-1311	41	43	acetylcholine	acetylcholine	NOUN
dti-1311	41	44	receptor	receptor	NOUN
dti-1311	41	45	antagonist	antagonist	NOUN
dti-1311	41	46	atropine	atropine	NOUN
dti-1311	41	47	(	(	PUNCT
dti-1311	41	48	2	2	NUM
dti-1311	41	49	mg	mg	PROPN
dti-1311	41	50	/	/	SYM
dti-1311	41	51	kg	kg	PROPN
dti-1311	41	52	,	,	PUNCT
dti-1311	41	53	i.p	i.p	PROPN
dti-1311	41	54	.	.	PROPN
dti-1311	41	55	)	)	PUNCT
dti-1311	41	56	,	,	PUNCT
dti-1311	41	57	the	the	DET
dti-1311	41	58	non	non	ADJ
dti-1311	41	59	-	-	ADJ
dti-1311	41	60	selective	selective	ADJ
dti-1311	41	61	opioid	opioid	ADJ
dti-1311	41	62	receptor	receptor	NOUN
dti-1311	41	63	antagonist	antagonist	NOUN
dti-1311	41	64	naloxone	naloxone	NOUN
dti-1311	41	65	(	(	PUNCT
dti-1311	41	66	5	5	NUM
dti-1311	41	67	mg	mg	PROPN
dti-1311	41	68	/	/	SYM
dti-1311	41	69	kg	kg	PROPN
dti-1311	41	70	,	,	PUNCT
dti-1311	41	71	i.p	i.p	PROPN
dti-1311	41	72	.	.	PROPN
dti-1311	41	73	)	)	PUNCT
dti-1311	41	74	,	,	PUNCT
dti-1311	41	75	the	the	DET
dti-1311	41	76	non	non	ADJ
dti-1311	41	77	-	-	ADJ
dti-1311	41	78	selective	selective	ADJ
dti-1311	41	79	adenosine	adenosine	NOUN
dti-1311	41	80	receptor	receptor	NOUN
dti-1311	41	81	antagonist	antagonist	NOUN
dti-1311	41	82	theophylline	theophylline	NOUN
dti-1311	41	83	(	(	PUNCT
dti-1311	41	84	20	20	NUM
dti-1311	41	85	mg	mg	NUM
dti-1311	41	86	/	/	SYM
dti-1311	41	87	kg	kg	PROPN
dti-1311	41	88	,	,	PUNCT
dti-1311	41	89	i.p	i.p	PROPN
dti-1311	41	90	.	.	PROPN
dti-1311	41	91	)	)	PUNCT
dti-1311	41	92	,	,	PUNCT
dti-1311	41	93	the	the	DET
dti-1311	41	94	gaba	gaba	PROPN
dti-1311	41	95	agonist	agonist	PROPN
dti-1311	41	96	baclofen	baclofen	PROPN
dti-1311	41	97	(	(	PUNCT
dti-1311	41	98	5	5	NUM
dti-1311	41	99	mg	mg	PROPN
dti-1311	41	100	/	/	SYM
dti-1311	41	101	kg	kg	PROPN
dti-1311	41	102	,	,	PUNCT
dti-1311	41	103	i.p	i.p	PROPN
dti-1311	41	104	.	.	PROPN
dti-1311	41	105	)	)	PUNCT
dti-1311	41	106	,	,	PUNCT
dti-1311	41	107	and	and	CCONJ
dti-1311	41	108	the	the	DET
dti-1311	41	109	potassium	potassium	NOUN
dti-1311	41	110	channel	channel	NOUN
dti-1311	41	111	blocker	blocker	NOUN
dti-1311	41	112	glibenclamide	glibenclamide	NOUN
dti-1311	41	113	(	(	PUNCT
dti-1311	41	114	5	5	NUM
dti-1311	41	115	mg/	mg/	NOUN
dti-1311	41	116	kg	kg	PROPN
dti-1311	41	117	,	,	PUNCT
dti-1311	41	118	i.p	i.p	PROPN
dti-1311	41	119	.	.	PROPN
dti-1311	41	120	)	)	PUNCT
dti-1311	41	121	,	,	PUNCT
dti-1311	41	122	indomethacin	indomethacin	X
dti-1311	41	123	(	(	PUNCT
dti-1311	41	124	5	5	NUM
dti-1311	41	125	mg	mg	PROPN
dti-1311	41	126	/	/	SYM
dti-1311	41	127	kg	kg	PROPN
dti-1311	41	128	,	,	PUNCT
dti-1311	41	129	i.p	i.p	PROPN
dti-1311	41	130	.	.	PROPN
dti-1311	41	131	)	)	PUNCT
dti-1311	41	132	were	be	AUX
dti-1311	41	133	examined	examine	VERB
dti-1311	41	134	on	on	ADP
dti-1311	41	135	antinociception	antinociception	NOUN
dti-1311	41	136	caused	cause	VERB
dti-1311	41	137	by	by	ADP
dti-1311	41	138	cinnarizine	cinnarizine	NOUN
dti-1311	41	139	.	.	PUNCT
dti-1311	42	1	furthermore	furthermore	ADV
dti-1311	42	2	,	,	PUNCT
dti-1311	42	3	the	the	DET
dti-1311	42	4	effect	effect	NOUN
dti-1311	42	5	of	of	ADP
dti-1311	42	6	the	the	DET
dti-1311	42	7	centrally	centrally	ADV
dti-1311	42	8	acting	act	VERB
dti-1311	42	9	dopamine	dopamine	NOUN
dti-1311	42	10	d2	d2	NOUN
dti-1311	42	11	receptor	receptor	NOUN
dti-1311	42	12	antagonists	antagonist	NOUN
dti-1311	42	13	,	,	PUNCT
dti-1311	42	14	sulpiride	sulpiride	ADV
dti-1311	42	15	(	(	PUNCT
dti-1311	42	16	10	10	NUM
dti-1311	42	17	mg	mg	NUM
dti-1311	42	18	/	/	SYM
dti-1311	42	19	kg	kg	PROPN
dti-1311	42	20	,	,	PUNCT
dti-1311	42	21	i.p	i.p	PROPN
dti-1311	42	22	.	.	PROPN
dti-1311	42	23	)	)	PUNCT
dti-1311	43	1	and	and	CCONJ
dti-1311	43	2	haloperidol	haloperidol	NOUN
dti-1311	43	3	(	(	PUNCT
dti-1311	43	4	1.5	1.5	NUM
dti-1311	43	5	mg	mg	PROPN
dti-1311	43	6	/	/	SYM
dti-1311	43	7	kg	kg	PROPN
dti-1311	43	8	,	,	PUNCT
dti-1311	43	9	i.p	i.p	PROPN
dti-1311	43	10	.	.	PROPN
dti-1311	43	11	)	)	PUNCT
dti-1311	43	12	,	,	PUNCT
dti-1311	43	13	the	the	DET
dti-1311	43	14	peripherally	peripherally	ADV
dti-1311	43	15	acting	act	VERB
dti-1311	43	16	d2	d2	NOUN
dti-1311	43	17	receptor	receptor	NOUN
dti-1311	43	18	antagonist	antagonist	NOUN
dti-1311	43	19	domperidone	domperidone	NOUN
dti-1311	43	20	(	(	PUNCT
dti-1311	43	21	10	10	NUM
dti-1311	43	22	mg	mg	NUM
dti-1311	43	23	/	/	SYM
dti-1311	43	24	kg	kg	PROPN
dti-1311	43	25	,	,	PUNCT
dti-1311	43	26	i.p	i.p	PROPN
dti-1311	43	27	.	.	PROPN
dti-1311	43	28	)	)	PUNCT
dti-1311	43	29	or	or	CCONJ
dti-1311	43	30	d2	d2	NOUN
dti-1311	43	31	receptor	receptor	NOUN
dti-1311	43	32	agonist	agonist	NOUN
dti-1311	43	33	bromocryptine	bromocryptine	NOUN
dti-1311	43	34	(	(	PUNCT
dti-1311	43	35	3	3	NUM
dti-1311	43	36	mg	mg	PROPN
dti-1311	43	37	/	/	SYM
dti-1311	43	38	kg	kg	PROPN
dti-1311	43	39	,	,	PUNCT
dti-1311	43	40	i.p	i.p	PROPN
dti-1311	43	41	.	.	PROPN
dti-1311	43	42	)	)	PUNCT
dti-1311	43	43	,	,	PUNCT
dti-1311	43	44	the	the	DET
dti-1311	43	45	d2	d2	PROPN
dti-1311	43	46	receptor	receptor	NOUN
dti-1311	43	47	antagonist	antagonist	NOUN
dti-1311	43	48	metoclopramide	metoclopramide	NOUN
dti-1311	43	49	(	(	PUNCT
dti-1311	43	50	10	10	NUM
dti-1311	43	51	mg	mg	NUM
dti-1311	43	52	/	/	SYM
dti-1311	43	53	kg	kg	NOUN
dti-1311	43	54	)	)	PUNCT
dti-1311	43	55	and	and	CCONJ
dti-1311	43	56	the	the	DET
dti-1311	43	57	non	non	ADJ
dti-1311	43	58	-	-	ADJ
dti-1311	43	59	selective	selective	ADJ
dti-1311	43	60	dopamine	dopamine	NOUN
dti-1311	43	61	receptor	receptor	NOUN
dti-1311	43	62	antagonist	antagonist	NOUN
dti-1311	43	63	chlorpromazine	chlorpromazine	NOUN
dti-1311	43	64	(	(	PUNCT
dti-1311	43	65	3	3	NUM
dti-1311	43	66	mg	mg	PROPN
dti-1311	43	67	/	/	SYM
dti-1311	43	68	kg	kg	PROPN
dti-1311	43	69	,	,	PUNCT
dti-1311	43	70	i.p	i.p	PROPN
dti-1311	43	71	.	.	PROPN
dti-1311	43	72	)	)	PUNCT
dti-1311	43	73	was	be	AUX
dti-1311	43	74	examined	examine	VERB
dti-1311	43	75	.	.	PUNCT
dti-1311	44	1	all	all	DET
dti-1311	44	2	drugs	drug	NOUN
dti-1311	44	3	were	be	AUX
dti-1311	44	4	administered	administer	VERB
dti-1311	44	5	30	30	NUM
dti-1311	44	6	min	min	NOUN
dti-1311	44	7	prior	prior	ADV
dti-1311	44	8	to	to	ADP
dti-1311	44	9	the	the	DET
dti-1311	44	10	abdominal	abdominal	ADJ
dti-1311	44	11	constriction	constriction	NOUN
dti-1311	44	12	assay	assay	VERB
dti-1311	44	13	.	.	PUNCT
dti-1311	45	1	rotarod	rotarod	NOUN
dti-1311	45	2	testing	testing	NOUN
dti-1311	45	3	motor	motor	NOUN
dti-1311	45	4	performance	performance	NOUN
dti-1311	45	5	was	be	AUX
dti-1311	45	6	measured	measure	VERB
dti-1311	45	7	as	as	ADP
dti-1311	45	8	the	the	DET
dti-1311	45	9	latency	latency	NOUN
dti-1311	45	10	to	to	PART
dti-1311	45	11	fall	fall	VERB
dti-1311	45	12	from	from	ADP
dti-1311	45	13	an	an	DET
dti-1311	45	14	accelerating	accelerate	VERB
dti-1311	45	15	rotarod	rotarod	NOUN
dti-1311	45	16	located	locate	VERB
dti-1311	45	17	over	over	ADP
dti-1311	45	18	plates	plate	NOUN
dti-1311	45	19	connected	connect	VERB
dti-1311	45	20	to	to	ADP
dti-1311	45	21	an	an	DET
dti-1311	45	22	automatic	automatic	ADJ
dti-1311	45	23	counter	counter	NOUN
dti-1311	45	24	(	(	PUNCT
dti-1311	45	25	ugo	ugo	PROPN
dti-1311	45	26	basile	basile	PROPN
dti-1311	45	27	,	,	PUNCT
dti-1311	45	28	varese	varese	PROPN
dti-1311	45	29	,	,	PUNCT
dti-1311	45	30	italy	italy	PROPN
dti-1311	45	31	)	)	PUNCT
dti-1311	45	32	.	.	PUNCT
dti-1311	46	1	mice	mouse	NOUN
dti-1311	46	2	were	be	AUX
dti-1311	46	3	trained	train	VERB
dti-1311	46	4	to	to	PART
dti-1311	46	5	remain	remain	VERB
dti-1311	46	6	on	on	ADP
dti-1311	46	7	a	a	DET
dti-1311	46	8	rotating	rotate	VERB
dti-1311	46	9	rod	rod	NOUN
dti-1311	46	10	for	for	ADP
dti-1311	46	11	2	2	NUM
dti-1311	46	12	min	min	NOUN
dti-1311	46	13	as	as	SCONJ
dti-1311	46	14	the	the	DET
dti-1311	46	15	rod	rod	NOUN
dti-1311	46	16	rotated	rotate	VERB
dti-1311	46	17	toward	toward	ADP
dti-1311	46	18	the	the	DET
dti-1311	46	19	animal	animal	NOUN
dti-1311	46	20	.	.	PUNCT
dti-1311	47	1	after	after	ADP
dti-1311	47	2	the	the	DET
dti-1311	47	3	2	2	NUM
dti-1311	47	4	-	-	PUNCT
dti-1311	47	5	min	min	NOUN
dti-1311	47	6	training	training	NOUN
dti-1311	47	7	period	period	NOUN
dti-1311	47	8	,	,	PUNCT
dti-1311	47	9	the	the	DET
dti-1311	47	10	mice	mouse	NOUN
dti-1311	47	11	were	be	AUX
dti-1311	47	12	administered	administer	VERB
dti-1311	47	13	vehicle	vehicle	NOUN
dti-1311	47	14	(	(	PUNCT
dti-1311	47	15	saline	saline	NOUN
dti-1311	47	16	)	)	PUNCT
dti-1311	47	17	or	or	CCONJ
dti-1311	47	18	drug	drug	NOUN
dti-1311	47	19	and	and	CCONJ
dti-1311	47	20	30	30	NUM
dti-1311	47	21	min	min	NOUN
dti-1311	47	22	later	later	ADV
dti-1311	47	23	placed	place	VERB
dti-1311	47	24	on	on	ADP
dti-1311	47	25	the	the	DET
dti-1311	47	26	rotating	rotate	VERB
dti-1311	47	27	rod	rod	NOUN
dti-1311	47	28	as	as	SCONJ
dti-1311	47	29	it	it	PRON
dti-1311	47	30	accelerated	accelerate	VERB
dti-1311	47	31	from	from	ADP
dti-1311	47	32	4	4	NUM
dti-1311	47	33	to	to	PART
dti-1311	47	34	40	40	NUM
dti-1311	47	35	rpm	rpm	NOUN
dti-1311	47	36	over	over	ADP
dti-1311	47	37	5	5	NUM
dti-1311	47	38	min	min	NOUN
dti-1311	47	39	and	and	CCONJ
dti-1311	47	40	the	the	DET
dti-1311	47	41	time	time	NOUN
dti-1311	47	42	that	that	PRON
dti-1311	47	43	they	they	PRON
dti-1311	47	44	could	could	AUX
dti-1311	47	45	remain	remain	VERB
dti-1311	47	46	on	on	ADP
dti-1311	47	47	the	the	DET
dti-1311	47	48	accelerating	accelerate	VERB
dti-1311	47	49	rod	rod	NOUN
dti-1311	47	50	was	be	AUX
dti-1311	47	51	noted	note	VERB
dti-1311	47	52	(	(	PUNCT
dti-1311	47	53	millan	millan	PROPN
dti-1311	47	54	et	et	PROPN
dti-1311	47	55	al	al	PROPN
dti-1311	47	56	.	.	PROPN
dti-1311	47	57	1994	1994	NUM
dti-1311	47	58	)	)	PUNCT
dti-1311	47	59	.	.	PUNCT
dti-1311	48	1	the	the	DET
dti-1311	48	2	cutoff	cutoff	NOUN
dti-1311	48	3	time	time	NOUN
dti-1311	48	4	was	be	AUX
dti-1311	48	5	600	600	NUM
dti-1311	48	6	sec	sec	PROPN
dti-1311	48	7	.	.	PUNCT
dti-1311	49	1	the	the	DET
dti-1311	49	2	time	time	NOUN
dti-1311	49	3	was	be	AUX
dti-1311	49	4	measured	measure	VERB
dti-1311	49	5	from	from	ADP
dti-1311	49	6	the	the	DET
dti-1311	49	7	start	start	NOUN
dti-1311	49	8	of	of	ADP
dti-1311	49	9	the	the	DET
dti-1311	49	10	acceleration	acceleration	NOUN
dti-1311	49	11	period	period	NOUN
dti-1311	49	12	.	.	PUNCT
dti-1311	50	1	the	the	DET
dti-1311	50	2	test	test	NOUN
dti-1311	50	3	was	be	AUX
dti-1311	50	4	repeated	repeat	VERB
dti-1311	50	5	2	2	NUM
dti-1311	50	6	h	h	NOUN
dti-1311	50	7	after	after	ADP
dti-1311	50	8	vehicle	vehicle	NOUN
dti-1311	50	9	or	or	CCONJ
dti-1311	50	10	drug	drug	NOUN
dti-1311	50	11	injection	injection	NOUN
dti-1311	50	12	.	.	PUNCT
dti-1311	51	1	six	six	NUM
dti-1311	51	2	animals	animal	NOUN
dti-1311	51	3	were	be	AUX
dti-1311	51	4	used	use	VERB
dti-1311	51	5	per	per	ADP
dti-1311	51	6	dose	dose	NOUN
dti-1311	51	7	and	and	CCONJ
dti-1311	51	8	for	for	ADP
dti-1311	51	9	the	the	DET
dti-1311	51	10	controls	control	NOUN
dti-1311	51	11	.	.	PUNCT
dti-1311	52	1	porsolt	porsolt	PROPN
dti-1311	52	2	’s	’s	PART
dti-1311	52	3	forced	force	VERB
dti-1311	52	4	-	-	PUNCT
dti-1311	52	5	swimming	swimming	NOUN
dti-1311	52	6	test	test	NOUN
dti-1311	52	7	each	each	DET
dti-1311	52	8	mouse	mouse	NOUN
dti-1311	52	9	was	be	AUX
dti-1311	52	10	placed	place	VERB
dti-1311	52	11	individually	individually	ADV
dti-1311	52	12	in	in	ADP
dti-1311	52	13	a	a	DET
dti-1311	52	14	glass	glass	NOUN
dti-1311	52	15	cylinder	cylinder	NOUN
dti-1311	52	16	(	(	PUNCT
dti-1311	52	17	diameter	diameter	NOUN
dti-1311	52	18	12	12	NUM
dti-1311	52	19	cm	cm	NOUN
dti-1311	52	20	,	,	PUNCT
dti-1311	52	21	height	height	NOUN
dti-1311	52	22	24	24	NUM
dti-1311	52	23	cm	cm	NOUN
dti-1311	52	24	)	)	PUNCT
dti-1311	52	25	fi	fi	NOUN
dti-1311	52	26	lled	lle	VERB
dti-1311	52	27	with	with	ADP
dti-1311	52	28	water	water	NOUN
dti-1311	52	29	at	at	ADP
dti-1311	52	30	a	a	DET
dti-1311	52	31	height	height	NOUN
dti-1311	52	32	of	of	ADP
dti-1311	52	33	12	12	NUM
dti-1311	52	34	cm	cm	NOUN
dti-1311	52	35	.	.	PUNCT
dti-1311	53	1	water	water	NOUN
dti-1311	53	2	temperature	temperature	NOUN
dti-1311	53	3	was	be	AUX
dti-1311	53	4	maintained	maintain	VERB
dti-1311	53	5	at	at	ADP
dti-1311	53	6	22–23	22–23	NUM
dti-1311	53	7	°	°	NOUN
dti-1311	53	8	c	c	NOUN
dti-1311	53	9	.	.	PUNCT
dti-1311	54	1	the	the	DET
dti-1311	54	2	animal	animal	NOUN
dti-1311	54	3	was	be	AUX
dti-1311	54	4	forced	force	VERB
dti-1311	54	5	to	to	PART
dti-1311	54	6	swim	swim	VERB
dti-1311	54	7	for	for	ADP
dti-1311	54	8	6	6	NUM
dti-1311	54	9	min	min	NOUN
dti-1311	54	10	and	and	CCONJ
dti-1311	54	11	the	the	DET
dti-1311	54	12	duration	duration	NOUN
dti-1311	54	13	of	of	ADP
dti-1311	54	14	immobility	immobility	NOUN
dti-1311	54	15	was	be	AUX
dti-1311	54	16	measured	measure	VERB
dti-1311	54	17	.	.	PUNCT
dti-1311	55	1	the	the	DET
dti-1311	55	2	mouse	mouse	NOUN
dti-1311	55	3	was	be	AUX
dti-1311	55	4	considered	consider	VERB
dti-1311	55	5	as	as	ADV
dti-1311	55	6	immobile	immobile	ADJ
dti-1311	55	7	when	when	SCONJ
dti-1311	55	8	it	it	PRON
dti-1311	55	9	stopped	stop	VERB
dti-1311	55	10	struggling	struggle	VERB
dti-1311	55	11	and	and	CCONJ
dti-1311	55	12	moved	move	VERB
dti-1311	55	13	only	only	ADV
dti-1311	55	14	to	to	PART
dti-1311	55	15	remain	remain	VERB
dti-1311	55	16	fl	fl	NOUN
dti-1311	55	17	oating	oate	VERB
dti-1311	55	18	in	in	ADP
dti-1311	55	19	the	the	DET
dti-1311	55	20	water	water	NOUN
dti-1311	55	21	,	,	PUNCT
dti-1311	55	22	keeping	keep	VERB
dti-1311	55	23	its	its	PRON
dti-1311	55	24	head	head	NOUN
dti-1311	55	25	above	above	ADP
dti-1311	55	26	water	water	NOUN
dti-1311	55	27	.	.	PUNCT
dti-1311	56	1	the	the	DET
dti-1311	56	2	fl	fl	NOUN
dti-1311	56	3	oating	oate	VERB
dti-1311	56	4	time	time	NOUN
dti-1311	56	5	,	,	PUNCT
dti-1311	56	6	which	which	PRON
dti-1311	56	7	is	be	AUX
dti-1311	56	8	used	use	VERB
dti-1311	56	9	as	as	ADP
dti-1311	56	10	the	the	DET
dti-1311	56	11	measure	measure	NOUN
dti-1311	56	12	of	of	ADP
dti-1311	56	13	despair	despair	NOUN
dti-1311	56	14	(	(	PUNCT
dti-1311	56	15	porsolt	porsolt	NOUN
dti-1311	56	16	et	et	PROPN
dti-1311	56	17	al	al	PROPN
dti-1311	56	18	.	.	PROPN
dti-1311	56	19	1977	1977	NUM
dti-1311	56	20	)	)	PUNCT
dti-1311	56	21	,	,	PUNCT
dti-1311	56	22	was	be	AUX
dti-1311	56	23	recorded	record	VERB
dti-1311	56	24	after	after	ADP
dti-1311	56	25	treatment	treatment	NOUN
dti-1311	56	26	after	after	ADP
dti-1311	56	27	treatment	treatment	NOUN
dti-1311	56	28	with	with	ADP
dti-1311	56	29	saline	saline	NOUN
dti-1311	56	30	,	,	PUNCT
dti-1311	56	31	cinnarizine	cinnarizine	NOUN
dti-1311	56	32	(	(	PUNCT
dti-1311	56	33	2.5	2.5	NUM
dti-1311	56	34	,	,	PUNCT
dti-1311	56	35	5	5	NUM
dti-1311	56	36	,	,	PUNCT
dti-1311	56	37	10	10	NUM
dti-1311	56	38	or	or	CCONJ
dti-1311	56	39	20	20	NUM
dti-1311	56	40	mg	mg	NUM
dti-1311	56	41	/	/	SYM
dti-1311	56	42	kg	kg	PROPN
dti-1311	56	43	,	,	PUNCT
dti-1311	56	44	s.c	s.c	PROPN
dti-1311	56	45	.	.	PROPN
dti-1311	56	46	)	)	PUNCT
dti-1311	56	47	or	or	CCONJ
dti-1311	56	48	imipramine	imipramine	NOUN
dti-1311	56	49	(	(	PUNCT
dti-1311	56	50	15	15	NUM
dti-1311	56	51	mg	mg	PROPN
dti-1311	56	52	/	/	SYM
dti-1311	56	53	kg	kg	PROPN
dti-1311	56	54	,	,	PUNCT
dti-1311	56	55	s.c	s.c	PROPN
dti-1311	56	56	.	.	PROPN
dti-1311	56	57	)	)	PUNCT
dti-1311	56	58	.	.	PUNCT
dti-1311	57	1	drug	drug	NOUN
dti-1311	57	2	target	target	NOUN
dti-1311	57	3	insights	insight	NOUN
dti-1311	57	4	2007	2007	NUM
dti-1311	57	5	:	:	PUNCT
dti-1311	57	6	2	2	NUM
dti-1311	57	7	31	31	NUM
dti-1311	57	8	modulation	modulation	NOUN
dti-1311	57	9	of	of	ADP
dti-1311	57	10	visceral	visceral	ADJ
dti-1311	57	11	nociception	nociception	NOUN
dti-1311	57	12	,	,	PUNCT
dti-1311	57	13	infl	infl	PROPN
dti-1311	57	14	ammation	ammation	NOUN
dti-1311	57	15	and	and	CCONJ
dti-1311	57	16	gastric	gastric	ADJ
dti-1311	57	17	mucosal	mucosal	NOUN
dti-1311	57	18	injury	injury	NOUN
dti-1311	57	19	carageenan	carageenan	NOUN
dti-1311	57	20	-	-	PUNCT
dti-1311	57	21	induced	induce	VERB
dti-1311	57	22	paw	paw	NOUN
dti-1311	57	23	oedema	oedema	NOUN
dti-1311	57	24	paw	paw	NOUN
dti-1311	57	25	swelling	swelling	NOUN
dti-1311	57	26	was	be	AUX
dti-1311	57	27	elicited	elicit	VERB
dti-1311	57	28	by	by	ADP
dti-1311	57	29	sub	sub	ADJ
dti-1311	57	30	-	-	ADJ
dti-1311	57	31	plantar	plantar	ADJ
dti-1311	57	32	injection	injection	NOUN
dti-1311	57	33	of	of	ADP
dti-1311	57	34	100	100	NUM
dti-1311	57	35	μl	μl	ADP
dti-1311	57	36	of	of	ADP
dti-1311	57	37	1	1	NUM
dti-1311	57	38	%	%	NOUN
dti-1311	57	39	sterile	sterile	ADJ
dti-1311	57	40	lambda	lambda	NOUN
dti-1311	57	41	carrageenan	carrageenan	NOUN
dti-1311	57	42	suspension	suspension	NOUN
dti-1311	57	43	in	in	ADP
dti-1311	57	44	saline	saline	NOUN
dti-1311	57	45	into	into	ADP
dti-1311	57	46	the	the	DET
dti-1311	57	47	right	right	ADJ
dti-1311	57	48	hind	hind	NOUN
dti-1311	57	49	paw	paw	NOUN
dti-1311	57	50	(	(	PUNCT
dti-1311	57	51	winter	winter	NOUN
dti-1311	57	52	et	et	PROPN
dti-1311	57	53	al	al	PROPN
dti-1311	57	54	.	.	PROPN
dti-1311	57	55	1962	1962	NUM
dti-1311	57	56	)	)	PUNCT
dti-1311	57	57	.	.	PUNCT
dti-1311	58	1	contralateral	contralateral	ADJ
dti-1311	58	2	paw	paw	NOUN
dti-1311	58	3	received	receive	VERB
dti-1311	58	4	an	an	DET
dti-1311	58	5	equal	equal	ADJ
dti-1311	58	6	volume	volume	NOUN
dti-1311	58	7	of	of	ADP
dti-1311	58	8	saline	saline	NOUN
dti-1311	58	9	.	.	PUNCT
dti-1311	59	1	the	the	DET
dti-1311	59	2	oedema	oedema	ADJ
dti-1311	59	3	component	component	NOUN
dti-1311	59	4	of	of	ADP
dti-1311	59	5	infl	infl	PROPN
dti-1311	59	6	ammation	ammation	NOUN
dti-1311	59	7	was	be	AUX
dti-1311	59	8	quantifi	quantifi	ADJ
dti-1311	59	9	ed	ed	NOUN
dti-1311	59	10	by	by	ADP
dti-1311	59	11	measuring	measure	VERB
dti-1311	59	12	the	the	DET
dti-1311	59	13	increase	increase	NOUN
dti-1311	59	14	in	in	ADP
dti-1311	59	15	paw	paw	NOUN
dti-1311	59	16	volume	volume	NOUN
dti-1311	59	17	(	(	PUNCT
dti-1311	59	18	ml	ml	NOUN
dti-1311	59	19	)	)	PUNCT
dti-1311	59	20	with	with	ADP
dti-1311	59	21	a	a	DET
dti-1311	59	22	plethysmometer	plethysmometer	NOUN
dti-1311	59	23	(	(	PUNCT
dti-1311	59	24	ugo	ugo	PROPN
dti-1311	59	25	basile	basile	PROPN
dti-1311	59	26	,	,	PUNCT
dti-1311	59	27	milan	milan	PROPN
dti-1311	59	28	,	,	PUNCT
dti-1311	59	29	italy	italy	PROPN
dti-1311	59	30	)	)	PUNCT
dti-1311	59	31	before	before	ADP
dti-1311	59	32	carrageenan	carrageenan	NOUN
dti-1311	59	33	injection	injection	NOUN
dti-1311	59	34	and	and	CCONJ
dti-1311	59	35	at	at	ADP
dti-1311	59	36	selected	select	VERB
dti-1311	59	37	times	time	NOUN
dti-1311	59	38	thereafter	thereafter	ADV
dti-1311	59	39	.	.	PUNCT
dti-1311	60	1	oedema	oedema	PROPN
dti-1311	60	2	was	be	AUX
dti-1311	60	3	expressed	express	VERB
dti-1311	60	4	as	as	ADP
dti-1311	60	5	a	a	DET
dti-1311	60	6	percentage	percentage	NOUN
dti-1311	60	7	of	of	ADP
dti-1311	60	8	change	change	NOUN
dti-1311	60	9	from	from	ADP
dti-1311	60	10	control	control	NOUN
dti-1311	60	11	(	(	PUNCT
dti-1311	60	12	pre	pre	ADJ
dti-1311	60	13	-	-	ADJ
dti-1311	60	14	drug	drug	ADJ
dti-1311	60	15	)	)	PUNCT
dti-1311	60	16	values	value	NOUN
dti-1311	60	17	.	.	PUNCT
dti-1311	61	1	the	the	DET
dti-1311	61	2	effect	effect	NOUN
dti-1311	61	3	cinnarizine	cinnarizine	NOUN
dti-1311	61	4	(	(	PUNCT
dti-1311	61	5	1.25	1.25	NUM
dti-1311	61	6	,	,	PUNCT
dti-1311	61	7	2.5	2.5	NUM
dti-1311	61	8	,	,	PUNCT
dti-1311	61	9	5	5	NUM
dti-1311	61	10	,	,	PUNCT
dti-1311	61	11	10	10	NUM
dti-1311	61	12	or	or	CCONJ
dti-1311	61	13	20	20	NUM
dti-1311	61	14	mg	mg	NUM
dti-1311	61	15	/	/	SYM
dti-1311	61	16	kg	kg	PROPN
dti-1311	61	17	,	,	PUNCT
dti-1311	61	18	s.c	s.c	PROPN
dti-1311	61	19	.	.	PROPN
dti-1311	61	20	,	,	PUNCT
dti-1311	61	21	0.2	0.2	NUM
dti-1311	61	22	ml	ml	NOUN
dti-1311	61	23	/	/	SYM
dti-1311	61	24	rat	rat	NOUN
dti-1311	61	25	,	,	PUNCT
dti-1311	61	26	n	n	NOUN
dti-1311	61	27	=	=	SYM
dti-1311	61	28	6/	6/	NUM
dti-1311	61	29	group	group	NOUN
dti-1311	61	30	)	)	PUNCT
dti-1311	61	31	was	be	AUX
dti-1311	61	32	studied	study	VERB
dti-1311	61	33	.	.	PUNCT
dti-1311	62	1	cinnarizine	cinnarizine	PROPN
dti-1311	62	2	was	be	AUX
dti-1311	62	3	administered	administer	VERB
dti-1311	62	4	30	30	NUM
dti-1311	62	5	min	min	NOUN
dti-1311	62	6	before	before	ADP
dti-1311	62	7	the	the	DET
dti-1311	62	8	injection	injection	NOUN
dti-1311	62	9	of	of	ADP
dti-1311	62	10	the	the	DET
dti-1311	62	11	carrageenan	carrageenan	NOUN
dti-1311	62	12	suspension	suspension	NOUN
dti-1311	62	13	.	.	PUNCT
dti-1311	63	1	the	the	DET
dti-1311	63	2	control	control	NOUN
dti-1311	63	3	groups	group	NOUN
dti-1311	63	4	received	receive	VERB
dti-1311	63	5	saline	saline	NOUN
dti-1311	63	6	(	(	PUNCT
dti-1311	63	7	0.2	0.2	NUM
dti-1311	63	8	ml	ml	NOUN
dti-1311	63	9	/	/	SYM
dti-1311	63	10	rat	rat	NOUN
dti-1311	63	11	,	,	PUNCT
dti-1311	63	12	n	n	NOUN
dti-1311	63	13	=	=	NUM
dti-1311	63	14	6	6	NUM
dti-1311	63	15	per	per	ADP
dti-1311	63	16	group	group	NOUN
dti-1311	63	17	;	;	PUNCT
dti-1311	63	18	s.c	s.c	PROPN
dti-1311	63	19	.	.	PROPN
dti-1311	63	20	)	)	PUNCT
dti-1311	63	21	.	.	PUNCT
dti-1311	64	1	gastric	gastric	ADJ
dti-1311	64	2	ulcerogenic	ulcerogenic	ADJ
dti-1311	64	3	studies	study	NOUN
dti-1311	64	4	gastric	gastric	ADJ
dti-1311	64	5	mucosal	mucosal	NOUN
dti-1311	64	6	damage	damage	NOUN
dti-1311	64	7	was	be	AUX
dti-1311	64	8	evoked	evoke	VERB
dti-1311	64	9	by	by	ADP
dti-1311	64	10	indomethacin	indomethacin	NOUN
dti-1311	64	11	(	(	PUNCT
dti-1311	64	12	20	20	NUM
dti-1311	64	13	mg	mg	NUM
dti-1311	64	14	/	/	SYM
dti-1311	64	15	kg	kg	PROPN
dti-1311	64	16	,	,	PUNCT
dti-1311	64	17	s.c	s.c	PROPN
dti-1311	64	18	.	.	PROPN
dti-1311	64	19	)	)	PUNCT
dti-1311	64	20	.	.	PUNCT
dti-1311	65	1	rats	rat	NOUN
dti-1311	65	2	received	receive	VERB
dti-1311	65	3	either	either	CCONJ
dti-1311	65	4	saline	saline	NOUN
dti-1311	65	5	(	(	PUNCT
dti-1311	65	6	0.2	0.2	NUM
dti-1311	65	7	ml	ml	NOUN
dti-1311	65	8	/	/	SYM
dti-1311	65	9	rat	rat	NOUN
dti-1311	65	10	,	,	PUNCT
dti-1311	65	11	s.c	s.c	PROPN
dti-1311	65	12	.	.	PROPN
dti-1311	65	13	,	,	PUNCT
dti-1311	65	14	n	n	NOUN
dti-1311	65	15	=	=	SYM
dti-1311	65	16	6	6	NUM
dti-1311	65	17	)	)	PUNCT
dti-1311	65	18	(	(	PUNCT
dti-1311	65	19	control	control	NOUN
dti-1311	65	20	)	)	PUNCT
dti-1311	65	21	or	or	CCONJ
dti-1311	65	22	cinnarizine	cinnarizine	NOUN
dti-1311	65	23	(	(	PUNCT
dti-1311	65	24	2.5	2.5	NUM
dti-1311	65	25	,	,	PUNCT
dti-1311	65	26	5	5	NUM
dti-1311	65	27	or	or	CCONJ
dti-1311	65	28	10	10	NUM
dti-1311	65	29	mg	mg	NUM
dti-1311	65	30	/	/	SYM
dti-1311	65	31	kg	kg	PROPN
dti-1311	65	32	,	,	PUNCT
dti-1311	65	33	0.2	0.2	NUM
dti-1311	65	34	ml	ml	NOUN
dti-1311	65	35	/	/	SYM
dti-1311	65	36	rat	rat	NOUN
dti-1311	65	37	,	,	PUNCT
dti-1311	65	38	s.c	s.c	PROPN
dti-1311	65	39	.	.	PROPN
dti-1311	65	40	,	,	PUNCT
dti-1311	65	41	n	n	NOUN
dti-1311	65	42	=	=	SYM
dti-1311	65	43	6	6	NUM
dti-1311	65	44	per	per	ADP
dti-1311	65	45	group	group	NOUN
dti-1311	65	46	)	)	PUNCT
dti-1311	65	47	.	.	PUNCT
dti-1311	66	1	rats	rat	NOUN
dti-1311	66	2	were	be	AUX
dti-1311	66	3	killed	kill	VERB
dti-1311	66	4	48	48	NUM
dti-1311	66	5	h	h	NOUN
dti-1311	66	6	later	later	ADV
dti-1311	66	7	.	.	PUNCT
dti-1311	67	1	gastric	gastric	ADJ
dti-1311	67	2	mucosal	mucosal	NOUN
dti-1311	67	3	lesions	lesion	NOUN
dti-1311	67	4	were	be	AUX
dti-1311	67	5	scaled	scale	VERB
dti-1311	67	6	as	as	SCONJ
dti-1311	67	7	described	describe	VERB
dti-1311	67	8	earlier	early	ADV
dti-1311	67	9	(	(	PUNCT
dti-1311	67	10	mózsik	mózsik	PROPN
dti-1311	67	11	et	et	PROPN
dti-1311	67	12	al	al	PROPN
dti-1311	67	13	.	.	PROPN
dti-1311	67	14	1982	1982	NUM
dti-1311	67	15	)	)	PUNCT
dti-1311	67	16	.	.	PUNCT
dti-1311	68	1	statistical	statistical	ADJ
dti-1311	68	2	analyses	analysis	NOUN
dti-1311	68	3	data	datum	NOUN
dti-1311	68	4	are	be	AUX
dti-1311	68	5	expressed	express	VERB
dti-1311	68	6	as	as	ADP
dti-1311	68	7	mean	mean	PROPN
dti-1311	68	8	±	±	NUM
dti-1311	68	9	s.e	s.e	PROPN
dti-1311	68	10	.	.	PUNCT
dti-1311	69	1	the	the	DET
dti-1311	69	2	effects	effect	NOUN
dti-1311	69	3	of	of	ADP
dti-1311	69	4	different	different	ADJ
dti-1311	69	5	drugs	drug	NOUN
dti-1311	69	6	used	use	VERB
dti-1311	69	7	in	in	ADP
dti-1311	69	8	the	the	DET
dti-1311	69	9	abdominal	abdominal	ADJ
dti-1311	69	10	constriction	constriction	NOUN
dti-1311	69	11	assay	assay	NOUN
dti-1311	69	12	are	be	AUX
dti-1311	69	13	also	also	ADV
dti-1311	69	14	expressed	express	VERB
dti-1311	69	15	as	as	ADP
dti-1311	69	16	percent	percent	NOUN
dti-1311	69	17	inhibition	inhibition	NOUN
dti-1311	69	18	(	(	PUNCT
dti-1311	69	19	%	%	INTJ
dti-1311	69	20	)	)	PUNCT
dti-1311	69	21	compared	compare	VERB
dti-1311	69	22	to	to	ADP
dti-1311	69	23	the	the	DET
dti-1311	69	24	control	control	NOUN
dti-1311	69	25	value	value	NOUN
dti-1311	69	26	.	.	PUNCT
dti-1311	70	1	differences	difference	NOUN
dti-1311	70	2	between	between	ADP
dti-1311	70	3	vehicle	vehicle	NOUN
dti-1311	70	4	(	(	PUNCT
dti-1311	70	5	control	control	NOUN
dti-1311	70	6	)	)	PUNCT
dti-1311	70	7	and	and	CCONJ
dti-1311	70	8	treatment	treatment	NOUN
dti-1311	70	9	groups	group	NOUN
dti-1311	70	10	were	be	AUX
dti-1311	70	11	determined	determine	VERB
dti-1311	70	12	by	by	ADP
dti-1311	70	13	using	use	VERB
dti-1311	70	14	one	one	NUM
dti-1311	70	15	and	and	CCONJ
dti-1311	70	16	two	two	NUM
dti-1311	70	17	-	-	PUNCT
dti-1311	70	18	way	way	NOUN
dti-1311	70	19	anova	anova	PROPN
dti-1311	70	20	followed	follow	VERB
dti-1311	70	21	by	by	ADP
dti-1311	70	22	multiple	multiple	ADJ
dti-1311	70	23	comparison	comparison	NOUN
dti-1311	70	24	by	by	ADP
dti-1311	70	25	the	the	DET
dti-1311	70	26	tukey	tukey	NOUN
dti-1311	70	27	’s	’s	PART
dti-1311	70	28	honestly	honestly	ADV
dti-1311	70	29	signifi	signifi	NOUN
dti-1311	70	30	ca	can	AUX
dti-1311	70	31	nt	not	PART
dti-1311	70	32	difference	difference	VERB
dti-1311	70	33	.	.	PUNCT
dti-1311	71	1	a	a	DET
dti-1311	71	2	probability	probability	NOUN
dti-1311	71	3	value	value	NOUN
dti-1311	71	4	less	less	ADJ
dti-1311	71	5	than	than	ADP
dti-1311	71	6	0.05	0.05	NUM
dti-1311	71	7	was	be	AUX
dti-1311	71	8	considered	consider	VERB
dti-1311	71	9	statistically	statistically	ADV
dti-1311	71	10	signifi	signifi	NOUN
dti-1311	71	11	ca	can	AUX
dti-1311	71	12	nt	nt	PRON
dti-1311	71	13	.	.	PUNCT
dti-1311	72	1	results	result	VERB
dti-1311	72	2	effect	effect	NOUN
dti-1311	72	3	of	of	ADP
dti-1311	72	4	cinnarizine	cinnarizine	NOUN
dti-1311	72	5	on	on	ADP
dti-1311	72	6	abdominal	abdominal	ADJ
dti-1311	72	7	constrictions	constriction	NOUN
dti-1311	72	8	induced	induce	VERB
dti-1311	72	9	by	by	ADP
dti-1311	72	10	acetic	acetic	ADJ
dti-1311	72	11	acid	acid	NOUN
dti-1311	72	12	cinnarizine	cinnarizine	NOUN
dti-1311	72	13	(	(	PUNCT
dti-1311	72	14	1.25	1.25	NUM
dti-1311	72	15	,	,	PUNCT
dti-1311	72	16	2.5	2.5	NUM
dti-1311	72	17	,	,	PUNCT
dti-1311	72	18	5	5	NUM
dti-1311	72	19	,	,	PUNCT
dti-1311	72	20	10	10	NUM
dti-1311	72	21	or	or	CCONJ
dti-1311	72	22	20	20	NUM
dti-1311	72	23	mg	mg	NUM
dti-1311	72	24	/	/	SYM
dti-1311	72	25	kg	kg	PROPN
dti-1311	72	26	,	,	PUNCT
dti-1311	72	27	s.c	s.c	PROPN
dti-1311	72	28	.	.	PROPN
dti-1311	72	29	)	)	PUNCT
dti-1311	72	30	caused	cause	VERB
dti-1311	72	31	dose	dose	NOUN
dti-1311	72	32	-	-	PUNCT
dti-1311	72	33	dependent	dependent	ADJ
dti-1311	72	34	inhibition	inhibition	NOUN
dti-1311	72	35	of	of	ADP
dti-1311	72	36	the	the	DET
dti-1311	72	37	abdominal	abdominal	ADJ
dti-1311	72	38	constrictions	constriction	NOUN
dti-1311	72	39	evoked	evoke	VERB
dti-1311	72	40	by	by	ADP
dti-1311	72	41	i.p	i.p	PROPN
dti-1311	72	42	.	.	PROPN
dti-1311	72	43	injection	injection	NOUN
dti-1311	72	44	of	of	ADP
dti-1311	72	45	acetic	acetic	ADJ
dti-1311	72	46	acid	acid	NOUN
dti-1311	72	47	by	by	ADP
dti-1311	72	48	38.7–99.4	38.7–99.4	NUM
dti-1311	72	49	%	%	NOUN
dti-1311	72	50	(	(	PUNCT
dti-1311	72	51	fig	fig	NOUN
dti-1311	72	52	.	.	PUNCT
dti-1311	73	1	1	1	NUM
dti-1311	73	2	)	)	PUNCT
dti-1311	73	3	.	.	PUNCT
dti-1311	74	1	this	this	DET
dti-1311	74	2	effect	effect	NOUN
dti-1311	74	3	of	of	ADP
dti-1311	74	4	cinnarizine	cinnarizine	NOUN
dti-1311	74	5	(	(	PUNCT
dti-1311	74	6	2.5	2.5	NUM
dti-1311	74	7	mg	mg	PROPN
dti-1311	74	8	/	/	SYM
dti-1311	74	9	kg	kg	PROPN
dti-1311	74	10	)	)	PUNCT
dti-1311	74	11	was	be	AUX
dti-1311	74	12	unaffected	unaffected	ADJ
dti-1311	74	13	by	by	ADP
dti-1311	74	14	co	co	NOUN
dti-1311	74	15	-	-	NOUN
dti-1311	74	16	administration	administration	NOUN
dti-1311	74	17	of	of	ADP
dti-1311	74	18	the	the	DET
dti-1311	74	19	centrally	centrally	ADV
dti-1311	74	20	acting	act	VERB
dti-1311	74	21	dopamine	dopamine	NOUN
dti-1311	74	22	d2	d2	NOUN
dti-1311	74	23	receptor	receptor	NOUN
dti-1311	74	24	antagonists	antagonist	NOUN
dti-1311	74	25	,	,	PUNCT
dti-1311	74	26	sulpiride	sulpiride	ADV
dti-1311	74	27	,	,	PUNCT
dti-1311	74	28	haloperidol	haloperidol	NOUN
dti-1311	74	29	or	or	CCONJ
dti-1311	74	30	metoclopramide	metoclopramide	NOUN
dti-1311	74	31	,	,	PUNCT
dti-1311	74	32	the	the	DET
dti-1311	74	33	peripherally	peripherally	ADV
dti-1311	74	34	acting	act	VERB
dti-1311	74	35	d2	d2	NOUN
dti-1311	74	36	receptor	receptor	NOUN
dti-1311	74	37	antagonist	antagonist	NOUN
dti-1311	74	38	domperidone	domperidone	NOUN
dti-1311	74	39	,	,	PUNCT
dti-1311	74	40	but	but	CCONJ
dti-1311	74	41	increased	increase	VERB
dti-1311	74	42	by	by	ADP
dti-1311	74	43	the	the	DET
dti-1311	74	44	d2	d2	PROPN
dti-1311	74	45	receptor	receptor	NOUN
dti-1311	74	46	agonist	agonist	NOUN
dti-1311	74	47	bromocryptine	bromocryptine	NOUN
dti-1311	74	48	and	and	CCONJ
dti-1311	74	49	by	by	ADP
dti-1311	74	50	the	the	DET
dti-1311	74	51	non	non	ADJ
dti-1311	74	52	-	-	ADJ
dti-1311	74	53	selective	selective	ADJ
dti-1311	74	54	dopamine	dopamine	NOUN
dti-1311	74	55	receptor	receptor	NOUN
dti-1311	74	56	antagonist	antagonist	NOUN
dti-1311	74	57	chlorpromazine	chlorpromazine	NOUN
dti-1311	74	58	(	(	PUNCT
dti-1311	74	59	fig	fig	NOUN
dti-1311	74	60	.	.	PUNCT
dti-1311	75	1	2	2	NUM
dti-1311	75	2	)	)	PUNCT
dti-1311	75	3	.	.	PUNCT
dti-1311	76	1	the	the	DET
dti-1311	76	2	antinociception	antinociception	NOUN
dti-1311	76	3	caused	cause	VERB
dti-1311	76	4	by	by	ADP
dti-1311	76	5	cinnarizine	cinnarizine	NOUN
dti-1311	76	6	was	be	AUX
dti-1311	76	7	unaffected	unaffected	ADJ
dti-1311	76	8	by	by	ADP
dti-1311	76	9	the	the	DET
dti-1311	76	10	opioid	opioid	ADJ
dti-1311	76	11	receptor	receptor	NOUN
dti-1311	76	12	antagonist	antagonist	NOUN
dti-1311	76	13	naloxone	naloxone	NOUN
dti-1311	76	14	,	,	PUNCT
dti-1311	76	15	but	but	CCONJ
dti-1311	76	16	enhanced	enhance	VERB
dti-1311	76	17	by	by	ADP
dti-1311	76	18	the	the	DET
dti-1311	76	19	beta	beta	NOUN
dti-1311	76	20	-	-	PUNCT
dti-1311	76	21	adrenergic	adrenergic	ADJ
dti-1311	76	22	antagonist	antagonist	NOUN
dti-1311	76	23	propranolol	propranolol	NOUN
dti-1311	76	24	,	,	PUNCT
dti-1311	76	25	the	the	DET
dti-1311	76	26	muscarinic	muscarinic	ADJ
dti-1311	76	27	receptor	receptor	NOUN
dti-1311	76	28	antagonist	antagonist	NOUN
dti-1311	76	29	atropine	atropine	NOUN
dti-1311	76	30	and	and	CCONJ
dti-1311	76	31	by	by	ADP
dti-1311	76	32	the	the	DET
dti-1311	76	33	alpha2	alpha2	NOUN
dti-1311	76	34	-	-	PUNCT
dti-1311	76	35	adrenergic	adrenergic	ADJ
dti-1311	76	36	antagonist	antagonist	NOUN
dti-1311	76	37	yohimbine	yohimbine	NOUN
dti-1311	76	38	(	(	PUNCT
dti-1311	76	39	fig	fig	NOUN
dti-1311	76	40	.	.	PUNCT
dti-1311	77	1	3	3	NUM
dti-1311	77	2	)	)	PUNCT
dti-1311	77	3	.	.	PUNCT
dti-1311	78	1	the	the	DET
dti-1311	78	2	antinociceptive	antinociceptive	ADJ
dti-1311	78	3	effect	effect	NOUN
dti-1311	78	4	of	of	ADP
dti-1311	78	5	cinnarizine	cinnarizine	NOUN
dti-1311	78	6	was	be	AUX
dti-1311	78	7	prevented	prevent	VERB
dti-1311	78	8	by	by	ADP
dti-1311	78	9	co	co	NOUN
dti-1311	78	10	-	-	NOUN
dti-1311	78	11	treatment	treatment	NOUN
dti-1311	78	12	with	with	ADP
dti-1311	78	13	the	the	DET
dti-1311	78	14	adenosine	adenosine	ADJ
dti-1311	78	15	receptor	receptor	NOUN
dti-1311	78	16	blocker	blocker	NOUN
dti-1311	78	17	theophylline	theophylline	NOUN
dti-1311	78	18	(	(	PUNCT
dti-1311	78	19	fig	fig	NOUN
dti-1311	78	20	.	.	PUNCT
dti-1311	79	1	4	4	NUM
dti-1311	79	2	)	)	PUNCT
dti-1311	79	3	and	and	CCONJ
dti-1311	79	4	by	by	ADP
dti-1311	79	5	k	k	ADJ
dti-1311	79	6	-	-	PUNCT
dti-1311	79	7	channel	channel	NOUN
dti-1311	79	8	blocker	blocker	NOUN
dti-1311	79	9	glibenclamide	glibenclamide	NOUN
dti-1311	79	10	(	(	PUNCT
dti-1311	79	11	fig	fig	NOUN
dti-1311	79	12	.	.	PUNCT
dti-1311	79	13	5	5	NUM
dti-1311	79	14	)	)	PUNCT
dti-1311	79	15	.	.	PUNCT
dti-1311	80	1	cinnarizine	cinnarizine	PROPN
dti-1311	80	2	at	at	ADP
dti-1311	80	3	2.5	2.5	NUM
dti-1311	80	4	mg	mg	NOUN
dti-1311	80	5	/	/	SYM
dti-1311	80	6	kg	kg	PROPN
dti-1311	80	7	reversed	reverse	VERB
dti-1311	80	8	the	the	DET
dti-1311	80	9	baclofen	baclofen	NOUN
dti-1311	80	10	-	-	PUNCT
dti-1311	80	11	induced	induce	VERB
dti-1311	80	12	antinociception	antinociception	NOUN
dti-1311	80	13	(	(	PUNCT
dti-1311	80	14	fig	fig	NOUN
dti-1311	80	15	.	.	PUNCT
dti-1311	81	1	5	5	NUM
dti-1311	81	2	)	)	PUNCT
dti-1311	81	3	.	.	PUNCT
dti-1311	82	1	cinnarizine	cinnarizine	PROPN
dti-1311	82	2	enhanced	enhance	VERB
dti-1311	82	3	the	the	DET
dti-1311	82	4	antinociceptive	antinociceptive	ADJ
dti-1311	82	5	effect	effect	NOUN
dti-1311	82	6	of	of	ADP
dti-1311	82	7	piracetam	piracetam	NOUN
dti-1311	82	8	or	or	CCONJ
dti-1311	82	9	vinpocetine	vinpocetine	NOUN
dti-1311	82	10	(	(	PUNCT
dti-1311	82	11	fig	fig	NOUN
dti-1311	82	12	.	.	PUNCT
dti-1311	82	13	6	6	NUM
dti-1311	82	14	)	)	PUNCT
dti-1311	82	15	.	.	PUNCT
dti-1311	83	1	when	when	SCONJ
dti-1311	83	2	indomethacin	indomethacin	PROPN
dti-1311	83	3	(	(	PUNCT
dti-1311	83	4	5	5	NUM
dti-1311	83	5	mg	mg	PROPN
dti-1311	83	6	/	/	SYM
dti-1311	83	7	kg	kg	PROPN
dti-1311	83	8	,	,	PUNCT
dti-1311	83	9	i.p	i.p	PROPN
dti-1311	83	10	.	.	PROPN
dti-1311	83	11	)	)	PUNCT
dti-1311	83	12	was	be	AUX
dti-1311	83	13	administered	administer	VERB
dti-1311	83	14	in	in	ADP
dti-1311	83	15	combination	combination	NOUN
dti-1311	83	16	with	with	ADP
dti-1311	83	17	cinnarizine	cinnarizine	NOUN
dti-1311	83	18	(	(	PUNCT
dti-1311	83	19	2.5	2.5	NUM
dti-1311	83	20	mg	mg	PROPN
dti-1311	83	21	/	/	SYM
dti-1311	83	22	kg	kg	PROPN
dti-1311	83	23	,	,	PUNCT
dti-1311	83	24	s.c	s.c	PROPN
dti-1311	83	25	)	)	PUNCT
dti-1311	83	26	,	,	PUNCT
dti-1311	83	27	an	an	DET
dti-1311	83	28	additive	additive	ADJ
dti-1311	83	29	effect	effect	NOUN
dti-1311	83	30	was	be	AUX
dti-1311	83	31	noted	note	VERB
dti-1311	83	32	(	(	PUNCT
dti-1311	83	33	fig	fig	NOUN
dti-1311	83	34	.	.	PUNCT
dti-1311	84	1	7	7	NUM
dti-1311	84	2	)	)	PUNCT
dti-1311	84	3	.	.	PUNCT
dti-1311	85	1	rotarod	rotarod	NOUN
dti-1311	85	2	testing	testing	NOUN
dti-1311	85	3	cinnarizine	cinnarizine	NOUN
dti-1311	85	4	(	(	PUNCT
dti-1311	85	5	1.5–20	1.5–20	NUM
dti-1311	85	6	mg	mg	PROPN
dti-1311	85	7	/	/	SYM
dti-1311	85	8	kg	kg	PROPN
dti-1311	85	9	)	)	PUNCT
dti-1311	85	10	did	do	AUX
dti-1311	85	11	not	not	PART
dti-1311	85	12	produce	produce	VERB
dti-1311	85	13	any	any	DET
dti-1311	85	14	signifi	signifi	NOUN
dti-1311	85	15	ca	can	AUX
dti-1311	85	16	nt	not	PART
dti-1311	85	17	changes	change	VERB
dti-1311	85	18	on	on	ADP
dti-1311	85	19	the	the	DET
dti-1311	85	20	rotarod	rotarod	NOUN
dti-1311	85	21	performances	performance	NOUN
dti-1311	85	22	of	of	ADP
dti-1311	85	23	the	the	DET
dti-1311	85	24	mice	mouse	NOUN
dti-1311	85	25	.	.	PUNCT
dti-1311	86	1	there	there	PRON
dti-1311	86	2	was	be	VERB
dti-1311	86	3	no	no	DET
dti-1311	86	4	signifi	signifi	NOUN
dti-1311	86	5	ca	can	AUX
dti-1311	86	6	nt	not	PART
dti-1311	86	7	difference	difference	VERB
dti-1311	86	8	between	between	ADP
dti-1311	86	9	the	the	DET
dti-1311	86	10	control	control	NOUN
dti-1311	86	11	group	group	NOUN
dti-1311	86	12	and	and	CCONJ
dti-1311	86	13	cinnarizine	cinnarizine	NOUN
dti-1311	86	14	-	-	PUNCT
dti-1311	86	15	treated	treat	VERB
dti-1311	86	16	groups	group	NOUN
dti-1311	86	17	in	in	ADP
dti-1311	86	18	the	the	DET
dti-1311	86	19	latency	latency	NOUN
dti-1311	86	20	to	to	PART
dti-1311	86	21	fall	fall	VERB
dti-1311	86	22	(	(	PUNCT
dti-1311	86	23	table	table	NOUN
dti-1311	86	24	1	1	NUM
dti-1311	86	25	)	)	PUNCT
dti-1311	86	26	.	.	PUNCT
dti-1311	87	1	effect	effect	NOUN
dti-1311	87	2	of	of	ADP
dti-1311	87	3	cinnaizine	cinnaizine	NOUN
dti-1311	87	4	on	on	ADP
dti-1311	87	5	immobility	immobility	NOUN
dti-1311	87	6	time	time	NOUN
dti-1311	87	7	in	in	ADP
dti-1311	87	8	porsolt	porsolt	NOUN
dti-1311	87	9	’s	’s	PART
dti-1311	87	10	forced	force	VERB
dti-1311	87	11	-	-	PUNCT
dti-1311	87	12	swimming	swimming	NOUN
dti-1311	87	13	test	test	NOUN
dti-1311	87	14	cinnarizine	cinnarizine	NOUN
dti-1311	87	15	administered	administer	VERB
dti-1311	87	16	at	at	ADP
dti-1311	87	17	2.5	2.5	NUM
dti-1311	87	18	mg	mg	NOUN
dti-1311	87	19	/	/	SYM
dti-1311	87	20	kg	kg	PROPN
dti-1311	87	21	reduced	reduce	VERB
dti-1311	87	22	immobility	immobility	NOUN
dti-1311	87	23	time	time	NOUN
dti-1311	87	24	in	in	ADP
dti-1311	87	25	the	the	DET
dti-1311	87	26	porsolt	porsolt	NOUN
dti-1311	87	27	’s	’s	PART
dti-1311	87	28	forced	force	VERB
dti-1311	87	29	-	-	PUNCT
dti-1311	87	30	swimming	swimming	NOUN
dti-1311	87	31	figure	figure	NOUN
dti-1311	87	32	1	1	NUM
dti-1311	87	33	.	.	PUNCT
dti-1311	87	34	effect	effect	NOUN
dti-1311	87	35	of	of	ADP
dti-1311	87	36	different	different	ADJ
dti-1311	87	37	doses	dose	NOUN
dti-1311	87	38	of	of	ADP
dti-1311	87	39	cinnarizine	cinnarizine	NOUN
dti-1311	87	40	(	(	PUNCT
dti-1311	87	41	1.25	1.25	NUM
dti-1311	87	42	,	,	PUNCT
dti-1311	87	43	2.5	2.5	NUM
dti-1311	87	44	,	,	PUNCT
dti-1311	87	45	5	5	NUM
dti-1311	87	46	,	,	PUNCT
dti-1311	87	47	10	10	NUM
dti-1311	87	48	and	and	CCONJ
dti-1311	87	49	20	20	NUM
dti-1311	87	50	mg	mg	NUM
dti-1311	87	51	/	/	SYM
dti-1311	87	52	kg	kg	NOUN
dti-1311	87	53	)	)	PUNCT
dti-1311	87	54	on	on	ADP
dti-1311	87	55	abdominal	abdominal	ADJ
dti-1311	87	56	constrictions	constriction	NOUN
dti-1311	87	57	caused	cause	VERB
dti-1311	87	58	by	by	ADP
dti-1311	87	59	i.p	i.p	PROPN
dti-1311	87	60	.	.	PROPN
dti-1311	87	61	injection	injection	NOUN
dti-1311	87	62	of	of	ADP
dti-1311	87	63	dilute	dilute	ADJ
dti-1311	87	64	acetic	acetic	ADJ
dti-1311	87	65	acid	acid	NOUN
dti-1311	87	66	in	in	ADP
dti-1311	87	67	mice	mouse	NOUN
dti-1311	87	68	.	.	PUNCT
dti-1311	88	1	saline	saline	NOUN
dti-1311	88	2	(	(	PUNCT
dti-1311	88	3	control	control	NOUN
dti-1311	88	4	)	)	PUNCT
dti-1311	88	5	or	or	CCONJ
dti-1311	88	6	cinnarizine	cinnarizine	NOUN
dti-1311	88	7	was	be	AUX
dti-1311	88	8	s.c	s.c	PROPN
dti-1311	88	9	.	.	PROPN
dti-1311	89	1	administered	administer	VERB
dti-1311	89	2	30	30	NUM
dti-1311	89	3	min	min	NOUN
dti-1311	89	4	prior	prior	ADV
dti-1311	89	5	to	to	ADP
dti-1311	89	6	testing	testing	NOUN
dti-1311	89	7	.	.	PUNCT
dti-1311	90	1	data	datum	NOUN
dti-1311	90	2	are	be	AUX
dti-1311	90	3	expressed	express	VERB
dti-1311	90	4	as	as	ADP
dti-1311	90	5	mean	mean	PROPN
dti-1311	90	6	±	±	NUM
dti-1311	90	7	s.e	s.e	PROPN
dti-1311	90	8	.	.	PROPN
dti-1311	90	9	percent	percent	NOUN
dti-1311	90	10	inhibition	inhibition	NOUN
dti-1311	90	11	(	(	PUNCT
dti-1311	90	12	%	%	INTJ
dti-1311	90	13	)	)	PUNCT
dti-1311	90	14	compared	compare	VERB
dti-1311	90	15	to	to	ADP
dti-1311	90	16	the	the	DET
dti-1311	90	17	control	control	NOUN
dti-1311	90	18	animals	animal	NOUN
dti-1311	90	19	are	be	AUX
dti-1311	90	20	also	also	ADV
dti-1311	90	21	shown	show	VERB
dti-1311	90	22	.	.	PUNCT
dti-1311	91	1	*	*	PUNCT
dti-1311	91	2	p	p	X
dti-1311	91	3	<	<	X
dti-1311	91	4	0.05	0.05	NUM
dti-1311	91	5	vs.	vs.	ADP
dti-1311	91	6	control	control	NOUN
dti-1311	91	7	.	.	PUNCT
dti-1311	92	1	six	six	NUM
dti-1311	92	2	mice	mouse	NOUN
dti-1311	92	3	were	be	AUX
dti-1311	92	4	used	use	VERB
dti-1311	92	5	per	per	ADP
dti-1311	92	6	each	each	DET
dti-1311	92	7	group	group	NOUN
dti-1311	92	8	.	.	PUNCT
dti-1311	93	1	con	con	PROPN
dti-1311	93	2	tro	tro	PROPN
dti-1311	93	3	l	l	PROPN
dti-1311	93	4	cinn	cinn	PROPN
dti-1311	93	5	ari	ari	PROPN
dti-1311	93	6	zin	zin	PROPN
dti-1311	93	7	e	e	NOUN
dti-1311	93	8	1	1	NUM
dti-1311	93	9	.25	.25	NUM
dti-1311	93	10	m	m	NOUN
dti-1311	93	11	g	g	PROPN
dti-1311	93	12	/	/	SYM
dti-1311	93	13	k	k	PROPN
dti-1311	93	14	g	g	PROPN
dti-1311	93	15	cinn	cinn	PROPN
dti-1311	93	16	ari	ari	PROPN
dti-1311	93	17	zin	zin	PROPN
dti-1311	93	18	e	e	PROPN
dti-1311	93	19	2	2	NUM
dti-1311	93	20	.5	.5	NUM
dti-1311	93	21	mg	mg	PROPN
dti-1311	93	22	/	/	SYM
dti-1311	93	23	k	k	PROPN
dti-1311	93	24	g	g	PROPN
dti-1311	93	25	cinn	cinn	PROPN
dti-1311	93	26	ari	ari	PROPN
dti-1311	93	27	zin	zin	PROPN
dti-1311	93	28	e	e	PROPN
dti-1311	93	29	5	5	NUM
dti-1311	93	30	m	m	NOUN
dti-1311	93	31	g	g	NOUN
dti-1311	93	32	/	/	SYM
dti-1311	93	33	k	k	PROPN
dti-1311	93	34	g	g	PROPN
dti-1311	93	35	cinn	cinn	PROPN
dti-1311	93	36	ari	ari	PROPN
dti-1311	93	37	zin	zin	PROPN
dti-1311	93	38	e	e	NOUN
dti-1311	93	39	1	1	NUM
dti-1311	93	40	0	0	NUM
dti-1311	93	41	m	m	NOUN
dti-1311	93	42	g	g	NOUN
dti-1311	93	43	/	/	SYM
dti-1311	93	44	k	k	PROPN
dti-1311	93	45	g	g	PROPN
dti-1311	93	46	cinn	cinn	PROPN
dti-1311	93	47	ari	ari	PROPN
dti-1311	93	48	zin	zin	PROPN
dti-1311	93	49	e	e	NOUN
dti-1311	93	50	2	2	NUM
dti-1311	93	51	0	0	NUM
dti-1311	93	52	m	m	NOUN
dti-1311	93	53	g	g	NOUN
dti-1311	93	54	/	/	SYM
dti-1311	93	55	k	k	PROPN
dti-1311	93	56	g	g	PROPN
dti-1311	93	57	0	0	NUM
dti-1311	93	58	10	10	NUM
dti-1311	93	59	20	20	NUM
dti-1311	93	60	30	30	NUM
dti-1311	93	61	40	40	NUM
dti-1311	93	62	50	50	NUM
dti-1311	93	63	60	60	NUM
dti-1311	93	64	70	70	NUM
dti-1311	94	1	*	*	PUNCT
dti-1311	95	1	*	*	PUNCT
dti-1311	96	1	*	*	PUNCT
dti-1311	96	2	*	*	PUNCT
dti-1311	97	1	*	*	PUNCT
dti-1311	97	2	-38.7	-38.7	NUM
dti-1311	97	3	%	%	NOUN
dti-1311	97	4	-53.1	-53.1	ADJ
dti-1311	97	5	%	%	NOUN
dti-1311	97	6	-94.5	-94.5	NUM
dti-1311	97	7	%	%	NOUN
dti-1311	97	8	-99.4	-99.4	NUM
dti-1311	97	9	%	%	NOUN
dti-1311	97	10	-58.6	-58.6	NOUN
dti-1311	97	11	%	%	NOUN
dti-1311	97	12	n	n	AUX
dti-1311	97	13	um	um	INTJ
dti-1311	97	14	be	be	AUX
dti-1311	97	15	r	r	NOUN
dti-1311	97	16	o	o	NOUN
dti-1311	97	17	f	f	X
dti-1311	98	1	a	a	DET
dti-1311	98	2	bd	bd	PROPN
dti-1311	98	3	om	om	PROPN
dti-1311	98	4	in	in	ADP
dti-1311	98	5	al	al	PROPN
dti-1311	98	6	c	c	PROPN
dti-1311	98	7	on	on	ADP
dti-1311	98	8	st	st	PROPN
dti-1311	98	9	ri	ri	PROPN
dti-1311	98	10	ct	ct	PROPN
dti-1311	98	11	io	io	X
dti-1311	98	12	ns	ns	PROPN
dti-1311	98	13	drug	drug	NOUN
dti-1311	98	14	target	target	NOUN
dti-1311	98	15	insights	insight	NOUN
dti-1311	98	16	2007	2007	NUM
dti-1311	98	17	:	:	PUNCT
dti-1311	98	18	232	232	NUM
dti-1311	98	19	omar	omar	PROPN
dti-1311	98	20	m.e	m.e	PROPN
dti-1311	98	21	.	.	PROPN
dti-1311	98	22	abdel	abdel	PROPN
dti-1311	98	23	-	-	PUNCT
dti-1311	98	24	salam	salam	PROPN
dti-1311	98	25	test	test	NOUN
dti-1311	98	26	by	by	ADP
dti-1311	98	27	24	24	NUM
dti-1311	98	28	%	%	NOUN
dti-1311	98	29	,	,	PUNCT
dti-1311	98	30	although	although	SCONJ
dti-1311	98	31	higher	high	ADJ
dti-1311	98	32	doses	dose	NOUN
dti-1311	98	33	of	of	ADP
dti-1311	98	34	the	the	DET
dti-1311	98	35	drug	drug	NOUN
dti-1311	98	36	failed	fail	VERB
dti-1311	98	37	to	to	PART
dti-1311	98	38	alter	alter	VERB
dti-1311	98	39	immobility	immobility	NOUN
dti-1311	98	40	time	time	NOUN
dti-1311	98	41	(	(	PUNCT
dti-1311	98	42	fig	fig	NOUN
dti-1311	98	43	.	.	PUNCT
dti-1311	99	1	8)	8)	NUM
dti-1311	99	2	.	.	PUNCT
dti-1311	99	3	effect	effect	NOUN
dti-1311	99	4	of	of	ADP
dti-1311	99	5	cinnarizine	cinnarizine	NOUN
dti-1311	99	6	on	on	ADP
dti-1311	99	7	the	the	DET
dti-1311	99	8	carrageenan	carrageenan	NOUN
dti-1311	99	9	-	-	PUNCT
dti-1311	99	10	induced	induce	VERB
dti-1311	99	11	paw	paw	NOUN
dti-1311	99	12	oedema	oedema	PROPN
dti-1311	99	13	carrageenan	carrageenan	NOUN
dti-1311	99	14	injected	inject	VERB
dti-1311	99	15	into	into	ADP
dti-1311	99	16	the	the	DET
dti-1311	99	17	rat	rat	NOUN
dti-1311	99	18	hind	hind	NOUN
dti-1311	99	19	paw	paw	PROPN
dti-1311	99	20	elicited	elicit	VERB
dti-1311	99	21	an	an	DET
dti-1311	99	22	infl	infl	PROPN
dti-1311	99	23	ammation	ammation	NOUN
dti-1311	99	24	(	(	PUNCT
dti-1311	99	25	swelling	swelling	NOUN
dti-1311	99	26	and	and	CCONJ
dti-1311	99	27	erythema	erythema	ADJ
dti-1311	99	28	)	)	PUNCT
dti-1311	99	29	and	and	CCONJ
dti-1311	99	30	a	a	DET
dti-1311	99	31	time	time	NOUN
dti-1311	99	32	-	-	PUNCT
dti-1311	99	33	dependent	dependent	ADJ
dti-1311	99	34	increase	increase	NOUN
dti-1311	99	35	in	in	ADP
dti-1311	99	36	paw	paw	NOUN
dti-1311	99	37	volume	volume	NOUN
dti-1311	99	38	.	.	PUNCT
dti-1311	100	1	in	in	ADP
dti-1311	100	2	the	the	DET
dti-1311	100	3	control	control	NOUN
dti-1311	100	4	group	group	NOUN
dti-1311	100	5	,	,	PUNCT
dti-1311	100	6	paw	paw	PROPN
dti-1311	100	7	volume	volume	NOUN
dti-1311	100	8	increased	increase	VERB
dti-1311	100	9	by	by	ADP
dti-1311	100	10	128.5	128.5	NUM
dti-1311	100	11	±	±	NUM
dti-1311	100	12	10.6	10.6	NUM
dti-1311	100	13	%	%	NOUN
dti-1311	100	14	at	at	ADP
dti-1311	100	15	4	4	NUM
dti-1311	100	16	h	h	NOUN
dti-1311	100	17	after	after	ADP
dti-1311	100	18	injection	injection	NOUN
dti-1311	100	19	of	of	ADP
dti-1311	100	20	carrageenan	carrageenan	NOUN
dti-1311	100	21	.	.	PUNCT
dti-1311	101	1	cinnarizine	cinnarizine	PROPN
dti-1311	101	2	at	at	ADP
dti-1311	101	3	1.25	1.25	NUM
dti-1311	101	4	or	or	CCONJ
dti-1311	101	5	2.5	2.5	NUM
dti-1311	101	6	administered	administer	VERB
dti-1311	101	7	s.c	s.c	PROPN
dti-1311	101	8	.	.	PROPN
dti-1311	101	9	,	,	PUNCT
dti-1311	101	10	30	30	NUM
dti-1311	101	11	min	min	NOUN
dti-1311	101	12	prior	prior	ADV
dti-1311	101	13	to	to	ADP
dti-1311	101	14	carrageenan	carrageenan	NOUN
dti-1311	101	15	had	have	VERB
dti-1311	101	16	no	no	DET
dti-1311	101	17	significant	significant	ADJ
dti-1311	101	18	effect	effect	NOUN
dti-1311	101	19	on	on	ADP
dti-1311	101	20	the	the	DET
dti-1311	101	21	paw	paw	NOUN
dti-1311	101	22	oedema	oedema	NOUN
dti-1311	101	23	.	.	PUNCT
dti-1311	102	1	cinnarizine	cinnarizine	NOUN
dti-1311	102	2	at	at	ADP
dti-1311	102	3	5	5	NUM
dti-1311	102	4	,	,	PUNCT
dti-1311	102	5	10	10	NUM
dti-1311	102	6	and	and	CCONJ
dti-1311	102	7	20	20	NUM
dti-1311	102	8	mg	mg	NUM
dti-1311	102	9	/	/	SYM
dti-1311	102	10	kg	kg	PROPN
dti-1311	102	11	induced	induce	VERB
dti-1311	102	12	a	a	DET
dti-1311	102	13	dose	dose	NOUN
dti-1311	102	14	-	-	PUNCT
dti-1311	102	15	dependent	dependent	ADJ
dti-1311	102	16	inhibition	inhibition	NOUN
dti-1311	102	17	of	of	ADP
dti-1311	102	18	paw	paw	ADJ
dti-1311	102	19	oedema	oedema	ADJ
dti-1311	102	20	response	response	NOUN
dti-1311	102	21	to	to	ADP
dti-1311	102	22	carrageenan	carrageenan	NOUN
dti-1311	102	23	(	(	PUNCT
dti-1311	102	24	100	100	NUM
dti-1311	102	25	ml	ml	NOUN
dti-1311	102	26	/	/	SYM
dti-1311	102	27	paw	paw	NOUN
dti-1311	102	28	)	)	PUNCT
dti-1311	102	29	which	which	PRON
dti-1311	102	30	was	be	AUX
dti-1311	102	31	apparent	apparent	ADJ
dti-1311	102	32	within	within	ADP
dti-1311	102	33	1	1	NUM
dti-1311	102	34	h	h	NOUN
dti-1311	102	35	of	of	ADP
dti-1311	102	36	carrageenan	carrageenan	NOUN
dti-1311	102	37	injection	injection	NOUN
dti-1311	102	38	and	and	CCONJ
dti-1311	102	39	with	with	ADP
dti-1311	102	40	a	a	DET
dti-1311	102	41	maximal	maximal	ADJ
dti-1311	102	42	inhibitory	inhibitory	ADJ
dti-1311	102	43	effect	effect	NOUN
dti-1311	102	44	of	of	ADP
dti-1311	102	45	–	–	PUNCT
dti-1311	102	46	22.7	22.7	NUM
dti-1311	102	47	,	,	PUNCT
dti-1311	102	48	–	–	PUNCT
dti-1311	102	49	29.9	29.9	NUM
dti-1311	102	50	and	and	CCONJ
dti-1311	102	51	–	–	PUNCT
dti-1311	102	52	43.4	43.4	NUM
dti-1311	102	53	%	%	NOUN
dti-1311	102	54	,	,	PUNCT
dti-1311	102	55	respectively	respectively	ADV
dti-1311	102	56	(	(	PUNCT
dti-1311	102	57	fig	fig	NOUN
dti-1311	102	58	.	.	PUNCT
dti-1311	102	59	9	9	NUM
dti-1311	102	60	)	)	PUNCT
dti-1311	102	61	.	.	PUNCT
dti-1311	103	1	the	the	DET
dti-1311	103	2	percentages	percentage	NOUN
dti-1311	103	3	of	of	ADP
dti-1311	103	4	inhibition	inhibition	NOUN
dti-1311	103	5	of	of	ADP
dti-1311	103	6	the	the	DET
dti-1311	103	7	oedema	oedema	ADJ
dti-1311	103	8	response	response	NOUN
dti-1311	103	9	were	be	AUX
dti-1311	103	10	–	–	PUNCT
dti-1311	103	11	27.3	27.3	NUM
dti-1311	103	12	,	,	PUNCT
dti-1311	103	13	–	–	PUNCT
dti-1311	103	14	22.7	22.7	NUM
dti-1311	103	15	,	,	PUNCT
dti-1311	103	16	–	–	PUNCT
dti-1311	103	17	17.8	17.8	NUM
dti-1311	103	18	,	,	PUNCT
dti-1311	103	19	–	–	PUNCT
dti-1311	103	20	19.6	19.6	NUM
dti-1311	103	21	%	%	NOUN
dti-1311	103	22	by	by	ADP
dti-1311	103	23	5	5	NUM
dti-1311	103	24	mg	mg	PROPN
dti-1311	103	25	/	/	SYM
dti-1311	103	26	kg	kg	PROPN
dti-1311	103	27	cinnarizine	cinnarizine	NOUN
dti-1311	103	28	;	;	PUNCT
dti-1311	103	29	–	–	PUNCT
dti-1311	103	30	23.6	23.6	NUM
dti-1311	103	31	,	,	PUNCT
dti-1311	103	32	–	–	PUNCT
dti-1311	103	33	28.8	28.8	NUM
dti-1311	103	34	,	,	PUNCT
dti-1311	103	35	–	–	PUNCT
dti-1311	103	36	29.9	29.9	NUM
dti-1311	103	37	,	,	PUNCT
dti-1311	103	38	–	–	PUNCT
dti-1311	103	39	21.2	21.2	NUM
dti-1311	103	40	%	%	NOUN
dti-1311	103	41	by	by	ADP
dti-1311	103	42	10	10	NUM
dti-1311	103	43	mg	mg	PROPN
dti-1311	103	44	/	/	SYM
dti-1311	103	45	kg	kg	PROPN
dti-1311	103	46	cinnarizine	cinnarizine	NOUN
dti-1311	103	47	and	and	CCONJ
dti-1311	103	48	–	–	PUNCT
dti-1311	103	49	43.4	43.4	NUM
dti-1311	103	50	,	,	PUNCT
dti-1311	103	51	–	–	PUNCT
dti-1311	103	52	38.7	38.7	NUM
dti-1311	103	53	,	,	PUNCT
dti-1311	103	54	–	–	PUNCT
dti-1311	103	55	37	37	NUM
dti-1311	103	56	,	,	PUNCT
dti-1311	103	57	–	–	PUNCT
dti-1311	103	58	26.4	26.4	NUM
dti-1311	103	59	%	%	NOUN
dti-1311	103	60	by	by	ADP
dti-1311	103	61	20	20	NUM
dti-1311	103	62	mg	mg	PROPN
dti-1311	103	63	/	/	SYM
dti-1311	103	64	kg	kg	PROPN
dti-1311	103	65	cinnarizine	cinnarizine	NOUN
dti-1311	103	66	at	at	ADP
dti-1311	103	67	1	1	NUM
dti-1311	103	68	,	,	PUNCT
dti-1311	103	69	2	2	NUM
dti-1311	103	70	,	,	PUNCT
dti-1311	103	71	3	3	NUM
dti-1311	103	72	and	and	CCONJ
dti-1311	103	73	4	4	NUM
dti-1311	103	74	h	h	NOUN
dti-1311	103	75	post	post	NOUN
dti-1311	103	76	-	-	NOUN
dti-1311	103	77	carrageenan	carrageenan	NOUN
dti-1311	103	78	,	,	PUNCT
dti-1311	103	79	respectively	respectively	ADV
dti-1311	103	80	.	.	PUNCT
dti-1311	104	1	two	two	NUM
dti-1311	104	2	-	-	PUNCT
dti-1311	104	3	way	way	NOUN
dti-1311	104	4	anova	anova	PROPN
dti-1311	104	5	revealed	reveal	VERB
dti-1311	104	6	a	a	DET
dti-1311	104	7	signifi	signifi	NOUN
dti-1311	104	8	ca	can	AUX
dti-1311	104	9	nt	not	PART
dti-1311	104	10	main	main	ADJ
dti-1311	104	11	effect	effect	NOUN
dti-1311	104	12	for	for	ADP
dti-1311	104	13	treatment	treatment	NOUN
dti-1311	104	14	(	(	PUNCT
dti-1311	104	15	f3	f3	ADJ
dti-1311	104	16	,	,	PUNCT
dti-1311	104	17	84	84	NUM
dti-1311	104	18	=	=	SYM
dti-1311	104	19	6.9	6.9	NUM
dti-1311	104	20	;	;	PUNCT
dti-1311	104	21	p	p	X
dti-1311	104	22	<	<	X
dti-1311	104	23	0.001	0.001	NUM
dti-1311	104	24	)	)	PUNCT
dti-1311	104	25	and	and	CCONJ
dti-1311	104	26	time	time	NOUN
dti-1311	104	27	(	(	PUNCT
dti-1311	104	28	f3	f3	ADJ
dti-1311	104	29	,	,	PUNCT
dti-1311	104	30	85	85	NUM
dti-1311	104	31	=	=	SYM
dti-1311	104	32	64.2	64.2	NUM
dti-1311	104	33	;	;	PUNCT
dti-1311	104	34	p	p	X
dti-1311	104	35	<	<	X
dti-1311	104	36	0.001	0.001	NUM
dti-1311	104	37	)	)	PUNCT
dti-1311	104	38	.	.	PUNCT
dti-1311	105	1	post	post	ADJ
dti-1311	105	2	-	-	ADJ
dti-1311	105	3	hoc	hoc	ADJ
dti-1311	105	4	analysis	analysis	NOUN
dti-1311	105	5	showed	show	VERB
dti-1311	105	6	signifi	signifi	NOUN
dti-1311	105	7	ca	can	AUX
dti-1311	105	8	nt	not	PART
dti-1311	105	9	inhibition	inhibition	VERB
dti-1311	105	10	of	of	ADP
dti-1311	105	11	oedema	oedema	ADJ
dti-1311	105	12	formation	formation	NOUN
dti-1311	105	13	by	by	ADP
dti-1311	105	14	5	5	NUM
dti-1311	105	15	,	,	PUNCT
dti-1311	105	16	10	10	NUM
dti-1311	105	17	or	or	CCONJ
dti-1311	105	18	20	20	NUM
dti-1311	105	19	mg	mg	NUM
dti-1311	105	20	/	/	SYM
dti-1311	105	21	kg	kg	PROPN
dti-1311	105	22	of	of	ADP
dti-1311	105	23	cinnarizine	cinnarizine	NOUN
dti-1311	105	24	at	at	ADP
dti-1311	105	25	all	all	DET
dti-1311	105	26	time	time	NOUN
dti-1311	105	27	points	point	NOUN
dti-1311	105	28	in	in	ADP
dti-1311	105	29	the	the	DET
dti-1311	105	30	test	test	NOUN
dti-1311	105	31	.	.	PUNCT
dti-1311	106	1	rats	rat	NOUN
dti-1311	106	2	treated	treat	VERB
dti-1311	106	3	with	with	ADP
dti-1311	106	4	cinnarizine	cinnarizine	NOUN
dti-1311	106	5	at	at	ADP
dti-1311	106	6	20	20	NUM
dti-1311	106	7	mg	mg	NOUN
dti-1311	106	8	/	/	SYM
dti-1311	106	9	kg	kg	PROPN
dti-1311	106	10	showed	show	VERB
dti-1311	106	11	signifi	signifi	NOUN
dti-1311	106	12	cantly	cantly	ADV
dti-1311	106	13	less	less	ADJ
dti-1311	106	14	oedema	oedema	ADJ
dti-1311	106	15	than	than	ADP
dti-1311	106	16	those	those	PRON
dti-1311	106	17	given	give	VERB
dti-1311	106	18	2.5	2.5	NUM
dti-1311	106	19	or	or	CCONJ
dti-1311	106	20	5	5	NUM
dti-1311	106	21	mg	mg	PROPN
dti-1311	106	22	/	/	SYM
dti-1311	106	23	kg	kg	PROPN
dti-1311	106	24	cinnarizine	cinnarizine	NOUN
dti-1311	106	25	at	at	ADP
dti-1311	106	26	1	1	NUM
dti-1311	106	27	,	,	PUNCT
dti-1311	106	28	2	2	NUM
dti-1311	106	29	and	and	CCONJ
dti-1311	106	30	3	3	NUM
dti-1311	106	31	h	h	NOUN
dti-1311	106	32	time	time	NOUN
dti-1311	106	33	points	point	NOUN
dti-1311	106	34	and	and	CCONJ
dti-1311	106	35	than	than	ADP
dti-1311	106	36	those	those	PRON
dti-1311	106	37	treated	treat	VERB
dti-1311	106	38	with	with	ADP
dti-1311	106	39	1.25	1.25	NUM
dti-1311	106	40	mg	mg	PROPN
dti-1311	106	41	/	/	SYM
dti-1311	106	42	kg	kg	PROPN
dti-1311	106	43	cinnarizine	cinnarizine	NOUN
dti-1311	106	44	at	at	ADV
dti-1311	106	45	all	all	DET
dti-1311	106	46	time	time	NOUN
dti-1311	106	47	points	point	NOUN
dti-1311	106	48	in	in	ADP
dti-1311	106	49	the	the	DET
dti-1311	106	50	test	test	NOUN
dti-1311	106	51	.	.	PUNCT
dti-1311	107	1	figure	figure	NOUN
dti-1311	107	2	2	2	NUM
dti-1311	107	3	.	.	PUNCT
dti-1311	107	4	effect	effect	NOUN
dti-1311	107	5	of	of	ADP
dti-1311	107	6	haloperidol	haloperidol	NOUN
dti-1311	107	7	(	(	PUNCT
dti-1311	107	8	1.5	1.5	NUM
dti-1311	107	9	mg	mg	PROPN
dti-1311	107	10	/	/	SYM
dti-1311	107	11	kg	kg	PROPN
dti-1311	107	12	,	,	PUNCT
dti-1311	107	13	i.p	i.p	PROPN
dti-1311	107	14	.	.	PROPN
dti-1311	107	15	)	)	PUNCT
dti-1311	107	16	,	,	PUNCT
dti-1311	107	17	sulpiride	sulpiride	ADV
dti-1311	107	18	(	(	PUNCT
dti-1311	107	19	10	10	NUM
dti-1311	107	20	mg	mg	NUM
dti-1311	107	21	/	/	SYM
dti-1311	107	22	kg	kg	PROPN
dti-1311	107	23	,	,	PUNCT
dti-1311	107	24	i.p	i.p	PROPN
dti-1311	107	25	.	.	PROPN
dti-1311	107	26	)	)	PUNCT
dti-1311	107	27	,	,	PUNCT
dti-1311	107	28	domperidone	domperidone	NOUN
dti-1311	107	29	(	(	PUNCT
dti-1311	107	30	10	10	NUM
dti-1311	107	31	mg	mg	NUM
dti-1311	107	32	/	/	SYM
dti-1311	107	33	kg	kg	PROPN
dti-1311	107	34	,	,	PUNCT
dti-1311	107	35	i.p	i.p	PROPN
dti-1311	107	36	.	.	PROPN
dti-1311	107	37	)	)	PUNCT
dti-1311	107	38	,	,	PUNCT
dti-1311	107	39	metoclopramide	metoclopramide	NOUN
dti-1311	107	40	(	(	PUNCT
dti-1311	107	41	10	10	NUM
dti-1311	107	42	mg	mg	NUM
dti-1311	107	43	/	/	SYM
dti-1311	107	44	kg	kg	PROPN
dti-1311	107	45	,	,	PUNCT
dti-1311	107	46	i.p	i.p	PROPN
dti-1311	107	47	.	.	PROPN
dti-1311	107	48	)	)	PUNCT
dti-1311	107	49	,	,	PUNCT
dti-1311	107	50	bromocryptine	bromocryptine	NOUN
dti-1311	107	51	(	(	PUNCT
dti-1311	107	52	3	3	NUM
dti-1311	107	53	mg	mg	PROPN
dti-1311	107	54	/	/	SYM
dti-1311	107	55	kg	kg	PROPN
dti-1311	107	56	,	,	PUNCT
dti-1311	107	57	i.p	i.p	PROPN
dti-1311	107	58	.	.	PROPN
dti-1311	107	59	)	)	PUNCT
dti-1311	108	1	and	and	CCONJ
dti-1311	108	2	chlorpromazine	chlorpromazine	NOUN
dti-1311	108	3	(	(	PUNCT
dti-1311	108	4	3	3	NUM
dti-1311	108	5	mg	mg	PROPN
dti-1311	108	6	/	/	SYM
dti-1311	108	7	kg	kg	PROPN
dti-1311	108	8	,	,	PUNCT
dti-1311	108	9	i.p	i.p	PROPN
dti-1311	108	10	.	.	PUNCT
dti-1311	108	11	)	)	PUNCT
dti-1311	109	1	on	on	ADP
dti-1311	109	2	antinociception	antinociception	NOUN
dti-1311	109	3	caused	cause	VERB
dti-1311	109	4	by	by	ADP
dti-1311	109	5	cinnarizine	cinnarizine	NOUN
dti-1311	109	6	(	(	PUNCT
dti-1311	109	7	2.5	2.5	NUM
dti-1311	109	8	mg	mg	PROPN
dti-1311	109	9	/	/	SYM
dti-1311	109	10	kg	kg	PROPN
dti-1311	109	11	,	,	PUNCT
dti-1311	109	12	s.c	s.c	PROPN
dti-1311	109	13	.	.	PROPN
dti-1311	109	14	)	)	PUNCT
dti-1311	110	1	in	in	ADP
dti-1311	110	2	the	the	DET
dti-1311	110	3	abdominal	abdominal	ADJ
dti-1311	110	4	constriction	constriction	NOUN
dti-1311	110	5	assay	assay	VERB
dti-1311	110	6	in	in	ADP
dti-1311	110	7	mice	mouse	NOUN
dti-1311	110	8	.	.	PUNCT
dti-1311	111	1	drugs	drug	NOUN
dti-1311	111	2	or	or	CCONJ
dti-1311	111	3	saline	saline	NOUN
dti-1311	111	4	(	(	PUNCT
dti-1311	111	5	control	control	NOUN
dti-1311	111	6	)	)	PUNCT
dti-1311	111	7	were	be	AUX
dti-1311	111	8	administered	administer	VERB
dti-1311	111	9	30	30	NUM
dti-1311	111	10	min	min	NOUN
dti-1311	111	11	prior	prior	ADV
dti-1311	111	12	to	to	ADP
dti-1311	111	13	testing	testing	NOUN
dti-1311	111	14	.	.	PUNCT
dti-1311	112	1	data	datum	NOUN
dti-1311	112	2	expressed	express	VERB
dti-1311	112	3	as	as	ADP
dti-1311	112	4	mean	mean	PROPN
dti-1311	112	5	±	±	NUM
dti-1311	112	6	s.e	s.e	PROPN
dti-1311	112	7	.	.	PROPN
dti-1311	112	8	percent	percent	NOUN
dti-1311	112	9	inhibition	inhibition	NOUN
dti-1311	112	10	(	(	PUNCT
dti-1311	112	11	%	%	INTJ
dti-1311	112	12	)	)	PUNCT
dti-1311	112	13	compared	compare	VERB
dti-1311	112	14	to	to	ADP
dti-1311	112	15	the	the	DET
dti-1311	112	16	control	control	NOUN
dti-1311	112	17	animals	animal	NOUN
dti-1311	112	18	is	be	AUX
dti-1311	112	19	shown	show	VERB
dti-1311	112	20	.	.	PUNCT
dti-1311	113	1	*	*	PUNCT
dti-1311	113	2	p	p	X
dti-1311	113	3	<	<	X
dti-1311	113	4	0.05	0.05	NUM
dti-1311	113	5	compared	compare	VERB
dti-1311	113	6	to	to	ADP
dti-1311	113	7	control	control	NOUN
dti-1311	113	8	and	and	CCONJ
dti-1311	113	9	between	between	ADP
dti-1311	113	10	different	different	ADJ
dti-1311	113	11	groups	group	NOUN
dti-1311	113	12	as	as	SCONJ
dti-1311	113	13	shown	show	VERB
dti-1311	113	14	in	in	ADP
dti-1311	113	15	the	the	DET
dti-1311	113	16	fi	fi	NOUN
dti-1311	113	17	gure	gure	NOUN
dti-1311	113	18	.	.	PUNCT
dti-1311	114	1	the	the	DET
dti-1311	114	2	plus	plus	ADJ
dti-1311	114	3	sign	sign	NOUN
dti-1311	114	4	(	(	PUNCT
dti-1311	114	5	+	+	X
dti-1311	114	6	)	)	PUNCT
dti-1311	114	7	indicates	indicate	VERB
dti-1311	114	8	signifi	signifi	NOUN
dti-1311	114	9	ca	can	AUX
dti-1311	114	10	nt	not	PART
dti-1311	114	11	change	change	VERB
dti-1311	114	12	from	from	ADP
dti-1311	114	13	the	the	DET
dti-1311	114	14	cinnarizine	cinnarizine	NOUN
dti-1311	114	15	alone	alone	ADV
dti-1311	114	16	(	(	PUNCT
dti-1311	114	17	2.5	2.5	NUM
dti-1311	114	18	mg	mg	NUM
dti-1311	114	19	/	/	SYM
dti-1311	114	20	kg)-treated	kg)-treate	VERB
dti-1311	114	21	group	group	NOUN
dti-1311	114	22	.	.	PUNCT
dti-1311	115	1	the	the	DET
dti-1311	115	2	(	(	PUNCT
dti-1311	115	3	#	#	NOUN
dti-1311	115	4	)	)	PUNCT
dti-1311	115	5	sign	sign	NOUN
dti-1311	115	6	indicates	indicate	VERB
dti-1311	115	7	signifi	signifi	NOUN
dti-1311	115	8	ca	can	AUX
dti-1311	115	9	nt	not	PART
dti-1311	115	10	difference	difference	VERB
dti-1311	115	11	from	from	ADP
dti-1311	115	12	the	the	DET
dti-1311	115	13	cinnarizine	cinnarizine	NOUN
dti-1311	115	14	+	+	CCONJ
dti-1311	115	15	chlorpromazine	chlorpromazine	NOUN
dti-1311	115	16	-	-	PUNCT
dti-1311	115	17	treated	treat	VERB
dti-1311	115	18	group	group	NOUN
dti-1311	115	19	.	.	PUNCT
dti-1311	116	1	six	six	NUM
dti-1311	116	2	mice	mouse	NOUN
dti-1311	116	3	were	be	AUX
dti-1311	116	4	used	use	VERB
dti-1311	116	5	per	per	ADP
dti-1311	116	6	each	each	DET
dti-1311	116	7	group	group	NOUN
dti-1311	116	8	.	.	PUNCT
dti-1311	117	1	figure	figure	NOUN
dti-1311	117	2	3	3	NUM
dti-1311	117	3	.	.	PUNCT
dti-1311	117	4	effect	effect	NOUN
dti-1311	117	5	of	of	ADP
dti-1311	117	6	naloxone	naloxone	NOUN
dti-1311	117	7	(	(	PUNCT
dti-1311	117	8	5	5	NUM
dti-1311	117	9	mg	mg	PROPN
dti-1311	117	10	/	/	SYM
dti-1311	117	11	kg	kg	PROPN
dti-1311	117	12	,	,	PUNCT
dti-1311	117	13	i.p	i.p	PROPN
dti-1311	117	14	.	.	PROPN
dti-1311	117	15	)	)	PUNCT
dti-1311	117	16	,	,	PUNCT
dti-1311	117	17	yohimbine	yohimbine	NOUN
dti-1311	117	18	(	(	PUNCT
dti-1311	117	19	5	5	NUM
dti-1311	117	20	mg	mg	PROPN
dti-1311	117	21	/	/	SYM
dti-1311	117	22	kg	kg	PROPN
dti-1311	117	23	,	,	PUNCT
dti-1311	117	24	i.p	i.p	PROPN
dti-1311	117	25	.	.	PROPN
dti-1311	117	26	)	)	PUNCT
dti-1311	117	27	,	,	PUNCT
dti-1311	117	28	atropine	atropine	NOUN
dti-1311	117	29	(	(	PUNCT
dti-1311	117	30	2	2	NUM
dti-1311	117	31	mg	mg	PROPN
dti-1311	117	32	/	/	SYM
dti-1311	117	33	kg	kg	PROPN
dti-1311	117	34	,	,	PUNCT
dti-1311	117	35	i.p	i.p	PROPN
dti-1311	117	36	.	.	PROPN
dti-1311	117	37	)	)	PUNCT
dti-1311	117	38	and	and	CCONJ
dti-1311	117	39	propranolol	propranolol	PROPN
dti-1311	117	40	(	(	PUNCT
dti-1311	117	41	2	2	NUM
dti-1311	117	42	mg	mg	PROPN
dti-1311	117	43	/	/	SYM
dti-1311	117	44	kg	kg	PROPN
dti-1311	117	45	,	,	PUNCT
dti-1311	117	46	i.p	i.p	PROPN
dti-1311	117	47	.	.	PUNCT
dti-1311	117	48	)	)	PUNCT
dti-1311	118	1	on	on	ADP
dti-1311	118	2	antinociception	antinociception	NOUN
dti-1311	118	3	caused	cause	VERB
dti-1311	118	4	by	by	ADP
dti-1311	118	5	cinnarizine	cinnarizine	NOUN
dti-1311	118	6	(	(	PUNCT
dti-1311	118	7	2.5	2.5	NUM
dti-1311	118	8	mg	mg	PROPN
dti-1311	118	9	/	/	SYM
dti-1311	118	10	kg	kg	PROPN
dti-1311	118	11	,	,	PUNCT
dti-1311	118	12	s.c	s.c	PROPN
dti-1311	118	13	.	.	PROPN
dti-1311	118	14	)	)	PUNCT
dti-1311	119	1	in	in	ADP
dti-1311	119	2	the	the	DET
dti-1311	119	3	abdominal	abdominal	ADJ
dti-1311	119	4	constriction	constriction	NOUN
dti-1311	119	5	assay	assay	VERB
dti-1311	119	6	.	.	PUNCT
dti-1311	120	1	drugs	drug	NOUN
dti-1311	120	2	or	or	CCONJ
dti-1311	120	3	saline	saline	NOUN
dti-1311	120	4	(	(	PUNCT
dti-1311	120	5	control	control	NOUN
dti-1311	120	6	)	)	PUNCT
dti-1311	120	7	were	be	AUX
dti-1311	120	8	administered	administer	VERB
dti-1311	120	9	30	30	NUM
dti-1311	120	10	min	min	NOUN
dti-1311	120	11	prior	prior	ADV
dti-1311	120	12	to	to	ADP
dti-1311	120	13	testing	testing	NOUN
dti-1311	120	14	.	.	PUNCT
dti-1311	121	1	data	datum	NOUN
dti-1311	121	2	expressed	express	VERB
dti-1311	121	3	as	as	ADP
dti-1311	121	4	mean	mean	PROPN
dti-1311	121	5	±	±	NUM
dti-1311	121	6	s.e	s.e	PROPN
dti-1311	121	7	.	.	PROPN
dti-1311	121	8	percent	percent	NOUN
dti-1311	121	9	inhibition	inhibition	NOUN
dti-1311	121	10	(	(	PUNCT
dti-1311	121	11	%	%	INTJ
dti-1311	121	12	)	)	PUNCT
dti-1311	121	13	compared	compare	VERB
dti-1311	121	14	to	to	ADP
dti-1311	121	15	the	the	DET
dti-1311	121	16	control	control	NOUN
dti-1311	121	17	animals	animal	NOUN
dti-1311	121	18	is	be	AUX
dti-1311	121	19	shown	show	VERB
dti-1311	121	20	.	.	PUNCT
dti-1311	122	1	*	*	PUNCT
dti-1311	122	2	p	p	X
dti-1311	122	3	<	<	X
dti-1311	122	4	0.05	0.05	NUM
dti-1311	122	5	vs.	vs.	ADP
dti-1311	122	6	control	control	NOUN
dti-1311	122	7	and	and	CCONJ
dti-1311	122	8	between	between	ADP
dti-1311	122	9	different	different	ADJ
dti-1311	122	10	groups	group	NOUN
dti-1311	122	11	as	as	SCONJ
dti-1311	122	12	shown	show	VERB
dti-1311	122	13	in	in	ADP
dti-1311	122	14	the	the	DET
dti-1311	122	15	fi	fi	NOUN
dti-1311	122	16	gure	gure	NOUN
dti-1311	122	17	.	.	PUNCT
dti-1311	123	1	the	the	DET
dti-1311	123	2	plus	plus	ADJ
dti-1311	123	3	sign	sign	NOUN
dti-1311	123	4	(	(	PUNCT
dti-1311	123	5	+	+	X
dti-1311	123	6	)	)	PUNCT
dti-1311	123	7	indicates	indicate	VERB
dti-1311	123	8	signifi	signifi	NOUN
dti-1311	123	9	ca	can	AUX
dti-1311	123	10	nt	not	PART
dti-1311	123	11	difference	difference	VERB
dti-1311	123	12	from	from	ADP
dti-1311	123	13	the	the	DET
dti-1311	123	14	cinnarizine	cinnarizine	NOUN
dti-1311	123	15	+	+	CCONJ
dti-1311	123	16	naloxonetreated	naloxonetreate	VERB
dti-1311	123	17	group	group	NOUN
dti-1311	123	18	.	.	PUNCT
dti-1311	124	1	six	six	NUM
dti-1311	124	2	mice	mouse	NOUN
dti-1311	124	3	were	be	AUX
dti-1311	124	4	used	use	VERB
dti-1311	124	5	per	per	ADP
dti-1311	124	6	each	each	DET
dti-1311	124	7	group	group	NOUN
dti-1311	124	8	.	.	PUNCT
dti-1311	125	1	table	table	NOUN
dti-1311	125	2	1	1	NUM
dti-1311	125	3	.	.	PUNCT
dti-1311	125	4	assessment	assessment	NOUN
dti-1311	125	5	of	of	ADP
dti-1311	125	6	motor	motor	NOUN
dti-1311	125	7	coordination	coordination	NOUN
dti-1311	125	8	in	in	ADP
dti-1311	125	9	cinnarizine	cinnarizine	NOUN
dti-1311	125	10	-	-	PUNCT
dti-1311	125	11	treated	treat	VERB
dti-1311	125	12	mice	mouse	NOUN
dti-1311	125	13	in	in	ADP
dti-1311	125	14	the	the	DET
dti-1311	125	15	rotarod	rotarod	NOUN
dti-1311	125	16	test	test	NOUN
dti-1311	125	17	.	.	PUNCT
dti-1311	126	1	treatment	treatment	NOUN
dti-1311	126	2	rotarod	rotarod	NOUN
dti-1311	126	3	latency	latency	NOUN
dti-1311	126	4	(	(	PUNCT
dti-1311	126	5	sec	sec	PROPN
dti-1311	126	6	)	)	PUNCT
dti-1311	126	7	saline	saline	VERB
dti-1311	126	8	446.4	446.4	NUM
dti-1311	126	9	±	±	NUM
dti-1311	126	10	54.1	54.1	NUM
dti-1311	126	11	cinnarizine	cinnarizine	NOUN
dti-1311	126	12	1.25	1.25	NUM
dti-1311	126	13	mg	mg	PROPN
dti-1311	126	14	/	/	SYM
dti-1311	126	15	kg	kg	PROPN
dti-1311	126	16	465.4	465.4	NUM
dti-1311	126	17	±	±	NUM
dti-1311	126	18	43.5	43.5	NUM
dti-1311	126	19	cinnarizine	cinnarizine	NOUN
dti-1311	126	20	2.5	2.5	NUM
dti-1311	126	21	mg	mg	NOUN
dti-1311	126	22	/	/	SYM
dti-1311	126	23	kg	kg	PROPN
dti-1311	126	24	512.8	512.8	NUM
dti-1311	126	25	±	±	NUM
dti-1311	126	26	35.7	35.7	NUM
dti-1311	126	27	cinnarizine	cinnarizine	NOUN
dti-1311	126	28	5.0	5.0	NUM
dti-1311	126	29	mg	mg	NOUN
dti-1311	126	30	/	/	SYM
dti-1311	126	31	kg	kg	PROPN
dti-1311	126	32	498.0	498.0	NUM
dti-1311	126	33	±	±	NUM
dti-1311	126	34	42.2	42.2	NUM
dti-1311	126	35	cinnarizine	cinnarizine	NOUN
dti-1311	126	36	10.0	10.0	NUM
dti-1311	126	37	mg	mg	NUM
dti-1311	126	38	/	/	SYM
dti-1311	126	39	kg	kg	PROPN
dti-1311	126	40	392.8	392.8	NUM
dti-1311	126	41	±	±	NUM
dti-1311	126	42	20.3	20.3	NUM
dti-1311	126	43	cinnarizine	cinnarizine	NOUN
dti-1311	126	44	20.0	20.0	NUM
dti-1311	126	45	mg	mg	NOUN
dti-1311	126	46	/	/	SYM
dti-1311	126	47	kg	kg	PROPN
dti-1311	126	48	375.4	375.4	NUM
dti-1311	126	49	±	±	NUM
dti-1311	126	50	46.0	46.0	NUM
dti-1311	126	51	data	datum	NOUN
dti-1311	126	52	represent	represent	VERB
dti-1311	126	53	mean	mean	PROPN
dti-1311	126	54	±	±	NUM
dti-1311	126	55	s.e	s.e	PROPN
dti-1311	126	56	.	.	PROPN
dti-1311	126	57	con	con	PROPN
dti-1311	126	58	tro	tro	PROPN
dti-1311	126	59	l	l	PROPN
dti-1311	126	60	cinn	cinn	PROPN
dti-1311	126	61	ari	ari	PROPN
dti-1311	126	62	zin	zin	NOUN
dti-1311	126	63	e	e	PROPN
dti-1311	126	64	2	2	NUM
dti-1311	126	65	.5	.5	NUM
dti-1311	127	1	mg	mg	PROPN
dti-1311	127	2	/	/	SYM
dti-1311	127	3	k	k	PROPN
dti-1311	127	4	g	g	PROPN
dti-1311	127	5	halo	halo	PROPN
dti-1311	127	6	pe	pe	PROPN
dti-1311	127	7	rid	rid	VERB
dti-1311	127	8	ol	ol	PROPN
dti-1311	128	1	+	+	CCONJ
dti-1311	128	2	c	c	PROPN
dti-1311	128	3	inn	inn	PROPN
dti-1311	128	4	ari	ari	PROPN
dti-1311	128	5	zin	zin	PROPN
dti-1311	128	6	e	e	PROPN
dti-1311	128	7	sulp	sulp	PROPN
dti-1311	128	8	irid	irid	PROPN
dti-1311	128	9	e	e	PROPN
dti-1311	129	1	+	+	PROPN
dti-1311	129	2	c	c	PROPN
dti-1311	129	3	inn	inn	PROPN
dti-1311	129	4	ari	ari	PROPN
dti-1311	129	5	zin	zin	PROPN
dti-1311	129	6	e	e	NOUN
dti-1311	129	7	dom	dom	NOUN
dti-1311	129	8	pe	pe	PROPN
dti-1311	129	9	rid	rid	VERB
dti-1311	129	10	on	on	ADP
dti-1311	129	11	e	e	PROPN
dti-1311	129	12	c	c	PROPN
dti-1311	129	13	inn	inn	PROPN
dti-1311	129	14	ari	ari	PROPN
dti-1311	129	15	zin	zin	PROPN
dti-1311	129	16	e	e	X
dti-1311	129	17	meta	meta	X
dti-1311	129	18	clo	clo	PROPN
dti-1311	129	19	pra	pra	PROPN
dti-1311	129	20	mide	mide	ADV
dti-1311	130	1	+	+	CCONJ
dti-1311	130	2	c	c	PROPN
dti-1311	130	3	inn	inn	PROPN
dti-1311	130	4	ari	ari	PROPN
dti-1311	130	5	zin	zin	NOUN
dti-1311	130	6	e	e	X
dti-1311	130	7	brom	brom	NOUN
dti-1311	130	8	oc	oc	PART
dti-1311	130	9	ryp	ryp	VERB
dti-1311	130	10	tin	tin	NOUN
dti-1311	130	11	e	e	NOUN
dti-1311	130	12	+	+	PROPN
dti-1311	130	13	c	c	PROPN
dti-1311	130	14	inn	inn	PROPN
dti-1311	130	15	ari	ari	PROPN
dti-1311	130	16	zin	zin	PROPN
dti-1311	130	17	e	e	PROPN
dti-1311	130	18	chlo	chlo	NOUN
dti-1311	130	19	rpr	rpr	PROPN
dti-1311	130	20	om	om	PROPN
dti-1311	130	21	az	az	PROPN
dti-1311	130	22	ine	ine	PROPN
dti-1311	131	1	+	+	CCONJ
dti-1311	132	1	cinn	cinn	PROPN
dti-1311	132	2	ari	ari	PROPN
dti-1311	132	3	zin	zin	PROPN
dti-1311	132	4	e	e	NOUN
dti-1311	132	5	0	0	NUM
dti-1311	132	6	10	10	NUM
dti-1311	132	7	20	20	NUM
dti-1311	132	8	30	30	NUM
dti-1311	132	9	40	40	NUM
dti-1311	132	10	50	50	NUM
dti-1311	132	11	60	60	NUM
dti-1311	132	12	70	70	NUM
dti-1311	132	13	80	80	NUM
dti-1311	132	14	90	90	NUM
dti-1311	132	15	*	*	PUNCT
dti-1311	133	1	*	*	PUNCT
dti-1311	134	1	*	*	PUNCT
dti-1311	134	2	*	*	PUNCT
dti-1311	134	3	*	*	PUNCT
dti-1311	134	4	-60.5	-60.5	NUM
dti-1311	134	5	%	%	NOUN
dti-1311	134	6	-70.1	-70.1	ADJ
dti-1311	134	7	%	%	NOUN
dti-1311	134	8	-66.4	-66.4	NUM
dti-1311	134	9	%	%	NOUN
dti-1311	135	1	-53.8%-48.1	-53.8%-48.1	NOUN
dti-1311	135	2	%	%	NOUN
dti-1311	135	3	-74.2	-74.2	ADJ
dti-1311	135	4	%	%	NOUN
dti-1311	135	5	-96.1	-96.1	NUM
dti-1311	135	6	%	%	NOUN
dti-1311	135	7	*	*	PUNCT
dti-1311	136	1	*	*	PUNCT
dti-1311	136	2	+	+	NOUN
dti-1311	136	3	+	+	NUM
dti-1311	136	4	#	#	NOUN
dti-1311	136	5	#	#	NOUN
dti-1311	136	6	#	#	NOUN
dti-1311	136	7	#	#	NOUN
dti-1311	136	8	#	#	NOUN
dti-1311	136	9	#	#	NOUN
dti-1311	136	10	n	n	NUM
dti-1311	136	11	um	um	INTJ
dti-1311	136	12	be	be	AUX
dti-1311	136	13	r	r	NOUN
dti-1311	136	14	o	o	NOUN
dti-1311	136	15	f	f	X
dti-1311	137	1	a	a	DET
dti-1311	137	2	bd	bd	PROPN
dti-1311	137	3	om	om	PROPN
dti-1311	137	4	in	in	ADP
dti-1311	137	5	al	al	PROPN
dti-1311	137	6	c	c	PROPN
dti-1311	137	7	on	on	ADP
dti-1311	137	8	st	st	PROPN
dti-1311	137	9	ri	ri	PROPN
dti-1311	137	10	ct	ct	PROPN
dti-1311	137	11	io	io	PROPN
dti-1311	138	1	ns	ns	INTJ
dti-1311	138	2	*	*	PUNCT
dti-1311	138	3	*	*	PUNCT
dti-1311	138	4	+	+	CCONJ
dti-1311	138	5	con	con	X
dti-1311	138	6	tro	tro	X
dti-1311	138	7	l	l	PROPN
dti-1311	138	8	cinn	cinn	PROPN
dti-1311	138	9	ari	ari	PROPN
dti-1311	138	10	zin	zin	NOUN
dti-1311	138	11	e	e	PROPN
dti-1311	138	12	2	2	NUM
dti-1311	138	13	.5	.5	NUM
dti-1311	138	14	mg	mg	PROPN
dti-1311	138	15	/	/	SYM
dti-1311	138	16	k	k	PROPN
dti-1311	138	17	g	g	PROPN
dti-1311	138	18	nalo	nalo	PROPN
dti-1311	138	19	xo	xo	PROPN
dti-1311	138	20	ne	ne	PROPN
dti-1311	139	1	+	+	PROPN
dti-1311	139	2	cinn	cinn	PROPN
dti-1311	139	3	ari	ari	PROPN
dti-1311	139	4	zin	zin	PROPN
dti-1311	139	5	e	e	PROPN
dti-1311	139	6	yoh	yoh	PROPN
dti-1311	140	1	i	i	PRON
dti-1311	140	2	m	m	VERB
dti-1311	140	3	bin	bin	NOUN
dti-1311	140	4	e	e	PROPN
dti-1311	141	1	+	+	PROPN
dti-1311	141	2	c	c	PROPN
dti-1311	141	3	inn	inn	PROPN
dti-1311	141	4	ari	ari	PROPN
dti-1311	141	5	zin	zin	PROPN
dti-1311	141	6	e	e	X
dti-1311	141	7	atro	atro	NOUN
dti-1311	141	8	pin	pin	PROPN
dti-1311	141	9	e	e	PROPN
dti-1311	141	10	+	+	PROPN
dti-1311	141	11	c	c	PROPN
dti-1311	141	12	inn	inn	PROPN
dti-1311	141	13	ari	ari	PROPN
dti-1311	141	14	zin	zin	PROPN
dti-1311	141	15	e	e	PROPN
dti-1311	141	16	prop	prop	NOUN
dti-1311	141	17	ran	run	VERB
dti-1311	141	18	olo	olo	PROPN
dti-1311	141	19	l	l	PROPN
dti-1311	142	1	+	+	CCONJ
dti-1311	142	2	c	c	PROPN
dti-1311	142	3	inn	inn	PROPN
dti-1311	142	4	ari	ari	PROPN
dti-1311	142	5	zin	zin	NOUN
dti-1311	142	6	e	e	NOUN
dti-1311	142	7	0	0	NUM
dti-1311	142	8	10	10	NUM
dti-1311	142	9	20	20	NUM
dti-1311	142	10	30	30	NUM
dti-1311	142	11	40	40	NUM
dti-1311	142	12	50	50	NUM
dti-1311	142	13	60	60	NUM
dti-1311	142	14	70	70	NUM
dti-1311	142	15	*	*	PUNCT
dti-1311	143	1	*	*	PUNCT
dti-1311	144	1	*	*	PUNCT
dti-1311	144	2	*	*	PUNCT
dti-1311	144	3	*	*	PUNCT
dti-1311	144	4	-48.3	-48.3	NUM
dti-1311	144	5	%	%	INTJ
dti-1311	144	6	-45.3	-45.3	INTJ
dti-1311	144	7	%	%	NOUN
dti-1311	144	8	-80.4	-80.4	NUM
dti-1311	144	9	%	%	NOUN
dti-1311	145	1	-80.4	-80.4	NUM
dti-1311	146	1	%	%	NOUN
dti-1311	147	1	-89.2	-89.2	INTJ
dti-1311	147	2	%	%	NOUN
dti-1311	148	1	+	+	CCONJ
dti-1311	149	1	+	+	ADJ
dti-1311	149	2	+	+	NOUN
dti-1311	149	3	n	n	AUX
dti-1311	149	4	um	um	INTJ
dti-1311	149	5	be	be	AUX
dti-1311	149	6	r	r	NOUN
dti-1311	149	7	o	o	NOUN
dti-1311	149	8	f	f	X
dti-1311	150	1	a	a	DET
dti-1311	150	2	bd	bd	PROPN
dti-1311	150	3	om	om	PROPN
dti-1311	150	4	in	in	ADP
dti-1311	150	5	al	al	PROPN
dti-1311	150	6	c	c	PROPN
dti-1311	150	7	on	on	ADP
dti-1311	150	8	st	st	PROPN
dti-1311	150	9	ri	ri	PROPN
dti-1311	150	10	ct	ct	PROPN
dti-1311	150	11	io	io	X
dti-1311	150	12	ns	ns	PROPN
dti-1311	150	13	drug	drug	NOUN
dti-1311	150	14	target	target	NOUN
dti-1311	150	15	insights	insight	NOUN
dti-1311	150	16	2007	2007	NUM
dti-1311	150	17	:	:	PUNCT
dti-1311	150	18	2	2	NUM
dti-1311	150	19	33	33	NUM
dti-1311	150	20	modulation	modulation	NOUN
dti-1311	150	21	of	of	ADP
dti-1311	150	22	visceral	visceral	ADJ
dti-1311	150	23	nociception	nociception	NOUN
dti-1311	150	24	,	,	PUNCT
dti-1311	150	25	infl	infl	PROPN
dti-1311	150	26	ammation	ammation	NOUN
dti-1311	150	27	and	and	CCONJ
dti-1311	150	28	gastric	gastric	ADJ
dti-1311	150	29	mucosal	mucosal	NOUN
dti-1311	150	30	injury	injury	NOUN
dti-1311	150	31	ruling	rule	VERB
dti-1311	150	32	out	out	ADP
dti-1311	150	33	the	the	DET
dti-1311	150	34	confounding	confound	VERB
dti-1311	150	35	infl	infl	PROPN
dti-1311	150	36	uence	uence	NOUN
dti-1311	150	37	of	of	ADP
dti-1311	150	38	a	a	DET
dti-1311	150	39	possible	possible	ADJ
dti-1311	150	40	sedative	sedative	ADJ
dti-1311	150	41	effect	effect	NOUN
dti-1311	150	42	.	.	PUNCT
dti-1311	151	1	in	in	ADP
dti-1311	151	2	man	man	NOUN
dti-1311	151	3	induction	induction	NOUN
dti-1311	151	4	of	of	ADP
dti-1311	151	5	extrapyramidal	extrapyramidal	ADJ
dti-1311	151	6	signs	sign	NOUN
dti-1311	151	7	by	by	ADP
dti-1311	151	8	cinnarizine	cinnarizine	NOUN
dti-1311	151	9	has	have	AUX
dti-1311	151	10	been	be	AUX
dti-1311	151	11	reported	report	VERB
dti-1311	151	12	,	,	PUNCT
dti-1311	151	13	due	due	ADP
dti-1311	151	14	to	to	ADP
dti-1311	151	15	its	its	PRON
dti-1311	151	16	antagonistic	antagonistic	ADJ
dti-1311	151	17	properties	property	NOUN
dti-1311	151	18	at	at	ADP
dti-1311	151	19	dopamine	dopamine	NOUN
dti-1311	151	20	d1	d1	PROPN
dti-1311	151	21	and	and	CCONJ
dti-1311	151	22	d2	d2	NOUN
dti-1311	151	23	receptors	receptor	NOUN
dti-1311	151	24	(	(	PUNCT
dti-1311	151	25	fabiani	fabiani	PROPN
dti-1311	151	26	et	et	PROPN
dti-1311	151	27	al	al	PROPN
dti-1311	151	28	.	.	PROPN
dti-1311	151	29	2004	2004	NUM
dti-1311	151	30	;	;	PUNCT
dti-1311	151	31	teive	teive	VERB
dti-1311	151	32	et	et	PROPN
dti-1311	151	33	al	al	PROPN
dti-1311	151	34	.	.	PROPN
dti-1311	151	35	2004	2004	NUM
dti-1311	151	36	)	)	PUNCT
dti-1311	151	37	.	.	PUNCT
dti-1311	152	1	it	it	PRON
dti-1311	152	2	is	be	AUX
dti-1311	152	3	likely	likely	ADJ
dti-1311	152	4	that	that	SCONJ
dti-1311	152	5	higher	high	ADJ
dti-1311	152	6	doses	dose	NOUN
dti-1311	152	7	are	be	AUX
dti-1311	152	8	required	require	VERB
dti-1311	152	9	in	in	ADP
dti-1311	152	10	mice	mouse	NOUN
dti-1311	152	11	for	for	ADP
dti-1311	152	12	cinnarizine	cinnarizine	NOUN
dti-1311	152	13	to	to	PART
dti-1311	152	14	impair	impair	VERB
dti-1311	152	15	motor	motor	NOUN
dti-1311	152	16	coordination	coordination	NOUN
dti-1311	152	17	signifi	signifi	NOUN
dti-1311	152	18	cantly	cantly	ADV
dti-1311	152	19	.	.	PUNCT
dti-1311	153	1	in	in	ADP
dti-1311	153	2	other	other	ADJ
dti-1311	153	3	studies	study	NOUN
dti-1311	153	4	,	,	PUNCT
dti-1311	153	5	cinnarizine	cinnarizine	NOUN
dti-1311	153	6	(	(	PUNCT
dti-1311	153	7	75	75	NUM
dti-1311	153	8	and	and	CCONJ
dti-1311	153	9	200	200	NUM
dti-1311	153	10	mg	mg	NUM
dti-1311	153	11	/	/	SYM
dti-1311	153	12	kg	kg	NOUN
dti-1311	153	13	)	)	PUNCT
dti-1311	153	14	antagonized	antagonize	VERB
dti-1311	153	15	the	the	DET
dti-1311	153	16	ethanol	ethanol	NOUN
dti-1311	153	17	-	-	PUNCT
dti-1311	153	18	induced	induce	VERB
dti-1311	153	19	impairment	impairment	NOUN
dti-1311	153	20	of	of	ADP
dti-1311	153	21	locomotor	locomotor	ADJ
dti-1311	153	22	activity	activity	NOUN
dti-1311	153	23	on	on	ADP
dti-1311	153	24	rota	rota	NOUN
dti-1311	153	25	-	-	PUNCT
dti-1311	153	26	rod	rod	NOUN
dti-1311	153	27	test	test	NOUN
dti-1311	153	28	in	in	ADP
dti-1311	153	29	mice	mouse	NOUN
dti-1311	153	30	(	(	PUNCT
dti-1311	153	31	czarnecka	czarnecka	NOUN
dti-1311	153	32	and	and	CCONJ
dti-1311	153	33	kubik	kubik	PROPN
dti-1311	153	34	-	-	PUNCT
dti-1311	153	35	bogucka	bogucka	NOUN
dti-1311	153	36	,	,	PUNCT
dti-1311	153	37	1993	1993	NUM
dti-1311	153	38	)	)	PUNCT
dti-1311	153	39	.	.	PUNCT
dti-1311	154	1	cinnarizine	cinnarizine	PROPN
dti-1311	154	2	induced	induce	VERB
dti-1311	154	3	no	no	DET
dti-1311	154	4	catalepsy	catalepsy	NOUN
dti-1311	154	5	in	in	ADP
dti-1311	154	6	mice	mouse	NOUN
dti-1311	154	7	at	at	ADP
dti-1311	154	8	the	the	DET
dti-1311	154	9	dose	dose	NOUN
dti-1311	154	10	of	of	ADP
dti-1311	154	11	20	20	NUM
dti-1311	154	12	mg	mg	PROPN
dti-1311	154	13	/	/	SYM
dti-1311	154	14	kg	kg	PROPN
dti-1311	154	15	,	,	PUNCT
dti-1311	154	16	inducing	induce	VERB
dti-1311	154	17	only	only	ADJ
dti-1311	154	18	mild	mild	ADJ
dti-1311	154	19	catalepsy	catalepsy	NOUN
dti-1311	154	20	at	at	ADP
dti-1311	154	21	the	the	DET
dti-1311	154	22	doses	dose	NOUN
dti-1311	154	23	of	of	ADP
dti-1311	154	24	60	60	NUM
dti-1311	154	25	and	and	CCONJ
dti-1311	154	26	180	180	NUM
dti-1311	154	27	mg	mg	NUM
dti-1311	154	28	/	/	SYM
dti-1311	154	29	kg	kg	PROPN
dti-1311	154	30	(	(	PUNCT
dti-1311	154	31	dall’igna	dall’igna	ADV
dti-1311	154	32	,	,	PUNCT
dti-1311	154	33	2005	2005	NUM
dti-1311	154	34	)	)	PUNCT
dti-1311	154	35	.	.	PUNCT
dti-1311	155	1	cinnarizine	cinnarizine	PROPN
dti-1311	155	2	administered	administer	VERB
dti-1311	155	3	via	via	ADP
dti-1311	155	4	subcutaneous	subcutaneous	ADJ
dti-1311	155	5	(	(	PUNCT
dti-1311	155	6	del	del	PROPN
dti-1311	155	7	pozo	pozo	PROPN
dti-1311	155	8	et	et	PROPN
dti-1311	155	9	al	al	PROPN
dti-1311	155	10	.	.	PROPN
dti-1311	155	11	1987	1987	NUM
dti-1311	155	12	)	)	PUNCT
dti-1311	155	13	or	or	CCONJ
dti-1311	155	14	intracerebroventricular	intracerebroventricular	ADJ
dti-1311	155	15	route	route	NOUN
dti-1311	155	16	(	(	PUNCT
dti-1311	155	17	miranda	miranda	PROPN
dti-1311	155	18	et	et	PROPN
dti-1311	155	19	al	al	PROPN
dti-1311	155	20	.	.	PROPN
dti-1311	155	21	1993	1993	NUM
dti-1311	155	22	)	)	PUNCT
dti-1311	155	23	produced	produce	VERB
dti-1311	155	24	a	a	DET
dti-1311	155	25	dose	dose	NOUN
dti-1311	155	26	-	-	PUNCT
dti-1311	155	27	dependent	dependent	ADJ
dti-1311	155	28	antinociception	antinociception	NOUN
dti-1311	155	29	in	in	ADP
dti-1311	155	30	acetic	acetic	ADJ
dti-1311	155	31	acid	acid	NOUN
dti-1311	155	32	writhing	writhe	VERB
dti-1311	155	33	test	test	NOUN
dti-1311	155	34	in	in	ADP
dti-1311	155	35	mice	mouse	NOUN
dti-1311	155	36	.	.	PUNCT
dti-1311	156	1	the	the	DET
dti-1311	156	2	writhing	writhe	VERB
dti-1311	156	3	response	response	NOUN
dti-1311	156	4	to	to	ADP
dti-1311	156	5	acetic	acetic	ADJ
dti-1311	156	6	acid	acid	NOUN
dti-1311	156	7	is	be	AUX
dti-1311	156	8	brought	bring	VERB
dti-1311	156	9	about	about	ADP
dti-1311	156	10	by	by	ADP
dti-1311	156	11	the	the	DET
dti-1311	156	12	release	release	NOUN
dti-1311	156	13	of	of	ADP
dti-1311	156	14	prostacyclin	prostacyclin	PROPN
dti-1311	156	15	synthesized	synthesize	VERB
dti-1311	156	16	by	by	ADP
dti-1311	156	17	cyclo	cyclo	NOUN
dti-1311	156	18	-	-	PUNCT
dti-1311	156	19	oxygenase	oxygenase	NOUN
dti-1311	156	20	in	in	ADP
dti-1311	156	21	the	the	DET
dti-1311	156	22	abdominal	abdominal	ADJ
dti-1311	156	23	cavity	cavity	NOUN
dti-1311	156	24	of	of	ADP
dti-1311	156	25	the	the	DET
dti-1311	156	26	mice	mouse	NOUN
dti-1311	156	27	(	(	PUNCT
dti-1311	156	28	berkenkopf	berkenkopf	NOUN
dti-1311	156	29	and	and	CCONJ
dti-1311	156	30	weichman	weichman	NOUN
dti-1311	156	31	,	,	PUNCT
dti-1311	156	32	1988	1988	NUM
dti-1311	156	33	)	)	PUNCT
dti-1311	156	34	.	.	PUNCT
dti-1311	157	1	it	it	PRON
dti-1311	157	2	is	be	AUX
dti-1311	157	3	reduced	reduce	VERB
dti-1311	157	4	by	by	ADP
dti-1311	157	5	cyclo	cyclo	NOUN
dti-1311	157	6	-	-	PUNCT
dti-1311	157	7	oxygenase	oxygenase	NOUN
dti-1311	157	8	inhibitors	inhibitor	NOUN
dti-1311	157	9	such	such	ADJ
dti-1311	157	10	as	as	ADP
dti-1311	157	11	meloxicam	meloxicam	NOUN
dti-1311	157	12	or	or	CCONJ
dti-1311	157	13	diclofenac	diclofenac	NOUN
dti-1311	157	14	(	(	PUNCT
dti-1311	157	15	santos	santos	PROPN
dti-1311	157	16	et	et	PROPN
dti-1311	157	17	al	al	PROPN
dti-1311	157	18	.	.	PROPN
dti-1311	157	19	1998	1998	NUM
dti-1311	157	20	)	)	PUNCT
dti-1311	157	21	,	,	PUNCT
dti-1311	157	22	by	by	ADP
dti-1311	157	23	figure	figure	NOUN
dti-1311	157	24	4	4	NUM
dti-1311	157	25	.	.	PUNCT
dti-1311	157	26	effect	effect	NOUN
dti-1311	157	27	of	of	ADP
dti-1311	157	28	theophylline	theophylline	NOUN
dti-1311	157	29	(	(	PUNCT
dti-1311	157	30	20	20	NUM
dti-1311	157	31	mg	mg	NUM
dti-1311	157	32	/	/	SYM
dti-1311	157	33	kg	kg	PROPN
dti-1311	157	34	,	,	PUNCT
dti-1311	157	35	i.p	i.p	PROPN
dti-1311	157	36	.	.	PUNCT
dti-1311	157	37	)	)	PUNCT
dti-1311	158	1	on	on	ADP
dti-1311	158	2	antinociception	antinociception	NOUN
dti-1311	158	3	caused	cause	VERB
dti-1311	158	4	by	by	ADP
dti-1311	158	5	cinnarizine	cinnarizine	NOUN
dti-1311	158	6	(	(	PUNCT
dti-1311	158	7	2.5	2.5	NUM
dti-1311	158	8	mg	mg	PROPN
dti-1311	158	9	/	/	SYM
dti-1311	158	10	kg	kg	PROPN
dti-1311	158	11	,	,	PUNCT
dti-1311	158	12	s.c	s.c	PROPN
dti-1311	158	13	.	.	PROPN
dti-1311	158	14	)	)	PUNCT
dti-1311	159	1	in	in	ADP
dti-1311	159	2	the	the	DET
dti-1311	159	3	abdominal	abdominal	ADJ
dti-1311	159	4	constriction	constriction	NOUN
dti-1311	159	5	assay	assay	VERB
dti-1311	159	6	.	.	PUNCT
dti-1311	160	1	drugs	drug	NOUN
dti-1311	160	2	or	or	CCONJ
dti-1311	160	3	saline	saline	NOUN
dti-1311	160	4	(	(	PUNCT
dti-1311	160	5	control	control	NOUN
dti-1311	160	6	)	)	PUNCT
dti-1311	160	7	were	be	AUX
dti-1311	160	8	administered	administer	VERB
dti-1311	160	9	30	30	NUM
dti-1311	160	10	min	min	NOUN
dti-1311	160	11	prior	prior	ADV
dti-1311	160	12	to	to	ADP
dti-1311	160	13	testing	testing	NOUN
dti-1311	160	14	.	.	PUNCT
dti-1311	161	1	data	datum	NOUN
dti-1311	161	2	expressed	express	VERB
dti-1311	161	3	as	as	ADP
dti-1311	161	4	mean	mean	PROPN
dti-1311	161	5	±	±	NUM
dti-1311	161	6	s.e	s.e	PROPN
dti-1311	161	7	.	.	PUNCT
dti-1311	162	1	*	*	PUNCT
dti-1311	162	2	p	p	X
dti-1311	162	3	<	<	X
dti-1311	162	4	0.05	0.05	NUM
dti-1311	162	5	compared	compare	VERB
dti-1311	162	6	to	to	ADP
dti-1311	162	7	control	control	PROPN
dti-1311	162	8	group	group	NOUN
dti-1311	162	9	.	.	PUNCT
dti-1311	163	1	the	the	DET
dti-1311	163	2	plus	plus	ADJ
dti-1311	163	3	sign	sign	NOUN
dti-1311	163	4	(	(	PUNCT
dti-1311	163	5	+	+	X
dti-1311	163	6	)	)	PUNCT
dti-1311	163	7	indicates	indicate	VERB
dti-1311	163	8	signifi	signifi	NOUN
dti-1311	163	9	ca	can	AUX
dti-1311	163	10	nt	not	PART
dti-1311	163	11	difference	difference	VERB
dti-1311	163	12	from	from	ADP
dti-1311	163	13	the	the	DET
dti-1311	163	14	cinnarizine	cinnarizine	NOUN
dti-1311	163	15	alone	alone	ADV
dti-1311	163	16	-	-	PUNCT
dti-1311	163	17	treated	treat	VERB
dti-1311	163	18	group	group	NOUN
dti-1311	163	19	.	.	PUNCT
dti-1311	164	1	six	six	NUM
dti-1311	164	2	mice	mouse	NOUN
dti-1311	164	3	were	be	AUX
dti-1311	164	4	used	use	VERB
dti-1311	164	5	per	per	ADP
dti-1311	164	6	each	each	DET
dti-1311	164	7	group	group	NOUN
dti-1311	164	8	.	.	PUNCT
dti-1311	165	1	figure	figure	NOUN
dti-1311	165	2	5	5	NUM
dti-1311	165	3	.	.	PUNCT
dti-1311	165	4	effect	effect	NOUN
dti-1311	165	5	of	of	ADP
dti-1311	165	6	glibenclamide	glibenclamide	NOUN
dti-1311	165	7	(	(	PUNCT
dti-1311	165	8	5	5	NUM
dti-1311	165	9	mg	mg	PROPN
dti-1311	165	10	/	/	SYM
dti-1311	165	11	kg	kg	PROPN
dti-1311	165	12	,	,	PUNCT
dti-1311	165	13	i.p	i.p	PROPN
dti-1311	165	14	.	.	PROPN
dti-1311	165	15	)	)	PUNCT
dti-1311	165	16	or	or	CCONJ
dti-1311	165	17	baclofen	baclofen	PROPN
dti-1311	165	18	(	(	PUNCT
dti-1311	165	19	5	5	NUM
dti-1311	165	20	or	or	CCONJ
dti-1311	165	21	10	10	NUM
dti-1311	165	22	mg	mg	NUM
dti-1311	165	23	/	/	SYM
dti-1311	165	24	kg	kg	PROPN
dti-1311	165	25	,	,	PUNCT
dti-1311	165	26	i.p	i.p	PROPN
dti-1311	165	27	.	.	PUNCT
dti-1311	165	28	)	)	PUNCT
dti-1311	166	1	on	on	ADP
dti-1311	166	2	antinociception	antinociception	NOUN
dti-1311	166	3	caused	cause	VERB
dti-1311	166	4	by	by	ADP
dti-1311	166	5	cinnarizine	cinnarizine	NOUN
dti-1311	166	6	(	(	PUNCT
dti-1311	166	7	2.5	2.5	NUM
dti-1311	166	8	mg	mg	PROPN
dti-1311	166	9	/	/	SYM
dti-1311	166	10	kg	kg	PROPN
dti-1311	166	11	,	,	PUNCT
dti-1311	166	12	s.c	s.c	PROPN
dti-1311	166	13	.	.	PROPN
dti-1311	166	14	)	)	PUNCT
dti-1311	167	1	in	in	ADP
dti-1311	167	2	the	the	DET
dti-1311	167	3	abdominal	abdominal	ADJ
dti-1311	167	4	constriction	constriction	NOUN
dti-1311	167	5	assay	assay	VERB
dti-1311	167	6	.	.	PUNCT
dti-1311	168	1	drugs	drug	NOUN
dti-1311	168	2	or	or	CCONJ
dti-1311	168	3	saline	saline	NOUN
dti-1311	168	4	(	(	PUNCT
dti-1311	168	5	control	control	NOUN
dti-1311	168	6	)	)	PUNCT
dti-1311	168	7	were	be	AUX
dti-1311	168	8	administered	administer	VERB
dti-1311	168	9	30	30	NUM
dti-1311	168	10	min	min	NOUN
dti-1311	168	11	prior	prior	ADV
dti-1311	168	12	to	to	ADP
dti-1311	168	13	testing	testing	NOUN
dti-1311	168	14	.	.	PUNCT
dti-1311	169	1	data	datum	NOUN
dti-1311	169	2	expressed	express	VERB
dti-1311	169	3	as	as	ADP
dti-1311	169	4	mean	mean	PROPN
dti-1311	169	5	±	±	NUM
dti-1311	169	6	s.e	s.e	PROPN
dti-1311	169	7	.	.	PROPN
dti-1311	169	8	percent	percent	NOUN
dti-1311	169	9	inhibition	inhibition	NOUN
dti-1311	169	10	(	(	PUNCT
dti-1311	169	11	%	%	INTJ
dti-1311	169	12	)	)	PUNCT
dti-1311	169	13	compared	compare	VERB
dti-1311	169	14	to	to	ADP
dti-1311	169	15	the	the	DET
dti-1311	169	16	control	control	NOUN
dti-1311	169	17	animals	animal	NOUN
dti-1311	169	18	is	be	AUX
dti-1311	169	19	shown	show	VERB
dti-1311	169	20	.	.	PUNCT
dti-1311	170	1	*	*	PUNCT
dti-1311	170	2	p	p	X
dti-1311	170	3	<	<	X
dti-1311	170	4	0.05	0.05	NUM
dti-1311	170	5	compared	compare	VERB
dti-1311	170	6	to	to	ADP
dti-1311	170	7	control	control	NOUN
dti-1311	170	8	group	group	NOUN
dti-1311	170	9	and	and	CCONJ
dti-1311	170	10	between	between	ADP
dti-1311	170	11	different	different	ADJ
dti-1311	170	12	groups	group	NOUN
dti-1311	170	13	as	as	SCONJ
dti-1311	170	14	shown	show	VERB
dti-1311	170	15	in	in	ADP
dti-1311	170	16	the	the	DET
dti-1311	170	17	fi	fi	NOUN
dti-1311	170	18	gure	gure	NOUN
dti-1311	170	19	.	.	PUNCT
dti-1311	171	1	six	six	NUM
dti-1311	171	2	mice	mouse	NOUN
dti-1311	171	3	were	be	AUX
dti-1311	171	4	used	use	VERB
dti-1311	171	5	per	per	ADP
dti-1311	171	6	each	each	DET
dti-1311	171	7	group	group	NOUN
dti-1311	171	8	.	.	PUNCT
dti-1311	172	1	effect	effect	NOUN
dti-1311	172	2	of	of	ADP
dti-1311	172	3	cinnarizine	cinnarizine	NOUN
dti-1311	172	4	on	on	ADP
dti-1311	172	5	gastric	gastric	ADJ
dti-1311	172	6	mucosal	mucosal	NOUN
dti-1311	172	7	lesions	lesion	NOUN
dti-1311	172	8	induced	induce	VERB
dti-1311	172	9	by	by	ADP
dti-1311	172	10	indomethacin	indomethacin	NOUN
dti-1311	172	11	in	in	ADP
dti-1311	172	12	the	the	DET
dti-1311	172	13	indomethacin	indomethacin	PROPN
dti-1311	172	14	control	control	NOUN
dti-1311	172	15	group	group	NOUN
dti-1311	172	16	,	,	PUNCT
dti-1311	172	17	the	the	DET
dti-1311	172	18	number	number	NOUN
dti-1311	172	19	and	and	CCONJ
dti-1311	172	20	severity	severity	NOUN
dti-1311	172	21	of	of	ADP
dti-1311	172	22	gastric	gastric	ADJ
dti-1311	172	23	mucosal	mucosal	NOUN
dti-1311	172	24	lesions	lesion	NOUN
dti-1311	172	25	were	be	AUX
dti-1311	172	26	5	5	NUM
dti-1311	172	27	±	±	NUM
dti-1311	172	28	0.68	0.68	NUM
dti-1311	172	29	and	and	CCONJ
dti-1311	172	30	7	7	NUM
dti-1311	172	31	±	±	NUM
dti-1311	172	32	1.0	1.0	NUM
dti-1311	172	33	,	,	PUNCT
dti-1311	172	34	respectively	respectively	ADV
dti-1311	172	35	.	.	PUNCT
dti-1311	173	1	this	this	PRON
dti-1311	173	2	was	be	AUX
dti-1311	173	3	signifi	signifi	NOUN
dti-1311	173	4	cantly	cantly	ADV
dti-1311	173	5	reduced	reduce	VERB
dti-1311	173	6	by	by	ADP
dti-1311	173	7	co	co	NOUN
dti-1311	173	8	-	-	NOUN
dti-1311	173	9	administration	administration	NOUN
dti-1311	173	10	of	of	ADP
dti-1311	173	11	cinnarizine	cinnarizine	NOUN
dti-1311	173	12	at	at	ADP
dti-1311	173	13	2.5	2.5	NUM
dti-1311	173	14	,	,	PUNCT
dti-1311	173	15	5	5	NUM
dti-1311	173	16	or	or	CCONJ
dti-1311	173	17	10	10	NUM
dti-1311	173	18	mg	mg	NUM
dti-1311	173	19	/	/	SYM
dti-1311	173	20	kg	kg	PROPN
dti-1311	173	21	.	.	PUNCT
dti-1311	174	1	it	it	PRON
dti-1311	174	2	was	be	AUX
dti-1311	174	3	noted	note	VERB
dti-1311	174	4	however	however	ADV
dti-1311	174	5	that	that	SCONJ
dti-1311	174	6	the	the	DET
dti-1311	174	7	lower	low	ADJ
dti-1311	174	8	doses	dose	NOUN
dti-1311	174	9	of	of	ADP
dti-1311	174	10	the	the	DET
dti-1311	174	11	drug	drug	NOUN
dti-1311	174	12	i.e.	i.e.	X
dti-1311	174	13	2.5	2.5	NUM
dti-1311	174	14	or	or	CCONJ
dti-1311	174	15	5	5	NUM
dti-1311	174	16	mg	mg	NUM
dti-1311	174	17	/	/	SYM
dti-1311	174	18	kg	kg	PROPN
dti-1311	174	19	were	be	AUX
dti-1311	174	20	more	more	ADV
dti-1311	174	21	effective	effective	ADJ
dti-1311	174	22	in	in	ADP
dti-1311	174	23	inhibiting	inhibit	VERB
dti-1311	174	24	the	the	DET
dti-1311	174	25	development	development	NOUN
dti-1311	174	26	of	of	ADP
dti-1311	174	27	gastric	gastric	ADJ
dti-1311	174	28	lesions	lesion	NOUN
dti-1311	174	29	than	than	ADP
dti-1311	174	30	the	the	DET
dti-1311	174	31	higher	high	ADJ
dti-1311	174	32	dose	dose	NOUN
dti-1311	174	33	of	of	ADP
dti-1311	174	34	10	10	NUM
dti-1311	174	35	mg	mg	PROPN
dti-1311	174	36	/	/	SYM
dti-1311	174	37	kg	kg	PROPN
dti-1311	174	38	.	.	PUNCT
dti-1311	175	1	thus	thus	ADV
dti-1311	175	2	cinnarizine	cinnarizine	VERB
dti-1311	175	3	at	at	ADP
dti-1311	175	4	doses	dose	NOUN
dti-1311	175	5	of	of	ADP
dti-1311	175	6	2.5	2.5	NUM
dti-1311	175	7	or	or	CCONJ
dti-1311	175	8	5	5	NUM
dti-1311	175	9	mg	mg	NUM
dti-1311	175	10	/	/	SYM
dti-1311	175	11	kg	kg	PROPN
dti-1311	175	12	,	,	PUNCT
dti-1311	175	13	reduced	reduce	VERB
dti-1311	175	14	the	the	DET
dti-1311	175	15	number	number	NOUN
dti-1311	175	16	and	and	CCONJ
dti-1311	175	17	severity	severity	NOUN
dti-1311	175	18	of	of	ADP
dti-1311	175	19	gastric	gastric	ADJ
dti-1311	175	20	mucosal	mucosal	NOUN
dti-1311	175	21	lesions	lesion	NOUN
dti-1311	175	22	caused	cause	VERB
dti-1311	175	23	by	by	ADP
dti-1311	175	24	indomethacin	indomethacin	NOUN
dti-1311	175	25	by	by	ADP
dti-1311	175	26	67	67	NUM
dti-1311	175	27	&	&	CCONJ
dti-1311	175	28	76	76	NUM
dti-1311	175	29	%	%	NOUN
dti-1311	175	30	and	and	CCONJ
dti-1311	175	31	by	by	ADP
dti-1311	175	32	68.6	68.6	NUM
dti-1311	175	33	&	&	CCONJ
dti-1311	175	34	74.4	74.4	NUM
dti-1311	175	35	%	%	NOUN
dti-1311	175	36	.	.	PUNCT
dti-1311	176	1	cinnarizine	cinnarizine	PROPN
dti-1311	176	2	at	at	ADP
dti-1311	176	3	10	10	NUM
dti-1311	176	4	mg	mg	PROPN
dti-1311	176	5	/	/	SYM
dti-1311	176	6	kg	kg	PROPN
dti-1311	176	7	,	,	PUNCT
dti-1311	176	8	reduced	reduce	VERB
dti-1311	176	9	the	the	DET
dti-1311	176	10	number	number	NOUN
dti-1311	176	11	and	and	CCONJ
dti-1311	176	12	severity	severity	NOUN
dti-1311	176	13	of	of	ADP
dti-1311	176	14	gastric	gastric	ADJ
dti-1311	176	15	lesions	lesion	NOUN
dti-1311	176	16	by	by	ADP
dti-1311	176	17	32	32	NUM
dti-1311	176	18	&	&	CCONJ
dti-1311	176	19	14.3	14.3	NUM
dti-1311	176	20	%	%	NOUN
dti-1311	176	21	(	(	PUNCT
dti-1311	176	22	fig	fig	NOUN
dti-1311	176	23	.	.	PUNCT
dti-1311	176	24	10	10	NUM
dti-1311	176	25	)	)	PUNCT
dti-1311	176	26	.	.	PUNCT
dti-1311	177	1	discussion	discussion	NOUN
dti-1311	177	2	the	the	DET
dti-1311	177	3	present	present	ADJ
dti-1311	177	4	study	study	NOUN
dti-1311	177	5	provides	provide	VERB
dti-1311	177	6	evidence	evidence	NOUN
dti-1311	177	7	that	that	SCONJ
dti-1311	177	8	cinnarizine	cinnarizine	PROPN
dti-1311	177	9	exerts	exert	VERB
dti-1311	177	10	different	different	ADJ
dti-1311	177	11	effects	effect	NOUN
dti-1311	177	12	on	on	ADP
dti-1311	177	13	visceral	visceral	ADJ
dti-1311	177	14	pain	pain	NOUN
dti-1311	177	15	,	,	PUNCT
dti-1311	177	16	infl	infl	PROPN
dti-1311	177	17	ammation	ammation	NOUN
dti-1311	177	18	and	and	CCONJ
dti-1311	177	19	on	on	ADP
dti-1311	177	20	the	the	DET
dti-1311	177	21	development	development	NOUN
dti-1311	177	22	of	of	ADP
dti-1311	177	23	gastric	gastric	ADJ
dti-1311	177	24	mucosal	mucosal	NOUN
dti-1311	177	25	damage	damage	NOUN
dti-1311	177	26	in	in	ADP
dti-1311	177	27	mice	mouse	NOUN
dti-1311	177	28	and	and	CCONJ
dti-1311	177	29	rat	rat	PROPN
dti-1311	177	30	.	.	PROPN
dti-1311	177	31	cinnarizine	cinnarizine	PROPN
dti-1311	177	32	(	(	PUNCT
dti-1311	177	33	1.25–20	1.25–20	NUM
dti-1311	177	34	mg	mg	NUM
dti-1311	177	35	/	/	SYM
dti-1311	177	36	kg	kg	PROPN
dti-1311	177	37	,	,	PUNCT
dti-1311	177	38	s.c	s.c	PROPN
dti-1311	177	39	.	.	PROPN
dti-1311	177	40	)	)	PUNCT
dti-1311	178	1	inhibited	inhibit	VERB
dti-1311	178	2	visceral	visceral	ADJ
dti-1311	178	3	pain	pain	NOUN
dti-1311	178	4	evoked	evoke	VERB
dti-1311	178	5	by	by	ADP
dti-1311	178	6	i.p	i.p	PROPN
dti-1311	178	7	.	.	PROPN
dti-1311	178	8	acetic	acetic	ADJ
dti-1311	178	9	acid	acid	NOUN
dti-1311	178	10	injection	injection	NOUN
dti-1311	178	11	in	in	ADP
dti-1311	178	12	mice	mouse	NOUN
dti-1311	178	13	.	.	PUNCT
dti-1311	179	1	cinnarizine	cinnarizine	PROPN
dti-1311	179	2	at	at	ADP
dti-1311	179	3	the	the	DET
dti-1311	179	4	doses	dose	NOUN
dti-1311	179	5	used	use	VERB
dti-1311	179	6	in	in	ADP
dti-1311	179	7	the	the	DET
dti-1311	179	8	present	present	ADJ
dti-1311	179	9	study	study	NOUN
dti-1311	179	10	did	do	AUX
dti-1311	179	11	not	not	PART
dti-1311	179	12	impair	impair	VERB
dti-1311	179	13	motor	motor	NOUN
dti-1311	179	14	performance	performance	NOUN
dti-1311	179	15	in	in	ADP
dti-1311	179	16	the	the	DET
dti-1311	179	17	rota	rota	NOUN
dti-1311	179	18	-	-	PUNCT
dti-1311	179	19	rod	rod	NOUN
dti-1311	179	20	test	test	NOUN
dti-1311	179	21	,	,	PUNCT
dti-1311	179	22	thus	thus	ADV
dti-1311	179	23	con	con	X
dti-1311	179	24	tro	tro	X
dti-1311	179	25	l	l	PROPN
dti-1311	179	26	cinn	cinn	PROPN
dti-1311	179	27	ari	ari	PROPN
dti-1311	179	28	zin	zin	NOUN
dti-1311	179	29	e	e	PROPN
dti-1311	179	30	2	2	NUM
dti-1311	179	31	.5	.5	NUM
dti-1311	179	32	mg	mg	PROPN
dti-1311	179	33	/	/	SYM
dti-1311	179	34	k	k	PROPN
dti-1311	179	35	g	g	PROPN
dti-1311	179	36	the	the	DET
dti-1311	179	37	op	op	NOUN
dti-1311	179	38	hy	hy	PROPN
dti-1311	179	39	llin	llin	PROPN
dti-1311	179	40	e	e	PROPN
dti-1311	179	41	2	2	NUM
dti-1311	179	42	0	0	NUM
dti-1311	179	43	m	m	NOUN
dti-1311	179	44	g	g	NOUN
dti-1311	179	45	/	/	SYM
dti-1311	179	46	k	k	PROPN
dti-1311	179	47	g	g	PROPN
dti-1311	179	48	cinn	cinn	PROPN
dti-1311	179	49	ari	ari	PROPN
dti-1311	179	50	zin	zin	NOUN
dti-1311	179	51	e	e	NOUN
dti-1311	179	52	+	+	CCONJ
dti-1311	179	53	the	the	DET
dti-1311	179	54	op	op	NOUN
dti-1311	179	55	hy	hy	PROPN
dti-1311	179	56	llin	llin	PROPN
dti-1311	179	57	e	e	PROPN
dti-1311	179	58	0	0	PROPN
dti-1311	179	59	10	10	NUM
dti-1311	179	60	20	20	NUM
dti-1311	179	61	30	30	NUM
dti-1311	179	62	40	40	NUM
dti-1311	179	63	50	50	NUM
dti-1311	179	64	60	60	NUM
dti-1311	179	65	70	70	NUM
dti-1311	179	66	*	*	PUNCT
dti-1311	180	1	+	+	ADJ
dti-1311	180	2	+	+	NUM
dti-1311	180	3	-49.7	-49.7	NOUN
dti-1311	180	4	%	%	NOUN
dti-1311	180	5	n	n	AUX
dti-1311	180	6	um	um	INTJ
dti-1311	180	7	be	be	AUX
dti-1311	180	8	r	r	NOUN
dti-1311	180	9	o	o	NOUN
dti-1311	180	10	f	f	X
dti-1311	181	1	a	a	DET
dti-1311	181	2	bd	bd	PROPN
dti-1311	181	3	om	om	PROPN
dti-1311	181	4	in	in	ADP
dti-1311	181	5	al	al	PROPN
dti-1311	181	6	c	c	PROPN
dti-1311	181	7	on	on	ADP
dti-1311	181	8	st	st	PROPN
dti-1311	181	9	ri	ri	PROPN
dti-1311	181	10	ct	ct	PROPN
dti-1311	181	11	io	io	X
dti-1311	181	12	ns	ns	X
dti-1311	181	13	con	con	PROPN
dti-1311	181	14	tro	tro	X
dti-1311	181	15	l	l	PROPN
dti-1311	181	16	cinn	cinn	PROPN
dti-1311	181	17	ari	ari	PROPN
dti-1311	181	18	zin	zin	NOUN
dti-1311	181	19	e	e	PROPN
dti-1311	181	20	2	2	NUM
dti-1311	181	21	.5	.5	NUM
dti-1311	182	1	mg	mg	PROPN
dti-1311	182	2	/	/	SYM
dti-1311	182	3	k	k	PROPN
dti-1311	182	4	g	g	PROPN
dti-1311	182	5	glib	glib	X
dti-1311	182	6	en	en	ADP
dti-1311	182	7	cla	cla	PROPN
dti-1311	182	8	mide	mide	NOUN
dti-1311	182	9	5	5	NUM
dti-1311	182	10	mg	mg	PROPN
dti-1311	182	11	/	/	SYM
dti-1311	182	12	k	k	NOUN
dti-1311	182	13	g	g	PROPN
dti-1311	183	1	+	+	PROPN
dti-1311	183	2	c	c	PROPN
dti-1311	183	3	inn	inn	PROPN
dti-1311	183	4	ari	ari	PROPN
dti-1311	183	5	zin	zin	NOUN
dti-1311	183	6	e	e	PROPN
dti-1311	183	7	2	2	NUM
dti-1311	183	8	.5	.5	NUM
dti-1311	183	9	mg	mg	PROPN
dti-1311	183	10	/	/	SYM
dti-1311	183	11	k	k	PROPN
dti-1311	183	12	g	g	PROPN
dti-1311	183	13	bac	bac	PROPN
dti-1311	183	14	lof	lof	PROPN
dti-1311	183	15	en	en	PROPN
dti-1311	183	16	5	5	NUM
dti-1311	183	17	mg	mg	PROPN
dti-1311	183	18	/	/	SYM
dti-1311	184	1	k	k	NOUN
dti-1311	185	1	g	g	PROPN
dti-1311	186	1	+	+	PROPN
dti-1311	186	2	c	c	PROPN
dti-1311	186	3	inn	inn	PROPN
dti-1311	186	4	ari	ari	PROPN
dti-1311	186	5	zin	zin	NOUN
dti-1311	186	6	e	e	PROPN
dti-1311	186	7	2	2	NUM
dti-1311	186	8	.5	.5	NUM
dti-1311	186	9	mg	mg	PROPN
dti-1311	186	10	/	/	SYM
dti-1311	186	11	k	k	PROPN
dti-1311	186	12	g	g	PROPN
dti-1311	186	13	bac	bac	PROPN
dti-1311	186	14	lof	lof	PROPN
dti-1311	186	15	en	en	PROPN
dti-1311	186	16	10	10	NUM
dti-1311	186	17	m	m	PROPN
dti-1311	186	18	g	g	NOUN
dti-1311	186	19	/	/	SYM
dti-1311	186	20	k	k	NOUN
dti-1311	186	21	g	g	PROPN
dti-1311	187	1	+	+	CCONJ
dti-1311	187	2	c	c	PROPN
dti-1311	187	3	inn	inn	PROPN
dti-1311	187	4	ari	ari	PROPN
dti-1311	187	5	zin	zin	NOUN
dti-1311	187	6	e	e	PROPN
dti-1311	187	7	2	2	NUM
dti-1311	187	8	.5	.5	NUM
dti-1311	187	9	mg	mg	PROPN
dti-1311	187	10	/	/	SYM
dti-1311	187	11	k	k	PROPN
dti-1311	188	1	g	g	PROPN
dti-1311	188	2	0	0	NUM
dti-1311	188	3	25	25	NUM
dti-1311	188	4	50	50	NUM
dti-1311	188	5	75	75	NUM
dti-1311	188	6	*	*	PUNCT
dti-1311	188	7	*	*	PUNCT
dti-1311	188	8	*	*	PUNCT
dti-1311	188	9	-61.2	-61.2	NUM
dti-1311	188	10	%	%	NOUN
dti-1311	188	11	-68.7	-68.7	NUM
dti-1311	188	12	%	%	NOUN
dti-1311	188	13	-48.6	-48.6	INTJ
dti-1311	188	14	%	%	NOUN
dti-1311	188	15	*	*	PUNCT
dti-1311	189	1	-97.5	-97.5	NUM
dti-1311	189	2	%	%	NOUN
dti-1311	189	3	-23.6	-23.6	NUM
dti-1311	189	4	%	%	NOUN
dti-1311	189	5	-35.9	-35.9	NOUN
dti-1311	189	6	%	%	NOUN
dti-1311	189	7	*	*	PUNCT
dti-1311	190	1	*	*	PUNCT
dti-1311	191	1	*	*	PUNCT
dti-1311	191	2	*	*	PUNCT
dti-1311	191	3	*	*	PUNCT
dti-1311	191	4	*	*	PUNCT
dti-1311	191	5	n	n	AUX
dti-1311	191	6	um	um	INTJ
dti-1311	191	7	be	be	AUX
dti-1311	191	8	r	r	NOUN
dti-1311	191	9	o	o	NOUN
dti-1311	191	10	f	f	X
dti-1311	192	1	a	a	DET
dti-1311	192	2	bd	bd	PROPN
dti-1311	192	3	om	om	PROPN
dti-1311	192	4	in	in	ADP
dti-1311	192	5	al	al	PROPN
dti-1311	192	6	c	c	PROPN
dti-1311	192	7	on	on	ADP
dti-1311	192	8	st	st	PROPN
dti-1311	192	9	ri	ri	PROPN
dti-1311	192	10	ct	ct	PROPN
dti-1311	192	11	io	io	X
dti-1311	192	12	ns	ns	PROPN
dti-1311	192	13	drug	drug	NOUN
dti-1311	192	14	target	target	NOUN
dti-1311	192	15	insights	insight	NOUN
dti-1311	192	16	2007	2007	NUM
dti-1311	192	17	:	:	PUNCT
dti-1311	192	18	234	234	NUM
dti-1311	192	19	omar	omar	PROPN
dti-1311	192	20	m.e	m.e	PROPN
dti-1311	192	21	.	.	PROPN
dti-1311	192	22	abdel	abdel	PROPN
dti-1311	192	23	-	-	PUNCT
dti-1311	192	24	salam	salam	PROPN
dti-1311	192	25	morphine	morphine	PROPN
dti-1311	192	26	(	(	PUNCT
dti-1311	192	27	baamonde	baamonde	NOUN
dti-1311	192	28	et	et	PROPN
dti-1311	192	29	al	al	PROPN
dti-1311	192	30	.	.	PROPN
dti-1311	192	31	1989	1989	NUM
dti-1311	192	32	)	)	PUNCT
dti-1311	192	33	and	and	CCONJ
dti-1311	192	34	by	by	ADP
dti-1311	192	35	antidepressant	antidepressant	ADJ
dti-1311	192	36	drugs	drug	NOUN
dti-1311	192	37	(	(	PUNCT
dti-1311	192	38	singh	singh	PROPN
dti-1311	192	39	et	et	PROPN
dti-1311	192	40	al	al	PROPN
dti-1311	192	41	.	.	PROPN
dti-1311	192	42	2001	2001	NUM
dti-1311	192	43	)	)	PUNCT
dti-1311	192	44	.	.	PUNCT
dti-1311	193	1	in	in	ADP
dti-1311	193	2	the	the	DET
dti-1311	193	3	present	present	ADJ
dti-1311	193	4	study	study	NOUN
dti-1311	193	5	,	,	PUNCT
dti-1311	193	6	an	an	DET
dti-1311	193	7	attempt	attempt	NOUN
dti-1311	193	8	was	be	AUX
dti-1311	193	9	made	make	VERB
dti-1311	193	10	to	to	PART
dti-1311	193	11	pharmacologically	pharmacologically	ADV
dti-1311	193	12	characterize	characterize	VERB
dti-1311	193	13	and	and	CCONJ
dti-1311	193	14	investigate	investigate	VERB
dti-1311	193	15	the	the	DET
dti-1311	193	16	possible	possible	ADJ
dti-1311	193	17	neural	neural	ADJ
dti-1311	193	18	pathways	pathway	NOUN
dti-1311	193	19	involved	involve	VERB
dti-1311	193	20	in	in	ADP
dti-1311	193	21	the	the	DET
dti-1311	193	22	analgesic	analgesic	ADJ
dti-1311	193	23	effect	effect	NOUN
dti-1311	193	24	of	of	ADP
dti-1311	193	25	cinnarizine	cinnarizine	NOUN
dti-1311	193	26	.	.	PUNCT
dti-1311	194	1	the	the	DET
dti-1311	194	2	possible	possible	ADJ
dti-1311	194	3	involvement	involvement	NOUN
dti-1311	194	4	of	of	ADP
dti-1311	194	5	neurotransmitter	neurotransmitter	NOUN
dti-1311	194	6	systems	system	NOUN
dti-1311	194	7	,	,	PUNCT
dti-1311	194	8	such	such	ADJ
dti-1311	194	9	as	as	ADP
dti-1311	194	10	dopaminergic	dopaminergic	ADJ
dti-1311	194	11	,	,	PUNCT
dti-1311	194	12	opioid	opioid	ADJ
dti-1311	194	13	,	,	PUNCT
dti-1311	194	14	purinergic	purinergic	NOUN
dti-1311	194	15	,	,	PUNCT
dti-1311	194	16	cholinergic	cholinergic	ADJ
dti-1311	194	17	,	,	PUNCT
dti-1311	194	18	catecholaminergic	catecholaminergic	ADJ
dti-1311	194	19	,	,	PUNCT
dti-1311	194	20	gabaergic	gabaergic	ADJ
dti-1311	194	21	,	,	PUNCT
dti-1311	194	22	systems	system	NOUN
dti-1311	194	23	as	as	ADV
dti-1311	194	24	well	well	ADV
dti-1311	194	25	as	as	ADP
dti-1311	194	26	atp	atp	NOUN
dti-1311	194	27	-	-	PUNCT
dti-1311	194	28	gated	gate	VERB
dti-1311	194	29	potassium	potassium	NOUN
dti-1311	194	30	channels	channel	NOUN
dti-1311	194	31	was	be	AUX
dti-1311	194	32	evaluated	evaluate	VERB
dti-1311	194	33	.	.	PUNCT
dti-1311	195	1	cinnarizine	cinnarizine	PROPN
dti-1311	195	2	possesses	possess	VERB
dti-1311	195	3	direct	direct	ADJ
dti-1311	195	4	anti	anti	ADJ
dti-1311	195	5	-	-	ADJ
dti-1311	195	6	dopaminergic	dopaminergic	ADJ
dti-1311	195	7	features	feature	NOUN
dti-1311	195	8	(	(	PUNCT
dti-1311	195	9	dopamine	dopamine	NOUN
dti-1311	195	10	d1	d1	NOUN
dti-1311	195	11	and	and	CCONJ
dti-1311	195	12	d2	d2	PROPN
dti-1311	195	13	receptor	receptor	NOUN
dti-1311	195	14	blockade	blockade	NOUN
dti-1311	195	15	)	)	PUNCT
dti-1311	195	16	that	that	PRON
dti-1311	195	17	are	be	AUX
dti-1311	195	18	likely	likely	ADJ
dti-1311	195	19	to	to	PART
dti-1311	195	20	contribute	contribute	VERB
dti-1311	195	21	to	to	ADP
dti-1311	195	22	the	the	DET
dti-1311	195	23	ability	ability	NOUN
dti-1311	195	24	of	of	ADP
dti-1311	195	25	this	this	DET
dti-1311	195	26	drug	drug	NOUN
dti-1311	195	27	to	to	PART
dti-1311	195	28	cause	cause	VERB
dti-1311	195	29	extrapyramdial	extrapyramdial	ADJ
dti-1311	195	30	symptoms	symptom	NOUN
dti-1311	195	31	(	(	PUNCT
dti-1311	195	32	reiriz	reiriz	NOUN
dti-1311	195	33	et	et	PROPN
dti-1311	195	34	al	al	PROPN
dti-1311	195	35	.	.	PROPN
dti-1311	195	36	1994	1994	NUM
dti-1311	195	37	;	;	PUNCT
dti-1311	195	38	brucke	brucke	NOUN
dti-1311	195	39	et	et	PROPN
dti-1311	195	40	al	al	PROPN
dti-1311	195	41	.	.	PROPN
dti-1311	195	42	1995	1995	NUM
dti-1311	195	43	)	)	PUNCT
dti-1311	195	44	.	.	PUNCT
dti-1311	196	1	dopamine	dopamine	NOUN
dti-1311	196	2	d2	d2	NOUN
dti-1311	196	3	receptors	receptor	NOUN
dti-1311	196	4	are	be	AUX
dti-1311	196	5	involved	involve	VERB
dti-1311	196	6	in	in	ADP
dti-1311	196	7	modulation	modulation	NOUN
dti-1311	196	8	of	of	ADP
dti-1311	196	9	nociceptive	nociceptive	ADJ
dti-1311	196	10	responses	response	NOUN
dti-1311	196	11	and	and	CCONJ
dti-1311	196	12	dopamine	dopamine	NOUN
dti-1311	196	13	d2	d2	NOUN
dti-1311	196	14	-	-	PUNCT
dti-1311	196	15	receptor	receptor	NOUN
dti-1311	196	16	antagonists	antagonist	NOUN
dti-1311	196	17	e.g.	e.g.	ADV
dti-1311	196	18	sulpiride	sulpiride	ADV
dti-1311	196	19	caused	cause	VERB
dti-1311	196	20	antinociception	antinociception	NOUN
dti-1311	196	21	in	in	ADP
dti-1311	196	22	different	different	ADJ
dti-1311	196	23	pain	pain	NOUN
dti-1311	196	24	models	model	NOUN
dti-1311	196	25	(	(	PUNCT
dti-1311	196	26	ben	ben	PROPN
dti-1311	196	27	-	-	NOUN
dti-1311	196	28	sreti	sreti	VERB
dti-1311	196	29	et	et	PROPN
dti-1311	196	30	al	al	PROPN
dti-1311	196	31	.	.	PROPN
dti-1311	196	32	1983	1983	NUM
dti-1311	196	33	;	;	PUNCT
dti-1311	196	34	rooney	rooney	NOUN
dti-1311	196	35	and	and	CCONJ
dti-1311	196	36	sewell	sewell	PROPN
dti-1311	196	37	,	,	PUNCT
dti-1311	196	38	1989	1989	NUM
dti-1311	196	39	;	;	PUNCT
dti-1311	196	40	frussa	frussa	ADJ
dti-1311	196	41	-	-	PUNCT
dti-1311	196	42	filho	filho	NOUN
dti-1311	196	43	et	et	NOUN
dti-1311	196	44	al.1996	al.1996	PROPN
dti-1311	196	45	)	)	PUNCT
dti-1311	196	46	.	.	PUNCT
dti-1311	197	1	there	there	PRON
dti-1311	197	2	is	be	VERB
dti-1311	197	3	also	also	ADV
dti-1311	197	4	an	an	DET
dti-1311	197	5	evidence	evidence	NOUN
dti-1311	197	6	of	of	ADP
dti-1311	197	7	dopaminemediated	dopaminemediated	ADJ
dti-1311	197	8	descending	descend	VERB
dti-1311	197	9	nociceptive	nociceptive	ADJ
dti-1311	197	10	inhibition	inhibition	NOUN
dti-1311	197	11	of	of	ADP
dti-1311	197	12	spinal	spinal	ADJ
dti-1311	197	13	neurons	neuron	NOUN
dti-1311	197	14	(	(	PUNCT
dti-1311	197	15	burkey	burkey	PROPN
dti-1311	197	16	et	et	PROPN
dti-1311	197	17	al	al	PROPN
dti-1311	197	18	.	.	PROPN
dti-1311	197	19	1999	1999	NUM
dti-1311	197	20	)	)	PUNCT
dti-1311	197	21	.	.	PUNCT
dti-1311	198	1	therefore	therefore	ADV
dti-1311	198	2	,	,	PUNCT
dti-1311	198	3	the	the	DET
dti-1311	198	4	involvement	involvement	NOUN
dti-1311	198	5	of	of	ADP
dti-1311	198	6	the	the	DET
dti-1311	198	7	dopamine	dopamine	NOUN
dti-1311	198	8	receptors	receptor	NOUN
dti-1311	198	9	in	in	ADP
dti-1311	198	10	antinociception	antinociception	NOUN
dti-1311	198	11	induced	induce	VERB
dti-1311	198	12	by	by	ADP
dti-1311	198	13	cinnarizine	cinnarizine	NOUN
dti-1311	198	14	was	be	AUX
dti-1311	198	15	investigated	investigate	VERB
dti-1311	198	16	.	.	PUNCT
dti-1311	199	1	the	the	DET
dti-1311	199	2	effect	effect	NOUN
dti-1311	199	3	of	of	ADP
dti-1311	199	4	cinnarizine	cinnarizine	NOUN
dti-1311	199	5	was	be	AUX
dti-1311	199	6	unaffected	unaffected	ADJ
dti-1311	199	7	by	by	ADP
dti-1311	199	8	coadministration	coadministration	NOUN
dti-1311	199	9	of	of	ADP
dti-1311	199	10	the	the	DET
dti-1311	199	11	centrally	centrally	ADV
dti-1311	199	12	acting	act	VERB
dti-1311	199	13	dopamine	dopamine	NOUN
dti-1311	199	14	d2	d2	NOUN
dti-1311	199	15	receptor	receptor	NOUN
dti-1311	199	16	antagonists	antagonist	NOUN
dti-1311	199	17	,	,	PUNCT
dti-1311	199	18	sulpiride	sulpiride	ADV
dti-1311	199	19	,	,	PUNCT
dti-1311	199	20	haloperidol	haloperidol	NOUN
dti-1311	199	21	or	or	CCONJ
dti-1311	199	22	metoclopramide	metoclopramide	NOUN
dti-1311	199	23	,	,	PUNCT
dti-1311	199	24	the	the	DET
dti-1311	199	25	peripherally	peripherally	ADV
dti-1311	199	26	acting	act	VERB
dti-1311	199	27	d2	d2	NOUN
dti-1311	199	28	receptor	receptor	NOUN
dti-1311	199	29	antagonist	antagonist	NOUN
dti-1311	199	30	domperidone	domperidone	NOUN
dti-1311	199	31	,	,	PUNCT
dti-1311	199	32	but	but	CCONJ
dti-1311	199	33	increased	increase	VERB
dti-1311	199	34	by	by	ADP
dti-1311	199	35	the	the	DET
dti-1311	199	36	d2	d2	PROPN
dti-1311	199	37	receptor	receptor	NOUN
dti-1311	199	38	agonist	agonist	NOUN
dti-1311	199	39	bromocryptine	bromocryptine	NOUN
dti-1311	199	40	and	and	CCONJ
dti-1311	199	41	by	by	ADP
dti-1311	199	42	the	the	DET
dti-1311	199	43	non	non	ADJ
dti-1311	199	44	-	-	ADJ
dti-1311	199	45	selective	selective	ADJ
dti-1311	199	46	dopamine	dopamine	NOUN
dti-1311	199	47	receptor	receptor	NOUN
dti-1311	199	48	antagonist	antagonist	NOUN
dti-1311	199	49	chlorpromazine	chlorpromazine	NOUN
dti-1311	199	50	.	.	PUNCT
dti-1311	200	1	these	these	DET
dti-1311	200	2	data	datum	NOUN
dti-1311	200	3	do	do	AUX
dti-1311	200	4	not	not	PART
dti-1311	200	5	suggest	suggest	VERB
dti-1311	200	6	the	the	DET
dti-1311	200	7	involvement	involvement	NOUN
dti-1311	200	8	of	of	ADP
dti-1311	200	9	dopamine	dopamine	NOUN
dti-1311	200	10	d2	d2	NOUN
dti-1311	200	11	receptors	receptor	NOUN
dti-1311	200	12	in	in	ADP
dti-1311	200	13	the	the	DET
dti-1311	200	14	visceral	visceral	ADJ
dti-1311	200	15	analgesic	analgesic	ADJ
dti-1311	200	16	properties	property	NOUN
dti-1311	200	17	of	of	ADP
dti-1311	200	18	cinnarizine	cinnarizine	NOUN
dti-1311	200	19	.	.	PUNCT
dti-1311	201	1	the	the	DET
dti-1311	201	2	antinociception	antinociception	NOUN
dti-1311	201	3	caused	cause	VERB
dti-1311	201	4	by	by	ADP
dti-1311	201	5	cinnarizine	cinnarizine	NOUN
dti-1311	201	6	was	be	AUX
dti-1311	201	7	in	in	ADP
dti-1311	201	8	also	also	ADV
dti-1311	201	9	unaffected	unaffected	ADJ
dti-1311	201	10	by	by	ADP
dti-1311	201	11	the	the	DET
dti-1311	201	12	opioid	opioid	ADJ
dti-1311	201	13	receptor	receptor	NOUN
dti-1311	201	14	antagonist	antagonist	NOUN
dti-1311	201	15	naloxone	naloxone	NOUN
dti-1311	201	16	,	,	PUNCT
dti-1311	201	17	which	which	PRON
dti-1311	201	18	is	be	AUX
dti-1311	201	19	in	in	ADP
dti-1311	201	20	agreement	agreement	NOUN
dti-1311	201	21	with	with	ADP
dti-1311	201	22	earlier	early	ADJ
dti-1311	201	23	reports	report	NOUN
dti-1311	201	24	(	(	PUNCT
dti-1311	201	25	miranda	miranda	PROPN
dti-1311	201	26	et	et	PROPN
dti-1311	201	27	al	al	PROPN
dti-1311	201	28	.	.	PROPN
dti-1311	201	29	1993	1993	NUM
dti-1311	201	30	)	)	PUNCT
dti-1311	201	31	.	.	PUNCT
dti-1311	202	1	the	the	DET
dti-1311	202	2	inhibition	inhibition	NOUN
dti-1311	202	3	of	of	ADP
dti-1311	202	4	adrenergic	adrenergic	ADJ
dti-1311	202	5	and	and	CCONJ
dti-1311	202	6	cholinergic	cholinergic	ADJ
dti-1311	202	7	systems	system	NOUN
dti-1311	202	8	appears	appear	VERB
dti-1311	202	9	to	to	PART
dti-1311	202	10	facilitate	facilitate	VERB
dti-1311	202	11	cinnarizine	cinnarizine	NOUN
dti-1311	202	12	-	-	PUNCT
dti-1311	202	13	induced	induce	VERB
dti-1311	202	14	antinociception	antinociception	NOUN
dti-1311	202	15	,	,	PUNCT
dti-1311	202	16	since	since	SCONJ
dti-1311	202	17	the	the	DET
dti-1311	202	18	co	co	NOUN
dti-1311	202	19	-	-	NOUN
dti-1311	202	20	administration	administration	NOUN
dti-1311	202	21	of	of	ADP
dti-1311	202	22	the	the	DET
dti-1311	202	23	beta	beta	NOUN
dti-1311	202	24	-	-	PUNCT
dti-1311	202	25	adrenergic	adrenergic	ADJ
dti-1311	202	26	antagonist	antagonist	NOUN
dti-1311	202	27	propranolol	propranolol	NOUN
dti-1311	202	28	,	,	PUNCT
dti-1311	202	29	the	the	DET
dti-1311	202	30	muscarinic	muscarinic	ADJ
dti-1311	202	31	receptor	receptor	NOUN
dti-1311	202	32	antagonist	antagonist	NOUN
dti-1311	202	33	atropine	atropine	NOUN
dti-1311	202	34	and	and	CCONJ
dti-1311	202	35	the	the	DET
dti-1311	202	36	alpha2adrenergic	alpha2adrenergic	ADJ
dti-1311	202	37	antagonist	antagonist	NOUN
dti-1311	202	38	yohimbine	yohimbine	NOUN
dti-1311	202	39	rather	rather	ADV
dti-1311	202	40	enhanced	enhance	VERB
dti-1311	202	41	the	the	DET
dti-1311	202	42	effect	effect	NOUN
dti-1311	202	43	of	of	ADP
dti-1311	202	44	cinnarizine	cinnarizine	NOUN
dti-1311	202	45	observed	observe	VERB
dti-1311	202	46	in	in	ADP
dti-1311	202	47	the	the	DET
dti-1311	202	48	present	present	ADJ
dti-1311	202	49	study	study	NOUN
dti-1311	202	50	.	.	PUNCT
dti-1311	203	1	most	most	ADJ
dti-1311	203	2	forms	form	NOUN
dti-1311	203	3	of	of	ADP
dti-1311	203	4	pain	pain	NOUN
dti-1311	203	5	arising	arise	VERB
dti-1311	203	6	from	from	ADP
dti-1311	203	7	the	the	DET
dti-1311	203	8	gastrointestinal	gastrointestinal	ADJ
dti-1311	203	9	tract	tract	NOUN
dti-1311	203	10	are	be	AUX
dti-1311	203	11	mediated	mediate	VERB
dti-1311	203	12	by	by	ADP
dti-1311	203	13	activity	activity	NOUN
dti-1311	203	14	in	in	ADP
dti-1311	203	15	visceral	visceral	ADJ
dti-1311	203	16	afferent	afferent	ADJ
dti-1311	203	17	fibres	fibre	NOUN
dti-1311	203	18	running	run	VERB
dti-1311	203	19	in	in	ADP
dti-1311	203	20	sympathetic	sympathetic	ADJ
dti-1311	203	21	nerves	nerve	NOUN
dti-1311	203	22	(	(	PUNCT
dti-1311	203	23	cervero	cervero	NOUN
dti-1311	203	24	,	,	PUNCT
dti-1311	203	25	1988	1988	NUM
dti-1311	203	26	)	)	PUNCT
dti-1311	203	27	.	.	PUNCT
dti-1311	204	1	coeliac	coeliac	NOUN
dti-1311	204	2	plexus	plexus	NOUN
dti-1311	204	3	block	block	NOUN
dti-1311	204	4	relieves	relieve	VERB
dti-1311	204	5	visceral	visceral	ADJ
dti-1311	204	6	pain	pain	NOUN
dti-1311	204	7	that	that	PRON
dti-1311	204	8	is	be	AUX
dti-1311	204	9	caused	cause	VERB
dti-1311	204	10	by	by	ADP
dti-1311	204	11	carcinoma	carcinoma	NOUN
dti-1311	204	12	of	of	ADP
dti-1311	204	13	the	the	DET
dti-1311	204	14	pancreas	pancrea	NOUN
dti-1311	204	15	,	,	PUNCT
dti-1311	204	16	stomach	stomach	NOUN
dti-1311	204	17	,	,	PUNCT
dti-1311	204	18	gall	gall	NOUN
dti-1311	204	19	bladder	bladder	NOUN
dti-1311	204	20	or	or	CCONJ
dti-1311	204	21	liver	liver	NOUN
dti-1311	204	22	(	(	PUNCT
dti-1311	204	23	brown	brown	PROPN
dti-1311	204	24	et	et	PROPN
dti-1311	204	25	al	al	PROPN
dti-1311	204	26	.	.	PROPN
dti-1311	204	27	1987	1987	NUM
dti-1311	204	28	;	;	PUNCT
dti-1311	204	29	eisenberg	eisenberg	PROPN
dti-1311	204	30	et	et	PROPN
dti-1311	204	31	al	al	PROPN
dti-1311	204	32	.	.	PROPN
dti-1311	204	33	1995	1995	NUM
dti-1311	204	34	)	)	PUNCT
dti-1311	204	35	.	.	PUNCT
dti-1311	205	1	chemical	chemical	NOUN
dti-1311	205	2	sympathectomy	sympathectomy	NOUN
dti-1311	205	3	attenuated	attenuate	VERB
dti-1311	205	4	visceral	visceral	ADJ
dti-1311	205	5	nociceptive	nociceptive	ADJ
dti-1311	205	6	responses	response	NOUN
dti-1311	205	7	figure	figure	VERB
dti-1311	205	8	6	6	NUM
dti-1311	205	9	.	.	PUNCT
dti-1311	205	10	effect	effect	NOUN
dti-1311	205	11	of	of	ADP
dti-1311	205	12	piracetam	piracetam	NOUN
dti-1311	205	13	(	(	PUNCT
dti-1311	205	14	300	300	NUM
dti-1311	205	15	mg	mg	PROPN
dti-1311	205	16	/	/	SYM
dti-1311	205	17	kg	kg	PROPN
dti-1311	205	18	,	,	PUNCT
dti-1311	205	19	i.p	i.p	PROPN
dti-1311	205	20	.	.	PROPN
dti-1311	205	21	)	)	PUNCT
dti-1311	205	22	or	or	CCONJ
dti-1311	205	23	vinpocetine	vinpocetine	NOUN
dti-1311	205	24	(	(	PUNCT
dti-1311	205	25	1.8	1.8	NUM
dti-1311	205	26	mg	mg	PROPN
dti-1311	205	27	/	/	SYM
dti-1311	205	28	kg	kg	PROPN
dti-1311	205	29	,	,	PUNCT
dti-1311	205	30	i.p	i.p	PROPN
dti-1311	205	31	.	.	PUNCT
dti-1311	205	32	)	)	PUNCT
dti-1311	206	1	on	on	ADP
dti-1311	206	2	antinociception	antinociception	NOUN
dti-1311	206	3	caused	cause	VERB
dti-1311	206	4	by	by	ADP
dti-1311	206	5	cinnarizine	cinnarizine	NOUN
dti-1311	206	6	(	(	PUNCT
dti-1311	206	7	2.5	2.5	NUM
dti-1311	206	8	mg	mg	PROPN
dti-1311	206	9	/	/	SYM
dti-1311	206	10	kg	kg	PROPN
dti-1311	206	11	,	,	PUNCT
dti-1311	206	12	s.c	s.c	PROPN
dti-1311	206	13	.	.	PROPN
dti-1311	206	14	)	)	PUNCT
dti-1311	207	1	in	in	ADP
dti-1311	207	2	the	the	DET
dti-1311	207	3	abdominal	abdominal	ADJ
dti-1311	207	4	constriction	constriction	NOUN
dti-1311	207	5	assay	assay	VERB
dti-1311	207	6	.	.	PUNCT
dti-1311	208	1	drugs	drug	NOUN
dti-1311	208	2	or	or	CCONJ
dti-1311	208	3	saline	saline	NOUN
dti-1311	208	4	(	(	PUNCT
dti-1311	208	5	control	control	NOUN
dti-1311	208	6	)	)	PUNCT
dti-1311	208	7	were	be	AUX
dti-1311	208	8	administered	administer	VERB
dti-1311	208	9	30	30	NUM
dti-1311	208	10	min	min	NOUN
dti-1311	208	11	prior	prior	ADV
dti-1311	208	12	to	to	ADP
dti-1311	208	13	testing	testing	NOUN
dti-1311	208	14	.	.	PUNCT
dti-1311	209	1	data	datum	NOUN
dti-1311	209	2	expressed	express	VERB
dti-1311	209	3	as	as	ADP
dti-1311	209	4	mean	mean	PROPN
dti-1311	209	5	±	±	NUM
dti-1311	209	6	s.e	s.e	PROPN
dti-1311	209	7	.	.	PROPN
dti-1311	209	8	percent	percent	NOUN
dti-1311	209	9	inhibition	inhibition	NOUN
dti-1311	209	10	(	(	PUNCT
dti-1311	209	11	%	%	INTJ
dti-1311	209	12	)	)	PUNCT
dti-1311	209	13	compared	compare	VERB
dti-1311	209	14	to	to	ADP
dti-1311	209	15	the	the	DET
dti-1311	209	16	control	control	NOUN
dti-1311	209	17	animals	animal	NOUN
dti-1311	209	18	is	be	AUX
dti-1311	209	19	shown	show	VERB
dti-1311	209	20	.	.	PUNCT
dti-1311	210	1	*	*	PUNCT
dti-1311	210	2	p	p	X
dti-1311	210	3	<	<	X
dti-1311	210	4	0.05	0.05	NUM
dti-1311	210	5	compared	compare	VERB
dti-1311	210	6	to	to	ADP
dti-1311	210	7	control	control	NOUN
dti-1311	210	8	and	and	CCONJ
dti-1311	210	9	between	between	ADP
dti-1311	210	10	different	different	ADJ
dti-1311	210	11	groups	group	NOUN
dti-1311	210	12	as	as	SCONJ
dti-1311	210	13	shown	show	VERB
dti-1311	210	14	in	in	ADP
dti-1311	210	15	the	the	DET
dti-1311	210	16	fi	fi	NOUN
dti-1311	210	17	gure	gure	NOUN
dti-1311	210	18	.	.	PUNCT
dti-1311	211	1	six	six	NUM
dti-1311	211	2	mice	mouse	NOUN
dti-1311	211	3	were	be	AUX
dti-1311	211	4	used	use	VERB
dti-1311	211	5	per	per	ADP
dti-1311	211	6	each	each	DET
dti-1311	211	7	group	group	NOUN
dti-1311	211	8	.	.	PUNCT
dti-1311	212	1	figure	figure	NOUN
dti-1311	212	2	7	7	NUM
dti-1311	212	3	.	.	PUNCT
dti-1311	212	4	effect	effect	NOUN
dti-1311	212	5	of	of	ADP
dti-1311	212	6	indomethacin	indomethacin	PROPN
dti-1311	212	7	(	(	PUNCT
dti-1311	212	8	ind	ind	NOUN
dti-1311	212	9	;	;	PUNCT
dti-1311	212	10	5	5	NUM
dti-1311	212	11	mg	mg	PROPN
dti-1311	212	12	/	/	SYM
dti-1311	212	13	kg	kg	PROPN
dti-1311	212	14	,	,	PUNCT
dti-1311	212	15	i.p	i.p	PROPN
dti-1311	212	16	.	.	PROPN
dti-1311	212	17	)	)	PUNCT
dti-1311	213	1	or	or	CCONJ
dti-1311	213	2	indomethacin	indomethacin	NOUN
dti-1311	213	3	(	(	PUNCT
dti-1311	213	4	5	5	NUM
dti-1311	213	5	mg	mg	PROPN
dti-1311	213	6	/	/	SYM
dti-1311	213	7	kg	kg	PROPN
dti-1311	213	8	,	,	PUNCT
dti-1311	213	9	i.p	i.p	PROPN
dti-1311	213	10	.	.	PUNCT
dti-1311	213	11	)	)	PUNCT
dti-1311	214	1	+	+	CCONJ
dti-1311	214	2	cinnarizine	cinnarizine	NOUN
dti-1311	214	3	(	(	PUNCT
dti-1311	214	4	2.5	2.5	NUM
dti-1311	214	5	mg	mg	PROPN
dti-1311	214	6	/	/	SYM
dti-1311	214	7	kg	kg	PROPN
dti-1311	214	8	,	,	PUNCT
dti-1311	214	9	s.c	s.c	PROPN
dti-1311	214	10	.	.	PROPN
dti-1311	214	11	)	)	PUNCT
dti-1311	215	1	visceral	visceral	ADJ
dti-1311	215	2	pain	pain	NOUN
dti-1311	215	3	in	in	ADP
dti-1311	215	4	the	the	DET
dti-1311	215	5	abdominal	abdominal	ADJ
dti-1311	215	6	constriction	constriction	NOUN
dti-1311	215	7	assay	assay	VERB
dti-1311	215	8	.	.	PUNCT
dti-1311	216	1	drugs	drug	NOUN
dti-1311	216	2	or	or	CCONJ
dti-1311	216	3	saline	saline	NOUN
dti-1311	216	4	(	(	PUNCT
dti-1311	216	5	control	control	NOUN
dti-1311	216	6	)	)	PUNCT
dti-1311	216	7	were	be	AUX
dti-1311	216	8	administered	administer	VERB
dti-1311	216	9	30	30	NUM
dti-1311	216	10	min	min	NOUN
dti-1311	216	11	prior	prior	ADV
dti-1311	216	12	to	to	ADP
dti-1311	216	13	testing	testing	NOUN
dti-1311	216	14	.	.	PUNCT
dti-1311	217	1	data	datum	NOUN
dti-1311	217	2	expressed	express	VERB
dti-1311	217	3	as	as	ADP
dti-1311	217	4	mean	mean	PROPN
dti-1311	217	5	±	±	NUM
dti-1311	217	6	s.e	s.e	PROPN
dti-1311	217	7	.	.	PROPN
dti-1311	217	8	percent	percent	NOUN
dti-1311	217	9	inhibition	inhibition	NOUN
dti-1311	217	10	(	(	PUNCT
dti-1311	217	11	%	%	INTJ
dti-1311	217	12	)	)	PUNCT
dti-1311	217	13	compared	compare	VERB
dti-1311	217	14	to	to	ADP
dti-1311	217	15	the	the	DET
dti-1311	217	16	control	control	NOUN
dti-1311	217	17	animals	animal	NOUN
dti-1311	217	18	is	be	AUX
dti-1311	217	19	shown	show	VERB
dti-1311	217	20	.	.	PUNCT
dti-1311	218	1	*	*	PUNCT
dti-1311	218	2	p	p	X
dti-1311	218	3	<	<	X
dti-1311	218	4	0.05	0.05	NUM
dti-1311	218	5	compared	compare	VERB
dti-1311	218	6	to	to	ADP
dti-1311	218	7	control	control	VERB
dti-1311	218	8	and	and	CCONJ
dti-1311	218	9	between	between	ADP
dti-1311	218	10	indomethacin	indomethacin	NOUN
dti-1311	218	11	or	or	CCONJ
dti-1311	218	12	indomethacin	indomethacin	NOUN
dti-1311	218	13	+	+	CCONJ
dti-1311	218	14	cinnarizine	cinnarizine	NOUN
dti-1311	218	15	as	as	SCONJ
dti-1311	218	16	shown	show	VERB
dti-1311	218	17	in	in	ADP
dti-1311	218	18	the	the	DET
dti-1311	218	19	fi	fi	NOUN
dti-1311	218	20	gure	gure	NOUN
dti-1311	218	21	.	.	PUNCT
dti-1311	219	1	six	six	NUM
dti-1311	219	2	mice	mouse	NOUN
dti-1311	219	3	were	be	AUX
dti-1311	219	4	used	use	VERB
dti-1311	219	5	per	per	ADP
dti-1311	219	6	each	each	DET
dti-1311	219	7	group	group	NOUN
dti-1311	219	8	.	.	PUNCT
dti-1311	220	1	con	con	PROPN
dti-1311	220	2	tro	tro	PROPN
dti-1311	220	3	l	l	PROPN
dti-1311	220	4	cinn	cinn	PROPN
dti-1311	220	5	ari	ari	PROPN
dti-1311	220	6	zin	zin	NOUN
dti-1311	220	7	e	e	PROPN
dti-1311	220	8	2	2	NUM
dti-1311	220	9	.5	.5	NUM
dti-1311	220	10	mg	mg	PROPN
dti-1311	220	11	/	/	SYM
dti-1311	220	12	k	k	PROPN
dti-1311	220	13	g	g	PROPN
dti-1311	220	14	pira	pira	PROPN
dti-1311	220	15	ce	ce	PROPN
dti-1311	220	16	tam	tam	PROPN
dti-1311	220	17	30	30	NUM
dti-1311	220	18	0	0	NUM
dti-1311	220	19	m	m	VERB
dti-1311	220	20	g	g	NOUN
dti-1311	220	21	/	/	SYM
dti-1311	220	22	k	k	NOUN
dti-1311	220	23	g	g	PROPN
dti-1311	220	24	+	+	CCONJ
dti-1311	220	25	c	c	PROPN
dti-1311	220	26	inn	inn	PROPN
dti-1311	220	27	ari	ari	PROPN
dti-1311	220	28	zin	zin	NOUN
dti-1311	220	29	e	e	PROPN
dti-1311	220	30	2	2	NUM
dti-1311	220	31	.5	.5	NUM
dti-1311	220	32	mg	mg	PROPN
dti-1311	220	33	/	/	SYM
dti-1311	220	34	k	k	PROPN
dti-1311	220	35	g	g	PROPN
dti-1311	220	36	vinp	vinp	NOUN
dti-1311	220	37	oc	oc	ADP
dti-1311	220	38	eti	eti	PROPN
dti-1311	220	39	ne	ne	ADP
dti-1311	220	40	1	1	NUM
dti-1311	220	41	.	.	NOUN
dti-1311	220	42	8	8	NUM
dti-1311	220	43	m	m	NOUN
dti-1311	220	44	g	g	PROPN
dti-1311	220	45	/	/	SYM
dti-1311	220	46	k	k	NOUN
dti-1311	220	47	g	g	PROPN
dti-1311	220	48	+	+	CCONJ
dti-1311	220	49	c	c	PROPN
dti-1311	220	50	inn	inn	PROPN
dti-1311	220	51	ari	ari	PROPN
dti-1311	220	52	zin	zin	NOUN
dti-1311	220	53	e	e	PROPN
dti-1311	220	54	2	2	NUM
dti-1311	220	55	.5	.5	NUM
dti-1311	220	56	mg	mg	PROPN
dti-1311	220	57	/	/	SYM
dti-1311	220	58	k	k	PROPN
dti-1311	221	1	g	g	PROPN
dti-1311	221	2	0	0	NUM
dti-1311	221	3	10	10	NUM
dti-1311	221	4	20	20	NUM
dti-1311	221	5	30	30	NUM
dti-1311	221	6	40	40	NUM
dti-1311	221	7	50	50	NUM
dti-1311	221	8	60	60	NUM
dti-1311	221	9	70	70	NUM
dti-1311	221	10	*	*	PUNCT
dti-1311	222	1	*	*	PUNCT
dti-1311	223	1	*	*	PUNCT
dti-1311	223	2	*	*	PUNCT
dti-1311	224	1	*	*	PUNCT
dti-1311	224	2	*	*	PUNCT
dti-1311	224	3	-51	-51	NUM
dti-1311	225	1	%	%	NOUN
dti-1311	225	2	-67.2	-67.2	NOUN
dti-1311	225	3	%	%	NOUN
dti-1311	225	4	-54.5	-54.5	NUM
dti-1311	225	5	%	%	NOUN
dti-1311	225	6	-74.2	-74.2	ADJ
dti-1311	225	7	%	%	NOUN
dti-1311	225	8	-56.1	-56.1	NOUN
dti-1311	225	9	%	%	NOUN
dti-1311	225	10	*	*	PUNCT
dti-1311	225	11	n	n	PART
dti-1311	225	12	um	um	INTJ
dti-1311	225	13	be	be	AUX
dti-1311	225	14	r	r	NOUN
dti-1311	225	15	o	o	NOUN
dti-1311	225	16	f	f	X
dti-1311	226	1	a	a	DET
dti-1311	226	2	bd	bd	PROPN
dti-1311	226	3	om	om	PROPN
dti-1311	226	4	in	in	ADP
dti-1311	226	5	al	al	PROPN
dti-1311	226	6	c	c	PROPN
dti-1311	226	7	on	on	ADP
dti-1311	226	8	st	st	PROPN
dti-1311	226	9	ri	ri	PROPN
dti-1311	226	10	ct	ct	PROPN
dti-1311	226	11	io	io	X
dti-1311	226	12	ns	ns	X
dti-1311	226	13	con	con	X
dti-1311	226	14	tro	tro	X
dti-1311	226	15	l	l	NOUN
dti-1311	226	16	in	in	ADP
dti-1311	226	17	d	d	PROPN
dti-1311	226	18	in	in	ADP
dti-1311	226	19	d	d	PROPN
dti-1311	227	1	+	+	CCONJ
dti-1311	227	2	cinn	cinn	PROPN
dti-1311	227	3	ari	ari	PROPN
dti-1311	227	4	zin	zin	NOUN
dti-1311	227	5	e	e	PROPN
dti-1311	227	6	2	2	NUM
dti-1311	227	7	.5	.5	NUM
dti-1311	227	8	mg	mg	PROPN
dti-1311	227	9	/	/	SYM
dti-1311	228	1	k	k	PROPN
dti-1311	228	2	g	g	PROPN
dti-1311	228	3	0	0	NUM
dti-1311	228	4	25	25	NUM
dti-1311	228	5	50	50	NUM
dti-1311	228	6	75	75	NUM
dti-1311	228	7	100	100	NUM
dti-1311	228	8	125	125	NUM
dti-1311	228	9	*	*	PUNCT
dti-1311	228	10	*	*	PUNCT
dti-1311	228	11	-61	-61	NUM
dti-1311	228	12	%	%	NOUN
dti-1311	228	13	-78.8	-78.8	NOUN
dti-1311	228	14	%	%	NOUN
dti-1311	228	15	*	*	PUNCT
dti-1311	228	16	n	n	PART
dti-1311	228	17	um	um	INTJ
dti-1311	228	18	be	be	AUX
dti-1311	228	19	r	r	NOUN
dti-1311	228	20	o	o	NOUN
dti-1311	228	21	f	f	X
dti-1311	229	1	a	a	DET
dti-1311	229	2	bd	bd	PROPN
dti-1311	229	3	om	om	PROPN
dti-1311	229	4	in	in	ADP
dti-1311	229	5	al	al	PROPN
dti-1311	229	6	c	c	PROPN
dti-1311	229	7	on	on	ADP
dti-1311	229	8	st	st	PROPN
dti-1311	229	9	ri	ri	PROPN
dti-1311	229	10	ct	ct	PROPN
dti-1311	229	11	io	io	X
dti-1311	229	12	ns	ns	PROPN
dti-1311	229	13	drug	drug	NOUN
dti-1311	229	14	target	target	NOUN
dti-1311	229	15	insights	insight	NOUN
dti-1311	229	16	2007	2007	NUM
dti-1311	229	17	:	:	PUNCT
dti-1311	229	18	2	2	NUM
dti-1311	229	19	35	35	NUM
dti-1311	229	20	modulation	modulation	NOUN
dti-1311	229	21	of	of	ADP
dti-1311	229	22	visceral	visceral	ADJ
dti-1311	229	23	nociception	nociception	NOUN
dti-1311	229	24	,	,	PUNCT
dti-1311	229	25	infl	infl	PROPN
dti-1311	229	26	ammation	ammation	NOUN
dti-1311	229	27	and	and	CCONJ
dti-1311	229	28	gastric	gastric	ADJ
dti-1311	229	29	mucosal	mucosal	NOUN
dti-1311	229	30	injury	injury	NOUN
dti-1311	229	31	(	(	PUNCT
dti-1311	229	32	kalmari	kalmari	PROPN
dti-1311	229	33	et	et	PROPN
dti-1311	229	34	al	al	PROPN
dti-1311	229	35	.	.	PROPN
dti-1311	229	36	2001	2001	NUM
dti-1311	229	37	)	)	PUNCT
dti-1311	229	38	,	,	PUNCT
dti-1311	229	39	while	while	SCONJ
dti-1311	229	40	the	the	DET
dti-1311	229	41	adrenergic	adrenergic	ADJ
dti-1311	229	42	neurone	neurone	NOUN
dti-1311	229	43	blocker	blocker	NOUN
dti-1311	229	44	guanethidine	guanethidine	NOUN
dti-1311	229	45	reduced	reduce	VERB
dti-1311	229	46	the	the	DET
dti-1311	229	47	number	number	NOUN
dti-1311	229	48	of	of	ADP
dti-1311	229	49	abdominal	abdominal	ADJ
dti-1311	229	50	constrictions	constriction	NOUN
dti-1311	229	51	induced	induce	VERB
dti-1311	229	52	by	by	ADP
dti-1311	229	53	acetic	acetic	ADJ
dti-1311	229	54	acid	acid	NOUN
dti-1311	229	55	in	in	ADP
dti-1311	229	56	mice	mouse	NOUN
dti-1311	229	57	(	(	PUNCT
dti-1311	229	58	duarte	duarte	PROPN
dti-1311	229	59	et	et	PROPN
dti-1311	229	60	al	al	PROPN
dti-1311	229	61	.	.	PROPN
dti-1311	229	62	1988	1988	NUM
dti-1311	229	63	)	)	PUNCT
dti-1311	229	64	.	.	PUNCT
dti-1311	230	1	beta	beta	ADJ
dti-1311	230	2	adrenoreceptor	adrenoreceptor	NOUN
dti-1311	230	3	antagonists	antagonist	NOUN
dti-1311	230	4	e.g.	e.g.	ADV
dti-1311	230	5	propranolol	propranolol	VERB
dti-1311	230	6	and	and	CCONJ
dti-1311	230	7	metoprolol	metoprolol	PROPN
dti-1311	230	8	reduced	reduce	VERB
dti-1311	230	9	visceral	visceral	ADJ
dti-1311	230	10	pain	pain	NOUN
dti-1311	230	11	caused	cause	VERB
dti-1311	230	12	by	by	ADP
dti-1311	230	13	i.p	i.p	PROPN
dti-1311	230	14	.	.	PROPN
dti-1311	230	15	injection	injection	NOUN
dti-1311	230	16	of	of	ADP
dti-1311	230	17	acetic	acetic	ADJ
dti-1311	230	18	acid	acid	NOUN
dti-1311	230	19	in	in	ADP
dti-1311	230	20	rat	rat	NOUN
dti-1311	230	21	(	(	PUNCT
dti-1311	230	22	korzeniewska	korzeniewska	ADJ
dti-1311	230	23	-	-	PUNCT
dti-1311	230	24	rybicka	rybicka	NOUN
dti-1311	230	25	and	and	CCONJ
dti-1311	230	26	plaznik	plaznik	NOUN
dti-1311	230	27	,	,	PUNCT
dti-1311	230	28	2001	2001	NUM
dti-1311	230	29	)	)	PUNCT
dti-1311	230	30	.	.	PUNCT
dti-1311	231	1	the	the	DET
dti-1311	231	2	spinal	spinal	ADJ
dti-1311	231	3	cholinergic	cholinergic	ADJ
dti-1311	231	4	system	system	NOUN
dti-1311	231	5	and	and	CCONJ
dti-1311	231	6	muscarinic	muscarinic	ADJ
dti-1311	231	7	receptors	receptor	NOUN
dti-1311	231	8	are	be	AUX
dti-1311	231	9	also	also	ADV
dti-1311	231	10	important	important	ADJ
dti-1311	231	11	for	for	ADP
dti-1311	231	12	regulation	regulation	NOUN
dti-1311	231	13	of	of	ADP
dti-1311	231	14	nociception	nociception	NOUN
dti-1311	231	15	.	.	PUNCT
dti-1311	232	1	spinally	spinally	ADV
dti-1311	232	2	administered	administer	VERB
dti-1311	232	3	muscarinic	muscarinic	ADJ
dti-1311	232	4	receptor	receptor	NOUN
dti-1311	232	5	agonists	agonist	NOUN
dti-1311	232	6	can	can	AUX
dti-1311	232	7	produce	produce	VERB
dti-1311	232	8	effective	effective	ADJ
dti-1311	232	9	analgesia	analgesia	NOUN
dti-1311	232	10	(	(	PUNCT
dti-1311	232	11	iwamoto	iwamoto	NOUN
dti-1311	232	12	and	and	CCONJ
dti-1311	232	13	marion	marion	NOUN
dti-1311	232	14	,	,	PUNCT
dti-1311	232	15	1993	1993	NUM
dti-1311	232	16	)	)	PUNCT
dti-1311	232	17	.	.	PUNCT
dti-1311	233	1	in	in	ADP
dti-1311	233	2	the	the	DET
dti-1311	233	3	mouse	mouse	NOUN
dti-1311	233	4	acetic	acetic	ADJ
dti-1311	233	5	acid	acid	NOUN
dti-1311	233	6	writhing	writhe	VERB
dti-1311	233	7	test	test	NOUN
dti-1311	233	8	,	,	PUNCT
dti-1311	233	9	m1	m1	NOUN
dti-1311	233	10	-	-	PUNCT
dti-1311	233	11	muscarinic	muscarinic	ADJ
dti-1311	233	12	agonists	agonist	NOUN
dti-1311	233	13	increased	increase	VERB
dti-1311	233	14	the	the	DET
dti-1311	233	15	pain	pain	NOUN
dti-1311	233	16	threshold	threshold	NOUN
dti-1311	233	17	(	(	PUNCT
dti-1311	233	18	bartolini	bartolini	NOUN
dti-1311	233	19	et	et	PROPN
dti-1311	233	20	al	al	PROPN
dti-1311	233	21	.	.	PROPN
dti-1311	233	22	1992	1992	NUM
dti-1311	233	23	)	)	PUNCT
dti-1311	233	24	,	,	PUNCT
dti-1311	233	25	while	while	SCONJ
dti-1311	233	26	atropine	atropine	NOUN
dti-1311	233	27	,	,	PUNCT
dti-1311	233	28	a	a	DET
dti-1311	233	29	cholinergic	cholinergic	ADJ
dti-1311	233	30	muscarinic	muscarinic	NOUN
dti-1311	233	31	antagonist	antagonist	NOUN
dti-1311	233	32	caused	cause	VERB
dti-1311	233	33	hyperalgesia	hyperalgesia	NOUN
dti-1311	233	34	only	only	ADV
dti-1311	233	35	when	when	SCONJ
dti-1311	233	36	administered	administer	VERB
dti-1311	233	37	at	at	ADP
dti-1311	233	38	high	high	ADJ
dti-1311	233	39	doses	dose	NOUN
dti-1311	233	40	of	of	ADP
dti-1311	233	41	5	5	NUM
dti-1311	233	42	mg	mg	NOUN
dti-1311	233	43	/	/	SYM
dti-1311	233	44	kg	kg	PROPN
dti-1311	233	45	(	(	PUNCT
dti-1311	233	46	ghelardini	ghelardini	NOUN
dti-1311	233	47	et	et	PROPN
dti-1311	233	48	al	al	PROPN
dti-1311	233	49	.	.	PROPN
dti-1311	233	50	1990	1990	NUM
dti-1311	233	51	)	)	PUNCT
dti-1311	233	52	.	.	PUNCT
dti-1311	234	1	in	in	ADP
dti-1311	234	2	contrast	contrast	NOUN
dti-1311	234	3	,	,	PUNCT
dti-1311	234	4	atropine	atropine	NOUN
dti-1311	234	5	administered	administer	VERB
dti-1311	234	6	at	at	ADP
dti-1311	234	7	low	low	ADJ
dti-1311	234	8	doses	dose	NOUN
dti-1311	234	9	of	of	ADP
dti-1311	234	10	1–100	1–100	NUM
dti-1311	234	11	μg	μg	PROPN
dti-1311	234	12	/	/	SYM
dti-1311	234	13	kg	kg	PROPN
dti-1311	234	14	,	,	PUNCT
dti-1311	234	15	resulted	result	VERB
dti-1311	234	16	in	in	ADP
dti-1311	234	17	analgesia	analgesia	PROPN
dti-1311	234	18	,	,	PUNCT
dti-1311	234	19	which	which	PRON
dti-1311	234	20	might	might	AUX
dti-1311	234	21	have	have	AUX
dti-1311	234	22	been	be	AUX
dti-1311	234	23	due	due	ADJ
dti-1311	234	24	to	to	ADP
dti-1311	234	25	amplification	amplification	NOUN
dti-1311	234	26	of	of	ADP
dti-1311	234	27	cholinergic	cholinergic	ADJ
dti-1311	234	28	transmission	transmission	NOUN
dti-1311	234	29	by	by	ADP
dti-1311	234	30	a	a	DET
dti-1311	234	31	selective	selective	ADJ
dti-1311	234	32	blockade	blockade	NOUN
dti-1311	234	33	of	of	ADP
dti-1311	234	34	presynaptic	presynaptic	ADJ
dti-1311	234	35	muscarinic	muscarinic	ADJ
dti-1311	234	36	autoreceptors	autoreceptor	NOUN
dti-1311	234	37	(	(	PUNCT
dti-1311	234	38	ghelardini	ghelardini	NOUN
dti-1311	234	39	et	et	PROPN
dti-1311	234	40	al	al	PROPN
dti-1311	234	41	.	.	PROPN
dti-1311	234	42	1990	1990	NUM
dti-1311	234	43	)	)	PUNCT
dti-1311	234	44	.	.	PUNCT
dti-1311	235	1	in	in	ADP
dti-1311	235	2	the	the	DET
dti-1311	235	3	present	present	ADJ
dti-1311	235	4	study	study	NOUN
dti-1311	235	5	,	,	PUNCT
dti-1311	235	6	atropine	atropine	NOUN
dti-1311	235	7	administered	administer	VERB
dti-1311	235	8	ip	ip	NOUN
dti-1311	235	9	at	at	ADP
dti-1311	235	10	2	2	NUM
dti-1311	235	11	mg	mg	PROPN
dti-1311	235	12	/	/	SYM
dti-1311	235	13	kg	kg	PROPN
dti-1311	235	14	increased	increase	VERB
dti-1311	235	15	the	the	DET
dti-1311	235	16	analgesic	analgesic	ADJ
dti-1311	235	17	effect	effect	NOUN
dti-1311	235	18	of	of	ADP
dti-1311	235	19	cinnarizine	cinnarizine	NOUN
dti-1311	235	20	,	,	PUNCT
dti-1311	235	21	thereby	thereby	ADV
dti-1311	235	22	,	,	PUNCT
dti-1311	235	23	suggesting	suggest	VERB
dti-1311	235	24	an	an	DET
dti-1311	235	25	interaction	interaction	NOUN
dti-1311	235	26	at	at	ADP
dti-1311	235	27	the	the	DET
dti-1311	235	28	muscarinic	muscarinic	ADJ
dti-1311	235	29	receptors	receptor	NOUN
dti-1311	235	30	.	.	PUNCT
dti-1311	236	1	adenosine	adenosine	NOUN
dti-1311	236	2	is	be	AUX
dti-1311	236	3	an	an	DET
dti-1311	236	4	endogenous	endogenous	ADJ
dti-1311	236	5	purine	purine	NOUN
dti-1311	236	6	nucleoside	nucleoside	NOUN
dti-1311	236	7	that	that	DET
dti-1311	236	8	functions	function	NOUN
dti-1311	236	9	as	as	ADP
dti-1311	236	10	an	an	DET
dti-1311	236	11	extracellular	extracellular	ADJ
dti-1311	236	12	signalling	signal	VERB
dti-1311	236	13	molecule	molecule	NOUN
dti-1311	236	14	.	.	PUNCT
dti-1311	237	1	it	it	PRON
dti-1311	237	2	is	be	AUX
dti-1311	237	3	released	release	VERB
dti-1311	237	4	locally	locally	ADV
dti-1311	237	5	at	at	ADP
dti-1311	237	6	sites	site	NOUN
dti-1311	237	7	of	of	ADP
dti-1311	237	8	cellular	cellular	ADJ
dti-1311	237	9	trauma	trauma	NOUN
dti-1311	237	10	,	,	PUNCT
dti-1311	237	11	and	and	CCONJ
dti-1311	237	12	interacts	interact	VERB
dti-1311	237	13	with	with	ADP
dti-1311	237	14	specifi	specifi	PROPN
dti-1311	237	15	c	c	PROPN
dti-1311	237	16	cell	cell	NOUN
dti-1311	237	17	-	-	PUNCT
dti-1311	237	18	surface	surface	NOUN
dti-1311	237	19	purinergic	purinergic	NOUN
dti-1311	237	20	receptors	receptor	NOUN
dti-1311	237	21	near	near	ADP
dti-1311	237	22	its	its	PRON
dti-1311	237	23	site	site	NOUN
dti-1311	237	24	of	of	ADP
dti-1311	237	25	release	release	NOUN
dti-1311	237	26	to	to	PART
dti-1311	237	27	exert	exert	VERB
dti-1311	237	28	its	its	PRON
dti-1311	237	29	effects	effect	NOUN
dti-1311	237	30	.	.	PUNCT
dti-1311	238	1	adenosine	adenosine	NOUN
dti-1311	238	2	acts	act	NOUN
dti-1311	238	3	as	as	ADP
dti-1311	238	4	an	an	DET
dti-1311	238	5	inhibitory	inhibitory	ADJ
dti-1311	238	6	neuromodulator	neuromodulator	NOUN
dti-1311	238	7	in	in	ADP
dti-1311	238	8	the	the	DET
dti-1311	238	9	central	central	ADJ
dti-1311	238	10	and	and	CCONJ
dti-1311	238	11	peripheral	peripheral	ADJ
dti-1311	238	12	nervous	nervous	ADJ
dti-1311	238	13	system	system	NOUN
dti-1311	238	14	(	(	PUNCT
dti-1311	238	15	kowaluk	kowaluk	PROPN
dti-1311	238	16	,	,	PUNCT
dti-1311	238	17	1998	1998	NUM
dti-1311	238	18	;	;	PUNCT
dti-1311	238	19	sawynok	sawynok	PROPN
dti-1311	238	20	,	,	PUNCT
dti-1311	238	21	1999	1999	NUM
dti-1311	238	22	)	)	PUNCT
dti-1311	238	23	.	.	PUNCT
dti-1311	239	1	blockade	blockade	NOUN
dti-1311	239	2	of	of	ADP
dti-1311	239	3	adenosine	adenosine	ADJ
dti-1311	239	4	receptors	receptor	NOUN
dti-1311	239	5	by	by	ADP
dti-1311	239	6	theophylline	theophylline	NOUN
dti-1311	239	7	,	,	PUNCT
dti-1311	239	8	a	a	DET
dti-1311	239	9	nonselective	nonselective	ADJ
dti-1311	239	10	adenosine	adenosine	NOUN
dti-1311	239	11	receptor	receptor	NOUN
dti-1311	239	12	antagonist	antagonist	NOUN
dti-1311	239	13	at	at	ADP
dti-1311	239	14	a1	a1	NOUN
dti-1311	239	15	and	and	CCONJ
dti-1311	239	16	a2	a2	NOUN
dti-1311	239	17	receptors	receptor	NOUN
dti-1311	239	18	,	,	PUNCT
dti-1311	239	19	was	be	AUX
dti-1311	239	20	shown	show	VERB
dti-1311	239	21	to	to	PART
dti-1311	239	22	induce	induce	VERB
dti-1311	239	23	hyperalgesia	hyperalgesia	NOUN
dti-1311	239	24	(	(	PUNCT
dti-1311	239	25	paalzow	paalzow	PROPN
dti-1311	239	26	,	,	PUNCT
dti-1311	239	27	1994	1994	NUM
dti-1311	239	28	)	)	PUNCT
dti-1311	239	29	.	.	PUNCT
dti-1311	240	1	adenosine	adenosine	ADJ
dti-1311	240	2	a1	a1	NOUN
dti-1311	240	3	receptor	receptor	NOUN
dti-1311	240	4	agonists	agonist	NOUN
dti-1311	240	5	are	be	AUX
dti-1311	240	6	effective	effective	ADJ
dti-1311	240	7	antinociceptive	antinociceptive	ADJ
dti-1311	240	8	agents	agent	NOUN
dti-1311	240	9	in	in	ADP
dti-1311	240	10	neuropathic	neuropathic	ADJ
dti-1311	240	11	and	and	CCONJ
dti-1311	240	12	infl	infl	PROPN
dti-1311	240	13	ammatory	ammatory	PROPN
dti-1311	240	14	pain	pain	NOUN
dti-1311	240	15	(	(	PUNCT
dti-1311	240	16	curros	curro	NOUN
dti-1311	240	17	-	-	PUNCT
dti-1311	240	18	criado	criado	NOUN
dti-1311	240	19	and	and	CCONJ
dti-1311	240	20	herrero	herrero	NOUN
dti-1311	240	21	,	,	PUNCT
dti-1311	240	22	2005	2005	NUM
dti-1311	240	23	)	)	PUNCT
dti-1311	240	24	and	and	CCONJ
dti-1311	240	25	mice	mouse	NOUN
dti-1311	240	26	lacking	lack	VERB
dti-1311	240	27	the	the	DET
dti-1311	240	28	adenosine	adenosine	ADJ
dti-1311	240	29	a1	a1	NOUN
dti-1311	240	30	receptor	receptor	NOUN
dti-1311	240	31	are	be	AUX
dti-1311	240	32	hyperalgesic	hyperalgesic	ADJ
dti-1311	240	33	(	(	PUNCT
dti-1311	240	34	wu	wu	PROPN
dti-1311	240	35	et	et	PROPN
dti-1311	240	36	al	al	PROPN
dti-1311	240	37	.	.	PROPN
dti-1311	240	38	2005	2005	NUM
dti-1311	240	39	)	)	PUNCT
dti-1311	240	40	.	.	PUNCT
dti-1311	241	1	in	in	ADP
dti-1311	241	2	the	the	DET
dti-1311	241	3	present	present	ADJ
dti-1311	241	4	study	study	NOUN
dti-1311	241	5	the	the	DET
dti-1311	241	6	antinociceptive	antinociceptive	ADJ
dti-1311	241	7	effect	effect	NOUN
dti-1311	241	8	of	of	ADP
dti-1311	241	9	cinnarizine	cinnarizine	NOUN
dti-1311	241	10	was	be	AUX
dti-1311	241	11	prevented	prevent	VERB
dti-1311	241	12	by	by	ADP
dti-1311	241	13	co	co	NOUN
dti-1311	241	14	-	-	NOUN
dti-1311	241	15	treatment	treatment	NOUN
dti-1311	241	16	with	with	ADP
dti-1311	241	17	the	the	DET
dti-1311	241	18	adenosine	adenosine	ADJ
dti-1311	241	19	receptor	receptor	NOUN
dti-1311	241	20	blocker	blocker	NOUN
dti-1311	241	21	theophylline	theophylline	NOUN
dti-1311	241	22	,	,	PUNCT
dti-1311	241	23	suggesting	suggest	VERB
dti-1311	241	24	that	that	SCONJ
dti-1311	241	25	cinnarizine	cinnarizine	NOUN
dti-1311	241	26	antinociception	antinociception	NOUN
dti-1311	241	27	involves	involve	VERB
dti-1311	241	28	adenosine	adenosine	ADJ
dti-1311	241	29	receptors	receptor	NOUN
dti-1311	241	30	.	.	PUNCT
dti-1311	242	1	adenosine	adenosine	ADJ
dti-1311	242	2	triphosphate	triphosphate	NOUN
dti-1311	242	3	(	(	PUNCT
dti-1311	242	4	atp)-sensitive	atp)-sensitive	ADJ
dti-1311	242	5	k+	k+	NOUN
dti-1311	242	6	channels	channel	NOUN
dti-1311	242	7	(	(	PUNCT
dti-1311	242	8	katp	katp	PROPN
dti-1311	242	9	)	)	PUNCT
dti-1311	242	10	play	play	VERB
dti-1311	242	11	an	an	DET
dti-1311	242	12	important	important	ADJ
dti-1311	242	13	role	role	NOUN
dti-1311	242	14	in	in	ADP
dti-1311	242	15	the	the	DET
dti-1311	242	16	mechanisms	mechanism	NOUN
dti-1311	242	17	of	of	ADP
dti-1311	242	18	pain	pain	NOUN
dti-1311	242	19	modulation	modulation	NOUN
dti-1311	242	20	(	(	PUNCT
dti-1311	242	21	asano	asano	PROPN
dti-1311	242	22	et	et	PROPN
dti-1311	242	23	al	al	PROPN
dti-1311	242	24	.	.	PROPN
dti-1311	242	25	2000	2000	NUM
dti-1311	242	26	;	;	PUNCT
dti-1311	242	27	han	han	PROPN
dti-1311	242	28	et	et	PROPN
dti-1311	242	29	al	al	PROPN
dti-1311	242	30	.	.	PROPN
dti-1311	242	31	2004	2004	NUM
dti-1311	242	32	;	;	PUNCT
dti-1311	242	33	rodrigues	rodrigue	NOUN
dti-1311	242	34	et	et	PROPN
dti-1311	242	35	al	al	PROPN
dti-1311	242	36	.	.	PROPN
dti-1311	242	37	2004	2004	NUM
dti-1311	242	38	)	)	PUNCT
dti-1311	242	39	.	.	PUNCT
dti-1311	243	1	intrathecal	intrathecal	ADJ
dti-1311	243	2	administration	administration	NOUN
dti-1311	243	3	of	of	ADP
dti-1311	243	4	katp	katp	PROPN
dti-1311	243	5	channel	channel	NOUN
dti-1311	243	6	openers	opener	NOUN
dti-1311	243	7	produces	produce	VERB
dti-1311	243	8	antinociception	antinociception	NOUN
dti-1311	243	9	(	(	PUNCT
dti-1311	243	10	asano	asano	PROPN
dti-1311	243	11	et	et	PROPN
dti-1311	243	12	al	al	PROPN
dti-1311	243	13	.	.	PROPN
dti-1311	243	14	2000	2000	NUM
dti-1311	243	15	)	)	PUNCT
dti-1311	243	16	.	.	PUNCT
dti-1311	244	1	they	they	PRON
dti-1311	244	2	can	can	AUX
dti-1311	244	3	also	also	ADV
dti-1311	244	4	contribute	contribute	VERB
dti-1311	244	5	to	to	ADP
dti-1311	244	6	the	the	DET
dti-1311	244	7	sensitization	sensitization	NOUN
dti-1311	244	8	of	of	ADP
dti-1311	244	9	primary	primary	ADJ
dti-1311	244	10	afferents	afferent	NOUN
dti-1311	244	11	observed	observe	VERB
dti-1311	244	12	in	in	ADP
dti-1311	244	13	gastrointestinal	gastrointestinal	ADJ
dti-1311	244	14	pain	pain	NOUN
dti-1311	244	15	states	state	NOUN
dti-1311	244	16	(	(	PUNCT
dti-1311	244	17	cervero	cervero	NOUN
dti-1311	244	18	and	and	CCONJ
dti-1311	244	19	laird	laird	PROPN
dti-1311	244	20	,	,	PUNCT
dti-1311	244	21	2003	2003	NUM
dti-1311	244	22	)	)	PUNCT
dti-1311	244	23	.	.	PUNCT
dti-1311	245	1	in	in	ADP
dti-1311	245	2	the	the	DET
dti-1311	245	3	present	present	ADJ
dti-1311	245	4	study	study	NOUN
dti-1311	245	5	,	,	PUNCT
dti-1311	245	6	antinociception	antinociception	NOUN
dti-1311	245	7	induced	induce	VERB
dti-1311	245	8	by	by	ADP
dti-1311	245	9	cinnarizine	cinnarizine	NOUN
dti-1311	245	10	was	be	AUX
dti-1311	245	11	prevented	prevent	VERB
dti-1311	245	12	by	by	ADP
dti-1311	245	13	the	the	DET
dti-1311	245	14	administration	administration	NOUN
dti-1311	245	15	of	of	ADP
dti-1311	245	16	glibenclamide	glibenclamide	NOUN
dti-1311	245	17	,	,	PUNCT
dti-1311	245	18	a	a	DET
dti-1311	245	19	blocker	blocker	NOUN
dti-1311	245	20	of	of	ADP
dti-1311	245	21	katp	katp	NOUN
dti-1311	245	22	channel	channel	NOUN
dti-1311	245	23	.	.	PUNCT
dti-1311	246	1	this	this	PRON
dti-1311	246	2	may	may	AUX
dti-1311	246	3	suggests	suggest	VERB
dti-1311	246	4	that	that	SCONJ
dti-1311	246	5	this	this	DET
dti-1311	246	6	antinociceptive	antinociceptive	ADJ
dti-1311	246	7	effect	effect	NOUN
dti-1311	246	8	of	of	ADP
dti-1311	246	9	cinnarizine	cinnarizine	NOUN
dti-1311	246	10	may	may	AUX
dti-1311	246	11	also	also	ADV
dti-1311	246	12	rely	rely	VERB
dti-1311	246	13	on	on	ADP
dti-1311	246	14	atpgated	atpgate	VERB
dti-1311	246	15	potassium	potassium	NOUN
dti-1311	246	16	channels	channel	NOUN
dti-1311	246	17	.	.	PUNCT
dti-1311	247	1	in	in	ADP
dti-1311	247	2	the	the	DET
dti-1311	247	3	present	present	ADJ
dti-1311	247	4	study	study	NOUN
dti-1311	247	5	also	also	ADV
dti-1311	247	6	the	the	DET
dti-1311	247	7	administration	administration	NOUN
dti-1311	247	8	of	of	ADP
dti-1311	247	9	cinnarizine	cinnarizine	PROPN
dti-1311	247	10	reversed	reverse	VERB
dti-1311	247	11	the	the	DET
dti-1311	247	12	baclofen	baclofen	NOUN
dti-1311	247	13	—	—	PUNCT
dti-1311	247	14	induced	induced	ADJ
dti-1311	247	15	antinociception	antinociception	NOUN
dti-1311	247	16	.	.	PUNCT
dti-1311	248	1	baclofen	baclofen	PROPN
dti-1311	248	2	,	,	PUNCT
dti-1311	248	3	a	a	DET
dti-1311	248	4	prototypical	prototypical	ADJ
dti-1311	248	5	agonist	agonist	NOUN
dti-1311	248	6	for	for	ADP
dti-1311	248	7	gabab	gabab	NOUN
dti-1311	248	8	receptors	receptor	NOUN
dti-1311	248	9	,	,	PUNCT
dti-1311	248	10	alters	alter	VERB
dti-1311	248	11	nociception	nociception	NOUN
dti-1311	248	12	at	at	ADP
dti-1311	248	13	the	the	DET
dti-1311	248	14	level	level	NOUN
dti-1311	248	15	of	of	ADP
dti-1311	248	16	the	the	DET
dti-1311	248	17	spinal	spinal	ADJ
dti-1311	248	18	cord	cord	NOUN
dti-1311	248	19	by	by	ADP
dti-1311	248	20	acting	act	VERB
dti-1311	248	21	on	on	ADP
dti-1311	248	22	gabab	gabab	NOUN
dti-1311	248	23	receptors	receptor	NOUN
dti-1311	248	24	located	locate	VERB
dti-1311	248	25	on	on	ADP
dti-1311	248	26	primary	primary	ADJ
dti-1311	248	27	afferent	afferent	NOUN
dti-1311	248	28	terminals	terminal	NOUN
dti-1311	248	29	and	and	CCONJ
dti-1311	248	30	is	be	AUX
dti-1311	248	31	known	know	VERB
dti-1311	248	32	to	to	PART
dti-1311	248	33	produce	produce	VERB
dti-1311	248	34	analgesia	analgesia	NOUN
dti-1311	248	35	in	in	ADP
dti-1311	248	36	man	man	NOUN
dti-1311	248	37	and	and	CCONJ
dti-1311	248	38	animals	animal	NOUN
dti-1311	248	39	(	(	PUNCT
dti-1311	248	40	dirig	dirig	NOUN
dti-1311	248	41	and	and	CCONJ
dti-1311	248	42	yaksh	yaksh	NOUN
dti-1311	248	43	,	,	PUNCT
dti-1311	248	44	1995	1995	NUM
dti-1311	248	45	;	;	PUNCT
dti-1311	248	46	hara	hara	PROPN
dti-1311	248	47	et	et	PROPN
dti-1311	248	48	al	al	PROPN
dti-1311	248	49	.	.	PROPN
dti-1311	248	50	2004	2004	NUM
dti-1311	248	51	)	)	PUNCT
dti-1311	248	52	.	.	PUNCT
dti-1311	249	1	cinnarizine	cinnarizine	PROPN
dti-1311	249	2	inhibits	inhibit	VERB
dti-1311	249	3	the	the	DET
dti-1311	249	4	reuptake	reuptake	NOUN
dti-1311	249	5	of	of	ADP
dti-1311	249	6	gaba	gaba	NOUN
dti-1311	249	7	by	by	ADP
dti-1311	249	8	sections	section	NOUN
dti-1311	249	9	of	of	ADP
dti-1311	249	10	the	the	DET
dti-1311	249	11	rat	rat	NOUN
dti-1311	249	12	brain	brain	NOUN
dti-1311	249	13	cortex	cortex	NOUN
dti-1311	249	14	(	(	PUNCT
dti-1311	249	15	mirzoian	mirzoian	PROPN
dti-1311	249	16	et	et	PROPN
dti-1311	249	17	al	al	PROPN
dti-1311	249	18	.	.	PROPN
dti-1311	249	19	1998	1998	NUM
dti-1311	249	20	)	)	PUNCT
dti-1311	249	21	,	,	PUNCT
dti-1311	249	22	which	which	PRON
dti-1311	249	23	is	be	AUX
dti-1311	249	24	likely	likely	ADJ
dti-1311	249	25	to	to	PART
dti-1311	249	26	account	account	VERB
dti-1311	249	27	for	for	ADP
dti-1311	249	28	the	the	DET
dti-1311	249	29	observed	observed	ADJ
dti-1311	249	30	effect	effect	NOUN
dti-1311	249	31	of	of	ADP
dti-1311	249	32	cinnarizine	cinnarizine	NOUN
dti-1311	249	33	on	on	ADP
dti-1311	249	34	the	the	DET
dti-1311	249	35	baclofen	baclofen	NOUN
dti-1311	249	36	-	-	PUNCT
dti-1311	249	37	antinociception	antinociception	NOUN
dti-1311	249	38	.	.	PUNCT
dti-1311	250	1	in	in	ADP
dti-1311	250	2	the	the	DET
dti-1311	250	3	present	present	ADJ
dti-1311	250	4	study	study	NOUN
dti-1311	250	5	,	,	PUNCT
dti-1311	250	6	the	the	DET
dti-1311	250	7	effect	effect	NOUN
dti-1311	250	8	of	of	ADP
dti-1311	250	9	cinnaizine	cinnaizine	NOUN
dti-1311	250	10	on	on	ADP
dti-1311	250	11	immobility	immobility	NOUN
dti-1311	250	12	time	time	NOUN
dti-1311	250	13	in	in	ADP
dti-1311	250	14	porsolt	porsolt	NOUN
dti-1311	250	15	’s	’s	PART
dti-1311	250	16	forced	force	VERB
dti-1311	250	17	-	-	PUNCT
dti-1311	250	18	swimming	swimming	NOUN
dti-1311	250	19	test	test	NOUN
dti-1311	250	20	,	,	PUNCT
dti-1311	250	21	a	a	DET
dti-1311	250	22	commonly	commonly	ADV
dti-1311	250	23	used	use	VERB
dti-1311	250	24	tool	tool	NOUN
dti-1311	250	25	for	for	ADP
dti-1311	250	26	screening	screening	NOUN
dti-1311	250	27	of	of	ADP
dti-1311	250	28	potential	potential	ADJ
dti-1311	250	29	antidepressants	antidepressant	NOUN
dti-1311	250	30	(	(	PUNCT
dti-1311	250	31	porsolt	porsolt	NOUN
dti-1311	250	32	et	et	PROPN
dti-1311	250	33	al	al	PROPN
dti-1311	250	34	.	.	PROPN
dti-1311	250	35	1977	1977	NUM
dti-1311	250	36	)	)	PUNCT
dti-1311	250	37	was	be	AUX
dti-1311	250	38	examined	examine	VERB
dti-1311	250	39	.	.	PUNCT
dti-1311	251	1	only	only	ADV
dti-1311	251	2	at	at	ADP
dti-1311	251	3	the	the	DET
dti-1311	251	4	dose	dose	NOUN
dti-1311	251	5	of	of	ADP
dti-1311	251	6	2.5	2.5	NUM
dti-1311	251	7	mg	mg	PROPN
dti-1311	251	8	/	/	SYM
dti-1311	251	9	kg	kg	PROPN
dti-1311	251	10	,	,	PUNCT
dti-1311	251	11	did	do	AUX
dti-1311	251	12	cinnarizine	cinnarizine	VERB
dti-1311	251	13	reduced	reduce	VERB
dti-1311	251	14	immobility	immobility	NOUN
dti-1311	251	15	time	time	NOUN
dti-1311	251	16	by	by	ADP
dti-1311	251	17	24	24	NUM
dti-1311	251	18	%	%	NOUN
dti-1311	251	19	,	,	PUNCT
dti-1311	251	20	although	although	SCONJ
dti-1311	251	21	higher	high	ADJ
dti-1311	251	22	doses	dose	NOUN
dti-1311	251	23	of	of	ADP
dti-1311	251	24	the	the	DET
dti-1311	251	25	drug	drug	NOUN
dti-1311	251	26	were	be	AUX
dti-1311	251	27	without	without	ADP
dti-1311	251	28	effect	effect	NOUN
dti-1311	251	29	.	.	PUNCT
dti-1311	252	1	other	other	ADJ
dti-1311	252	2	researches	research	NOUN
dti-1311	252	3	reported	report	VERB
dti-1311	252	4	a	a	DET
dti-1311	252	5	decrease	decrease	NOUN
dti-1311	252	6	of	of	ADP
dti-1311	252	7	immobility	immobility	NOUN
dti-1311	252	8	time	time	NOUN
dti-1311	252	9	by	by	ADP
dti-1311	252	10	5	5	NUM
dti-1311	252	11	mg	mg	PROPN
dti-1311	252	12	/	/	SYM
dti-1311	252	13	kg	kg	PROPN
dti-1311	252	14	of	of	ADP
dti-1311	252	15	cinnarizine	cinnarizine	NOUN
dti-1311	252	16	(	(	PUNCT
dti-1311	252	17	sushma	sushma	PROPN
dti-1311	252	18	et	et	PROPN
dti-1311	252	19	al	al	PROPN
dti-1311	252	20	.	.	PROPN
dti-1311	252	21	2004	2004	NUM
dti-1311	252	22	)	)	PUNCT
dti-1311	252	23	.	.	PUNCT
dti-1311	253	1	figure	figure	VERB
dti-1311	253	2	8	8	NUM
dti-1311	253	3	.	.	PUNCT
dti-1311	254	1	effect	effect	NOUN
dti-1311	254	2	of	of	ADP
dti-1311	254	3	different	different	ADJ
dti-1311	254	4	doses	dose	NOUN
dti-1311	254	5	of	of	ADP
dti-1311	254	6	cinnarizine	cinnarizine	NOUN
dti-1311	254	7	(	(	PUNCT
dti-1311	254	8	1.25	1.25	NUM
dti-1311	254	9	,	,	PUNCT
dti-1311	254	10	2.5	2.5	NUM
dti-1311	254	11	,	,	PUNCT
dti-1311	254	12	5	5	NUM
dti-1311	254	13	,	,	PUNCT
dti-1311	254	14	10	10	NUM
dti-1311	254	15	and	and	CCONJ
dti-1311	254	16	20	20	NUM
dti-1311	254	17	mg	mg	NUM
dti-1311	254	18	/	/	SYM
dti-1311	254	19	kg	kg	NOUN
dti-1311	254	20	)	)	PUNCT
dti-1311	254	21	on	on	ADP
dti-1311	254	22	the	the	DET
dti-1311	254	23	fl	fl	NOUN
dti-1311	254	24	oating	oate	VERB
dti-1311	254	25	time	time	NOUN
dti-1311	254	26	in	in	ADP
dti-1311	254	27	porsolt	porsolt	NOUN
dti-1311	254	28	’s	’s	PART
dti-1311	254	29	forced	force	VERB
dti-1311	254	30	-	-	PUNCT
dti-1311	254	31	swimming	swimming	NOUN
dti-1311	254	32	test	test	NOUN
dti-1311	254	33	in	in	ADP
dti-1311	254	34	mice	mouse	NOUN
dti-1311	254	35	.	.	PUNCT
dti-1311	255	1	data	datum	NOUN
dti-1311	255	2	expressed	express	VERB
dti-1311	255	3	as	as	ADP
dti-1311	255	4	mean	mean	PROPN
dti-1311	255	5	±	±	NUM
dti-1311	255	6	s.e	s.e	PROPN
dti-1311	255	7	.	.	PROPN
dti-1311	255	8	percent	percent	NOUN
dti-1311	255	9	inhibition	inhibition	NOUN
dti-1311	255	10	(	(	PUNCT
dti-1311	255	11	%	%	INTJ
dti-1311	255	12	)	)	PUNCT
dti-1311	255	13	compared	compare	VERB
dti-1311	255	14	to	to	ADP
dti-1311	255	15	the	the	DET
dti-1311	255	16	control	control	NOUN
dti-1311	255	17	animals	animal	NOUN
dti-1311	255	18	is	be	AUX
dti-1311	255	19	shown	show	VERB
dti-1311	255	20	.	.	PUNCT
dti-1311	256	1	*	*	PUNCT
dti-1311	256	2	p	p	X
dti-1311	256	3	<	<	X
dti-1311	256	4	0.05	0.05	NUM
dti-1311	256	5	compared	compare	VERB
dti-1311	256	6	to	to	ADP
dti-1311	256	7	saline	saline	ADJ
dti-1311	256	8	control	control	NOUN
dti-1311	256	9	.	.	PUNCT
dti-1311	257	1	six	six	NUM
dti-1311	257	2	mice	mouse	NOUN
dti-1311	257	3	were	be	AUX
dti-1311	257	4	used	use	VERB
dti-1311	257	5	per	per	ADP
dti-1311	257	6	each	each	DET
dti-1311	257	7	group	group	NOUN
dti-1311	257	8	.	.	PUNCT
dti-1311	258	1	con	con	PROPN
dti-1311	258	2	tro	tro	PROPN
dti-1311	258	3	l	l	PROPN
dti-1311	258	4	cinn	cinn	PROPN
dti-1311	258	5	ari	ari	PROPN
dti-1311	258	6	zin	zin	PROPN
dti-1311	258	7	e	e	NOUN
dti-1311	258	8	1	1	NUM
dti-1311	258	9	.25	.25	NUM
dti-1311	258	10	m	m	NOUN
dti-1311	258	11	g	g	PROPN
dti-1311	258	12	/	/	SYM
dti-1311	258	13	k	k	PROPN
dti-1311	258	14	g	g	PROPN
dti-1311	258	15	cinn	cinn	PROPN
dti-1311	258	16	ari	ari	PROPN
dti-1311	258	17	zin	zin	PROPN
dti-1311	258	18	e	e	PROPN
dti-1311	258	19	2	2	NUM
dti-1311	258	20	.5	.5	NUM
dti-1311	258	21	mg	mg	PROPN
dti-1311	258	22	/	/	SYM
dti-1311	258	23	k	k	PROPN
dti-1311	258	24	g	g	PROPN
dti-1311	258	25	cinn	cinn	PROPN
dti-1311	258	26	ari	ari	PROPN
dti-1311	258	27	zin	zin	PROPN
dti-1311	258	28	e	e	PROPN
dti-1311	258	29	5	5	NUM
dti-1311	258	30	m	m	NOUN
dti-1311	258	31	g	g	NOUN
dti-1311	258	32	/	/	SYM
dti-1311	258	33	k	k	PROPN
dti-1311	258	34	g	g	PROPN
dti-1311	258	35	cinn	cinn	PROPN
dti-1311	258	36	ari	ari	PROPN
dti-1311	258	37	zin	zin	PROPN
dti-1311	258	38	e	e	NOUN
dti-1311	258	39	1	1	NUM
dti-1311	258	40	0	0	NUM
dti-1311	258	41	m	m	NOUN
dti-1311	258	42	g	g	NOUN
dti-1311	258	43	/	/	SYM
dti-1311	258	44	k	k	PROPN
dti-1311	258	45	g	g	PROPN
dti-1311	258	46	cinn	cinn	PROPN
dti-1311	258	47	ari	ari	PROPN
dti-1311	258	48	zin	zin	PROPN
dti-1311	258	49	e	e	NOUN
dti-1311	258	50	2	2	NUM
dti-1311	258	51	0	0	NUM
dti-1311	258	52	m	m	NOUN
dti-1311	258	53	g	g	NOUN
dti-1311	258	54	/	/	SYM
dti-1311	258	55	k	k	PROPN
dti-1311	258	56	g	g	PROPN
dti-1311	258	57	0	0	NUM
dti-1311	258	58	100	100	NUM
dti-1311	258	59	200	200	NUM
dti-1311	258	60	300	300	NUM
dti-1311	258	61	*	*	PUNCT
dti-1311	259	1	-24.7	-24.7	PROPN
dti-1311	259	2	%	%	X
dti-1311	259	3	se	se	X
dti-1311	259	4	co	co	PROPN
dti-1311	259	5	nd	nd	PROPN
dti-1311	259	6	s	s	PART
dti-1311	259	7	"	"	PUNCT
dti-1311	259	8	i	i	PRON
dti-1311	259	9	m	m	VERB
dti-1311	259	10	m	m	VERB
dti-1311	259	11	ob	ob	ADJ
dti-1311	259	12	ile	ile	PROPN
dti-1311	259	13	"	"	PUNCT
dti-1311	259	14	tim	tim	PROPN
dti-1311	259	15	e	e	PROPN
dti-1311	259	16	ou	ou	ADP
dti-1311	259	17	t	t	PROPN
dti-1311	259	18	o	o	X
dti-1311	259	19	f	f	PROPN
dti-1311	259	20	6	6	NUM
dti-1311	259	21	m	m	VERB
dti-1311	259	22	in	in	ADP
dti-1311	259	23	ut	ut	PROPN
dti-1311	259	24	es	es	PROPN
dti-1311	259	25	drug	drug	NOUN
dti-1311	259	26	target	target	NOUN
dti-1311	259	27	insights	insight	NOUN
dti-1311	259	28	2007	2007	NUM
dti-1311	259	29	:	:	PUNCT
dti-1311	259	30	236	236	NUM
dti-1311	259	31	omar	omar	PROPN
dti-1311	259	32	m.e	m.e	PROPN
dti-1311	259	33	.	.	PROPN
dti-1311	259	34	abdel	abdel	PROPN
dti-1311	259	35	-	-	PUNCT
dti-1311	259	36	salam	salam	PROPN
dti-1311	259	37	dopamine	dopamine	PROPN
dti-1311	259	38	is	be	AUX
dti-1311	259	39	implicated	implicate	VERB
dti-1311	259	40	in	in	ADP
dti-1311	259	41	the	the	DET
dti-1311	259	42	symptoms	symptom	NOUN
dti-1311	259	43	of	of	ADP
dti-1311	259	44	depression	depression	NOUN
dti-1311	259	45	(	(	PUNCT
dti-1311	259	46	willner	willner	NOUN
dti-1311	259	47	,	,	PUNCT
dti-1311	259	48	1995	1995	NUM
dti-1311	259	49	;	;	PUNCT
dti-1311	259	50	brunswick	brunswick	PROPN
dti-1311	259	51	et	et	PROPN
dti-1311	259	52	al	al	PROPN
dti-1311	259	53	.	.	PROPN
dti-1311	259	54	2003	2003	NUM
dti-1311	259	55	;	;	PUNCT
dti-1311	259	56	remy	remy	PROPN
dti-1311	259	57	et	et	PROPN
dti-1311	259	58	al	al	PROPN
dti-1311	259	59	.	.	PROPN
dti-1311	259	60	2005	2005	NUM
dti-1311	259	61	)	)	PUNCT
dti-1311	259	62	and	and	CCONJ
dti-1311	259	63	dopamine	dopamine	NOUN
dti-1311	259	64	re	re	ADJ
dti-1311	259	65	-	-	NOUN
dti-1311	259	66	uptake	uptake	ADJ
dti-1311	259	67	inhibitors	inhibitor	NOUN
dti-1311	259	68	,	,	PUNCT
dti-1311	259	69	bupropion	bupropion	NOUN
dti-1311	259	70	and	and	CCONJ
dti-1311	259	71	nomifensine	nomifensine	NOUN
dti-1311	259	72	reduce	reduce	VERB
dti-1311	259	73	immobility	immobility	NOUN
dti-1311	259	74	in	in	ADP
dti-1311	259	75	the	the	DET
dti-1311	259	76	forced	force	VERB
dti-1311	259	77	swimming	swimming	NOUN
dti-1311	259	78	test	test	NOUN
dti-1311	259	79	by	by	ADP
dti-1311	259	80	activation	activation	NOUN
dti-1311	259	81	of	of	ADP
dti-1311	259	82	d1	d1	PROPN
dti-1311	259	83	and	and	CCONJ
dti-1311	259	84	d2	d2	NOUN
dti-1311	259	85	receptors	receptor	NOUN
dti-1311	259	86	(	(	PUNCT
dti-1311	259	87	yamada	yamada	PROPN
dti-1311	259	88	et	et	PROPN
dti-1311	259	89	al	al	PROPN
dti-1311	259	90	.	.	PROPN
dti-1311	259	91	2004	2004	NUM
dti-1311	259	92	)	)	PUNCT
dti-1311	259	93	.	.	PUNCT
dti-1311	260	1	cinnarizine	cinnarizine	PROPN
dti-1311	260	2	,	,	PUNCT
dti-1311	260	3	however	however	ADV
dti-1311	260	4	,	,	PUNCT
dti-1311	260	5	exerts	exert	VERB
dti-1311	260	6	direct	direct	ADJ
dti-1311	260	7	anti	anti	ADJ
dti-1311	260	8	-	-	ADJ
dti-1311	260	9	dopaminergic	dopaminergic	ADJ
dti-1311	260	10	effects	effect	NOUN
dti-1311	260	11	(	(	PUNCT
dti-1311	260	12	dopamine	dopamine	NOUN
dti-1311	260	13	d1	d1	NOUN
dti-1311	260	14	and	and	CCONJ
dti-1311	260	15	d2	d2	PROPN
dti-1311	260	16	receptor	receptor	NOUN
dti-1311	260	17	blockade	blockade	NOUN
dti-1311	260	18	)	)	PUNCT
dti-1311	260	19	(	(	PUNCT
dti-1311	260	20	reiriz	reiriz	NOUN
dti-1311	260	21	et	et	PROPN
dti-1311	260	22	al	al	PROPN
dti-1311	260	23	.	.	PROPN
dti-1311	260	24	1994	1994	NUM
dti-1311	260	25	;	;	PUNCT
dti-1311	260	26	brucke	brucke	NOUN
dti-1311	260	27	et	et	PROPN
dti-1311	260	28	al	al	PROPN
dti-1311	260	29	.	.	PROPN
dti-1311	260	30	1995	1995	NUM
dti-1311	260	31	)	)	PUNCT
dti-1311	260	32	.	.	PUNCT
dti-1311	261	1	it	it	PRON
dti-1311	261	2	is	be	AUX
dti-1311	261	3	worthy	worthy	ADJ
dti-1311	261	4	to	to	PART
dti-1311	261	5	mention	mention	VERB
dti-1311	261	6	that	that	DET
dti-1311	261	7	cinnarizine	cinnarizine	NOUN
dti-1311	261	8	also	also	ADV
dti-1311	261	9	displays	display	VERB
dti-1311	261	10	inhibitory	inhibitory	ADJ
dti-1311	261	11	activity	activity	NOUN
dti-1311	261	12	on	on	ADP
dti-1311	261	13	catecholamine	catecholamine	NOUN
dti-1311	261	14	uptake	uptake	NOUN
dti-1311	261	15	in	in	ADP
dti-1311	261	16	storage	storage	NOUN
dti-1311	261	17	vesicles	vesicle	NOUN
dti-1311	261	18	(	(	PUNCT
dti-1311	261	19	terland	terland	NOUN
dti-1311	261	20	and	and	CCONJ
dti-1311	261	21	flatmark	flatmark	NOUN
dti-1311	261	22	,	,	PUNCT
dti-1311	261	23	1999	1999	NUM
dti-1311	261	24	)	)	PUNCT
dti-1311	261	25	which	which	PRON
dti-1311	261	26	could	could	AUX
dti-1311	261	27	be	be	AUX
dti-1311	261	28	involved	involve	VERB
dti-1311	261	29	at	at	ADP
dti-1311	261	30	least	least	ADJ
dti-1311	261	31	in	in	ADP
dti-1311	261	32	part	part	NOUN
dti-1311	261	33	in	in	ADP
dti-1311	261	34	the	the	DET
dti-1311	261	35	observed	observed	ADJ
dti-1311	261	36	decrease	decrease	NOUN
dti-1311	261	37	in	in	ADP
dti-1311	261	38	immobility	immobility	NOUN
dti-1311	261	39	time	time	NOUN
dti-1311	261	40	by	by	ADP
dti-1311	261	41	the	the	DET
dti-1311	261	42	drug	drug	NOUN
dti-1311	261	43	.	.	PUNCT
dti-1311	262	1	in	in	ADP
dti-1311	262	2	paw	paw	NOUN
dti-1311	262	3	oedema	oedema	NOUN
dti-1311	262	4	caused	cause	VERB
dti-1311	262	5	by	by	ADP
dti-1311	262	6	carrageenan	carrageenan	NOUN
dti-1311	262	7	,	,	PUNCT
dti-1311	262	8	cinnarizine	cinnarizine	NOUN
dti-1311	262	9	at	at	ADP
dti-1311	262	10	doses	dose	NOUN
dti-1311	262	11	of	of	ADP
dti-1311	262	12	5–20	5–20	PROPN
dti-1311	262	13	mg	mg	PROPN
dti-1311	262	14	/	/	SYM
dti-1311	262	15	kg	kg	PROPN
dti-1311	262	16	,	,	PUNCT
dti-1311	262	17	produced	produce	VERB
dti-1311	262	18	a	a	DET
dti-1311	262	19	dosedependent	dosedependent	NOUN
dti-1311	262	20	and	and	CCONJ
dti-1311	262	21	marked	mark	VERB
dti-1311	262	22	inhibition	inhibition	NOUN
dti-1311	262	23	of	of	ADP
dti-1311	262	24	paw	paw	ADJ
dti-1311	262	25	oedema	oedema	ADJ
dti-1311	262	26	response	response	NOUN
dti-1311	262	27	to	to	ADP
dti-1311	262	28	carrageenan	carrageenan	NOUN
dti-1311	262	29	.	.	PUNCT
dti-1311	263	1	cinnarizine	cinnarizine	PROPN
dti-1311	263	2	in	in	ADP
dti-1311	263	3	low	low	ADJ
dti-1311	263	4	doses	dose	NOUN
dti-1311	263	5	failed	fail	VERB
dti-1311	263	6	to	to	PART
dti-1311	263	7	reduce	reduce	VERB
dti-1311	263	8	the	the	DET
dti-1311	263	9	infl	infl	PROPN
dti-1311	263	10	ammatory	ammatory	NOUN
dti-1311	263	11	response	response	NOUN
dti-1311	263	12	.	.	PUNCT
dti-1311	264	1	this	this	DET
dti-1311	264	2	result	result	NOUN
dti-1311	264	3	is	be	AUX
dti-1311	264	4	in	in	ADP
dti-1311	264	5	accordance	accordance	NOUN
dti-1311	264	6	to	to	ADP
dti-1311	264	7	what	what	PRON
dti-1311	264	8	has	have	AUX
dti-1311	264	9	been	be	AUX
dti-1311	264	10	reported	report	VERB
dti-1311	264	11	previously	previously	ADV
dti-1311	264	12	of	of	ADP
dti-1311	264	13	the	the	DET
dti-1311	264	14	anti	anti	ADJ
dti-1311	264	15	-	-	ADJ
dti-1311	264	16	infl	infl	ADJ
dti-1311	264	17	ammatory	ammatory	NOUN
dti-1311	264	18	property	property	NOUN
dti-1311	264	19	of	of	ADP
dti-1311	264	20	cinnarizine	cinnarizine	NOUN
dti-1311	264	21	(	(	PUNCT
dti-1311	264	22	blazso	blazso	PROPN
dti-1311	264	23	et	et	PROPN
dti-1311	264	24	al	al	PROPN
dti-1311	264	25	.	.	PROPN
dti-1311	264	26	1999	1999	NUM
dti-1311	264	27	)	)	PUNCT
dti-1311	264	28	.	.	PUNCT
dti-1311	265	1	time	time	NOUN
dti-1311	265	2	(	(	PUNCT
dti-1311	265	3	h	h	NOUN
dti-1311	265	4	)	)	PUNCT
dti-1311	265	5	0	0	NUM
dti-1311	265	6	1	1	NUM
dti-1311	265	7	2	2	NUM
dti-1311	265	8	3	3	NUM
dti-1311	265	9	4	4	NUM
dti-1311	265	10	5	5	NUM
dti-1311	265	11	%	%	NOUN
dti-1311	265	12	in	in	ADP
dti-1311	265	13	cr	cr	PROPN
dti-1311	265	14	ea	ea	X
dti-1311	265	15	se	se	PROPN
dti-1311	265	16	in	in	ADP
dti-1311	265	17	p	p	PROPN
dti-1311	265	18	aw	aw	INTJ
dti-1311	265	19	v	v	X
dti-1311	265	20	ol	ol	PROPN
dti-1311	265	21	um	um	INTJ
dti-1311	265	22	e	e	X
dti-1311	265	23	(	(	PUNCT
dti-1311	265	24	o	o	INTJ
dti-1311	265	25	ed	ed	NOUN
dti-1311	265	26	em	em	PRON
dti-1311	265	27	a	a	X
dti-1311	265	28	)	)	PUNCT
dti-1311	265	29	0	0	NUM
dti-1311	265	30	20	20	NUM
dti-1311	265	31	40	40	NUM
dti-1311	265	32	60	60	NUM
dti-1311	265	33	80	80	NUM
dti-1311	265	34	100	100	NUM
dti-1311	265	35	120	120	NUM
dti-1311	265	36	140	140	NUM
dti-1311	265	37	160	160	NUM
dti-1311	265	38	carrageenan	carrageenan	NOUN
dti-1311	265	39	control	control	NOUN
dti-1311	265	40	cinnarizine	cinnarizine	VERB
dti-1311	265	41	1.25	1.25	NUM
dti-1311	265	42	mg	mg	PROPN
dti-1311	265	43	/	/	SYM
dti-1311	265	44	kg	kg	PROPN
dti-1311	265	45	cinnarizine	cinnarizine	VERB
dti-1311	265	46	2.5	2.5	NUM
dti-1311	265	47	mg	mg	PROPN
dti-1311	265	48	/	/	SYM
dti-1311	265	49	kg	kg	PROPN
dti-1311	265	50	cinnarizine	cinnarizine	VERB
dti-1311	265	51	5	5	NUM
dti-1311	265	52	mg	mg	PROPN
dti-1311	265	53	/	/	SYM
dti-1311	265	54	kg	kg	PROPN
dti-1311	265	55	cinnarizine	cinnarizine	VERB
dti-1311	265	56	10	10	NUM
dti-1311	265	57	mg	mg	PROPN
dti-1311	265	58	/	/	SYM
dti-1311	265	59	kg	kg	PROPN
dti-1311	265	60	cinnarizine	cinnarizine	VERB
dti-1311	265	61	20	20	NUM
dti-1311	265	62	mg	mg	PROPN
dti-1311	265	63	/	/	SYM
dti-1311	265	64	kg	kg	NOUN
dti-1311	265	65	*	*	PUNCT
dti-1311	266	1	*	*	PUNCT
dti-1311	267	1	*	*	PUNCT
dti-1311	268	1	*	*	PUNCT
dti-1311	269	1	*	*	PUNCT
dti-1311	270	1	*	*	PUNCT
dti-1311	271	1	*	*	PUNCT
dti-1311	272	1	*	*	PUNCT
dti-1311	272	2	*	*	PUNCT
dti-1311	272	3	*	*	PUNCT
dti-1311	272	4	*	*	PUNCT
dti-1311	272	5	figure	figure	NOUN
dti-1311	272	6	9	9	NUM
dti-1311	272	7	.	.	PUNCT
dti-1311	272	8	effect	effect	NOUN
dti-1311	272	9	of	of	ADP
dti-1311	272	10	different	different	ADJ
dti-1311	272	11	doses	dose	NOUN
dti-1311	272	12	of	of	ADP
dti-1311	272	13	cinnarizine	cinnarizine	NOUN
dti-1311	272	14	(	(	PUNCT
dti-1311	272	15	1.25	1.25	NUM
dti-1311	272	16	,	,	PUNCT
dti-1311	272	17	2.5	2.5	NUM
dti-1311	272	18	,	,	PUNCT
dti-1311	272	19	5	5	NUM
dti-1311	272	20	,	,	PUNCT
dti-1311	272	21	10	10	NUM
dti-1311	272	22	and	and	CCONJ
dti-1311	272	23	20	20	NUM
dti-1311	272	24	mg	mg	NUM
dti-1311	272	25	/	/	SYM
dti-1311	272	26	kg	kg	NOUN
dti-1311	272	27	)	)	PUNCT
dti-1311	272	28	on	on	ADP
dti-1311	272	29	the	the	DET
dti-1311	272	30	paw	paw	NOUN
dti-1311	272	31	odema	odema	NOUN
dti-1311	272	32	caused	cause	VERB
dti-1311	272	33	by	by	ADP
dti-1311	272	34	sub	sub	ADJ
dti-1311	272	35	-	-	ADJ
dti-1311	272	36	plantar	plantar	ADJ
dti-1311	272	37	injection	injection	NOUN
dti-1311	272	38	of	of	ADP
dti-1311	272	39	carrageenan	carrageenan	NOUN
dti-1311	272	40	in	in	ADP
dti-1311	272	41	rats	rat	NOUN
dti-1311	272	42	.	.	PUNCT
dti-1311	273	1	data	datum	NOUN
dti-1311	273	2	expressed	express	VERB
dti-1311	273	3	as	as	ADP
dti-1311	273	4	mean	mean	PROPN
dti-1311	273	5	±	±	NUM
dti-1311	273	6	s.e	s.e	PROPN
dti-1311	273	7	.	.	PROPN
dti-1311	273	8	percent	percent	NOUN
dti-1311	273	9	inhibition	inhibition	NOUN
dti-1311	273	10	(	(	PUNCT
dti-1311	273	11	%	%	INTJ
dti-1311	273	12	)	)	PUNCT
dti-1311	273	13	compared	compare	VERB
dti-1311	273	14	to	to	ADP
dti-1311	273	15	the	the	DET
dti-1311	273	16	control	control	NOUN
dti-1311	273	17	animals	animal	NOUN
dti-1311	273	18	is	be	AUX
dti-1311	273	19	shown	show	VERB
dti-1311	273	20	.	.	PUNCT
dti-1311	274	1	*	*	PUNCT
dti-1311	274	2	p	p	X
dti-1311	274	3	<	<	X
dti-1311	274	4	0.05	0.05	NUM
dti-1311	274	5	compared	compare	VERB
dti-1311	274	6	to	to	ADP
dti-1311	274	7	saline	saline	ADJ
dti-1311	274	8	control	control	NOUN
dti-1311	274	9	.	.	PUNCT
dti-1311	275	1	six	six	NUM
dti-1311	275	2	rats	rat	NOUN
dti-1311	275	3	were	be	AUX
dti-1311	275	4	used	use	VERB
dti-1311	275	5	per	per	ADP
dti-1311	275	6	each	each	DET
dti-1311	275	7	group	group	NOUN
dti-1311	275	8	.	.	PUNCT
dti-1311	276	1	figure	figure	NOUN
dti-1311	276	2	10	10	NUM
dti-1311	276	3	.	.	PUNCT
dti-1311	277	1	effect	effect	NOUN
dti-1311	277	2	of	of	ADP
dti-1311	277	3	cinnarizine	cinnarizine	NOUN
dti-1311	277	4	(	(	PUNCT
dti-1311	277	5	2.5	2.5	NUM
dti-1311	277	6	,	,	PUNCT
dti-1311	277	7	5	5	NUM
dti-1311	277	8	and	and	CCONJ
dti-1311	277	9	10	10	NUM
dti-1311	277	10	mg	mg	NUM
dti-1311	277	11	/	/	SYM
dti-1311	277	12	kg	kg	NOUN
dti-1311	277	13	)	)	PUNCT
dti-1311	277	14	on	on	ADP
dti-1311	277	15	the	the	DET
dti-1311	277	16	number	number	NOUN
dti-1311	277	17	and	and	CCONJ
dti-1311	277	18	severity	severity	NOUN
dti-1311	277	19	of	of	ADP
dti-1311	277	20	gastric	gastric	ADJ
dti-1311	277	21	lesions	lesion	NOUN
dti-1311	277	22	caused	cause	VERB
dti-1311	277	23	by	by	ADP
dti-1311	277	24	s.c	s.c	PROPN
dti-1311	277	25	.	.	PROPN
dti-1311	277	26	indomethacin	indomethacin	PROPN
dti-1311	277	27	(	(	PUNCT
dti-1311	277	28	20	20	NUM
dti-1311	277	29	mg	mg	NUM
dti-1311	277	30	/	/	SYM
dti-1311	277	31	kg	kg	NOUN
dti-1311	277	32	)	)	PUNCT
dti-1311	277	33	in	in	ADP
dti-1311	277	34	rats	rat	NOUN
dti-1311	277	35	.	.	PUNCT
dti-1311	278	1	data	datum	NOUN
dti-1311	278	2	expressed	express	VERB
dti-1311	278	3	as	as	ADP
dti-1311	278	4	mean	mean	PROPN
dti-1311	278	5	±	±	NUM
dti-1311	278	6	s.e	s.e	PROPN
dti-1311	278	7	.	.	PROPN
dti-1311	278	8	*	*	PUNCT
dti-1311	279	1	p	p	X
dti-1311	279	2	<	<	X
dti-1311	279	3	0.05	0.05	NUM
dti-1311	279	4	compared	compare	VERB
dti-1311	279	5	to	to	ADP
dti-1311	279	6	saline	saline	ADJ
dti-1311	279	7	control	control	NOUN
dti-1311	279	8	.	.	PUNCT
dti-1311	280	1	the	the	DET
dti-1311	280	2	plus	plus	ADJ
dti-1311	280	3	sign	sign	NOUN
dti-1311	280	4	(	(	PUNCT
dti-1311	280	5	+	+	X
dti-1311	280	6	)	)	PUNCT
dti-1311	280	7	indicates	indicate	VERB
dti-1311	280	8	signifi	signifi	NOUN
dti-1311	280	9	ca	can	AUX
dti-1311	280	10	nt	not	PART
dti-1311	280	11	difference	difference	VERB
dti-1311	280	12	from	from	ADP
dti-1311	280	13	the	the	DET
dti-1311	280	14	2.5	2.5	NUM
dti-1311	280	15	mg	mg	PROPN
dti-1311	280	16	/	/	SYM
dti-1311	280	17	kg	kg	PROPN
dti-1311	280	18	cinnarizine	cinnarizine	PROPN
dti-1311	280	19	group	group	NOUN
dti-1311	280	20	.	.	PUNCT
dti-1311	281	1	six	six	NUM
dti-1311	281	2	rats	rat	NOUN
dti-1311	281	3	were	be	AUX
dti-1311	281	4	used	use	VERB
dti-1311	281	5	per	per	ADP
dti-1311	281	6	each	each	DET
dti-1311	281	7	group	group	NOUN
dti-1311	281	8	.	.	PUNCT
dti-1311	282	1	in	in	ADP
dti-1311	282	2	d	d	PROPN
dti-1311	282	3	c	c	NOUN
dti-1311	282	4	on	on	ADP
dti-1311	282	5	tro	tro	X
dti-1311	282	6	l	l	PROPN
dti-1311	282	7	+	+	CCONJ
dti-1311	282	8	c	c	PROPN
dti-1311	282	9	inn	inn	PROPN
dti-1311	282	10	ari	ari	PROPN
dti-1311	282	11	zin	zin	NOUN
dti-1311	282	12	e	e	PROPN
dti-1311	282	13	2	2	NUM
dti-1311	282	14	.5	.5	NUM
dti-1311	282	15	mg	mg	PROPN
dti-1311	282	16	/	/	SYM
dti-1311	282	17	k	k	PROPN
dti-1311	282	18	g	g	PROPN
dti-1311	282	19	+	+	PROPN
dti-1311	282	20	c	c	PROPN
dti-1311	282	21	inn	inn	PROPN
dti-1311	282	22	ari	ari	PROPN
dti-1311	282	23	zin	zin	NOUN
dti-1311	282	24	e	e	PROPN
dti-1311	282	25	5	5	NUM
dti-1311	282	26	m	m	NOUN
dti-1311	282	27	g	g	NOUN
dti-1311	282	28	/	/	SYM
dti-1311	282	29	k	k	NOUN
dti-1311	282	30	g	g	PROPN
dti-1311	282	31	+	+	CCONJ
dti-1311	282	32	c	c	PROPN
dti-1311	282	33	inn	inn	PROPN
dti-1311	282	34	ari	ari	PROPN
dti-1311	282	35	zin	zin	NOUN
dti-1311	282	36	e	e	NOUN
dti-1311	282	37	1	1	NUM
dti-1311	282	38	0	0	NUM
dti-1311	282	39	m	m	NOUN
dti-1311	282	40	g	g	NOUN
dti-1311	282	41	/	/	SYM
dti-1311	282	42	k	k	PROPN
dti-1311	282	43	g	g	PROPN
dti-1311	282	44	in	in	ADP
dti-1311	282	45	d	d	PROPN
dti-1311	282	46	c	c	NOUN
dti-1311	282	47	on	on	ADP
dti-1311	282	48	tro	tro	X
dti-1311	282	49	l	l	PROPN
dti-1311	283	1	+	+	CCONJ
dti-1311	283	2	c	c	PROPN
dti-1311	283	3	inn	inn	PROPN
dti-1311	283	4	ari	ari	PROPN
dti-1311	283	5	zin	zin	NOUN
dti-1311	283	6	e	e	PROPN
dti-1311	283	7	2	2	NUM
dti-1311	283	8	.5	.5	NUM
dti-1311	283	9	mg	mg	PROPN
dti-1311	283	10	/	/	SYM
dti-1311	283	11	k	k	PROPN
dti-1311	283	12	g	g	PROPN
dti-1311	284	1	+	+	PROPN
dti-1311	284	2	c	c	PROPN
dti-1311	284	3	inn	inn	PROPN
dti-1311	284	4	ari	ari	PROPN
dti-1311	284	5	zin	zin	NOUN
dti-1311	285	1	e	e	PROPN
dti-1311	285	2	5	5	NUM
dti-1311	285	3	m	m	NOUN
dti-1311	285	4	g	g	NOUN
dti-1311	285	5	/	/	SYM
dti-1311	285	6	k	k	NOUN
dti-1311	285	7	g	g	PROPN
dti-1311	286	1	+	+	CCONJ
dti-1311	286	2	c	c	PROPN
dti-1311	286	3	inn	inn	PROPN
dti-1311	286	4	ari	ari	PROPN
dti-1311	286	5	zin	zin	NOUN
dti-1311	286	6	e	e	NOUN
dti-1311	286	7	1	1	NUM
dti-1311	286	8	0	0	NUM
dti-1311	286	9	m	m	NOUN
dti-1311	286	10	g	g	NOUN
dti-1311	286	11	/	/	SYM
dti-1311	286	12	k	k	PROPN
dti-1311	286	13	g	g	NOUN
dti-1311	286	14	0	0	NUM
dti-1311	286	15	1	1	NUM
dti-1311	286	16	2	2	NUM
dti-1311	286	17	3	3	NUM
dti-1311	286	18	4	4	NUM
dti-1311	286	19	5	5	NUM
dti-1311	286	20	6	6	NUM
dti-1311	286	21	7	7	NUM
dti-1311	286	22	8	8	NUM
dti-1311	286	23	*	*	PUNCT
dti-1311	287	1	*	*	PUNCT
dti-1311	287	2	*	*	PUNCT
dti-1311	287	3	*	*	PUNCT
dti-1311	287	4	*	*	PUNCT
dti-1311	287	5	number	number	NOUN
dti-1311	287	6	of	of	ADP
dti-1311	287	7	lesions	lesion	NOUN
dti-1311	287	8	-64	-64	PUNCT
dti-1311	287	9	%	%	NOUN
dti-1311	287	10	-76	-76	NUM
dti-1311	287	11	%	%	NOUN
dti-1311	287	12	-32	-32	SYM
dti-1311	287	13	%	%	NOUN
dti-1311	287	14	-68.6	-68.6	NOUN
dti-1311	287	15	%	%	NOUN
dti-1311	288	1	-74.3	-74.3	X
dti-1311	288	2	%	%	NOUN
dti-1311	288	3	-14.3	-14.3	PRON
dti-1311	288	4	%	%	NOUN
dti-1311	288	5	severity	severity	NOUN
dti-1311	288	6	of	of	ADP
dti-1311	288	7	lesions	lesion	NOUN
dti-1311	288	8	+	+	X
dti-1311	288	9	+	+	CCONJ
dti-1311	288	10	g	g	NOUN
dti-1311	288	11	as	as	ADP
dti-1311	288	12	tri	tri	PROPN
dti-1311	288	13	cm	cm	NOUN
dti-1311	288	14	uc	uc	INTJ
dti-1311	288	15	os	os	PROPN
dti-1311	288	16	al	al	PROPN
dti-1311	288	17	le	le	PROPN
dti-1311	288	18	si	si	X
dti-1311	288	19	on	on	ADP
dti-1311	288	20	s	s	NOUN
dti-1311	288	21	drug	drug	NOUN
dti-1311	288	22	target	target	NOUN
dti-1311	288	23	insights	insight	NOUN
dti-1311	288	24	2007	2007	NUM
dti-1311	288	25	:	:	PUNCT
dti-1311	288	26	2	2	NUM
dti-1311	288	27	37	37	NUM
dti-1311	288	28	modulation	modulation	NOUN
dti-1311	288	29	of	of	ADP
dti-1311	288	30	visceral	visceral	ADJ
dti-1311	288	31	nociception	nociception	NOUN
dti-1311	288	32	,	,	PUNCT
dti-1311	288	33	infl	infl	PROPN
dti-1311	288	34	ammation	ammation	NOUN
dti-1311	288	35	and	and	CCONJ
dti-1311	288	36	gastric	gastric	ADJ
dti-1311	288	37	mucosal	mucosal	NOUN
dti-1311	288	38	injury	injury	NOUN
dti-1311	288	39	the	the	DET
dti-1311	288	40	effect	effect	NOUN
dti-1311	288	41	of	of	ADP
dti-1311	288	42	cinnarizine	cinnarizine	NOUN
dti-1311	288	43	on	on	ADP
dti-1311	288	44	gastric	gastric	ADJ
dti-1311	288	45	mucosa	mucosa	NOUN
dti-1311	288	46	was	be	AUX
dti-1311	288	47	also	also	ADV
dti-1311	288	48	examined	examine	VERB
dti-1311	288	49	in	in	ADP
dti-1311	288	50	the	the	DET
dti-1311	288	51	present	present	ADJ
dti-1311	288	52	study	study	NOUN
dti-1311	288	53	.	.	PUNCT
dti-1311	289	1	gastric	gastric	ADJ
dti-1311	289	2	lesions	lesion	NOUN
dti-1311	289	3	induced	induce	VERB
dti-1311	289	4	by	by	ADP
dti-1311	289	5	indomethacin	indomethacin	NOUN
dti-1311	289	6	were	be	AUX
dti-1311	289	7	reduced	reduce	VERB
dti-1311	289	8	dose	dose	NOUN
dti-1311	289	9	-	-	PUNCT
dti-1311	289	10	dependently	dependently	ADV
dti-1311	289	11	by	by	ADP
dti-1311	289	12	co	co	NOUN
dti-1311	289	13	-	-	NOUN
dti-1311	289	14	administration	administration	NOUN
dti-1311	289	15	of	of	ADP
dti-1311	289	16	cinnarizine	cinnarizine	NOUN
dti-1311	289	17	,	,	PUNCT
dti-1311	289	18	although	although	SCONJ
dti-1311	289	19	it	it	PRON
dti-1311	289	20	was	be	AUX
dti-1311	289	21	noted	note	VERB
dti-1311	289	22	that	that	SCONJ
dti-1311	289	23	this	this	DET
dti-1311	289	24	effect	effect	NOUN
dti-1311	289	25	was	be	AUX
dti-1311	289	26	more	more	ADV
dti-1311	289	27	evident	evident	ADJ
dti-1311	289	28	with	with	ADP
dti-1311	289	29	lower	low	ADJ
dti-1311	289	30	doses	dose	NOUN
dti-1311	289	31	of	of	ADP
dti-1311	289	32	2.5	2.5	NUM
dti-1311	289	33	,	,	PUNCT
dti-1311	289	34	5	5	NUM
dti-1311	289	35	mg	mg	NUM
dti-1311	289	36	/	/	SYM
dti-1311	289	37	kg	kg	PROPN
dti-1311	289	38	.	.	PUNCT
dti-1311	290	1	studies	study	NOUN
dti-1311	290	2	indicated	indicate	VERB
dti-1311	290	3	that	that	SCONJ
dti-1311	290	4	cold	cold	ADJ
dti-1311	290	5	/	/	SYM
dti-1311	290	6	restraint	restraint	NOUN
dti-1311	290	7	stressand	stressand	NOUN
dti-1311	290	8	ethanol	ethanol	NOUN
dti-1311	290	9	-	-	PUNCT
dti-1311	290	10	induced	induce	VERB
dti-1311	290	11	lesions	lesion	NOUN
dti-1311	290	12	was	be	AUX
dti-1311	290	13	decreased	decrease	VERB
dti-1311	290	14	by	by	ADP
dti-1311	290	15	the	the	DET
dti-1311	290	16	administration	administration	NOUN
dti-1311	290	17	of	of	ADP
dti-1311	290	18	cinnarizine	cinnarizine	NOUN
dti-1311	290	19	,	,	PUNCT
dti-1311	290	20	possibly	possibly	ADV
dti-1311	290	21	due	due	ADJ
dti-1311	290	22	to	to	PART
dti-1311	290	23	decrease	decrease	VERB
dti-1311	290	24	in	in	ADP
dti-1311	290	25	the	the	DET
dti-1311	290	26	elevated	elevated	ADJ
dti-1311	290	27	histamine	histamine	NOUN
dti-1311	290	28	content	content	NOUN
dti-1311	290	29	by	by	ADP
dti-1311	290	30	the	the	DET
dti-1311	290	31	drug	drug	NOUN
dti-1311	290	32	(	(	PUNCT
dti-1311	290	33	marazova	marazova	X
dti-1311	290	34	et	et	PROPN
dti-1311	290	35	al	al	PROPN
dti-1311	290	36	.	.	PROPN
dti-1311	290	37	1993	1993	NUM
dti-1311	290	38	;	;	PUNCT
dti-1311	290	39	lozeva	lozeva	PROPN
dti-1311	290	40	et	et	PROPN
dti-1311	290	41	al	al	PROPN
dti-1311	290	42	.	.	PROPN
dti-1311	290	43	1994	1994	NUM
dti-1311	290	44	)	)	PUNCT
dti-1311	290	45	.	.	PUNCT
dti-1311	291	1	cinnarizine	cinnarizine	PROPN
dti-1311	291	2	has	have	VERB
dti-1311	291	3	a	a	DET
dti-1311	291	4	complex	complex	ADJ
dti-1311	291	5	the	the	DET
dti-1311	291	6	complex	complex	ADJ
dti-1311	291	7	mechanism	mechanism	NOUN
dti-1311	291	8	of	of	ADP
dti-1311	291	9	action	action	NOUN
dti-1311	291	10	.	.	PUNCT
dti-1311	292	1	in	in	ADP
dti-1311	292	2	addition	addition	NOUN
dti-1311	292	3	to	to	ADP
dti-1311	292	4	a	a	DET
dti-1311	292	5	calcium	calcium	NOUN
dti-1311	292	6	channel	channel	NOUN
dti-1311	292	7	blocking	block	VERB
dti-1311	292	8	activity	activity	NOUN
dti-1311	292	9	and	and	CCONJ
dti-1311	292	10	antihistaminic	antihistaminic	NOUN
dti-1311	292	11	properties	property	NOUN
dti-1311	292	12	,	,	PUNCT
dti-1311	292	13	binding	bind	VERB
dti-1311	292	14	to	to	ADP
dti-1311	292	15	both	both	CCONJ
dti-1311	292	16	h1	h1	VERB
dti-1311	292	17	and	and	CCONJ
dti-1311	292	18	h2	h2	NOUN
dti-1311	292	19	receptors	receptor	NOUN
dti-1311	292	20	(	(	PUNCT
dti-1311	292	21	nagai	nagai	PROPN
dti-1311	292	22	et	et	PROPN
dti-1311	292	23	al	al	PROPN
dti-1311	292	24	.	.	PROPN
dti-1311	292	25	1986	1986	NUM
dti-1311	292	26	;	;	PUNCT
dti-1311	292	27	nguyen	nguyen	PROPN
dti-1311	292	28	et	et	PROPN
dti-1311	292	29	al	al	PROPN
dti-1311	292	30	.	.	PROPN
dti-1311	292	31	2001	2001	NUM
dti-1311	292	32	)	)	PUNCT
dti-1311	292	33	,	,	PUNCT
dti-1311	292	34	the	the	DET
dti-1311	292	35	drug	drug	NOUN
dti-1311	292	36	displayed	display	VERB
dti-1311	292	37	dopamine	dopamine	NOUN
dti-1311	292	38	d1	d1	PROPN
dti-1311	292	39	and	and	CCONJ
dti-1311	292	40	d2	d2	NOUN
dti-1311	292	41	receptor	receptor	NOUN
dti-1311	292	42	blocking	blocking	NOUN
dti-1311	292	43	effects	effect	NOUN
dti-1311	292	44	as	as	ADV
dti-1311	292	45	well	well	ADV
dti-1311	292	46	as	as	ADP
dti-1311	292	47	inhibitory	inhibitory	ADJ
dti-1311	292	48	effects	effect	NOUN
dti-1311	292	49	on	on	ADP
dti-1311	292	50	the	the	DET
dti-1311	292	51	reuptake	reuptake	NOUN
dti-1311	292	52	of	of	ADP
dti-1311	292	53	gaba	gaba	PROPN
dti-1311	292	54	(	(	PUNCT
dti-1311	292	55	mirzoian	mirzoian	NOUN
dti-1311	292	56	et	et	PROPN
dti-1311	292	57	al	al	PROPN
dti-1311	292	58	.	.	PROPN
dti-1311	292	59	1998	1998	NUM
dti-1311	292	60	)	)	PUNCT
dti-1311	292	61	and	and	CCONJ
dti-1311	292	62	on	on	ADP
dti-1311	292	63	catecholamine	catecholamine	NOUN
dti-1311	292	64	uptake	uptake	NOUN
dti-1311	292	65	(	(	PUNCT
dti-1311	292	66	terland	terland	NOUN
dti-1311	292	67	and	and	CCONJ
dti-1311	292	68	flatmark	flatmark	NOUN
dti-1311	292	69	,	,	PUNCT
dti-1311	292	70	1999	1999	NUM
dti-1311	292	71	)	)	PUNCT
dti-1311	292	72	.	.	PUNCT
dti-1311	293	1	the	the	DET
dti-1311	293	2	antihistaminic	antihistaminic	NOUN
dti-1311	293	3	or	or	CCONJ
dti-1311	293	4	catecholamine	catecholamine	NOUN
dti-1311	293	5	reuptake	reuptake	NOUN
dti-1311	293	6	blocking	block	VERB
dti-1311	293	7	properties	property	NOUN
dti-1311	293	8	might	might	AUX
dti-1311	293	9	be	be	AUX
dti-1311	293	10	involved	involve	VERB
dti-1311	293	11	in	in	ADP
dti-1311	293	12	the	the	DET
dti-1311	293	13	antioedema	antioedema	ADJ
dti-1311	293	14	effect	effect	NOUN
dti-1311	293	15	observed	observe	VERB
dti-1311	293	16	in	in	ADP
dti-1311	293	17	the	the	DET
dti-1311	293	18	present	present	ADJ
dti-1311	293	19	study	study	NOUN
dti-1311	293	20	.	.	PUNCT
dti-1311	294	1	the	the	DET
dti-1311	294	2	benefi	benefi	PROPN
dti-1311	294	3	cial	cial	ADJ
dti-1311	294	4	effect	effect	NOUN
dti-1311	294	5	of	of	ADP
dti-1311	294	6	cinnarizine	cinnarizine	NOUN
dti-1311	294	7	on	on	ADP
dti-1311	294	8	gastric	gastric	ADJ
dti-1311	294	9	lesions	lesion	NOUN
dti-1311	294	10	can	can	AUX
dti-1311	294	11	be	be	AUX
dti-1311	294	12	attributed	attribute	VERB
dti-1311	294	13	to	to	ADP
dti-1311	294	14	inhibition	inhibition	NOUN
dti-1311	294	15	of	of	ADP
dti-1311	294	16	gastric	gastric	ADJ
dti-1311	294	17	acid	acid	NOUN
dti-1311	294	18	secretion	secretion	NOUN
dti-1311	294	19	(	(	PUNCT
dti-1311	294	20	bouclier	bouclier	NOUN
dti-1311	294	21	and	and	CCONJ
dti-1311	294	22	spedding	spedding	NOUN
dti-1311	294	23	,	,	PUNCT
dti-1311	294	24	1985	1985	NUM
dti-1311	294	25	)	)	PUNCT
dti-1311	294	26	,	,	PUNCT
dti-1311	294	27	to	to	ADP
dti-1311	294	28	its	its	PRON
dti-1311	294	29	vasodilator	vasodilator	NOUN
dti-1311	294	30	properties	property	NOUN
dti-1311	294	31	(	(	PUNCT
dti-1311	294	32	izumo	izumo	PROPN
dti-1311	294	33	et	et	PROPN
dti-1311	294	34	al	al	PROPN
dti-1311	294	35	.	.	PROPN
dti-1311	294	36	1999	1999	NUM
dti-1311	294	37	)	)	PUNCT
dti-1311	294	38	,	,	PUNCT
dti-1311	294	39	leading	lead	VERB
dti-1311	294	40	to	to	ADP
dti-1311	294	41	an	an	DET
dti-1311	294	42	increase	increase	NOUN
dti-1311	294	43	in	in	ADP
dti-1311	294	44	gastric	gastric	ADJ
dti-1311	294	45	mucosal	mucosal	NOUN
dti-1311	294	46	blood	blood	NOUN
dti-1311	294	47	fl	fl	INTJ
dti-1311	294	48	ow	ow	INTJ
dti-1311	294	49	or	or	CCONJ
dti-1311	294	50	to	to	ADP
dti-1311	294	51	its	its	PRON
dti-1311	294	52	antihistaminic	antihistaminic	NOUN
dti-1311	294	53	properties	property	NOUN
dti-1311	294	54	(	(	PUNCT
dti-1311	294	55	nagai	nagai	PROPN
dti-1311	294	56	et	et	PROPN
dti-1311	294	57	al	al	PROPN
dti-1311	294	58	.	.	PROPN
dti-1311	294	59	1986	1986	NUM
dti-1311	294	60	;	;	PUNCT
dti-1311	295	1	nguyen	nguyen	PROPN
dti-1311	295	2	et	et	PROPN
dti-1311	295	3	al	al	PROPN
dti-1311	295	4	.	.	PROPN
dti-1311	295	5	2001	2001	NUM
dti-1311	295	6	)	)	PUNCT
dti-1311	295	7	.	.	PUNCT
dti-1311	296	1	in	in	ADP
dti-1311	296	2	summary	summary	NOUN
dti-1311	296	3	the	the	DET
dti-1311	296	4	present	present	ADJ
dti-1311	296	5	study	study	NOUN
dti-1311	296	6	confi	confi	VERB
dti-1311	296	7	rms	rm	NOUN
dti-1311	296	8	and	and	CCONJ
dti-1311	296	9	extends	extend	VERB
dti-1311	296	10	previous	previous	ADJ
dti-1311	296	11	studies	study	NOUN
dti-1311	296	12	suggesting	suggest	VERB
dti-1311	296	13	anti	anti	ADJ
dti-1311	296	14	-	-	ADJ
dti-1311	296	15	infl	infl	ADJ
dti-1311	296	16	ammatory	ammatory	NOUN
dti-1311	296	17	,	,	PUNCT
dti-1311	296	18	antinociceptive	antinociceptive	ADJ
dti-1311	296	19	and	and	CCONJ
dti-1311	296	20	gastric	gastric	ADJ
dti-1311	296	21	protective	protective	ADJ
dti-1311	296	22	properties	property	NOUN
dti-1311	296	23	for	for	ADP
dti-1311	296	24	cinnarizine	cinnarizine	NOUN
dti-1311	296	25	.	.	PUNCT
dti-1311	297	1	the	the	DET
dti-1311	297	2	study	study	NOUN
dti-1311	297	3	indicates	indicate	VERB
dti-1311	297	4	that	that	SCONJ
dti-1311	297	5	mechanism	mechanism	NOUN
dti-1311	297	6	by	by	ADP
dti-1311	297	7	which	which	PRON
dti-1311	297	8	cinnarizine	cinnarizine	VERB
dti-1311	297	9	modulates	modulate	NOUN
dti-1311	297	10	pain	pain	NOUN
dti-1311	297	11	transmission	transmission	NOUN
dti-1311	297	12	is	be	AUX
dti-1311	297	13	likely	likely	ADJ
dti-1311	297	14	to	to	PART
dti-1311	297	15	involve	involve	VERB
dti-1311	297	16	adenosine	adenosine	NOUN
dti-1311	297	17	receptors	receptor	NOUN
dti-1311	297	18	and	and	CCONJ
dti-1311	297	19	atpgated	atpgate	VERB
dti-1311	297	20	potassium	potassium	NOUN
dti-1311	297	21	channels	channel	NOUN
dti-1311	297	22	.	.	PUNCT
dti-1311	298	1	the	the	DET
dti-1311	298	2	study	study	NOUN
dti-1311	298	3	in	in	ADP
dti-1311	298	4	addition	addition	NOUN
dti-1311	298	5	shows	show	VERB
dti-1311	298	6	that	that	SCONJ
dti-1311	298	7	cinnarizine	cinnarizine	PROPN
dti-1311	298	8	inhibits	inhibit	VERB
dti-1311	298	9	gaba	gaba	NOUN
dti-1311	298	10	-	-	PUNCT
dti-1311	298	11	mediated	mediate	VERB
dti-1311	298	12	antinociception	antinociception	NOUN
dti-1311	298	13	.	.	PUNCT
dti-1311	299	1	references	reference	NOUN
dti-1311	299	2	asano	asano	PROPN
dti-1311	299	3	,	,	PUNCT
dti-1311	299	4	t.	t.	PROPN
dti-1311	299	5	,	,	PUNCT
dti-1311	299	6	dohi	dohi	PROPN
dti-1311	299	7	,	,	PUNCT
dti-1311	299	8	s.	s.	PROPN
dti-1311	299	9	and	and	CCONJ
dti-1311	299	10	iida	iida	PROPN
dti-1311	299	11	h.	h.	PROPN
dti-1311	299	12	2000	2000	NUM
dti-1311	299	13	.	.	PUNCT
dti-1311	300	1	antinociceptive	antinociceptive	ADJ
dti-1311	300	2	action	action	NOUN
dti-1311	300	3	of	of	ADP
dti-1311	300	4	epidural	epidural	ADJ
dti-1311	300	5	k1	k1	PROPN
dti-1311	300	6	atp	atp	PROPN
dti-1311	300	7	channel	channel	NOUN
dti-1311	300	8	openers	opener	NOUN
dti-1311	300	9	via	via	ADP
dti-1311	300	10	interaction	interaction	NOUN
dti-1311	300	11	with	with	ADP
dti-1311	300	12	morphine	morphine	NOUN
dti-1311	300	13	and	and	CCONJ
dti-1311	300	14	an	an	DET
dti-1311	300	15	2	2	NUM
dti-1311	300	16	-	-	PUNCT
dti-1311	300	17	adrenergic	adrenergic	ADJ
dti-1311	300	18	agonist	agonist	NOUN
dti-1311	300	19	in	in	ADP
dti-1311	300	20	rats	rat	NOUN
dti-1311	300	21	.	.	PUNCT
dti-1311	301	1	anesth	anesth	PROPN
dti-1311	301	2	.	.	PROPN
dti-1311	301	3	analg	analg	PROPN
dti-1311	301	4	.	.	PUNCT
dti-1311	301	5	,	,	PUNCT
dti-1311	302	1	90:1146–51	90:1146–51	X
dti-1311	302	2	.	.	PUNCT
dti-1311	302	3	baamonde	baamonde	PROPN
dti-1311	302	4	,	,	PUNCT
dti-1311	302	5	a.	a.	NOUN
dti-1311	302	6	,	,	PUNCT
dti-1311	302	7	hidalgo	hidalgo	PROPN
dti-1311	302	8	,	,	PUNCT
dti-1311	302	9	a.	a.	NOUN
dti-1311	302	10	and	and	CCONJ
dti-1311	302	11	andres	andre	NOUN
dti-1311	302	12	-	-	PUNCT
dti-1311	302	13	trelles	trelle	NOUN
dti-1311	302	14	,	,	PUNCT
dti-1311	302	15	f.	f.	PROPN
dti-1311	302	16	1989	1989	NUM
dti-1311	302	17	.	.	PUNCT
dti-1311	303	1	sex	sex	NOUN
dti-1311	303	2	-	-	PUNCT
dti-1311	303	3	related	relate	VERB
dti-1311	303	4	differences	difference	NOUN
dti-1311	303	5	in	in	ADP
dti-1311	303	6	the	the	DET
dti-1311	303	7	effects	effect	NOUN
dti-1311	303	8	of	of	ADP
dti-1311	303	9	morphine	morphine	NOUN
dti-1311	303	10	and	and	CCONJ
dti-1311	303	11	stress	stress	NOUN
dti-1311	303	12	on	on	ADP
dti-1311	303	13	visceral	visceral	ADJ
dti-1311	303	14	pain	pain	NOUN
dti-1311	303	15	.	.	PUNCT
dti-1311	304	1	neuropharmacology	neuropharmacology	NOUN
dti-1311	304	2	,	,	PUNCT
dti-1311	304	3	28:967–970	28:967–970	PROPN
dti-1311	304	4	.	.	PUNCT
dti-1311	305	1	bartolini	bartolini	PROPN
dti-1311	305	2	,	,	PUNCT
dti-1311	305	3	a.	a.	NOUN
dti-1311	305	4	,	,	PUNCT
dti-1311	305	5	ghelardini	ghelardini	PROPN
dti-1311	305	6	,	,	PUNCT
dti-1311	305	7	c.	c.	PROPN
dti-1311	305	8	,	,	PUNCT
dti-1311	305	9	fantetti	fantetti	PROPN
dti-1311	305	10	,	,	PUNCT
dti-1311	305	11	l.	l.	PROPN
dti-1311	305	12	,	,	PUNCT
dti-1311	305	13	malcangio	malcangio	NOUN
dti-1311	305	14	,	,	PUNCT
dti-1311	305	15	m.	m.	NOUN
dti-1311	305	16	,	,	PUNCT
dti-1311	305	17	malmberg	malmberg	PROPN
dti-1311	305	18	-	-	PUNCT
dti-1311	305	19	aiello	aiello	PROPN
dti-1311	305	20	,	,	PUNCT
dti-1311	305	21	p.	p.	NOUN
dti-1311	305	22	and	and	CCONJ
dti-1311	305	23	giotti	giotti	PROPN
dti-1311	305	24	,	,	PUNCT
dti-1311	305	25	a.	a.	NOUN
dti-1311	305	26	1992	1992	NUM
dti-1311	305	27	.	.	PUNCT
dti-1311	306	1	role	role	NOUN
dti-1311	306	2	of	of	ADP
dti-1311	306	3	muscarinic	muscarinic	ADJ
dti-1311	306	4	receptor	receptor	NOUN
dti-1311	306	5	subtypes	subtype	NOUN
dti-1311	306	6	in	in	ADP
dti-1311	306	7	central	central	ADJ
dti-1311	306	8	antinociception	antinociception	NOUN
dti-1311	306	9	.	.	PUNCT
dti-1311	307	1	br	br	PROPN
dti-1311	307	2	.	.	PUNCT
dti-1311	308	1	j.	j.	PROPN
dti-1311	308	2	pharmacol	pharmacol	PROPN
dti-1311	308	3	.	.	PROPN
dti-1311	308	4	,	,	PUNCT
dti-1311	308	5	105:77–82	105:77–82	X
dti-1311	308	6	.	.	PUNCT
dti-1311	308	7	ben	ben	PROPN
dti-1311	308	8	-	-	PUNCT
dti-1311	308	9	sreti	sreti	PROPN
dti-1311	308	10	,	,	PUNCT
dti-1311	308	11	m.m	m.m	PROPN
dti-1311	308	12	.	.	PROPN
dti-1311	308	13	,	,	PUNCT
dti-1311	308	14	gonzalez	gonzalez	PROPN
dti-1311	308	15	,	,	PUNCT
dti-1311	308	16	j.p	j.p	PROPN
dti-1311	308	17	.	.	PROPN
dti-1311	308	18	and	and	CCONJ
dti-1311	308	19	sewell	sewell	PROPN
dti-1311	308	20	,	,	PUNCT
dti-1311	308	21	r.d	r.d	PROPN
dti-1311	308	22	.	.	PROPN
dti-1311	308	23	1983	1983	NUM
dti-1311	308	24	.	.	PUNCT
dti-1311	309	1	differential	differential	ADJ
dti-1311	309	2	effects	effect	NOUN
dti-1311	309	3	of	of	ADP
dti-1311	309	4	skf	skf	PROPN
dti-1311	309	5	38393	38393	NUM
dti-1311	309	6	and	and	CCONJ
dti-1311	309	7	ly	ly	ADP
dti-1311	309	8	141865	141865	NUM
dti-1311	309	9	on	on	ADP
dti-1311	309	10	nociception	nociception	NOUN
dti-1311	309	11	and	and	CCONJ
dti-1311	309	12	morphine	morphine	NOUN
dti-1311	309	13	analgesia	analgesia	NOUN
dti-1311	309	14	.	.	PUNCT
dti-1311	310	1	life	life	PROPN
dti-1311	310	2	sci	sci	PROPN
dti-1311	310	3	.	.	PROPN
dti-1311	310	4	,	,	PUNCT
dti-1311	310	5	33	33	NUM
dti-1311	310	6	(	(	PUNCT
dti-1311	310	7	suppl	suppl	PROPN
dti-1311	310	8	1):665–658	1):665–658	NUM
dti-1311	310	9	.	.	PUNCT
dti-1311	310	10	berkenkopf	berkenkopf	NOUN
dti-1311	310	11	,	,	PUNCT
dti-1311	310	12	j.w	j.w	PROPN
dti-1311	310	13	.	.	PROPN
dti-1311	310	14	and	and	CCONJ
dti-1311	310	15	weichman	weichman	PROPN
dti-1311	310	16	,	,	PUNCT
dti-1311	310	17	b.m	b.m	PROPN
dti-1311	310	18	.	.	PROPN
dti-1311	310	19	1988	1988	NUM
dti-1311	310	20	.	.	PUNCT
dti-1311	311	1	production	production	NOUN
dti-1311	311	2	of	of	ADP
dti-1311	311	3	prostacyclin	prostacyclin	NOUN
dti-1311	311	4	in	in	ADP
dti-1311	311	5	mice	mouse	NOUN
dti-1311	311	6	following	follow	VERB
dti-1311	311	7	intraperitoneal	intraperitoneal	ADJ
dti-1311	311	8	injection	injection	NOUN
dti-1311	311	9	of	of	ADP
dti-1311	311	10	acetic	acetic	ADJ
dti-1311	311	11	acid	acid	NOUN
dti-1311	311	12	,	,	PUNCT
dti-1311	311	13	phenylbenzoquinone	phenylbenzoquinone	NOUN
dti-1311	311	14	and	and	CCONJ
dti-1311	311	15	zymosan	zymosan	NOUN
dti-1311	311	16	:	:	PUNCT
dti-1311	311	17	its	its	PRON
dti-1311	311	18	role	role	NOUN
dti-1311	311	19	in	in	ADP
dti-1311	311	20	the	the	DET
dti-1311	311	21	writhing	writhe	VERB
dti-1311	311	22	response	response	NOUN
dti-1311	311	23	.	.	PUNCT
dti-1311	312	1	prostaglandins	prostaglandin	NOUN
dti-1311	312	2	,	,	PUNCT
dti-1311	313	1	36:693–709	36:693–709	PROPN
dti-1311	313	2	.	.	PUNCT
dti-1311	313	3	blazso	blazso	PROPN
dti-1311	313	4	,	,	PUNCT
dti-1311	313	5	g.	g.	PROPN
dti-1311	313	6	,	,	PUNCT
dti-1311	313	7	razga	razga	NOUN
dti-1311	313	8	,	,	PUNCT
dti-1311	313	9	z.	z.	PROPN
dti-1311	313	10	and	and	CCONJ
dti-1311	313	11	gabor	gabor	PROPN
dti-1311	313	12	,	,	PUNCT
dti-1311	313	13	m.	m.	NOUN
dti-1311	313	14	1999	1999	NUM
dti-1311	313	15	.	.	PUNCT
dti-1311	314	1	effects	effect	NOUN
dti-1311	314	2	of	of	ADP
dti-1311	314	3	cinnarizine	cinnarizine	NOUN
dti-1311	314	4	on	on	ADP
dti-1311	314	5	different	different	ADJ
dti-1311	314	6	experimentally	experimentally	ADV
dti-1311	314	7	induced	induce	VERB
dti-1311	314	8	oedemas	oedema	NOUN
dti-1311	314	9	.	.	PUNCT
dti-1311	315	1	fundam	fundam	PROPN
dti-1311	315	2	.	.	PUNCT
dti-1311	316	1	clin	clin	PROPN
dti-1311	316	2	.	.	PUNCT
dti-1311	317	1	pharmacol	pharmacol	PROPN
dti-1311	317	2	.	.	PROPN
dti-1311	317	3	,	,	PUNCT
dti-1311	317	4	13:91–95	13:91–95	NUM
dti-1311	317	5	.	.	PUNCT
dti-1311	317	6	bouclier	bouclier	NOUN
dti-1311	317	7	,	,	PUNCT
dti-1311	317	8	m.	m.	NOUN
dti-1311	317	9	and	and	CCONJ
dti-1311	317	10	spedding	spedding	NOUN
dti-1311	317	11	,	,	PUNCT
dti-1311	317	12	m.	m.	NOUN
dti-1311	317	13	1985	1985	NUM
dti-1311	317	14	.	.	PUNCT
dti-1311	318	1	differential	differential	ADJ
dti-1311	318	2	effects	effect	NOUN
dti-1311	318	3	of	of	ADP
dti-1311	318	4	calcium	calcium	NOUN
dti-1311	318	5	channel	channel	NOUN
dti-1311	318	6	antagonists	antagonist	NOUN
dti-1311	318	7	on	on	ADP
dti-1311	318	8	histamine	histamine	NOUN
dti-1311	318	9	and	and	CCONJ
dti-1311	318	10	pentagastrin	pentagastrin	ADV
dti-1311	318	11	-	-	PUNCT
dti-1311	318	12	stimulated	stimulate	VERB
dti-1311	318	13	gastric	gastric	ADJ
dti-1311	318	14	acid	acid	NOUN
dti-1311	318	15	secretion	secretion	NOUN
dti-1311	318	16	in	in	ADP
dti-1311	318	17	the	the	DET
dti-1311	318	18	rat	rat	NOUN
dti-1311	318	19	.	.	PUNCT
dti-1311	319	1	agents	agents	PROPN
dti-1311	319	2	actions,16:491–495	actions,16:491–495	PROPN
dti-1311	319	3	.	.	PUNCT
dti-1311	320	1	brown	brown	PROPN
dti-1311	320	2	,	,	PUNCT
dti-1311	320	3	d.l	d.l	PROPN
dti-1311	320	4	.	.	PROPN
dti-1311	320	5	,	,	PUNCT
dti-1311	320	6	bulley	bulley	PROPN
dti-1311	320	7	,	,	PUNCT
dti-1311	320	8	c.k	c.k	PROPN
dti-1311	320	9	.	.	PROPN
dti-1311	320	10	and	and	CCONJ
dti-1311	320	11	quiel	quiel	PROPN
dti-1311	320	12	,	,	PUNCT
dti-1311	320	13	e.l	e.l	PROPN
dti-1311	320	14	.	.	PROPN
dti-1311	320	15	1987	1987	NUM
dti-1311	320	16	.	.	PUNCT
dti-1311	321	1	neurolytic	neurolytic	ADJ
dti-1311	321	2	celiac	celiac	ADJ
dti-1311	321	3	plexus	plexus	NOUN
dti-1311	321	4	block	block	NOUN
dti-1311	321	5	for	for	ADP
dti-1311	321	6	pancreatic	pancreatic	ADJ
dti-1311	321	7	cancer	cancer	NOUN
dti-1311	321	8	pain	pain	NOUN
dti-1311	321	9	.	.	PUNCT
dti-1311	322	1	anesth	anesth	PROPN
dti-1311	322	2	.	.	PROPN
dti-1311	322	3	analg	analg	PROPN
dti-1311	322	4	.	.	PUNCT
dti-1311	323	1	,	,	PUNCT
dti-1311	323	2	66:869–873	66:869–873	PROPN
dti-1311	323	3	.	.	PUNCT
dti-1311	324	1	brucke	brucke	NOUN
dti-1311	324	2	,	,	PUNCT
dti-1311	324	3	t.	t.	PROPN
dti-1311	324	4	,	,	PUNCT
dti-1311	324	5	wober	wober	PROPN
dti-1311	324	6	,	,	PUNCT
dti-1311	324	7	c.	c.	PROPN
dti-1311	324	8	,	,	PUNCT
dti-1311	324	9	podreka	podreka	PROPN
dti-1311	324	10	,	,	PUNCT
dti-1311	324	11	i.	i.	NOUN
dti-1311	324	12	,	,	PUNCT
dti-1311	324	13	wober	wober	NOUN
dti-1311	324	14	-	-	PUNCT
dti-1311	324	15	bingol	bingol	NOUN
dti-1311	324	16	,	,	PUNCT
dti-1311	324	17	c.	c.	NOUN
dti-1311	324	18	,	,	PUNCT
dti-1311	324	19	asenbaum	asenbaum	PROPN
dti-1311	324	20	,	,	PUNCT
dti-1311	324	21	s.	s.	PROPN
dti-1311	324	22	,	,	PUNCT
dti-1311	324	23	aull	aull	NOUN
dti-1311	324	24	,	,	PUNCT
dti-1311	324	25	s.	s.	PROPN
dti-1311	324	26	,	,	PUNCT
dti-1311	324	27	wenger	wenger	PROPN
dti-1311	324	28	,	,	PUNCT
dti-1311	324	29	s.	s.	PROPN
dti-1311	324	30	,	,	PUNCT
dti-1311	324	31	ilieva	ilieva	PROPN
dti-1311	324	32	,	,	PUNCT
dti-1311	324	33	d.	d.	PROPN
dti-1311	324	34	,	,	PUNCT
dti-1311	324	35	harasko	harasko	ADV
dti-1311	324	36	-	-	PUNCT
dti-1311	324	37	van	van	PROPN
dti-1311	324	38	der	der	PROPN
dti-1311	324	39	meer	meer	PROPN
dti-1311	324	40	,	,	PUNCT
dti-1311	324	41	c.	c.	PROPN
dti-1311	324	42	and	and	CCONJ
dti-1311	324	43	wessely	wessely	ADV
dti-1311	324	44	p.	p.	NOUN
dti-1311	324	45	et	et	NOUN
dti-1311	325	1	al	al	PROPN
dti-1311	325	2	.	.	PROPN
dti-1311	325	3	1995	1995	NUM
dti-1311	325	4	.	.	PUNCT
dti-1311	326	1	d2	d2	NOUN
dti-1311	326	2	receptor	receptor	NOUN
dti-1311	326	3	blockade	blockade	NOUN
dti-1311	326	4	by	by	ADP
dti-1311	326	5	fl	fl	ADP
dti-1311	326	6	unarizine	unarizine	ADJ
dti-1311	326	7	and	and	CCONJ
dti-1311	326	8	cinnarizine	cinnarizine	NOUN
dti-1311	326	9	explains	explain	VERB
dti-1311	326	10	extrapyramidal	extrapyramidal	ADJ
dti-1311	326	11	side	side	NOUN
dti-1311	326	12	effects	effect	NOUN
dti-1311	326	13	.	.	PUNCT
dti-1311	327	1	a	a	DET
dti-1311	327	2	spect	spect	ADJ
dti-1311	327	3	study	study	NOUN
dti-1311	327	4	.	.	PUNCT
dti-1311	328	1	j.	j.	PROPN
dti-1311	328	2	cereb	cereb	PROPN
dti-1311	328	3	.	.	PUNCT
dti-1311	329	1	blood	blood	NOUN
dti-1311	329	2	.	.	PUNCT
dti-1311	330	1	flow	flow	NOUN
dti-1311	330	2	.	.	PUNCT
dti-1311	331	1	metab	metab	PROPN
dti-1311	331	2	.	.	PUNCT
dti-1311	331	3	,	,	PUNCT
dti-1311	331	4	15:513–518	15:513–518	PROPN
dti-1311	331	5	.	.	PUNCT
dti-1311	332	1	brunswick	brunswick	PROPN
dti-1311	332	2	,	,	PUNCT
dti-1311	332	3	d.j	d.j	PROPN
dti-1311	332	4	.	.	PROPN
dti-1311	332	5	,	,	PUNCT
dti-1311	332	6	amsterdam	amsterdam	PROPN
dti-1311	332	7	,	,	PUNCT
dti-1311	332	8	j.d	j.d	PROPN
dti-1311	332	9	.	.	PROPN
dti-1311	332	10	,	,	PUNCT
dti-1311	332	11	mozley	mozley	PROPN
dti-1311	332	12	,	,	PUNCT
dti-1311	332	13	p.d	p.d	PROPN
dti-1311	332	14	.	.	PROPN
dti-1311	332	15	and	and	CCONJ
dti-1311	332	16	newberg	newberg	PROPN
dti-1311	332	17	,	,	PUNCT
dti-1311	332	18	a.	a.	NOUN
dti-1311	332	19	2003	2003	NUM
dti-1311	332	20	.	.	PUNCT
dti-1311	333	1	greater	great	ADJ
dti-1311	333	2	availability	availability	NOUN
dti-1311	333	3	of	of	ADP
dti-1311	333	4	brain	brain	NOUN
dti-1311	333	5	dopamine	dopamine	NOUN
dti-1311	333	6	transporters	transporter	NOUN
dti-1311	333	7	in	in	ADP
dti-1311	333	8	major	major	ADJ
dti-1311	333	9	depression	depression	NOUN
dti-1311	333	10	shown	show	VERB
dti-1311	333	11	by	by	ADP
dti-1311	333	12	[	[	X
dti-1311	333	13	99mtc]trodat-1	99mtc]trodat-1	NUM
dti-1311	333	14	spect	spect	ADJ
dti-1311	333	15	imaging	imaging	NOUN
dti-1311	333	16	.	.	PUNCT
dti-1311	334	1	am	be	AUX
dti-1311	334	2	.	.	PUNCT
dti-1311	335	1	j.	j.	PROPN
dti-1311	335	2	psychiatry	psychiatry	PROPN
dti-1311	335	3	.	.	PUNCT
dti-1311	335	4	,	,	PUNCT
dti-1311	335	5	160:1836–1841	160:1836–1841	PROPN
dti-1311	335	6	.	.	PUNCT
dti-1311	336	1	burkey	burkey	PROPN
dti-1311	336	2	,	,	PUNCT
dti-1311	336	3	a.r	a.r	PROPN
dti-1311	336	4	.	.	PROPN
dti-1311	336	5	,	,	PUNCT
dti-1311	336	6	carstens	carstens	PROPN
dti-1311	336	7	,	,	PUNCT
dti-1311	336	8	e.	e.	PROPN
dti-1311	336	9	and	and	CCONJ
dti-1311	336	10	jasmin	jasmin	PROPN
dti-1311	336	11	,	,	PUNCT
dti-1311	336	12	l.	l.	PROPN
dti-1311	336	13	1999	1999	NUM
dti-1311	336	14	.	.	PUNCT
dti-1311	337	1	dopamine	dopamine	NOUN
dti-1311	337	2	reuptake	reuptake	NOUN
dti-1311	337	3	inhibition	inhibition	NOUN
dti-1311	337	4	in	in	ADP
dti-1311	337	5	the	the	DET
dti-1311	337	6	rostral	rostral	ADJ
dti-1311	337	7	agranular	agranular	ADJ
dti-1311	337	8	insular	insular	ADJ
dti-1311	337	9	cortex	cortex	NOUN
dti-1311	337	10	produces	produce	VERB
dti-1311	337	11	antinociception	antinociception	NOUN
dti-1311	337	12	.	.	PUNCT
dti-1311	338	1	j.	j.	PROPN
dti-1311	338	2	neurosci	neurosci	PROPN
dti-1311	338	3	.	.	PROPN
dti-1311	338	4	,	,	PUNCT
dti-1311	338	5	19:4169–4179	19:4169–4179	NUM
dti-1311	338	6	.	.	PUNCT
dti-1311	338	7	cervero	cervero	NOUN
dti-1311	338	8	,	,	PUNCT
dti-1311	338	9	f.	f.	PROPN
dti-1311	338	10	1988	1988	NUM
dti-1311	338	11	.	.	PUNCT
dti-1311	339	1	neurophysiology	neurophysiology	NOUN
dti-1311	339	2	of	of	ADP
dti-1311	339	3	gastrointestinal	gastrointestinal	ADJ
dti-1311	339	4	pain	pain	NOUN
dti-1311	339	5	.	.	PUNCT
dti-1311	340	1	baillieres	bailliere	NOUN
dti-1311	340	2	.	.	PUNCT
dti-1311	341	1	clin	clin	PROPN
dti-1311	341	2	.	.	PUNCT
dti-1311	341	3	gastroenterol	gastroenterol	PROPN
dti-1311	341	4	.	.	PUNCT
dti-1311	341	5	,	,	PUNCT
dti-1311	342	1	2:183–99	2:183–99	PROPN
dti-1311	342	2	.	.	PUNCT
dti-1311	342	3	cervero	cervero	PROPN
dti-1311	342	4	,	,	PUNCT
dti-1311	342	5	f.	f.	PROPN
dti-1311	342	6	and	and	CCONJ
dti-1311	342	7	laird	laird	PROPN
dti-1311	342	8	,	,	PUNCT
dti-1311	342	9	j.m	j.m	PROPN
dti-1311	342	10	.	.	PROPN
dti-1311	342	11	2003	2003	NUM
dti-1311	342	12	.	.	PUNCT
dti-1311	343	1	role	role	NOUN
dti-1311	343	2	of	of	ADP
dti-1311	343	3	ion	ion	NOUN
dti-1311	343	4	channels	channel	NOUN
dti-1311	343	5	in	in	ADP
dti-1311	343	6	mechanisms	mechanism	NOUN
dti-1311	343	7	controlling	control	VERB
dti-1311	343	8	gastrointestinal	gastrointestinal	ADJ
dti-1311	343	9	pain	pain	NOUN
dti-1311	343	10	pathways	pathway	NOUN
dti-1311	343	11	.	.	PUNCT
dti-1311	344	1	curr	curr	PROPN
dti-1311	344	2	.	.	PUNCT
dti-1311	345	1	opin	opin	NOUN
dti-1311	345	2	.	.	PUNCT
dti-1311	346	1	pharmacol	pharmacol	PROPN
dti-1311	346	2	.	.	PROPN
dti-1311	346	3	,	,	PUNCT
dti-1311	346	4	3:608–612	3:608–612	NUM
dti-1311	346	5	.	.	PUNCT
dti-1311	347	1	curros	curro	NOUN
dti-1311	347	2	-	-	PUNCT
dti-1311	347	3	criado	criado	NOUN
dti-1311	347	4	,	,	PUNCT
dti-1311	347	5	m.m	m.m	PROPN
dti-1311	347	6	.	.	PROPN
dti-1311	347	7	and	and	CCONJ
dti-1311	347	8	herrero	herrero	PROPN
dti-1311	347	9	,	,	PUNCT
dti-1311	347	10	j.f	j.f	PROPN
dti-1311	347	11	.	.	PROPN
dti-1311	347	12	2005	2005	NUM
dti-1311	347	13	.	.	PUNCT
dti-1311	348	1	the	the	DET
dti-1311	348	2	antinociceptive	antinociceptive	ADJ
dti-1311	348	3	effects	effect	NOUN
dti-1311	348	4	of	of	ADP
dti-1311	348	5	the	the	DET
dti-1311	348	6	systemic	systemic	ADJ
dti-1311	348	7	adenosine	adenosine	NOUN
dti-1311	348	8	a1	a1	NOUN
dti-1311	348	9	receptor	receptor	NOUN
dti-1311	348	10	agonist	agonist	NOUN
dti-1311	348	11	cpa	cpa	NOUN
dti-1311	348	12	in	in	ADP
dti-1311	348	13	the	the	DET
dti-1311	348	14	absence	absence	NOUN
dti-1311	348	15	and	and	CCONJ
dti-1311	348	16	in	in	ADP
dti-1311	348	17	the	the	DET
dti-1311	348	18	presence	presence	NOUN
dti-1311	348	19	of	of	ADP
dti-1311	348	20	spinal	spinal	ADJ
dti-1311	348	21	cord	cord	NOUN
dti-1311	348	22	sensitization	sensitization	NOUN
dti-1311	348	23	.	.	PUNCT
dti-1311	349	1	pharmacol	pharmacol	PROPN
dti-1311	349	2	.	.	PUNCT
dti-1311	350	1	biochem	biochem	PROPN
dti-1311	350	2	.	.	PUNCT
dti-1311	351	1	behav	behav	PROPN
dti-1311	351	2	.	.	PUNCT
dti-1311	351	3	,	,	PUNCT
dti-1311	352	1	82:721–726	82:721–726	NUM
dti-1311	352	2	.	.	PUNCT
dti-1311	353	1	czarnecka	czarnecka	PROPN
dti-1311	353	2	,	,	PUNCT
dti-1311	353	3	e.	e.	PROPN
dti-1311	353	4	and	and	CCONJ
dti-1311	353	5	kubik	kubik	PROPN
dti-1311	353	6	-	-	PUNCT
dti-1311	353	7	bogucka	bogucka	PROPN
dti-1311	353	8	,	,	PUNCT
dti-1311	353	9	e.	e.	PROPN
dti-1311	353	10	1993	1993	NUM
dti-1311	353	11	.	.	PUNCT
dti-1311	354	1	effects	effect	NOUN
dti-1311	354	2	of	of	ADP
dti-1311	354	3	calcium	calcium	NOUN
dti-1311	354	4	antagonists	antagonist	NOUN
dti-1311	354	5	on	on	ADP
dti-1311	354	6	central	central	ADJ
dti-1311	354	7	actions	action	NOUN
dti-1311	354	8	of	of	ADP
dti-1311	354	9	ethanol	ethanol	NOUN
dti-1311	354	10	:	:	PUNCT
dti-1311	354	11	comparative	comparative	ADJ
dti-1311	354	12	studies	study	NOUN
dti-1311	354	13	with	with	ADP
dti-1311	354	14	nifedipine	nifedipine	NOUN
dti-1311	354	15	,	,	PUNCT
dti-1311	354	16	verapamil	verapamil	NOUN
dti-1311	354	17	and	and	CCONJ
dti-1311	354	18	cinnarizine	cinnarizine	NOUN
dti-1311	354	19	.	.	PUNCT
dti-1311	355	1	alcohol	alcohol	PROPN
dti-1311	355	2	.	.	PUNCT
dti-1311	356	1	alcohol	alcohol	PROPN
dti-1311	356	2	.	.	PROPN
dti-1311	356	3	,	,	PUNCT
dti-1311	356	4	28:649–655	28:649–655	PROPN
dti-1311	356	5	.	.	PUNCT
dti-1311	357	1	dall’igna	dall’igna	PROPN
dti-1311	357	2	,	,	PUNCT
dti-1311	357	3	o.p	o.p	PROPN
dti-1311	357	4	.	.	PROPN
dti-1311	357	5	2005	2005	NUM
dti-1311	357	6	.	.	PUNCT
dti-1311	358	1	cinnarizine	cinnarizine	PROPN
dti-1311	358	2	has	have	VERB
dti-1311	358	3	an	an	DET
dti-1311	358	4	atypical	atypical	ADJ
dti-1311	358	5	antipsychotic	antipsychotic	ADJ
dti-1311	358	6	profi	profi	NOUN
dti-1311	358	7	le	le	X
dti-1311	358	8	in	in	ADP
dti-1311	358	9	animal	animal	NOUN
dti-1311	358	10	models	model	NOUN
dti-1311	358	11	of	of	ADP
dti-1311	358	12	psychosis	psychosis	NOUN
dti-1311	358	13	.	.	PUNCT
dti-1311	359	1	j.	j.	PROPN
dti-1311	359	2	psychopharmacol	psychopharmacol	PROPN
dti-1311	359	3	.	.	PROPN
dti-1311	359	4	,	,	PUNCT
dti-1311	360	1	19:342–346	19:342–346	NUM
dti-1311	360	2	.	.	PUNCT
dti-1311	361	1	del	del	PROPN
dti-1311	361	2	pozo	pozo	PROPN
dti-1311	361	3	,	,	PUNCT
dti-1311	361	4	e.	e.	PROPN
dti-1311	361	5	,	,	PUNCT
dti-1311	361	6	caro	caro	PROPN
dti-1311	361	7	,	,	PUNCT
dti-1311	361	8	g.	g.	PROPN
dti-1311	361	9	and	and	CCONJ
dti-1311	361	10	baeyens	baeyen	NOUN
dti-1311	361	11	,	,	PUNCT
dti-1311	361	12	j.m	j.m	PROPN
dti-1311	361	13	.	.	PROPN
dti-1311	361	14	1987	1987	NUM
dti-1311	361	15	.	.	PUNCT
dti-1311	362	1	analgesic	analgesic	ADJ
dti-1311	362	2	effects	effect	NOUN
dti-1311	362	3	of	of	ADP
dti-1311	362	4	several	several	ADJ
dti-1311	362	5	calcium	calcium	NOUN
dti-1311	362	6	channel	channel	NOUN
dti-1311	362	7	blockers	blocker	NOUN
dti-1311	362	8	in	in	ADP
dti-1311	362	9	mice	mouse	NOUN
dti-1311	362	10	.	.	PUNCT
dti-1311	363	1	eur	eur	PROPN
dti-1311	363	2	.	.	PUNCT
dti-1311	364	1	j.	j.	PROPN
dti-1311	364	2	pharmacol	pharmacol	PROPN
dti-1311	364	3	.	.	PROPN
dti-1311	364	4	,	,	PUNCT
dti-1311	364	5	137:155–160	137:155–160	NUM
dti-1311	364	6	.	.	PUNCT
dti-1311	365	1	dirig	dirig	PROPN
dti-1311	365	2	,	,	PUNCT
dti-1311	365	3	d.m	d.m	PROPN
dti-1311	365	4	.	.	PROPN
dti-1311	365	5	and	and	CCONJ
dti-1311	365	6	yaksh	yaksh	PROPN
dti-1311	365	7	,	,	PUNCT
dti-1311	365	8	t.l	t.l	PROPN
dti-1311	365	9	.	.	PROPN
dti-1311	365	10	1995	1995	NUM
dti-1311	365	11	.	.	PUNCT
dti-1311	366	1	intrathecal	intrathecal	ADJ
dti-1311	366	2	baclofen	baclofen	PROPN
dti-1311	366	3	and	and	CCONJ
dti-1311	366	4	muscimol	muscimol	PROPN
dti-1311	366	5	,	,	PUNCT
dti-1311	366	6	but	but	CCONJ
dti-1311	366	7	not	not	PART
dti-1311	366	8	midazolam	midazolam	PROPN
dti-1311	366	9	,	,	PUNCT
dti-1311	366	10	are	be	AUX
dti-1311	366	11	antinociceptive	antinociceptive	ADJ
dti-1311	366	12	using	use	VERB
dti-1311	366	13	the	the	DET
dti-1311	366	14	rat	rat	ADJ
dti-1311	366	15	-	-	PUNCT
dti-1311	366	16	formalin	formalin	NOUN
dti-1311	366	17	model	model	NOUN
dti-1311	366	18	.	.	PUNCT
dti-1311	367	1	j.	j.	PROPN
dti-1311	367	2	pharmacol	pharmacol	PROPN
dti-1311	367	3	.	.	PUNCT
dti-1311	368	1	exp	exp	PROPN
dti-1311	368	2	.	.	PUNCT
dti-1311	369	1	ther	ther	PROPN
dti-1311	369	2	.	.	PUNCT
dti-1311	369	3	,	,	PUNCT
dti-1311	370	1	275:219–227	275:219–227	NUM
dti-1311	370	2	.	.	PUNCT
dti-1311	371	1	duarte	duarte	PROPN
dti-1311	371	2	,	,	PUNCT
dti-1311	371	3	i.d	i.d	PROPN
dti-1311	371	4	.	.	PROPN
dti-1311	371	5	,	,	PUNCT
dti-1311	371	6	nakamura	nakamura	PROPN
dti-1311	371	7	,	,	PUNCT
dti-1311	371	8	m.	m.	NOUN
dti-1311	371	9	and	and	CCONJ
dti-1311	371	10	ferreira	ferreira	PROPN
dti-1311	371	11	,	,	PUNCT
dti-1311	371	12	s.h	s.h	PROPN
dti-1311	371	13	.	.	PROPN
dti-1311	371	14	1988	1988	NUM
dti-1311	371	15	.	.	PUNCT
dti-1311	372	1	participation	participation	NOUN
dti-1311	372	2	of	of	ADP
dti-1311	372	3	the	the	DET
dti-1311	372	4	sympathetic	sympathetic	ADJ
dti-1311	372	5	system	system	NOUN
dti-1311	372	6	in	in	ADP
dti-1311	372	7	acetic	acetic	ADJ
dti-1311	372	8	acid	acid	NOUN
dti-1311	372	9	-	-	PUNCT
dti-1311	372	10	induced	induce	VERB
dti-1311	372	11	writhing	writhing	NOUN
dti-1311	372	12	in	in	ADP
dti-1311	372	13	mice	mouse	NOUN
dti-1311	372	14	.	.	PUNCT
dti-1311	373	1	braz	braz	PROPN
dti-1311	373	2	.	.	PUNCT
dti-1311	374	1	j.	j.	PROPN
dti-1311	374	2	med	med	PROPN
dti-1311	374	3	.	.	PUNCT
dti-1311	375	1	biol	biol	PROPN
dti-1311	375	2	.	.	PUNCT
dti-1311	376	1	res	re	NOUN
dti-1311	376	2	.	.	PROPN
dti-1311	376	3	,	,	PUNCT
dti-1311	376	4	21:341–343	21:341–343	PROPN
dti-1311	376	5	.	.	PUNCT
dti-1311	377	1	eisenberg	eisenberg	PROPN
dti-1311	377	2	,	,	PUNCT
dti-1311	377	3	e.	e.	PROPN
dti-1311	377	4	,	,	PUNCT
dti-1311	377	5	carr	carr	PROPN
dti-1311	377	6	,	,	PUNCT
dti-1311	377	7	d.b	d.b	PROPN
dti-1311	377	8	.	.	PROPN
dti-1311	377	9	and	and	CCONJ
dti-1311	377	10	chalmers	chalmer	NOUN
dti-1311	377	11	,	,	PUNCT
dti-1311	377	12	t.c	t.c	PROPN
dti-1311	377	13	.	.	PROPN
dti-1311	377	14	1995	1995	NUM
dti-1311	377	15	.	.	PUNCT
dti-1311	378	1	neurolytic	neurolytic	ADJ
dti-1311	378	2	celiac	celiac	ADJ
dti-1311	378	3	plexus	plexus	NOUN
dti-1311	378	4	block	block	NOUN
dti-1311	378	5	for	for	ADP
dti-1311	378	6	treatment	treatment	NOUN
dti-1311	378	7	of	of	ADP
dti-1311	378	8	cancer	cancer	NOUN
dti-1311	378	9	pain	pain	NOUN
dti-1311	378	10	:	:	PUNCT
dti-1311	378	11	a	a	DET
dti-1311	378	12	meta	meta	ADJ
dti-1311	378	13	-	-	PUNCT
dti-1311	378	14	analysis	analysis	NOUN
dti-1311	378	15	.	.	PUNCT
dti-1311	379	1	anesth	anesth	PROPN
dti-1311	379	2	.	.	PROPN
dti-1311	379	3	analg	analg	PROPN
dti-1311	379	4	.	.	PUNCT
dti-1311	379	5	,	,	PUNCT
dti-1311	380	1	80:290–295	80:290–295	PROPN
dti-1311	380	2	.	.	PUNCT
dti-1311	380	3	fabiani	fabiani	PROPN
dti-1311	380	4	,	,	PUNCT
dti-1311	380	5	g.	g.	PROPN
dti-1311	380	6	,	,	PUNCT
dti-1311	380	7	pastro	pastro	NOUN
dti-1311	380	8	,	,	PUNCT
dti-1311	380	9	p.c	p.c	PROPN
dti-1311	380	10	.	.	PROPN
dti-1311	380	11	and	and	CCONJ
dti-1311	380	12	froehner	froehner	NOUN
dti-1311	380	13	,	,	PUNCT
dti-1311	380	14	c.	c.	PROPN
dti-1311	380	15	2004	2004	NUM
dti-1311	380	16	.	.	PUNCT
dti-1311	381	1	parkinsonism	parkinsonism	NOUN
dti-1311	381	2	and	and	CCONJ
dti-1311	381	3	other	other	ADJ
dti-1311	381	4	movement	movement	NOUN
dti-1311	381	5	disorders	disorder	NOUN
dti-1311	381	6	in	in	ADP
dti-1311	381	7	outpatients	outpatient	NOUN
dti-1311	381	8	in	in	ADP
dti-1311	381	9	chronic	chronic	ADJ
dti-1311	381	10	use	use	NOUN
dti-1311	381	11	of	of	ADP
dti-1311	381	12	cinnarizine	cinnarizine	NOUN
dti-1311	381	13	and	and	CCONJ
dti-1311	381	14	fl	fl	PROPN
dti-1311	381	15	unarizine	unarizine	VERB
dti-1311	381	16	.	.	PUNCT
dti-1311	382	1	arq	arq	PROPN
dti-1311	382	2	.	.	PUNCT
dti-1311	383	1	neuropsiquiatr	neuropsiquiatr	PROPN
dti-1311	383	2	.	.	PROPN
dti-1311	383	3	,	,	PUNCT
dti-1311	383	4	62:784–788	62:784–788	PROPN
dti-1311	383	5	.	.	PUNCT
dti-1311	384	1	frussa	frussa	ADJ
dti-1311	384	2	-	-	PUNCT
dti-1311	384	3	filho	filho	PROPN
dti-1311	384	4	,	,	PUNCT
dti-1311	384	5	r.	r.	PROPN
dti-1311	384	6	,	,	PUNCT
dti-1311	384	7	rocha	rocha	PROPN
dti-1311	384	8	,	,	PUNCT
dti-1311	384	9	j.b	j.b	PROPN
dti-1311	384	10	.	.	PROPN
dti-1311	384	11	and	and	CCONJ
dti-1311	384	12	conceicao	conceicao	PROPN
dti-1311	384	13	,	,	PUNCT
dti-1311	384	14	i.m	i.m	PROPN
dti-1311	384	15	.	.	PROPN
dti-1311	384	16	1996	1996	NUM
dti-1311	384	17	.	.	PUNCT
dti-1311	385	1	effects	effect	NOUN
dti-1311	385	2	of	of	ADP
dti-1311	385	3	dopaminergic	dopaminergic	ADJ
dti-1311	385	4	agents	agent	NOUN
dti-1311	385	5	on	on	ADP
dti-1311	385	6	visceral	visceral	ADJ
dti-1311	385	7	pain	pain	NOUN
dti-1311	385	8	measured	measure	VERB
dti-1311	385	9	by	by	ADP
dti-1311	385	10	the	the	DET
dti-1311	385	11	mouse	mouse	NOUN
dti-1311	385	12	writhing	writhe	VERB
dti-1311	385	13	test	test	NOUN
dti-1311	385	14	.	.	PUNCT
dti-1311	386	1	arch	arch	NOUN
dti-1311	386	2	.	.	PUNCT
dti-1311	387	1	int	int	NOUN
dti-1311	387	2	.	.	PUNCT
dti-1311	388	1	pharmacodyn	pharmacodyn	ADV
dti-1311	388	2	.	.	PUNCT
dti-1311	389	1	ther	ther	ADV
dti-1311	389	2	.	.	PUNCT
dti-1311	389	3	,	,	PUNCT
dti-1311	390	1	331:74–93	331:74–93	NUM
dti-1311	390	2	.	.	PUNCT
dti-1311	391	1	ghelardini	ghelardini	PROPN
dti-1311	391	2	,	,	PUNCT
dti-1311	391	3	c.	c.	PROPN
dti-1311	391	4	,	,	PUNCT
dti-1311	391	5	malmberg	malmberg	PROPN
dti-1311	391	6	-	-	PUNCT
dti-1311	391	7	aiello	aiello	PROPN
dti-1311	391	8	,	,	PUNCT
dti-1311	391	9	p.	p.	PROPN
dti-1311	391	10	,	,	PUNCT
dti-1311	391	11	giotti	giotti	PROPN
dti-1311	391	12	,	,	PUNCT
dti-1311	391	13	a.	a.	NOUN
dti-1311	391	14	,	,	PUNCT
dti-1311	391	15	malcangio	malcangio	NOUN
dti-1311	391	16	,	,	PUNCT
dti-1311	391	17	m.	m.	NOUN
dti-1311	391	18	and	and	CCONJ
dti-1311	391	19	bartolini	bartolini	NOUN
dti-1311	391	20	a.	a.	NOUN
dti-1311	391	21	1990	1990	NUM
dti-1311	391	22	.	.	PUNCT
dti-1311	392	1	investigation	investigation	NOUN
dti-1311	392	2	into	into	ADP
dti-1311	392	3	atropine	atropine	NOUN
dti-1311	392	4	-	-	PUNCT
dti-1311	392	5	induced	induce	VERB
dti-1311	392	6	antinociception	antinociception	NOUN
dti-1311	392	7	.	.	PUNCT
dti-1311	393	1	br	br	PROPN
dti-1311	393	2	.	.	PUNCT
dti-1311	394	1	j.	j.	PROPN
dti-1311	394	2	pharmacol	pharmacol	PROPN
dti-1311	394	3	.	.	PROPN
dti-1311	394	4	,	,	PUNCT
dti-1311	394	5	101:49–54	101:49–54	NUM
dti-1311	394	6	.	.	PUNCT
dti-1311	394	7	han	han	PROPN
dti-1311	394	8	,	,	PUNCT
dti-1311	394	9	b.f	b.f	PROPN
dti-1311	394	10	.	.	PROPN
dti-1311	394	11	,	,	PUNCT
dti-1311	394	12	zhang	zhang	PROPN
dti-1311	394	13	,	,	PUNCT
dti-1311	394	14	c.	c.	PROPN
dti-1311	394	15	,	,	PUNCT
dti-1311	394	16	reyes	reyes	PROPN
dti-1311	394	17	-	-	PUNCT
dti-1311	394	18	vazquez	vazquez	PROPN
dti-1311	394	19	,	,	PUNCT
dti-1311	394	20	c.	c.	PROPN
dti-1311	394	21	,	,	PUNCT
dti-1311	394	22	qiao	qiao	PROPN
dti-1311	394	23	,	,	PUNCT
dti-1311	394	24	j.t	j.t	PROPN
dti-1311	394	25	.	.	PROPN
dti-1311	394	26	and	and	CCONJ
dti-1311	394	27	dafny	dafny	PROPN
dti-1311	394	28	,	,	PUNCT
dti-1311	394	29	n.	n.	PROPN
dti-1311	394	30	2004	2004	NUM
dti-1311	394	31	.	.	PUNCT
dti-1311	395	1	atp	atp	NOUN
dti-1311	395	2	-	-	PUNCT
dti-1311	395	3	sensitive	sensitive	ADJ
dti-1311	395	4	potassium	potassium	NOUN
dti-1311	395	5	channels	channel	NOUN
dti-1311	395	6	and	and	CCONJ
dti-1311	395	7	endogenous	endogenous	ADJ
dti-1311	395	8	adenosine	adenosine	NOUN
dti-1311	395	9	are	be	AUX
dti-1311	395	10	involved	involve	VERB
dti-1311	395	11	in	in	ADP
dti-1311	395	12	spinal	spinal	ADJ
dti-1311	395	13	antinociception	antinociception	NOUN
dti-1311	395	14	produced	produce	VERB
dti-1311	395	15	by	by	ADP
dti-1311	395	16	locus	locus	ADJ
dti-1311	395	17	coeruleus	coeruleus	NOUN
dti-1311	395	18	stimulation	stimulation	NOUN
dti-1311	395	19	.	.	PUNCT
dti-1311	396	1	int	int	NOUN
dti-1311	396	2	.	.	PUNCT
dti-1311	397	1	j.	j.	PROPN
dti-1311	397	2	neurosci	neurosci	PROPN
dti-1311	397	3	.	.	PROPN
dti-1311	397	4	,	,	PUNCT
dti-1311	397	5	114:961–974	114:961–974	NUM
dti-1311	397	6	hara	hara	NOUN
dti-1311	397	7	,	,	PUNCT
dti-1311	397	8	k.	k.	PROPN
dti-1311	397	9	,	,	PUNCT
dti-1311	397	10	saito	saito	PROPN
dti-1311	397	11	,	,	PUNCT
dti-1311	397	12	y.	y.	PROPN
dti-1311	397	13	,	,	PUNCT
dti-1311	397	14	kirihara	kirihara	PROPN
dti-1311	397	15	,	,	PUNCT
dti-1311	397	16	y.	y.	PROPN
dti-1311	397	17	and	and	CCONJ
dti-1311	397	18	sakura	sakura	PROPN
dti-1311	397	19	,	,	PUNCT
dti-1311	397	20	s.	s.	PROPN
dti-1311	397	21	2004	2004	NUM
dti-1311	397	22	.	.	PUNCT
dti-1311	398	1	the	the	DET
dti-1311	398	2	interaction	interaction	NOUN
dti-1311	398	3	between	between	ADP
dti-1311	398	4	gamma	gamma	NOUN
dti-1311	398	5	-	-	PUNCT
dti-1311	398	6	aminobutyric	aminobutyric	ADJ
dti-1311	398	7	acid	acid	NOUN
dti-1311	398	8	agonists	agonist	NOUN
dti-1311	398	9	and	and	CCONJ
dti-1311	398	10	diltiazem	diltiazem	NOUN
dti-1311	398	11	in	in	ADP
dti-1311	398	12	visceral	visceral	ADJ
dti-1311	398	13	antinociception	antinociception	NOUN
dti-1311	398	14	in	in	ADP
dti-1311	398	15	rats	rat	NOUN
dti-1311	398	16	.	.	PUNCT
dti-1311	399	1	anesth	anesth	PROPN
dti-1311	399	2	.	.	PROPN
dti-1311	399	3	analg	analg	PROPN
dti-1311	399	4	,	,	PUNCT
dti-1311	399	5	98:1380–1384	98:1380–1384	PROPN
dti-1311	399	6	.	.	PUNCT
dti-1311	399	7	hirose	hirose	PROPN
dti-1311	399	8	,	,	PUNCT
dti-1311	399	9	g.	g.	PROPN
dti-1311	399	10	2006	2006	NUM
dti-1311	399	11	.	.	PUNCT
dti-1311	400	1	drug	drug	NOUN
dti-1311	400	2	induced	induce	VERB
dti-1311	400	3	parkinsonism	parkinsonism	NOUN
dti-1311	400	4	:	:	PUNCT
dti-1311	400	5	a	a	DET
dti-1311	400	6	review	review	NOUN
dti-1311	400	7	.	.	PUNCT
dti-1311	401	1	j.	j.	PROPN
dti-1311	401	2	neurol	neurol	PROPN
dti-1311	401	3	.	.	PUNCT
dti-1311	401	4	,	,	PUNCT
dti-1311	401	5	253	253	NUM
dti-1311	401	6	suppl	suppl	ADJ
dti-1311	401	7	3	3	NUM
dti-1311	401	8	:	:	PUNCT
dti-1311	401	9	iii22	iii22	PROPN
dti-1311	401	10	–	–	PUNCT
dti-1311	401	11	iii24	iii24	PROPN
dti-1311	401	12	.	.	PUNCT
dti-1311	402	1	iwamoto	iwamoto	PROPN
dti-1311	402	2	,	,	PUNCT
dti-1311	402	3	e.t	e.t	PROPN
dti-1311	402	4	.	.	PROPN
dti-1311	402	5	and	and	CCONJ
dti-1311	402	6	marion	marion	PROPN
dti-1311	402	7	,	,	PUNCT
dti-1311	402	8	l.	l.	PROPN
dti-1311	402	9	1993	1993	NUM
dti-1311	402	10	.	.	PUNCT
dti-1311	403	1	characterization	characterization	NOUN
dti-1311	403	2	of	of	ADP
dti-1311	403	3	the	the	DET
dti-1311	403	4	antinociception	antinociception	NOUN
dti-1311	403	5	produced	produce	VERB
dti-1311	403	6	by	by	ADP
dti-1311	403	7	intrathecally	intrathecally	ADV
dti-1311	403	8	administered	administer	VERB
dti-1311	403	9	muscarinic	muscarinic	ADJ
dti-1311	403	10	agonists	agonist	NOUN
dti-1311	403	11	in	in	ADP
dti-1311	403	12	rats	rat	NOUN
dti-1311	403	13	.	.	PUNCT
dti-1311	404	1	j.	j.	PROPN
dti-1311	404	2	pharmacol	pharmacol	PROPN
dti-1311	404	3	.	.	PUNCT
dti-1311	405	1	exp	exp	PROPN
dti-1311	405	2	.	.	PUNCT
dti-1311	406	1	ther	ther	PROPN
dti-1311	406	2	.	.	PUNCT
dti-1311	406	3	,	,	PUNCT
dti-1311	407	1	266:329–38	266:329–38	PROPN
dti-1311	407	2	.	.	PUNCT
dti-1311	407	3	drug	drug	NOUN
dti-1311	407	4	target	target	NOUN
dti-1311	407	5	insights	insight	NOUN
dti-1311	407	6	2007	2007	NUM
dti-1311	407	7	:	:	PUNCT
dti-1311	407	8	238	238	NUM
dti-1311	407	9	omar	omar	PROPN
dti-1311	407	10	m.e	m.e	PROPN
dti-1311	407	11	.	.	PROPN
dti-1311	407	12	abdel	abdel	PROPN
dti-1311	407	13	-	-	PUNCT
dti-1311	407	14	salam	salam	PROPN
dti-1311	407	15	izumo	izumo	PROPN
dti-1311	407	16	,	,	PUNCT
dti-1311	407	17	t.	t.	PROPN
dti-1311	407	18	,	,	PUNCT
dti-1311	407	19	suzuki	suzuki	PROPN
dti-1311	407	20	,	,	PUNCT
dti-1311	407	21	g.	g.	PROPN
dti-1311	407	22	,	,	PUNCT
dti-1311	407	23	chen	chen	PROPN
dti-1311	407	24	,	,	PUNCT
dti-1311	407	25	z.	z.	PROPN
dti-1311	407	26	,	,	PUNCT
dti-1311	407	27	fujii	fujii	PROPN
dti-1311	407	28	,	,	PUNCT
dti-1311	407	29	y.	y.	PROPN
dti-1311	407	30	and	and	CCONJ
dti-1311	407	31	kamei	kamei	PROPN
dti-1311	407	32	,	,	PUNCT
dti-1311	407	33	c.	c.	PROPN
dti-1311	407	34	1999	1999	NUM
dti-1311	407	35	.	.	PUNCT
dti-1311	408	1	effects	effect	NOUN
dti-1311	408	2	of	of	ADP
dti-1311	408	3	certain	certain	ADJ
dti-1311	408	4	cerebral	cerebral	ADJ
dti-1311	408	5	circulation	circulation	NOUN
dti-1311	408	6	activating	activate	VERB
dti-1311	408	7	drugs	drug	NOUN
dti-1311	408	8	on	on	ADP
dti-1311	408	9	regional	regional	ADJ
dti-1311	408	10	cerebral	cerebral	ADJ
dti-1311	408	11	blood	blood	NOUN
dti-1311	408	12	fl	fl	INTJ
dti-1311	408	13	ow	ow	INTJ
dti-1311	408	14	in	in	ADP
dti-1311	408	15	rats	rat	NOUN
dti-1311	408	16	.	.	PUNCT
dti-1311	409	1	methods	method	NOUN
dti-1311	409	2	find	find	VERB
dti-1311	409	3	.	.	PUNCT
dti-1311	410	1	exp	exp	PROPN
dti-1311	410	2	.	.	PUNCT
dti-1311	411	1	clin	clin	PROPN
dti-1311	411	2	.	.	PUNCT
dti-1311	412	1	pharmacol	pharmacol	PROPN
dti-1311	412	2	.	.	PROPN
dti-1311	412	3	,	,	PUNCT
dti-1311	412	4	21:279–83	21:279–83	PROPN
dti-1311	412	5	.	.	PUNCT
dti-1311	413	1	kalmari	kalmari	PROPN
dti-1311	413	2	,	,	PUNCT
dti-1311	413	3	j.	j.	PROPN
dti-1311	413	4	,	,	PUNCT
dti-1311	413	5	niissalo	niissalo	PROPN
dti-1311	413	6	,	,	PUNCT
dti-1311	413	7	s.	s.	PROPN
dti-1311	413	8	,	,	PUNCT
dti-1311	413	9	konttinen	konttinen	PROPN
dti-1311	413	10	,	,	PUNCT
dti-1311	413	11	y.t	y.t	PROPN
dti-1311	413	12	.	.	PROPN
dti-1311	413	13	and	and	CCONJ
dti-1311	413	14	pertovaara	pertovaara	PROPN
dti-1311	413	15	a.	a.	PROPN
dti-1311	413	16	2001	2001	NUM
dti-1311	413	17	.	.	PUNCT
dti-1311	414	1	modulation	modulation	NOUN
dti-1311	414	2	of	of	ADP
dti-1311	414	3	visceral	visceral	ADJ
dti-1311	414	4	nociceptive	nociceptive	ADJ
dti-1311	414	5	responses	response	NOUN
dti-1311	414	6	of	of	ADP
dti-1311	414	7	rat	rat	NOUN
dti-1311	414	8	spinal	spinal	ADJ
dti-1311	414	9	dorsal	dorsal	NOUN
dti-1311	414	10	horn	horn	NOUN
dti-1311	414	11	neurons	neuron	NOUN
dti-1311	414	12	by	by	ADP
dti-1311	414	13	sympathectomy	sympathectomy	NOUN
dti-1311	414	14	.	.	PUNCT
dti-1311	415	1	neuroreport	neuroreport	NOUN
dti-1311	415	2	.	.	PUNCT
dti-1311	415	3	,	,	PUNCT
dti-1311	415	4	12:797–801	12:797–801	NUM
dti-1311	415	5	.	.	PUNCT
dti-1311	416	1	korzeniewska	korzeniewska	PROPN
dti-1311	416	2	-	-	PUNCT
dti-1311	416	3	rybicka	rybicka	NOUN
dti-1311	416	4	,	,	PUNCT
dti-1311	416	5	i.	i.	PROPN
dti-1311	416	6	and	and	CCONJ
dti-1311	416	7	plaznik	plaznik	PROPN
dti-1311	416	8	a.	a.	PROPN
dti-1311	416	9	2001	2001	NUM
dti-1311	416	10	.	.	PUNCT
dti-1311	417	1	role	role	NOUN
dti-1311	417	2	of	of	ADP
dti-1311	417	3	serotonergic	serotonergic	ADJ
dti-1311	417	4	and	and	CCONJ
dti-1311	417	5	noradrenergic	noradrenergic	ADJ
dti-1311	417	6	systems	system	NOUN
dti-1311	417	7	in	in	ADP
dti-1311	417	8	a	a	DET
dti-1311	417	9	model	model	NOUN
dti-1311	417	10	of	of	ADP
dti-1311	417	11	visceral	visceral	ADJ
dti-1311	417	12	pain	pain	NOUN
dti-1311	417	13	.	.	PUNCT
dti-1311	418	1	pol	pol	PROPN
dti-1311	418	2	.	.	PUNCT
dti-1311	419	1	j.	j.	PROPN
dti-1311	419	2	pharmacol	pharmacol	PROPN
dti-1311	419	3	.	.	PROPN
dti-1311	419	4	,	,	PUNCT
dti-1311	419	5	53:475–480	53:475–480	NOUN
dti-1311	419	6	.	.	PUNCT
dti-1311	420	1	koster	koster	PROPN
dti-1311	420	2	,	,	PUNCT
dti-1311	420	3	r.	r.	PROPN
dti-1311	420	4	,	,	PUNCT
dti-1311	420	5	anderson	anderson	PROPN
dti-1311	420	6	,	,	PUNCT
dti-1311	420	7	m.	m.	NOUN
dti-1311	420	8	and	and	CCONJ
dti-1311	420	9	de	de	ADP
dti-1311	420	10	beer	beer	NOUN
dti-1311	420	11	,	,	PUNCT
dti-1311	420	12	e.j	e.j	PROPN
dti-1311	420	13	.	.	PROPN
dti-1311	420	14	1959	1959	NUM
dti-1311	420	15	.	.	PUNCT
dti-1311	421	1	acetic	acetic	ADJ
dti-1311	421	2	acid	acid	NOUN
dti-1311	421	3	for	for	ADP
dti-1311	421	4	analgesic	analgesic	ADJ
dti-1311	421	5	screening	screening	NOUN
dti-1311	421	6	.	.	PUNCT
dti-1311	422	1	fed	fed	PROPN
dti-1311	422	2	.	.	PUNCT
dti-1311	423	1	proc	proc	PROPN
dti-1311	423	2	.	.	PROPN
dti-1311	423	3	,	,	PUNCT
dti-1311	423	4	18:412	18:412	NUM
dti-1311	423	5	.	.	PUNCT
dti-1311	424	1	kowaluk	kowaluk	PROPN
dti-1311	424	2	,	,	PUNCT
dti-1311	424	3	e.a	e.a	PROPN
dti-1311	424	4	.	.	PROPN
dti-1311	424	5	1998	1998	NUM
dti-1311	424	6	.	.	PUNCT
dti-1311	425	1	adenosine	adenosine	ADJ
dti-1311	425	2	modulation	modulation	NOUN
dti-1311	425	3	:	:	PUNCT
dti-1311	425	4	a	a	DET
dti-1311	425	5	novel	novel	ADJ
dti-1311	425	6	approach	approach	NOUN
dti-1311	425	7	to	to	ADP
dti-1311	425	8	analgesia	analgesia	PROPN
dti-1311	425	9	and	and	CCONJ
dti-1311	425	10	infl	infl	PROPN
dti-1311	425	11	ammation	ammation	PROPN
dti-1311	425	12	.	.	PUNCT
dti-1311	426	1	expert	expert	NOUN
dti-1311	426	2	opin	opin	NOUN
dti-1311	426	3	.	.	PUNCT
dti-1311	427	1	investig	investig	PROPN
dti-1311	427	2	.	.	PUNCT
dti-1311	428	1	drugs	drug	NOUN
dti-1311	428	2	,	,	PUNCT
dti-1311	428	3	7:535–543	7:535–543	NUM
dti-1311	428	4	.	.	PUNCT
dti-1311	429	1	lozeva	lozeva	PROPN
dti-1311	429	2	,	,	PUNCT
dti-1311	429	3	v.	v.	ADV
dti-1311	429	4	,	,	PUNCT
dti-1311	429	5	marazova	marazova	PROPN
dti-1311	429	6	,	,	PUNCT
dti-1311	429	7	k.	k.	PROPN
dti-1311	429	8	and	and	CCONJ
dti-1311	429	9	belcheva	belcheva	PROPN
dti-1311	429	10	,	,	PUNCT
dti-1311	429	11	a.	a.	PROPN
dti-1311	429	12	1994	1994	NUM
dti-1311	429	13	.	.	PUNCT
dti-1311	430	1	gastric	gastric	ADJ
dti-1311	430	2	histamine	histamine	NOUN
dti-1311	430	3	content	content	NOUN
dti-1311	430	4	and	and	CCONJ
dti-1311	430	5	ulcer	ulcer	NOUN
dti-1311	430	6	formation	formation	NOUN
dti-1311	430	7	in	in	ADP
dti-1311	430	8	rats	rat	NOUN
dti-1311	430	9	with	with	ADP
dti-1311	430	10	ethanol	ethanol	NOUN
dti-1311	430	11	-	-	PUNCT
dti-1311	430	12	induced	induce	VERB
dti-1311	430	13	injury	injury	NOUN
dti-1311	430	14	.	.	PUNCT
dti-1311	431	1	effects	effect	NOUN
dti-1311	431	2	of	of	ADP
dti-1311	431	3	cinnarizine	cinnarizine	NOUN
dti-1311	431	4	and	and	CCONJ
dti-1311	431	5	fl	fl	PROPN
dti-1311	431	6	unarizine	unarizine	VERB
dti-1311	431	7	.	.	PUNCT
dti-1311	432	1	agents	agent	NOUN
dti-1311	432	2	actions	action	NOUN
dti-1311	432	3	,	,	PUNCT
dti-1311	432	4	41	41	NUM
dti-1311	432	5	spec	spec	NOUN
dti-1311	432	6	no	no	INTJ
dti-1311	432	7	:	:	PUNCT
dti-1311	432	8	c91–92	c91–92	PROPN
dti-1311	432	9	.	.	PUNCT
dti-1311	433	1	mansooreh	mansooreh	NOUN
dti-1311	433	2	,	,	PUNCT
dti-1311	433	3	t.	t.	PROPN
dti-1311	433	4	,	,	PUNCT
dti-1311	433	5	hossein	hossein	PROPN
dti-1311	433	6	,	,	PUNCT
dti-1311	433	7	a.	a.	NOUN
dti-1311	433	8	and	and	CCONJ
dti-1311	433	9	parvin	parvin	PROPN
dti-1311	433	10	,	,	PUNCT
dti-1311	433	11	t.	t.	PROPN
dti-1311	433	12	2006	2006	NUM
dti-1311	433	13	.	.	PUNCT
dti-1311	434	1	open	open	ADJ
dti-1311	434	2	-	-	PUNCT
dti-1311	434	3	label	label	NOUN
dti-1311	434	4	trial	trial	NOUN
dti-1311	434	5	of	of	ADP
dti-1311	434	6	cinnarizine	cinnarizine	NOUN
dti-1311	434	7	in	in	ADP
dti-1311	434	8	migraine	migraine	PROPN
dti-1311	434	9	prophylaxis	prophylaxis	PROPN
dti-1311	434	10	.	.	PUNCT
dti-1311	435	1	headache	headache	PROPN
dti-1311	435	2	,	,	PUNCT
dti-1311	435	3	46:498–502	46:498–502	PROPN
dti-1311	435	4	.	.	PUNCT
dti-1311	435	5	marazova	marazova	PROPN
dti-1311	435	6	,	,	PUNCT
dti-1311	435	7	k.	k.	PROPN
dti-1311	435	8	,	,	PUNCT
dti-1311	435	9	lozeva	lozeva	PROPN
dti-1311	435	10	,	,	PUNCT
dti-1311	435	11	v.	v.	PROPN
dti-1311	435	12	and	and	CCONJ
dti-1311	435	13	belcheva	belcheva	PROPN
dti-1311	435	14	,	,	PUNCT
dti-1311	435	15	a.	a.	NOUN
dti-1311	435	16	1993	1993	NUM
dti-1311	435	17	.	.	PUNCT
dti-1311	436	1	gastric	gastric	ADJ
dti-1311	436	2	histamine	histamine	NOUN
dti-1311	436	3	content	content	NOUN
dti-1311	436	4	and	and	CCONJ
dti-1311	436	5	gastric	gastric	ADJ
dti-1311	436	6	ulcer	ulcer	NOUN
dti-1311	436	7	formation	formation	NOUN
dti-1311	436	8	in	in	ADP
dti-1311	436	9	cold	cold	ADJ
dti-1311	436	10	/	/	SYM
dti-1311	436	11	restraint	restraint	NOUN
dti-1311	436	12	stressed	stress	VERB
dti-1311	436	13	rats	rat	NOUN
dti-1311	436	14	:	:	PUNCT
dti-1311	436	15	effects	effect	NOUN
dti-1311	436	16	of	of	ADP
dti-1311	436	17	cinnarizine	cinnarizine	NOUN
dti-1311	436	18	and	and	CCONJ
dti-1311	436	19	fl	fl	PROPN
dti-1311	436	20	unarizine	unarizine	VERB
dti-1311	436	21	.	.	PUNCT
dti-1311	437	1	infl	infl	PROPN
dti-1311	437	2	ammation	ammation	PROPN
dti-1311	437	3	research	research	PROPN
dti-1311	437	4	,	,	PUNCT
dti-1311	437	5	38	38	NUM
dti-1311	437	6	:	:	PUNCT
dti-1311	437	7	c301	c301	PROPN
dti-1311	437	8	–	–	PUNCT
dti-1311	437	9	c303	c303	PROPN
dti-1311	437	10	.	.	PUNCT
dti-1311	438	1	miranda	miranda	PROPN
dti-1311	438	2	,	,	PUNCT
dti-1311	438	3	h.f	h.f	PROPN
dti-1311	438	4	.	.	PROPN
dti-1311	438	5	,	,	PUNCT
dti-1311	438	6	pelissier	pelissier	NOUN
dti-1311	438	7	,	,	PUNCT
dti-1311	438	8	t.	t.	NOUN
dti-1311	438	9	and	and	CCONJ
dti-1311	438	10	sierralta	sierralta	PROPN
dti-1311	438	11	,	,	PUNCT
dti-1311	438	12	f.	f.	PROPN
dti-1311	438	13	1993	1993	NUM
dti-1311	438	14	.	.	PUNCT
dti-1311	439	1	analgesic	analgesic	ADJ
dti-1311	439	2	effects	effect	NOUN
dti-1311	439	3	of	of	ADP
dti-1311	439	4	intracerebroventricular	intracerebroventricular	ADJ
dti-1311	439	5	administration	administration	NOUN
dti-1311	439	6	of	of	ADP
dti-1311	439	7	calcium	calcium	NOUN
dti-1311	439	8	channel	channel	NOUN
dti-1311	439	9	blockers	blocker	NOUN
dti-1311	439	10	in	in	ADP
dti-1311	439	11	mice	mouse	NOUN
dti-1311	439	12	.	.	PUNCT
dti-1311	440	1	gen	gen	PROPN
dti-1311	440	2	.	.	PROPN
dti-1311	440	3	pharmacol	pharmacol	PROPN
dti-1311	440	4	.	.	PROPN
dti-1311	440	5	,	,	PUNCT
dti-1311	440	6	24:201–204	24:201–204	NUM
dti-1311	440	7	.	.	PUNCT
dti-1311	440	8	mirzoian	mirzoian	PROPN
dti-1311	440	9	,	,	PUNCT
dti-1311	440	10	n.r	n.r	PROPN
dti-1311	440	11	.	.	PROPN
dti-1311	440	12	,	,	PUNCT
dti-1311	440	13	akopian	akopian	PROPN
dti-1311	440	14	,	,	PUNCT
dti-1311	440	15	v.p	v.p	PROPN
dti-1311	440	16	.	.	PROPN
dti-1311	440	17	,	,	PUNCT
dti-1311	440	18	kocharian	kocharian	PROPN
dti-1311	440	19	,	,	PUNCT
dti-1311	440	20	a.z	a.z	PROPN
dti-1311	440	21	.	.	PROPN
dti-1311	440	22	,	,	PUNCT
dti-1311	440	23	knarian	knarian	PROPN
dti-1311	440	24	,	,	PUNCT
dti-1311	440	25	v.a	v.a	PROPN
dti-1311	440	26	.	.	PROPN
dti-1311	440	27	,	,	PUNCT
dti-1311	440	28	arakelian	arakelian	PROPN
dti-1311	440	29	,	,	PUNCT
dti-1311	440	30	l.	l.	PROPN
dti-1311	440	31	and	and	CCONJ
dti-1311	440	32	gevorkian	gevorkian	PROPN
dti-1311	440	33	,	,	PUNCT
dti-1311	440	34	v.a	v.a	PROPN
dti-1311	440	35	.	.	PROPN
dti-1311	440	36	1998	1998	NUM
dti-1311	440	37	.	.	PUNCT
dti-1311	441	1	gaba	gaba	PROPN
dti-1311	441	2	reuptake	reuptake	NOUN
dti-1311	441	3	by	by	ADP
dti-1311	441	4	rat	rat	NOUN
dti-1311	441	5	brain	brain	NOUN
dti-1311	441	6	slices	slice	NOUN
dti-1311	441	7	in	in	ADP
dti-1311	441	8	hypokinesia	hypokinesia	NOUN
dti-1311	441	9	and	and	CCONJ
dti-1311	441	10	under	under	ADP
dti-1311	441	11	the	the	DET
dti-1311	441	12	infl	infl	PROPN
dti-1311	441	13	uence	uence	NOUN
dti-1311	441	14	of	of	ADP
dti-1311	441	15	cinnarizine	cinnarizine	NOUN
dti-1311	441	16	and	and	CCONJ
dti-1311	441	17	fl	fl	PROPN
dti-1311	441	18	unarizine	unarizine	VERB
dti-1311	441	19	.	.	PUNCT
dti-1311	442	1	eksp	eksp	PROPN
dti-1311	442	2	.	.	PUNCT
dti-1311	443	1	klin	klin	PROPN
dti-1311	443	2	.	.	PUNCT
dti-1311	444	1	farmakol	farmakol	PROPN
dti-1311	444	2	.	.	PUNCT
dti-1311	444	3	,	,	PUNCT
dti-1311	444	4	61:15–17	61:15–17	PROPN
dti-1311	444	5	.	.	PUNCT
dti-1311	445	1	mózsik	mózsik	PROPN
dti-1311	445	2	,	,	PUNCT
dti-1311	445	3	gy	gy	NOUN
dti-1311	445	4	.	.	PROPN
dti-1311	445	5	,	,	PUNCT
dti-1311	445	6	móron	móron	PROPN
dti-1311	445	7	,	,	PUNCT
dti-1311	445	8	f.	f.	PROPN
dti-1311	445	9	and	and	CCONJ
dti-1311	445	10	jávor	jávor	PROPN
dti-1311	445	11	,	,	PUNCT
dti-1311	445	12	t.	t.	PROPN
dti-1311	445	13	1982	1982	NUM
dti-1311	445	14	.	.	PUNCT
dti-1311	446	1	cellular	cellular	ADJ
dti-1311	446	2	mechanisms	mechanism	NOUN
dti-1311	446	3	of	of	ADP
dti-1311	446	4	the	the	DET
dti-1311	446	5	development	development	NOUN
dti-1311	446	6	of	of	ADP
dti-1311	446	7	gastric	gastric	ADJ
dti-1311	446	8	mucosal	mucosal	NOUN
dti-1311	446	9	damage	damage	NOUN
dti-1311	446	10	and	and	CCONJ
dti-1311	446	11	of	of	ADP
dti-1311	446	12	gastric	gastric	ADJ
dti-1311	446	13	cytoprotection	cytoprotection	NOUN
dti-1311	446	14	induced	induce	VERB
dti-1311	446	15	by	by	ADP
dti-1311	446	16	prostacyclin	prostacyclin	PROPN
dti-1311	446	17	in	in	ADP
dti-1311	446	18	rats	rat	NOUN
dti-1311	446	19	a	a	DET
dti-1311	446	20	pharmacological	pharmacological	ADJ
dti-1311	446	21	study	study	NOUN
dti-1311	446	22	.	.	PUNCT
dti-1311	447	1	prostaglandins	prostaglandin	NOUN
dti-1311	447	2	leukot	leukot	VERB
dti-1311	447	3	.	.	PUNCT
dti-1311	448	1	med	med	PROPN
dti-1311	448	2	.	.	PROPN
dti-1311	448	3	,	,	PUNCT
dti-1311	448	4	9:71–84	9:71–84	PROPN
dti-1311	448	5	.	.	PUNCT
dti-1311	449	1	nagai	nagai	PROPN
dti-1311	449	2	,	,	PUNCT
dti-1311	449	3	h.	h.	PROPN
dti-1311	449	4	,	,	PUNCT
dti-1311	449	5	yakuo	yakuo	PROPN
dti-1311	449	6	,	,	PUNCT
dti-1311	449	7	i.	i.	PROPN
dti-1311	449	8	,	,	PUNCT
dti-1311	449	9	yamada	yamada	PROPN
dti-1311	449	10	,	,	PUNCT
dti-1311	449	11	h.	h.	PROPN
dti-1311	449	12	,	,	PUNCT
dti-1311	449	13	inagaki	inagaki	PROPN
dti-1311	449	14	,	,	PUNCT
dti-1311	449	15	n.	n.	NOUN
dti-1311	449	16	,	,	PUNCT
dti-1311	449	17	goto	goto	NOUN
dti-1311	449	18	,	,	PUNCT
dti-1311	449	19	s.	s.	PROPN
dti-1311	449	20	and	and	CCONJ
dti-1311	449	21	koda	koda	PROPN
dti-1311	449	22	,	,	PUNCT
dti-1311	449	23	a.	a.	NOUN
dti-1311	449	24	1986	1986	NUM
dti-1311	449	25	.	.	PUNCT
dti-1311	450	1	effect	effect	NOUN
dti-1311	450	2	of	of	ADP
dti-1311	450	3	cinnarizine	cinnarizine	NOUN
dti-1311	450	4	on	on	ADP
dti-1311	450	5	ige	ige	PROPN
dti-1311	450	6	antibody	antibody	NOUN
dti-1311	450	7	mediated	mediate	VERB
dti-1311	450	8	allergic	allergic	ADJ
dti-1311	450	9	reaction	reaction	NOUN
dti-1311	450	10	in	in	ADP
dti-1311	450	11	mice	mouse	NOUN
dti-1311	450	12	and	and	CCONJ
dti-1311	450	13	rats	rat	NOUN
dti-1311	450	14	.	.	PUNCT
dti-1311	451	1	j.	j.	PROPN
dti-1311	451	2	pharmacobiodyn	pharmacobiodyn	PROPN
dti-1311	451	3	.	.	PUNCT
dti-1311	451	4	,	,	PUNCT
dti-1311	451	5	9:923–927	9:923–927	NUM
dti-1311	451	6	.	.	PUNCT
dti-1311	452	1	negrotti	negrotti	PROPN
dti-1311	452	2	,	,	PUNCT
dti-1311	452	3	a.	a.	NOUN
dti-1311	452	4	and	and	CCONJ
dti-1311	452	5	calzetti	calzetti	PROPN
dti-1311	452	6	,	,	PUNCT
dti-1311	452	7	s.	s.	PROPN
dti-1311	452	8	1997	1997	NUM
dti-1311	452	9	.	.	PUNCT
dti-1311	453	1	a	a	DET
dti-1311	453	2	long	long	ADJ
dti-1311	453	3	-	-	PUNCT
dti-1311	453	4	term	term	NOUN
dti-1311	453	5	follow	follow	NOUN
dti-1311	453	6	-	-	PUNCT
dti-1311	453	7	up	up	ADP
dti-1311	453	8	study	study	NOUN
dti-1311	453	9	of	of	ADP
dti-1311	453	10	cinnarizine	cinnarizine	NOUN
dti-1311	453	11	and	and	CCONJ
dti-1311	453	12	fl	fl	ADP
dti-1311	453	13	unarizine	unarizine	VERB
dti-1311	453	14	-	-	PUNCT
dti-1311	453	15	induced	induce	VERB
dti-1311	453	16	parkinsonism	parkinsonism	NOUN
dti-1311	453	17	.	.	PUNCT
dti-1311	454	1	mov	mov	NOUN
dti-1311	454	2	.	.	PUNCT
dti-1311	454	3	disord	disord	PROPN
dti-1311	454	4	.	.	PUNCT
dti-1311	454	5	,	,	PUNCT
dti-1311	454	6	12:107–110	12:107–110	PROPN
dti-1311	454	7	.	.	PUNCT
dti-1311	455	1	nguyen	nguyen	PROPN
dti-1311	455	2	,	,	PUNCT
dti-1311	455	3	t.	t.	PROPN
dti-1311	455	4	,	,	PUNCT
dti-1311	455	5	shapiro	shapiro	PROPN
dti-1311	455	6	,	,	PUNCT
dti-1311	455	7	d.a	d.a	PROPN
dti-1311	455	8	.	.	PROPN
dti-1311	455	9	,	,	PUNCT
dti-1311	455	10	george	george	PROPN
dti-1311	455	11	,	,	PUNCT
dti-1311	455	12	s.r	s.r	PROPN
dti-1311	455	13	.	.	PROPN
dti-1311	455	14	,	,	PUNCT
dti-1311	455	15	setola	setola	PROPN
dti-1311	455	16	,	,	PUNCT
dti-1311	455	17	v.	v.	PROPN
dti-1311	455	18	,	,	PUNCT
dti-1311	455	19	lee	lee	PROPN
dti-1311	455	20	,	,	PUNCT
dti-1311	455	21	d.k	d.k	PROPN
dti-1311	455	22	.	.	PROPN
dti-1311	455	23	,	,	PUNCT
dti-1311	455	24	cheng	cheng	PROPN
dti-1311	455	25	,	,	PUNCT
dti-1311	455	26	r.	r.	PROPN
dti-1311	455	27	,	,	PUNCT
dti-1311	455	28	rauser	rauser	PROPN
dti-1311	455	29	,	,	PUNCT
dti-1311	455	30	l.	l.	PROPN
dti-1311	455	31	,	,	PUNCT
dti-1311	455	32	lee	lee	PROPN
dti-1311	455	33	,	,	PUNCT
dti-1311	455	34	s.p	s.p	PROPN
dti-1311	455	35	.	.	PROPN
dti-1311	455	36	,	,	PUNCT
dti-1311	455	37	lynch	lynch	PROPN
dti-1311	455	38	,	,	PUNCT
dti-1311	455	39	k.r	k.r	PROPN
dti-1311	455	40	.	.	PROPN
dti-1311	455	41	,	,	PUNCT
dti-1311	455	42	roth	roth	PROPN
dti-1311	455	43	b.l	b.l	PROPN
dti-1311	455	44	.	.	PROPN
dti-1311	455	45	and	and	CCONJ
dti-1311	455	46	o’dowd	o’dowd	PROPN
dti-1311	455	47	,	,	PUNCT
dti-1311	455	48	b.f	b.f	PROPN
dti-1311	455	49	.	.	PROPN
dti-1311	455	50	2001	2001	NUM
dti-1311	455	51	.	.	PUNCT
dti-1311	456	1	discovery	discovery	NOUN
dti-1311	456	2	of	of	ADP
dti-1311	456	3	a	a	DET
dti-1311	456	4	novel	novel	ADJ
dti-1311	456	5	member	member	NOUN
dti-1311	456	6	of	of	ADP
dti-1311	456	7	the	the	DET
dti-1311	456	8	histamine	histamine	NOUN
dti-1311	456	9	receptor	receptor	NOUN
dti-1311	456	10	family	family	NOUN
dti-1311	456	11	.	.	PUNCT
dti-1311	457	1	mol	mol	PROPN
dti-1311	457	2	.	.	PUNCT
dti-1311	457	3	pharmacol	pharmacol	PROPN
dti-1311	457	4	.	.	PROPN
dti-1311	457	5	,	,	PUNCT
dti-1311	458	1	59:427−433	59:427−433	X
dti-1311	458	2	.	.	PUNCT
dti-1311	459	1	paget	paget	PROPN
dti-1311	459	2	,	,	PUNCT
dti-1311	459	3	g.e	g.e	PROPN
dti-1311	459	4	.	.	PROPN
dti-1311	459	5	and	and	CCONJ
dti-1311	459	6	barnes	barnes	PROPN
dti-1311	459	7	,	,	PUNCT
dti-1311	459	8	j.m	j.m	PROPN
dti-1311	459	9	.	.	NOUN
dti-1311	459	10	toxicity	toxicity	NOUN
dti-1311	459	11	tests	test	NOUN
dti-1311	459	12	.	.	PUNCT
dti-1311	460	1	1964	1964	NUM
dti-1311	460	2	.	.	PUNCT
dti-1311	461	1	in	in	ADP
dti-1311	461	2	evaluation	evaluation	NOUN
dti-1311	461	3	of	of	ADP
dti-1311	461	4	drug	drug	NOUN
dti-1311	461	5	activities	activity	NOUN
dti-1311	461	6	pharmacometics	pharmacometic	NOUN
dti-1311	461	7	.	.	PUNCT
dti-1311	462	1	eds	ed	NOUN
dti-1311	462	2	.	.	PUNCT
dti-1311	463	1	laurence	laurence	PROPN
dti-1311	463	2	dr	dr	PROPN
dti-1311	463	3	,	,	PUNCT
dti-1311	463	4	bacharach	bacharach	PROPN
dti-1311	463	5	al	al	PROPN
dti-1311	463	6	.	.	PROPN
dti-1311	463	7	london	london	PROPN
dti-1311	463	8	and	and	CCONJ
dti-1311	463	9	newyork	newyork	PROPN
dti-1311	463	10	:	:	PUNCT
dti-1311	463	11	academic	academic	ADJ
dti-1311	463	12	press	press	NOUN
dti-1311	463	13	,	,	PUNCT
dti-1311	463	14	pp	pp	ADJ
dti-1311	463	15	.	.	PUNCT
dti-1311	464	1	1–135	1–135	NUM
dti-1311	464	2	.	.	PUNCT
dti-1311	465	1	paalzow	paalzow	PROPN
dti-1311	465	2	,	,	PUNCT
dti-1311	465	3	g.h	g.h	PROPN
dti-1311	465	4	.	.	PROPN
dti-1311	465	5	1994	1994	NUM
dti-1311	465	6	.	.	PUNCT
dti-1311	466	1	noradrenaline	noradrenaline	NOUN
dti-1311	466	2	but	but	CCONJ
dti-1311	466	3	not	not	PART
dti-1311	466	4	dopamine	dopamine	NOUN
dti-1311	466	5	involved	involve	VERB
dti-1311	466	6	in	in	ADP
dti-1311	466	7	nmda	nmda	ADJ
dti-1311	466	8	receptor	receptor	NOUN
dti-1311	466	9	-	-	PUNCT
dti-1311	466	10	mediated	mediate	VERB
dti-1311	466	11	hyperalgesiainduced	hyperalgesiainduce	VERB
dti-1311	466	12	by	by	ADP
dti-1311	466	13	theophylline	theophylline	NOUN
dti-1311	466	14	in	in	ADP
dti-1311	466	15	awake	awake	ADJ
dti-1311	466	16	rats	rat	NOUN
dti-1311	466	17	.	.	PUNCT
dti-1311	467	1	eur	eur	PROPN
dti-1311	467	2	.	.	PUNCT
dti-1311	468	1	j.	j.	PROPN
dti-1311	468	2	pharmacol	pharmacol	PROPN
dti-1311	468	3	.	.	PROPN
dti-1311	468	4	,	,	PUNCT
dti-1311	468	5	252:87–97	252:87–97	X
dti-1311	468	6	.	.	PUNCT
dti-1311	468	7	porsolt	porsolt	PROPN
dti-1311	468	8	,	,	PUNCT
dti-1311	468	9	r.d	r.d	PROPN
dti-1311	468	10	.	.	PROPN
dti-1311	468	11	,	,	PUNCT
dti-1311	468	12	le	le	PROPN
dti-1311	468	13	pichon	pichon	PROPN
dti-1311	468	14	,	,	PUNCT
dti-1311	468	15	m.	m.	NOUN
dti-1311	468	16	and	and	CCONJ
dti-1311	468	17	jalfre	jalfre	NOUN
dti-1311	468	18	,	,	PUNCT
dti-1311	468	19	m.	m.	NOUN
dti-1311	468	20	1977	1977	NUM
dti-1311	468	21	.	.	PUNCT
dti-1311	469	1	depression	depression	NOUN
dti-1311	469	2	:	:	PUNCT
dti-1311	469	3	a	a	DET
dti-1311	469	4	new	new	ADJ
dti-1311	469	5	animal	animal	NOUN
dti-1311	469	6	model	model	NOUN
dti-1311	469	7	sensitive	sensitive	ADJ
dti-1311	469	8	to	to	ADP
dti-1311	469	9	antidepressant	antidepressant	ADJ
dti-1311	469	10	treatments	treatment	NOUN
dti-1311	469	11	.	.	PUNCT
dti-1311	470	1	nature	nature	NOUN
dti-1311	470	2	,	,	PUNCT
dti-1311	470	3	266:730–732	266:730–732	NUM
dti-1311	470	4	.	.	PUNCT
dti-1311	471	1	rego	rego	PROPN
dti-1311	471	2	,	,	PUNCT
dti-1311	471	3	e.m	e.m	PROPN
dti-1311	471	4	.	.	PROPN
dti-1311	471	5	,	,	PUNCT
dti-1311	471	6	corrado	corrado	PROPN
dti-1311	471	7	,	,	PUNCT
dti-1311	471	8	a.p	a.p	PROPN
dti-1311	471	9	.	.	PROPN
dti-1311	471	10	and	and	CCONJ
dti-1311	471	11	prado	prado	PROPN
dti-1311	471	12	,	,	PUNCT
dti-1311	471	13	w.a	w.a	PROPN
dti-1311	471	14	.	.	PROPN
dti-1311	471	15	1990	1990	NUM
dti-1311	471	16	.	.	PUNCT
dti-1311	472	1	antinociceptive	antinociceptive	ADJ
dti-1311	472	2	effects	effect	NOUN
dti-1311	472	3	of	of	ADP
dti-1311	472	4	calcium	calcium	NOUN
dti-1311	472	5	channel	channel	NOUN
dti-1311	472	6	blockers	blocker	NOUN
dti-1311	472	7	in	in	ADP
dti-1311	472	8	the	the	DET
dti-1311	472	9	rat	rat	PROPN
dti-1311	472	10	.	.	PROPN
dti-1311	472	11	braz	braz	PROPN
dti-1311	472	12	.	.	PUNCT
dti-1311	473	1	j.	j.	PROPN
dti-1311	473	2	med	med	PROPN
dti-1311	473	3	.	.	PUNCT
dti-1311	474	1	biol	biol	PROPN
dti-1311	474	2	.	.	PUNCT
dti-1311	475	1	res	re	NOUN
dti-1311	475	2	.	.	PROPN
dti-1311	475	3	,	,	PUNCT
dti-1311	476	1	23:297–305	23:297–305	NUM
dti-1311	476	2	.	.	PUNCT
dti-1311	477	1	reiriz	reiriz	NOUN
dti-1311	477	2	,	,	PUNCT
dti-1311	477	3	j.	j.	PROPN
dti-1311	477	4	,	,	PUNCT
dti-1311	477	5	ambrosio	ambrosio	PROPN
dti-1311	477	6	,	,	PUNCT
dti-1311	477	7	s.	s.	PROPN
dti-1311	477	8	,	,	PUNCT
dti-1311	477	9	cobos	cobos	PROPN
dti-1311	477	10	,	,	PUNCT
dti-1311	477	11	a.	a.	NOUN
dti-1311	477	12	,	,	PUNCT
dti-1311	477	13	ballarin	ballarin	NOUN
dti-1311	477	14	,	,	PUNCT
dti-1311	477	15	m.	m.	NOUN
dti-1311	477	16	,	,	PUNCT
dti-1311	477	17	tolosa	tolosa	NOUN
dti-1311	477	18	,	,	PUNCT
dti-1311	477	19	e.	e.	PROPN
dti-1311	477	20	and	and	CCONJ
dti-1311	477	21	mahy	mahy	PROPN
dti-1311	477	22	,	,	PUNCT
dti-1311	477	23	n.	n.	NOUN
dti-1311	477	24	1994	1994	NUM
dti-1311	477	25	.	.	PUNCT
dti-1311	478	1	dopaminergic	dopaminergic	ADJ
dti-1311	478	2	function	function	NOUN
dti-1311	478	3	in	in	ADP
dti-1311	478	4	rat	rat	NOUN
dti-1311	478	5	brain	brain	NOUN
dti-1311	478	6	after	after	ADP
dti-1311	478	7	oral	oral	ADJ
dti-1311	478	8	administration	administration	NOUN
dti-1311	478	9	of	of	ADP
dti-1311	478	10	calcium	calcium	NOUN
dti-1311	478	11	-	-	PUNCT
dti-1311	478	12	channel	channel	NOUN
dti-1311	478	13	blockers	blocker	NOUN
dti-1311	478	14	or	or	CCONJ
dti-1311	478	15	haloperidol	haloperidol	NOUN
dti-1311	478	16	.	.	PUNCT
dti-1311	479	1	a	a	DET
dti-1311	479	2	microdialysis	microdialysis	NOUN
dti-1311	479	3	study	study	NOUN
dti-1311	479	4	.	.	PUNCT
dti-1311	480	1	j.	j.	PROPN
dti-1311	480	2	neural	neural	PROPN
dti-1311	480	3	.	.	PUNCT
dti-1311	481	1	transm	transm	PROPN
dti-1311	481	2	.	.	PUNCT
dti-1311	482	1	gen	gen	PROPN
dti-1311	482	2	.	.	PROPN
dti-1311	482	3	sect	sect	PROPN
dti-1311	482	4	.	.	PUNCT
dti-1311	482	5	,	,	PUNCT
dti-1311	482	6	95:195–207	95:195–207	PROPN
dti-1311	482	7	.	.	PUNCT
dti-1311	483	1	remy	remy	PROPN
dti-1311	483	2	,	,	PUNCT
dti-1311	483	3	p.	p.	NOUN
dti-1311	483	4	,	,	PUNCT
dti-1311	483	5	doder	doder	NOUN
dti-1311	483	6	,	,	PUNCT
dti-1311	483	7	m.	m.	NOUN
dti-1311	483	8	,	,	PUNCT
dti-1311	483	9	lees	lee	NOUN
dti-1311	483	10	,	,	PUNCT
dti-1311	483	11	a.	a.	NOUN
dti-1311	483	12	,	,	PUNCT
dti-1311	483	13	turjanski	turjanski	NOUN
dti-1311	483	14	,	,	PUNCT
dti-1311	483	15	n.	n.	NOUN
dti-1311	483	16	and	and	CCONJ
dti-1311	483	17	brooks	brooks	PROPN
dti-1311	483	18	,	,	PUNCT
dti-1311	483	19	d.	d.	PROPN
dti-1311	483	20	2005	2005	NUM
dti-1311	483	21	.	.	PUNCT
dti-1311	484	1	depression	depression	NOUN
dti-1311	484	2	in	in	ADP
dti-1311	484	3	parkinson	parkinson	NOUN
dti-1311	484	4	’s	’s	PART
dti-1311	484	5	disease	disease	NOUN
dti-1311	484	6	:	:	PUNCT
dti-1311	484	7	loss	loss	NOUN
dti-1311	484	8	of	of	ADP
dti-1311	484	9	dopamine	dopamine	NOUN
dti-1311	484	10	and	and	CCONJ
dti-1311	484	11	noradrenaline	noradrenaline	ADJ
dti-1311	484	12	innervation	innervation	NOUN
dti-1311	484	13	in	in	ADP
dti-1311	484	14	the	the	DET
dti-1311	484	15	limbic	limbic	ADJ
dti-1311	484	16	system	system	NOUN
dti-1311	484	17	.	.	PUNCT
dti-1311	485	1	brain	brain	NOUN
dti-1311	485	2	,	,	PUNCT
dti-1311	485	3	128:1314–1322	128:1314–1322	PROPN
dti-1311	485	4	.	.	PUNCT
dti-1311	485	5	rodrigues	rodrigues	PROPN
dti-1311	485	6	,	,	PUNCT
dti-1311	485	7	a.r.a	a.r.a	PROPN
dti-1311	485	8	.	.	PROPN
dti-1311	485	9	,	,	PUNCT
dti-1311	485	10	castro	castro	PROPN
dti-1311	485	11	,	,	PUNCT
dti-1311	485	12	m.s.a	m.s.a	NOUN
dti-1311	485	13	.	.	PROPN
dti-1311	485	14	,	,	PUNCT
dti-1311	485	15	francischi	francischi	PROPN
dti-1311	485	16	,	,	PUNCT
dti-1311	485	17	j.n	j.n	PROPN
dti-1311	485	18	.	.	PROPN
dti-1311	485	19	,	,	PUNCT
dti-1311	485	20	perez	perez	PROPN
dti-1311	485	21	,	,	PUNCT
dti-1311	485	22	a.c	a.c	PROPN
dti-1311	485	23	.	.	PROPN
dti-1311	485	24	and	and	CCONJ
dti-1311	485	25	duarte	duarte	PROPN
dti-1311	485	26	,	,	PUNCT
dti-1311	485	27	i.d.g	i.d.g	ADJ
dti-1311	485	28	.	.	PUNCT
dti-1311	485	29	2004	2004	NUM
dti-1311	485	30	.	.	PUNCT
dti-1311	486	1	participation	participation	NOUN
dti-1311	486	2	of	of	ADP
dti-1311	486	3	atp	atp	PROPN
dti-1311	486	4	-	-	PUNCT
dti-1311	486	5	sensitive	sensitive	ADJ
dti-1311	486	6	k+	k+	NOUN
dti-1311	486	7	channels	channel	NOUN
dti-1311	486	8	in	in	ADP
dti-1311	486	9	the	the	DET
dti-1311	486	10	peripheral	peripheral	ADJ
dti-1311	486	11	antinociceptive	antinociceptive	ADJ
dti-1311	486	12	effect	effect	NOUN
dti-1311	486	13	of	of	ADP
dti-1311	486	14	fentanyl	fentanyl	NOUN
dti-1311	486	15	in	in	ADP
dti-1311	486	16	rats	rat	NOUN
dti-1311	486	17	.	.	PUNCT
dti-1311	487	1	braz	braz	PROPN
dti-1311	487	2	.	.	PUNCT
dti-1311	488	1	j.	j.	PROPN
dti-1311	488	2	med	med	PROPN
dti-1311	488	3	.	.	PUNCT
dti-1311	489	1	biol	biol	PROPN
dti-1311	489	2	.	.	PUNCT
dti-1311	490	1	res	re	NOUN
dti-1311	490	2	.	.	PROPN
dti-1311	490	3	,	,	PUNCT
dti-1311	490	4	38:91–97	38:91–97	NUM
dti-1311	490	5	.	.	PUNCT
dti-1311	491	1	rooney	rooney	PROPN
dti-1311	491	2	,	,	PUNCT
dti-1311	491	3	k.f	k.f	PROPN
dti-1311	491	4	.	.	PROPN
dti-1311	491	5	and	and	CCONJ
dti-1311	491	6	sewell	sewell	PROPN
dti-1311	491	7	,	,	PUNCT
dti-1311	491	8	r.d	r.d	PROPN
dti-1311	491	9	.	.	PROPN
dti-1311	491	10	1989	1989	NUM
dti-1311	491	11	.	.	PUNCT
dti-1311	492	1	evaluation	evaluation	NOUN
dti-1311	492	2	of	of	ADP
dti-1311	492	3	selective	selective	ADJ
dti-1311	492	4	actions	action	NOUN
dti-1311	492	5	of	of	ADP
dti-1311	492	6	dopamine	dopamine	NOUN
dti-1311	492	7	d-1	d-1	NOUN
dti-1311	492	8	and	and	CCONJ
dti-1311	492	9	d-2	d-2	NOUN
dti-1311	492	10	receptor	receptor	NOUN
dti-1311	492	11	agonists	agonist	NOUN
dti-1311	492	12	and	and	CCONJ
dti-1311	492	13	antagonists	antagonist	NOUN
dti-1311	492	14	on	on	ADP
dti-1311	492	15	opioid	opioid	ADJ
dti-1311	492	16	antinociception	antinociception	NOUN
dti-1311	492	17	.	.	PUNCT
dti-1311	493	1	eur	eur	PROPN
dti-1311	493	2	.	.	PUNCT
dti-1311	494	1	j.	j.	PROPN
dti-1311	494	2	pharmacol	pharmacol	PROPN
dti-1311	494	3	.	.	PROPN
dti-1311	494	4	,	,	PUNCT
dti-1311	494	5	168:329–336	168:329–336	NUM
dti-1311	494	6	.	.	PUNCT
dti-1311	495	1	santos	santos	PROPN
dti-1311	495	2	,	,	PUNCT
dti-1311	495	3	a.r	a.r	PROPN
dti-1311	495	4	.	.	PROPN
dti-1311	495	5	,	,	PUNCT
dti-1311	495	6	vedana	vedana	PROPN
dti-1311	495	7	,	,	PUNCT
dti-1311	495	8	e.m	e.m	PROPN
dti-1311	495	9	.	.	PROPN
dti-1311	495	10	and	and	CCONJ
dti-1311	495	11	de	de	NOUN
dti-1311	495	12	-	-	NOUN
dti-1311	495	13	freitas	freitas	NOUN
dti-1311	495	14	,	,	PUNCT
dti-1311	495	15	g.a	g.a	PROPN
dti-1311	495	16	.	.	PROPN
dti-1311	495	17	1998	1998	NUM
dti-1311	495	18	.	.	PUNCT
dti-1311	496	1	antinociceptive	antinociceptive	ADJ
dti-1311	496	2	effect	effect	NOUN
dti-1311	496	3	of	of	ADP
dti-1311	496	4	meloxicam	meloxicam	NOUN
dti-1311	496	5	,	,	PUNCT
dti-1311	496	6	in	in	ADP
dti-1311	496	7	neurogenic	neurogenic	ADJ
dti-1311	496	8	and	and	CCONJ
dti-1311	496	9	infl	infl	PROPN
dti-1311	496	10	ammatory	ammatory	NOUN
dti-1311	496	11	nociceptive	nociceptive	ADJ
dti-1311	496	12	models	model	NOUN
dti-1311	496	13	in	in	ADP
dti-1311	496	14	mice	mouse	NOUN
dti-1311	496	15	.	.	PUNCT
dti-1311	497	1	infl	infl	PROPN
dti-1311	497	2	amm	amm	PROPN
dti-1311	497	3	.	.	PROPN
dti-1311	497	4	,	,	PUNCT
dti-1311	497	5	res	res	PROPN
dti-1311	497	6	.	.	PROPN
dti-1311	497	7	,	,	PUNCT
dti-1311	497	8	47:302–307	47:302–307	PROPN
dti-1311	497	9	.	.	PUNCT
dti-1311	498	1	sawynok	sawynok	PROPN
dti-1311	498	2	,	,	PUNCT
dti-1311	498	3	j.	j.	PROPN
dti-1311	498	4	1998	1998	NUM
dti-1311	498	5	.	.	PUNCT
dti-1311	499	1	adenosine	adenosine	ADJ
dti-1311	499	2	receptor	receptor	NOUN
dti-1311	499	3	activation	activation	NOUN
dti-1311	499	4	and	and	CCONJ
dti-1311	499	5	nociception	nociception	NOUN
dti-1311	499	6	.	.	PUNCT
dti-1311	500	1	eur	eur	PROPN
dti-1311	500	2	.	.	PUNCT
dti-1311	501	1	j.	j.	PROPN
dti-1311	501	2	pharmacol	pharmacol	PROPN
dti-1311	501	3	.	.	PROPN
dti-1311	501	4	,	,	PUNCT
dti-1311	501	5	347:1–11	347:1–11	X
dti-1311	501	6	.	.	PUNCT
dti-1311	501	7	singh	singh	PROPN
dti-1311	501	8	,	,	PUNCT
dti-1311	501	9	v.p	v.p	PROPN
dti-1311	501	10	.	.	PROPN
dti-1311	501	11	,	,	PUNCT
dti-1311	501	12	jain	jain	PROPN
dti-1311	501	13	,	,	PUNCT
dti-1311	501	14	n.k	n.k	PROPN
dti-1311	501	15	.	.	PROPN
dti-1311	501	16	and	and	CCONJ
dti-1311	501	17	kulkarni	kulkarni	PROPN
dti-1311	501	18	,	,	PUNCT
dti-1311	501	19	s.k	s.k	PROPN
dti-1311	501	20	.	.	PROPN
dti-1311	501	21	2001	2001	NUM
dti-1311	501	22	.	.	PUNCT
dti-1311	502	1	on	on	ADP
dti-1311	502	2	the	the	DET
dti-1311	502	3	antinociceptive	antinociceptive	ADJ
dti-1311	502	4	effect	effect	NOUN
dti-1311	502	5	of	of	ADP
dti-1311	502	6	fl	fl	NOUN
dti-1311	502	7	uoxetine	uoxetine	ADJ
dti-1311	502	8	,	,	PUNCT
dti-1311	502	9	a	a	DET
dti-1311	502	10	selective	selective	ADJ
dti-1311	502	11	serotonin	serotonin	NOUN
dti-1311	502	12	reuptake	reuptake	NOUN
dti-1311	502	13	inhibitor	inhibitor	NOUN
dti-1311	502	14	.	.	PUNCT
dti-1311	503	1	brain	brain	NOUN
dti-1311	503	2	.	.	PUNCT
dti-1311	504	1	res	re	NOUN
dti-1311	504	2	.	.	PROPN
dti-1311	504	3	,	,	PUNCT
dti-1311	504	4	915:218–226	915:218–226	NUM
dti-1311	504	5	.	.	PUNCT
dti-1311	505	1	sushma	sushma	PROPN
dti-1311	505	2	,	,	PUNCT
dti-1311	505	3	m.	m.	NOUN
dti-1311	505	4	,	,	PUNCT
dti-1311	505	5	sudha	sudha	PROPN
dti-1311	505	6	,	,	PUNCT
dti-1311	505	7	s.	s.	PROPN
dti-1311	505	8	and	and	CCONJ
dti-1311	505	9	guido	guido	PROPN
dti-1311	505	10	,	,	PUNCT
dti-1311	505	11	s.	s.	PROPN
dti-1311	505	12	2004	2004	NUM
dti-1311	505	13	.	.	PUNCT
dti-1311	506	1	effect	effect	NOUN
dti-1311	506	2	of	of	ADP
dti-1311	506	3	calcium	calcium	NOUN
dti-1311	506	4	channel	channel	NOUN
dti-1311	506	5	blockers	blocker	NOUN
dti-1311	506	6	on	on	ADP
dti-1311	506	7	antidepressant	antidepressant	ADJ
dti-1311	506	8	activity	activity	NOUN
dti-1311	506	9	following	follow	VERB
dti-1311	506	10	electroconvulsive	electroconvulsive	ADJ
dti-1311	506	11	shock	shock	NOUN
dti-1311	506	12	in	in	ADP
dti-1311	506	13	mice	mouse	NOUN
dti-1311	506	14	.	.	PUNCT
dti-1311	507	1	indian	indian	PROPN
dti-1311	507	2	j.	j.	PROPN
dti-1311	507	3	pharmacol	pharmacol	PROPN
dti-1311	507	4	.	.	PROPN
dti-1311	507	5	,	,	PUNCT
dti-1311	507	6	36:317–319	36:317–319	PROPN
dti-1311	507	7	teive	teive	NOUN
dti-1311	507	8	,	,	PUNCT
dti-1311	507	9	h.a	h.a	PROPN
dti-1311	507	10	.	.	PROPN
dti-1311	507	11	,	,	PUNCT
dti-1311	507	12	troiano	troiano	PROPN
dti-1311	507	13	,	,	PUNCT
dti-1311	507	14	a.r	a.r	PROPN
dti-1311	507	15	.	.	PROPN
dti-1311	507	16	,	,	PUNCT
dti-1311	507	17	germiniani	germiniani	PROPN
dti-1311	507	18	,	,	PUNCT
dti-1311	507	19	f.m	f.m	PROPN
dti-1311	507	20	.	.	PROPN
dti-1311	507	21	and	and	CCONJ
dti-1311	507	22	werneck	werneck	PROPN
dti-1311	507	23	,	,	PUNCT
dti-1311	507	24	l.c	l.c	PROPN
dti-1311	507	25	.	.	PROPN
dti-1311	507	26	2004	2004	NUM
dti-1311	507	27	.	.	PUNCT
dti-1311	508	1	flunarizine	flunarizine	PROPN
dti-1311	508	2	and	and	CCONJ
dti-1311	508	3	cinnarizine	cinnarizine	NOUN
dti-1311	508	4	-	-	PUNCT
dti-1311	508	5	induced	induce	VERB
dti-1311	508	6	parkinsonism	parkinsonism	NOUN
dti-1311	508	7	:	:	PUNCT
dti-1311	508	8	a	a	DET
dti-1311	508	9	historical	historical	ADJ
dti-1311	508	10	and	and	CCONJ
dti-1311	508	11	clinical	clinical	ADJ
dti-1311	508	12	analysis	analysis	NOUN
dti-1311	508	13	.	.	PUNCT
dti-1311	509	1	parkinsonism	parkinsonism	PROPN
dti-1311	509	2	relat	relat	PROPN
dti-1311	509	3	.	.	PUNCT
dti-1311	510	1	disord	disord	PROPN
dti-1311	510	2	.	.	PUNCT
dti-1311	510	3	,	,	PUNCT
dti-1311	511	1	10:243–245	10:243–245	NUM
dti-1311	511	2	.	.	PUNCT
dti-1311	512	1	terland	terland	NOUN
dti-1311	512	2	,	,	PUNCT
dti-1311	512	3	o.	o.	NOUN
dti-1311	512	4	and	and	CCONJ
dti-1311	512	5	flatmark	flatmark	ADJ
dti-1311	512	6	,	,	PUNCT
dti-1311	512	7	t.	t.	PROPN
dti-1311	512	8	1999	1999	NUM
dti-1311	512	9	.	.	PUNCT
dti-1311	513	1	drug	drug	NOUN
dti-1311	513	2	-	-	PUNCT
dti-1311	513	3	induced	induce	VERB
dti-1311	513	4	parkinsonism	parkinsonism	NOUN
dti-1311	513	5	:	:	PUNCT
dti-1311	514	1	cinnarizine	cinnarizine	NOUN
dti-1311	514	2	and	and	CCONJ
dti-1311	514	3	fl	fl	PROPN
dti-1311	514	4	unarizine	unarizine	ADJ
dti-1311	514	5	are	be	AUX
dti-1311	514	6	potent	potent	ADJ
dti-1311	514	7	uncouplers	uncoupler	NOUN
dti-1311	514	8	of	of	ADP
dti-1311	514	9	the	the	DET
dti-1311	514	10	vacuolar	vacuolar	ADJ
dti-1311	514	11	h+-atpase	h+-atpase	PROPN
dti-1311	514	12	in	in	ADP
dti-1311	514	13	catecholamine	catecholamine	NOUN
dti-1311	514	14	storage	storage	NOUN
dti-1311	514	15	vesicles	vesicle	NOUN
dti-1311	514	16	.	.	PUNCT
dti-1311	515	1	neuropharmacology	neuropharmacology	NOUN
dti-1311	515	2	,	,	PUNCT
dti-1311	515	3	38:879–882	38:879–882	PROPN
dti-1311	515	4	.	.	PUNCT
dti-1311	516	1	willner	willner	NOUN
dti-1311	516	2	,	,	PUNCT
dti-1311	516	3	p.	p.	NOUN
dti-1311	516	4	1995	1995	NUM
dti-1311	516	5	.	.	PUNCT
dti-1311	517	1	dopaminergic	dopaminergic	ADJ
dti-1311	517	2	mechanisms	mechanism	NOUN
dti-1311	517	3	in	in	ADP
dti-1311	517	4	depression	depression	NOUN
dti-1311	517	5	and	and	CCONJ
dti-1311	517	6	mania	mania	NOUN
dti-1311	517	7	,	,	PUNCT
dti-1311	517	8	in	in	ADP
dti-1311	517	9	psychopharmacology	psychopharmacology	NOUN
dti-1311	517	10	:	:	PUNCT
dti-1311	517	11	the	the	DET
dti-1311	517	12	fourth	fourth	ADJ
dti-1311	517	13	generation	generation	NOUN
dti-1311	517	14	of	of	ADP
dti-1311	517	15	progress	progress	NOUN
dti-1311	517	16	.	.	PUNCT
dti-1311	518	1	edited	edit	VERB
dti-1311	518	2	by	by	ADP
dti-1311	518	3	bloom	bloom	NOUN
dti-1311	518	4	,	,	PUNCT
dti-1311	518	5	f.e	f.e	PROPN
dti-1311	518	6	.	.	PROPN
dti-1311	518	7	and	and	CCONJ
dti-1311	518	8	kupfer	kupfer	PROPN
dti-1311	518	9	,	,	PUNCT
dti-1311	518	10	d.j	d.j	PROPN
dti-1311	518	11	.	.	PROPN
dti-1311	518	12	new	new	PROPN
dti-1311	518	13	york	york	PROPN
dti-1311	518	14	,	,	PUNCT
dti-1311	518	15	raven	raven	PROPN
dti-1311	518	16	press	press	PROPN
dti-1311	518	17	,	,	PUNCT
dti-1311	518	18	pp	pp	ADP
dti-1311	518	19	.	.	PUNCT
dti-1311	519	1	921–931	921–931	NUM
dti-1311	519	2	.	.	PUNCT
dti-1311	519	3	winter	winter	NOUN
dti-1311	519	4	,	,	PUNCT
dti-1311	519	5	c.a	c.a	PROPN
dti-1311	519	6	.	.	PROPN
dti-1311	519	7	,	,	PUNCT
dti-1311	519	8	risley	risley	PROPN
dti-1311	519	9	,	,	PUNCT
dti-1311	519	10	e.a	e.a	PROPN
dti-1311	519	11	.	.	PROPN
dti-1311	519	12	and	and	CCONJ
dti-1311	519	13	nuss	nuss	PROPN
dti-1311	519	14	,	,	PUNCT
dti-1311	519	15	g.w	g.w	PROPN
dti-1311	519	16	.	.	PROPN
dti-1311	519	17	1962	1962	NUM
dti-1311	519	18	.	.	PUNCT
dti-1311	520	1	carrageenan	carrageenan	NOUN
dti-1311	520	2	-	-	PUNCT
dti-1311	520	3	induced	induce	VERB
dti-1311	520	4	edema	edema	NOUN
dti-1311	520	5	in	in	ADP
dti-1311	520	6	hind	hind	NOUN
dti-1311	520	7	paw	paw	NOUN
dti-1311	520	8	of	of	ADP
dti-1311	520	9	the	the	DET
dti-1311	520	10	rat	rat	NOUN
dti-1311	520	11	as	as	ADP
dti-1311	520	12	an	an	DET
dti-1311	520	13	assay	assay	NOUN
dti-1311	520	14	for	for	ADP
dti-1311	520	15	antiinfl	antiinfl	NOUN
dti-1311	520	16	ammatory	ammatory	NOUN
dti-1311	520	17	drugs	drug	NOUN
dti-1311	520	18	.	.	PUNCT
dti-1311	521	1	proc	proc	NOUN
dti-1311	521	2	.	.	PUNCT
dti-1311	522	1	soc	soc	PROPN
dti-1311	522	2	.	.	PUNCT
dti-1311	523	1	exp	exp	NOUN
dti-1311	523	2	.	.	PUNCT
dti-1311	524	1	biol	biol	PROPN
dti-1311	524	2	.	.	PUNCT
dti-1311	525	1	med	med	PROPN
dti-1311	525	2	.	.	PROPN
dti-1311	525	3	,	,	PUNCT
dti-1311	526	1	111:544–52	111:544–52	NUM
dti-1311	526	2	.	.	PUNCT
dti-1311	527	1	wu	wu	PROPN
dti-1311	527	2	,	,	PUNCT
dti-1311	527	3	w.p	w.p	PROPN
dti-1311	527	4	.	.	PROPN
dti-1311	527	5	,	,	PUNCT
dti-1311	527	6	hao	hao	PROPN
dti-1311	527	7	,	,	PUNCT
dti-1311	527	8	j.x	j.x	PROPN
dti-1311	527	9	.	.	PROPN
dti-1311	527	10	,	,	PUNCT
dti-1311	527	11	halldner	halldner	PROPN
dti-1311	527	12	,	,	PUNCT
dti-1311	527	13	l.	l.	PROPN
dti-1311	527	14	,	,	PUNCT
dti-1311	527	15	lovdahl	lovdahl	PROPN
dti-1311	527	16	,	,	PUNCT
dti-1311	527	17	c.	c.	NOUN
dti-1311	527	18	,	,	PUNCT
dti-1311	527	19	delander	delander	NOUN
dti-1311	527	20	,	,	PUNCT
dti-1311	527	21	g.e	g.e	PROPN
dti-1311	527	22	.	.	PROPN
dti-1311	527	23	,	,	PUNCT
dti-1311	527	24	wiesenfeldhallin	wiesenfeldhallin	PROPN
dti-1311	527	25	,	,	PUNCT
dti-1311	527	26	z.	z.	PROPN
dti-1311	527	27	,	,	PUNCT
dti-1311	527	28	fredholm	fredholm	PROPN
dti-1311	527	29	,	,	PUNCT
dti-1311	527	30	b.b	b.b	PROPN
dti-1311	527	31	.	.	PROPN
dti-1311	527	32	and	and	CCONJ
dti-1311	527	33	xu	xu	PROPN
dti-1311	527	34	,	,	PUNCT
dti-1311	527	35	x.j	x.j	PROPN
dti-1311	527	36	.	.	PROPN
dti-1311	527	37	2005	2005	NUM
dti-1311	527	38	.	.	PUNCT
dti-1311	528	1	increased	increase	VERB
dti-1311	528	2	nociceptive	nociceptive	ADJ
dti-1311	528	3	response	response	NOUN
dti-1311	528	4	in	in	ADP
dti-1311	528	5	mice	mouse	NOUN
dti-1311	528	6	lacking	lack	VERB
dti-1311	528	7	the	the	DET
dti-1311	528	8	adenosine	adenosine	ADJ
dti-1311	528	9	a1	a1	NOUN
dti-1311	528	10	receptor	receptor	NOUN
dti-1311	528	11	.	.	PUNCT
dti-1311	529	1	pain	pain	NOUN
dti-1311	529	2	,	,	PUNCT
dti-1311	529	3	113:395	113:395	PROPN
dti-1311	529	4	–	–	PUNCT
dti-1311	529	5	404	404	NUM
dti-1311	529	6	.	.	PUNCT
dti-1311	530	1	yamadaa	yamadaa	NOUN
dti-1311	530	2	,	,	PUNCT
dti-1311	530	3	j.	j.	PROPN
dti-1311	530	4	,	,	PUNCT
dti-1311	530	5	sugimotoa	sugimotoa	PROPN
dti-1311	530	6	,	,	PUNCT
dti-1311	530	7	y.	y.	PROPN
dti-1311	530	8	and	and	CCONJ
dti-1311	530	9	yamadab	yamadab	PROPN
dti-1311	530	10	s.	s.	PROPN
dti-1311	530	11	2004	2004	NUM
dti-1311	530	12	.	.	PUNCT
dti-1311	531	1	involvement	involvement	NOUN
dti-1311	531	2	of	of	ADP
dti-1311	531	3	dopamine	dopamine	NOUN
dti-1311	531	4	receptors	receptor	NOUN
dti-1311	531	5	in	in	ADP
dti-1311	531	6	the	the	DET
dti-1311	531	7	anti	anti	ADJ
dti-1311	531	8	-	-	ADJ
dti-1311	531	9	immobility	immobility	ADJ
dti-1311	531	10	effects	effect	NOUN
dti-1311	531	11	of	of	ADP
dti-1311	531	12	dopamine	dopamine	NOUN
dti-1311	531	13	re	re	NOUN
dti-1311	531	14	-	-	NOUN
dti-1311	531	15	uptake	uptake	ADJ
dti-1311	531	16	inhibitors	inhibitor	NOUN
dti-1311	531	17	in	in	ADP
dti-1311	531	18	the	the	DET
dti-1311	531	19	forced	force	VERB
dti-1311	531	20	swimming	swimming	NOUN
dti-1311	531	21	test	test	NOUN
dti-1311	531	22	.	.	PUNCT
dti-1311	532	1	eur	eur	PROPN
dti-1311	532	2	.	.	PUNCT
dti-1311	533	1	j.	j.	PROPN
dti-1311	533	2	pharmacol	pharmacol	PROPN
dti-1311	533	3	.	.	PROPN
dti-1311	533	4	,	,	PUNCT
dti-1311	533	5	504:207–211	504:207–211	NUM
dti-1311	533	6	.	.	PUNCT